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Flap	  endonuclease-­‐1	  (FEN-­‐1)	  is	  a	  divalent	  metal-­‐ion	  dependent	  phosphodiesterase	  that	  has	  es-­‐
sential	   roles	   during	   DNA	   metabolism	   in	   all	   organisms.	   FEN-­‐1	   hydrolyses	   selective	   substrate	  
structures	   that	   contain	  duplex-­‐duplex	   junctions	  endonucleolytically	   at	   single-­‐strand	  DNA	   (ssD-­‐
NA)	  and	  double-­‐strand	  DNA	  (dsDNA)	  junctions	  (fen	  activity)	  as	  well	  as	  exonucleolytically	  on	  sub-­‐
strates	   lacking	   5'-­‐ssflaps	   (exo	   activity).	   ssDNA	   flaps	  may	   also	   contain	   secondary	   structure	   and	  
the	  reaction	  of	  these	  substrates	  is	  referred	  as	  gap	  endonuclease	  activity	  (gen	  activity).	  In	  all	  cas-­‐
es,	  FEN-­‐1	  hydrolyses	  optimal	  substrates	  that	  have	  a	  single	  nucleotide	  3'-­‐flap	  making	  a	  single	  in-­‐
cision	  one	  nucleotide	   into	   the	   substrate	   5'-­‐duplex.	  Association	  of	   optimal	   substrates	  with	   the	  
enzyme	  and	  their	  correct	  positioning	  for	  reaction	  requires	  both	  global	  and	  local	  conformational	  
changes	  of	  DNA	  substrates.	  Substrates	  are	  bent	  at	  the	  duplex-­‐duplex	  junction	  and	  the	  terminus	  
of	  the	  5'-­‐duplex	  must	  untwist	  into	  the	  active	  site.	  
Previously,	  FEN-­‐1	  active	  site	  mutations	   linked	  with	  cancers	  have	  been	  shown	  to	  affect	  FEN-­‐1’s	  
activity	  in	  vitro.	  However,	  reports	  of	  the	  effects	  of	  these	  mutations	  differ	  from	  one	  study	  to	  an-­‐
other.	   It	  was	   suggested	   that	   E160D	   and	   A159V	  mouse	   FEN-­‐1	   (mFEN-­‐1)	  mutations	   cause	   lung	  
cancer	   in	  mice	  by	  decreasing	  exo	  and	  gen	  activities	  of	  FEN-­‐1	  but	  not	   fen	  activity,	  but	  this	  was	  
contradicted	  by	  a	  later	  study.	  To	  address	  this	  discrepancy	  the	  properties	  of	  mFEN-­‐1	  and	  its	  mu-­‐
tations	  were	  studied.	   In	  chapter	  3	   it	   is	  shown	  that	  FEN-­‐1	  has	  the	  ability	   to	  recognise	  different	  
substrates	  using	  same	  active	  site	  and	  chemistry	  with	  a	  slight	  preference	  for	  the	  double	  flap	  sub-­‐
strates.	  The	  ability	  of	  the	  enzyme	  to	  bind	  substrates	  in	  a	  bent	  conformation	  was	  assayed	  using	  
FRET,	  with	  dyes	  located	  on	  each	  duplex	  arm.	  This	  demonstrated	  that	  active	  site	  metal	  ions	  and	  
presumably	  the	  processes	  that	  require	  them	  are	  not	  required	  to	  bind	  substrate	   in	  a	  bent	  con-­‐
formation.	  The	  divalent	  metal	  ion	  dependent	  local	  untwisting	  of	  the	  DNA	  necessary	  to	  place	  the	  
substrate	  within	  the	  active	  site	  was	   interrogated	  using	  exciton	  coupled	  CD	  of	  tandem	  2-­‐amino	  
purines	   located	  at	   the	   junction	   terminus	  of	   the	  5'-­‐duplex.	  Although	   the	  absence	  of	   the	  5'-­‐flap	  
led	  to	  modest	  reductions	  in	  the	  rate	  of	  reaction,	  the	  enzyme’s	  ability	  to	  bend	  and	  twist	  the	  sub-­‐
strate	  were	  not	  dramatically	  affected	  unless	  a	  5'-­‐phosphate	  monoester	  was	  absent	  from	  the	  exo	  
substrate.	  The	  active	  site	  mutations	  E160D	  and	  A159V	  decreased	  the	  catalytic	  efficiency	  of	  the	  
enzyme	   on	   all	   substrates	   to	   a	   comparable	   extent.	   Furthermore,	   investigations	   of	   individual	  
sterps	  of	  the	  reaction	  where	  undertaken	  and	  suggested	  that	  these	  rate	  decreases	  may	  be	  partly	  





Studying	  the	  structure-­‐function	  relationships	  of	  human	  FEN-­‐1	  (hFEN-­‐1)	  particularly	   focused	  on	  
the	  ability	  of	  the	  enzyme	  to	  bring	  about	  global	  and	  local	  substrate	  structural	  changes	  necessary	  
for	   catalysis	   (chapter	   4).	   In	   agreement	   with	   the	   mFEN-­‐1	   results,	   the	   presence	   of	   the	   5'-­‐
phosphate	  monoester	   of	   the	   exo	   substrate	  was	   required	   for	   perfect	   conformational	   changes	  
and	   substrate	   bending.	   In	   addition,	   the	   absence	   of	   the	   3'-­‐flap	   destabilised	   enzyme-­‐substrate	  
complexes.	   In	  contrast,	  mutations	  of	  the	  enzyme	  generally	  altered	  the	  capacity	  to	  bring	  about	  
local	  conformational	  changes	  required	  for	  catalysis	  rather	  than	  altering	  substrate	  bending.	  The	  
active	  site	  mutations	  D181A	  and	  the	  helical	  arch	  mutations	  Y40A,	  K93A,	  R100A,	  helix	  breaking	  
L130P,	   and	   K93AR100A	   all	   prevented	   an	   ideal	   local	   DNA	   conformational	   change,	   leading	   to	   a	  
deficit	  in	  catalysis.	  However,	  mutation	  of	  helical	  arch	  residue	  Lys	  93	  did	  not	  alter	  bending	  or	  ac-­‐
tive	  site	  positioning	  implying	  a	  solely	  catalytic	  role	  for	  this	  residue.	  In	  contrast,	  repulsive	  helical	  
arch	  mutations	  R104EK132E	  and	  Quad	  E	  did	  alter	  substrate	  binding	  abilities,	  as	  did	  the	  3'-­‐flap	  
pocket	  mutation	  L53A.	  Taken	  together,	  the	  results	   imply	  that	  while	  the	  requirements	  for	  bent	  
DNA-­‐protein	   complex	   formation	   are	   relatively	  modest	   (a	   3'-­‐flap	   and	   its	   binding	   site	   and	   a	   5'-­‐
phosphate)	  most	  protein	  mutations	  are	   tolerated.	  However,	  moving	  DNA	   to	   the	  active	   site	   to	  
allow	  reaction	  requires	  divalent	  metal	  ions,	  the	  intact	  structure	  of	  helical	  cap	  and	  the	  presence	  
of	  a	  substantive	  amount	  of	  conserved	  hFEN-­‐1	  amino	  acid	  residues	  highlighting	  this	  to	  be	  a	  key	  







2-­‐Amino	  Purine	  (Adenosine	  analogue).	  
Alanine.	  
aa	   Amino	  acid.	  




Auto	  induction	  media.	  
Aspartic	  acid.	  
Arginine.	  
BER	   Base	  excision	  repair.	  
BSA	  
bp	  








Double	  flap.	  	  
Denaturing	  high-­‐pressure	  liquid	  chromatography.	  
DNA	   Deoxyribonucleic	  acid.	  
DSB	  
DNU	  
DNA	  Double	  strand	  break.	  
Double	  nucleotide	  Unpairing.	  











Energy	  transfer	  efficiency.	  
Enzyme-­‐product.	  
Enzyme-­‐substrate.	  
Exciton	  coupling	  circular	  dichroism.	  
EDTA	   Ethylenediaminetetraacetic	  acid.	  




Minimum	  energy	  transfer	  efficiency.	  





Fluorescence	  resonance	  energy	  transfer.	  
GEN-­‐1	  
Glu/E	  	  
Gap-­‐dependent	  5'-­‐endonuclease.	  	  
Glutamic	  acid.	  




Hydroxyethylpiperazineethane	  sulphonic	  acid.	  


















lpBER	   Long	  patch	  base	  excision	  repair.	  
LB	   Luria	  borth	  media.	  
m	   Mouse.	  	  










Optical	  Density.	  	  
Product.	  
Proline.	  
Proliferating	  cell	  nuclear	  antigen.	  
RNA	   Ribonucleic	  acid.	  







Reduced	  reaction	  buffer.	  
Replication	  protein	  A.	  
Minimum	  distance	  between	  donor	  and	  acceptor.	  
Maximum	  distance	  between	  donor	  and	  acceptor.	  	  
Substrate.	  
Streptavidin.	  
spBER	   	  Short-­‐patch	  base	  excision	  repair.	  
SB	  	   	  Storage	  buffer.	  













TCE	   Trichloroethanol.	  
TEMED	   Tetramethylethylene	  diamine.	  
Tbab	  
Val/V	  
Tetrabutyl	  ammonium	  bromide.	  
Valine.	  
WT	   Wild	  type.	  
XPG	   Xeroderma	  pigmentosum	  complementation	  group	  G.	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Chapter	  1:	  Introduction	  to	  FEN-­‐1	  Enzyme:	  
The	   enzyme	   Flap	   EndoNuclease-­‐1	   (FEN-­‐1),	   which	   exists	   in	   all	   kingdoms	   of	   life,	   is	   essential	   in	  
mammals.	   FEN-­‐1	   is	   a	   structure-­‐specific	   5'-­‐nuclease	   enzyme	  with	   a	   phosphodiesterase	   activity	  
capable	  of	   catalysing	  a	   specific	   incision	   in	  a	  variety	  of	  DNA	  structures.	   FEN-­‐1	  performs	  critical	  
roles	  during	  DNA	  replication	  and	  repair	  removing	  single-­‐stranded	  5'-­‐flaps	  from	  bifurcated	  nucle-­‐
ic	  acid	  structures	  using	  its	  divalent	  metal	  ion	  active	  site.1	  In	  presence	  of	  water	  and	  at	  physiologi-­‐
cal	  pH	  7	  the	  enzyme	  hydrolyses	  a	  specific	  phosphodiester	  bond	  between	  two	  adjacent	  nucleo-­‐
tides	  to	  produce	  a	  double-­‐strand	  DNA	  product	  with	  a	  5'-­‐phosphate	  end	  and	  a	  single-­‐strand	  flap	  
product	  with	   a	   3'-­‐OH	  end	   (figure	  1.1).2-­‐5	   To	  understand	   the	  enzyme’s	   ability	   to	   recognise	   and	  
cleave	   a	   certain	   single	   phosphodiester	   bond	   in	   a	   specific	  DNA	   substrate,	   a	   detailed	   review	  of	  
DNA	  and	  FEN-­‐1	  structures	  and	  properties	  will	  be	  undertaken.	  	  
	  
Figure	  1.1.	  Hydrolysis	  of	  phosphodiester	  bond	  by	  FEN-­‐1	  producing	  two	  products	  with	  5'-­‐phosphate	  monoester	  end	  and	  
a	  3'-­‐OH	  end.	  
1.1.	  FEN-­‐1	  substrate	  (DNA):	  
DNA	  is	  the	  genetic	   information	  carrier	   in	  all	  of	  cellular	   life.	  Bacterial	  DNA	  is	  carried	  as	  a	  single	  
circular	   molecule	   that	   is	   supported	   with	   different	   packaging	   proteins.	   However,	   the	   DNA	   is	  
packaged	  differently	  in	  eukaryotes,	  as	  a	  set	  of	  chromosomes	  associated	  with	  packaging	  proteins	  
in	  the	  cell’s	  nucleus.	  The	  chromosomes	  also	  contain	  many	  other	  proteins	  that	  are	  required	  for	  
DNA	  metabolism	   such	   as	   gene	   expression,	   DNA	   replication	   and	   DNA	   repair.	   Despite	   being	   a	  
tightly	  folded	  complex,	  DNA	  can	  interact	  easily	  with	  many	  enzymes	  in	  the	  cell	  to	  be	  for	  example:	  
replicated,	  repaired,	  or	  expressed.	  Amazingly,	  DNA	  is	  the	  only	  molecule	  capable	  of	  directing	  its	  
own	  synthesis.	  DNA	  was	  first	  defined	  as	  a	  linear	  sequence	  of	  nucleotides	  that	  carries	  the	  genetic	  




the	   genetic	   material.	   Further	   studies	   proposed	   and	   then	   determined	   the	   three	   dimensional	  
atomic	  structure	  of	  DNA.	  These	  later	  models	  produced	  further	  understanding	  of	  DNA’s	  biologi-­‐
cal	  function.6	  
As	  shown	   in	   figure	  1.2,	  DNA	   is	  a	  double	  helix	  containing	   two	   long	  polynucleotide	  strands	   that	  
are	  coiled	  around	  the	  same	  axis,	  but	  running	  in	  opposite	  directions	  (antiparallel,	  one	  from	  5ʹ′	  to	  
3ʹ′	  and	  the	  other	  3ʹ′	  to	  5ʹ′).	  Each	  individual	  repeating	  nucleotide	  unit	  comprises	  of	  a	  2-­‐deoxyribose	  
sugar,	  a	  phosphate	  group,	  and	  a	  nitrogen	  base	  (purine	  or	  pyrimidine).	  The	  nucleotides	  are	  con-­‐
nected	  by	  a	  3'-­‐5'	   phosphodiester	   linkage	  between	   sugar	  molecules	   to	   form	  one	   strand	  of	   the	  
DNA.	  The	  phosphodiester	  bonds	  can	  be	  considered	  as	  the	  bridges	  that	  hold	  the	  chain	  together.	  
Thus	  the	  backbone	  of	  the	  DNA	  strand	  is	  formed	  when	  a	  3'-­‐OH	  of	  sugar	  group	  of	  one	  nucleotide	  
forms	  a	  covalent	  bond	  with	  a	  5'-­‐OPO32-­‐	  of	   sugar	  group	  of	  another	  adjacent	  nucleotide.	   In	   this	  
condensation	  reaction,	  one	  molecule	  of	  water	  is	  lost.6-­‐8	  	  
	  
Figure	  1.2.	  Part	  of	  middle	  of	  a	  DNA	  duplex	  model	  to	  show	  the	  general	  DNA	  chemical	  structure	  contains	  the	  pentose	  





Alongside	   the	  phosphodiester	  bonds,	   the	  DNA	  structure	  cannot	  be	  completed	  without	   the	   in-­‐
ternal	  hydrogen	  bonds,	  which	  hold	  the	  two	  strands	  together.	  These	  hydrogen	  bonds	  occur	  be-­‐
tween	  purines	  and	  pyrimidines.	  As	  see	  in	  figure	  1.3	  the	  adenine	  (A)	  and	  guanine	  (G)	  are	  purines	  
that	  have	  two	  rings,	  while	  the	  cytosine	  (C)	  and	  thymine	  (T)	  are	  pyrimidines	  and	  contain	  one	  ring.	  	  
	  
Figure	  1.3.	  The	  nitrogenous	  bases	  of	  DNA.	  Adenine	  (A)	  and	  guanine	  (G)	  are	  double	  ring	  purine	  bases,	  while	  the	  cyto-­‐
sine	  (C)	  and	  thymine	  (T)	  are	  single	  ring	  pyrimidine	  bases.	  
Accordingly	  the	  base	  pairing	  will	  always	  follow	  the	  rule	  A	  pairs	  only	  with	  T,	  and	  G	  pairs	  only	  with	  
C.	   As	   the	   hydrogen	  bond	  occurs	   between	   a	   partially	   positively	   charged	  hydrogen	   atom	  and	   a	  
partially	  negatively	  charged	  acceptor	  atom	  (oxygen	  or	  nitrogen),	  the	  A-­‐T	  base	  pair	  forms	  2	  hy-­‐
drogen	  bonds,	  whereas	   the	  G-­‐C	  base	  pair	   produces	   3	   hydrogen	  bonds.	   The	   strength	  of	   these	  
bonds	  depends	  on	  the	  orientations	  of	  the	  participating	  atoms,	  however	  they	  are	  still	  quite	  weak	  
bonds,	  which	   is	   a	   very	   important	   property	   during	   the	   different	   DNA	   functions.	   In	   addition	   to	  
these	  hydrogen	  bonds	   the	   twisted	  DNA	  structure	   is	  also	   supported	  by	  another	   force	   resulting	  
from	  stacking	  of	  the	  bases	  on	  top	  of	  each	  other.7	  This	  stacking	  increases	  the	  DNA’s	  stability	  by	  
enhancing	  the	  interaction	  and	  reducing	  the	  spaces	  between	  the	  base	  pairs.	  The	  hydrophilicity	  of	  
the	  phosphate	  groups	  places	  these	  on	  the	  outside	  of	  the	  molecule.	  	  
RNA	  (RiboNucleic	  Acid)	  is	  polynucleotide	  sequence	  that	  is	  related	  to	  the	  DNA.	  RNA	  copies	  of	  the	  
DNA	  are	  made	  during	  DNA	  transcription	  process	  that	  ultimately	  leads	  to	  translation	  and	  protein	  
synthesis.	  RNA	  copies	  and	  transfers	  the	  information	  from	  the	  DNA	  to	  direct	  the	  synthesis	  of	  pro-­‐
teins,	  transferring	  the	  information	  into	  another	  chemical	  form.	  These	  differences	  in	  function	  are	  
facilitated	   by	   some	   variances	   between	  DNA	  and	  RNA	   structure	   (figure	   1.4).	   RNA	   contains	   the	  
ribose	  sugar	  rather	  than	  2-­‐deoxyribose	  sugar,	  which	  means	  that	  the	  2nd	  carbon	  of	  the	  sugar	  in	  
RNA	  has	  an	  attached	  OH	  group,	  while	  in	  DNA	  it	  has	  an	  attached	  H.	  Unlike	  DNA,	  RNA	  is	  a	  single-­‐
stranded	  molecule	  can	  fold	  upon	  itself	  by	  base	  pairing	  the	  molecule	  to	  form	  a	  three-­‐diminsional	  




since	  RNA	  uses	  uracil	  instead	  of	  thymine.	  Both	  bases	  have	  similar	  general	  structure	  but	  the	  ura-­‐
cil	  lacks	  a	  methyl	  group	  on	  its	  ring.6,7	  
	  
Figure	  1.4.	  The	  differences	  between	  the	  DNA	  and	  RNA	  molecules.	  
As	  a	  result	  of	  these	  small	  differences,	  DNA	  and	  RNA	  have	  different	  stability	  reflecting	  their	  func-­‐
tions.	  DNA,	   used	   for	   storage	   and	   transmission	  of	   genetic	   information,	   is	   required	   to	   be	  more	  
stable	  than	  the	  RNA,	  which	  is	  used	  to	  transfer	  genetic	  code	  for	  protein	  synthesis.	  In	  DNA,	  the	  2-­‐
deoxyribose	  sugar	  gives	  more	  stability	  to	  the	  DNA	  molecule.	  This	  is	  because	  in	  the	  ribose	  sugar,	  
the	  OH	  group	  on	  the	  2nd	  carbon	  can	  attack	  the	  phosphodiester	  bond	  leading	  to	  phosphodiester	  
bond	  cleavage	  and	  reduced	  stability.	  In	  addition	  using	  thymine	  in	  DNA	  increases	  its	  stability	  by	  
reducing	  mutations.	  As	  known	  in	  DNA,	  cytosine	  is	  converted	  to	  uracil	  around	  100	  times	  per	  cell	  
per	  day,	  but	  the	  cell	  can	  repair	  it	  by	  substituting	  the	  uracil	  with	  cytosine	  again.	  However,	  using	  
uracil	   instead	  of	  thymine	   in	  DNA	  structure	  can	  produce	  a	  major	  problem.	   In	  this	  case,	   the	  cell	  
cannot	  recognise	  if	  the	  uracil	  belongs	  there	  or	  not	  and	  will	  stop	  repair.6	  
Although	   the	  double	  helix	   is	   the	  most	   common	   image	  of	   the	  DNA,	   this	  molecule	  also	  has	   the	  
ability	  to	  produce	  a	  number	  of	  other	  important	  structures	  during	  the	  different	  DNA	  processes.	  
In	  eukaryotes,	  DNA	  is	  processed	  in	  two	  ways	  to	  maintain	  and	  transfer	  the	  information.	  In	  these	  
processes,	   genetic	   information	   is	   copied	   into	  more	  DNA	   during	  DNA	   replication	   or	   ultimately	  




major	  roles	   in	  organising	  and	  successfully	   transferring	  the	   information.	  Accordingly	  with	  these	  
interactions	  of	  DNA,	  a	  number	  of	  complex	  structures	  using	  one	  or	  both	  strands	  of	  DNA	  will	  be	  
formed	  (figure	  1.5).4,9	  
	  
Figure	  1.5.	  Alternative	  DNA	  structures	  that	  are	  the	  result	  of	  different	  DNA	  processes.	  
1.2.	  Synthesis	  and	  hydrolysis	  of	  the	  DNA	  backbone:	  
Phosphodiester-­‐bonds	  are	  key	  structural	  features	  of	  the	  DNA	  backbone.	  Formation	  and	  break-­‐
ing	  of	  these	  bonds	  underlie	  all	   life	  process	  such	  as	  DNA	  replication,	  repair	  and	  recombination.	  
Enzyme-­‐catalysed	  mechanisms,	  whether	   synthesis	   or	   hydrolysis,	   usually	  make	   or	   break	   phos-­‐
phodiester	  bond	  using	  metal	  ions	  within	  their	  active	  sites.10,11	  	  
On	   one	   hand,	   formation	   of	   phosphodiester	   bonds	   are	   required	   to	   synthesise	  DNA	   strands	   by	  
adding	  nucleotides.	  The	  bond	  results	  from	  a	  nucleotide	  transfer	  reaction	  from	  a	  dNTP	  molecule	  
to	  the	  growing	  DNA	  chain	  and	  is	  catalysed	  by	  a	  polymerase.	  This	  polymerisation	  reaction	  mech-­‐
anism	  requires	   the	   two	  metal	   ions	  of	   the	  polymerase	  active	  site	  and	  was	  deduced	   to	  be	  SN2P	  
forming	  a	  pentacovalent	  phosphate	  transition	  state	  (figure	  1.6).	  This	  substrate	  alignment	  allows	  
deprotonation	  of	  the	  3'-­‐OH	  of	  the	  DNA	  strand	  by	  the	  adjacent	  water	  molecule.	  The	  new	  bond	  
forms	  when	   the	  deprotonated	  3'-­‐OH	  of	   the	  DNA	   strand	  attacks	   the	  α-­‐phosphate	  of	   the	  dNTP	  
molecule	  breaking	  the	  phosphoanhydride	  bond	  between	  the	  α	  and	  β-­‐phosphates	  of	   the	  dNTP	  








Figure	  1.6.	  Phosphodiester-­‐bond	  synthesis	  to	  extend	  DNA	  structure	  with	  one	  nucleotide	  from	  a	  dNTP	  molecule	  using	  
the	  two	  metal	  ions	  active	  site	  of	  the	  polymerase	  in	  presence	  of	  water.	  
Per	   contra,	   phosphodiester	   bond	  hydrolysis	   facilitates	  most	   of	   the	  biological	   processes	  of	   the	  
DNA	   such	   as	   synthesis,	   manipulation	   and	   repair.	   The	   great	   stability	   of	   these	   bonds	   requires	  
phosphodiesterases	   to	   catalyse	   their	   hydrolysis	   reactions.	   Nucleases	   are	   phosphodiesterases	  
that	  typically	  work	  with	  a	  high	  degree	  of	  specificity	  in	  function	  and	  reaction	  sites	  of	  hydrolysis.	  
As	  these	  bonds	  form	  the	  sugar-­‐phosphate-­‐sugar	  backbone	  of	  the	  DNA,	  each	  bond	  between	  two	  
nucleotides	  has	  two	  bridges	  of	  P-­‐O	  (figure	  1.7).	  Accordingly,	  nucleases	  can	  cleave	  one	  of	  the	  two	  
bridges,	  5'	  or	  3',	  in	  the	  DNA	  strand	  to	  produce	  a	  3'-­‐OH	  and	  5'-­‐phosphate	  products	  (Figure	  1.7.a)	  
or	   a	   3'-­‐phosphate	   and	   5'-­‐OH	  products	   (figure	   1.7.b)	   respectively.	   The	   attacking	   nucleophile	   is	  
always	   opposite	   of	   the	   leaving	   group	   in	   a	   penta-­‐covalent	   intermediate	   or	   transition	   state	   to	  
form	  the	  3'	  or	  5'	  OH-­‐product.	  Most	  of	   the	  nucleases	  prefer	   to	  attack	   the	  5'	   side	   (figure	  1.7.a)	  
likely	  because	  the	  3'-­‐OH	  product	  is	  a	  nucleophile	  that	  can	  be	  passed	  onto	  other	  reactions	  such	  
as	  DNA	  synthesis,	  whereas	   the	  5'-­‐phosphate	  product	   is	   an	   ideal	   complementary	   substrate	   for	  





Figure	  1.7.	  The	  two	  different	  ways	  the	  phosphpodiester	  bond	  can	  be	  attacked	  by	  the	  HO-­‐	  nucleophile.	  In	  route	  (a)	  the	  
nucleophile	  attacks	  the	  5'	  side	  producing	  a	  3'-­‐OH	  and	  a	  5'-­‐phosphate	  products,	  while	  in	  (b)	  it	  attacks	  the	  3'	  side	  pro-­‐
ducing	  a	  3'-­‐phosphate	  and	  a	  5'-­‐OH	  products.	  (The	  five	  co-­‐ordinate	  transition	  sate	  or	  intermediate	  is	  shown).	  
In	  general,	  both	  the	  synthesis	  and	  the	  hydrolysis	  of	  DNA	  backbone	  can	  be	  considered	  as	  a	  nu-­‐
cleophilic	  attack,	  with	  RO-­‐	  replacing	  PPi	  during	  DNA	  synthesis	  and	  HO-­‐	  replacing	  RO-­‐	  in	  DNA	  hy-­‐
drolysis.	   There	   are	   three	   possible	  mechanisms	   that	   have	   been	   suggested	   for	   this	   nucleophilic	  
substitution.	  In	  the	  first	  mechanistic	  model,	  the	  leaving	  group	  departs	  after	  formation	  of	  a	  high-­‐
ly	   negatively	   charged	   pentacovalent	   phosphate	   intermediate,	   which	   results	   from	   the	   nucleo-­‐
philic	  addition.	  This	   is	  usually	   referred	   to	  as	  an	  addition-­‐elimination	  mechanism	  or	  associative	  
mechanism	  with	  intermediate	  (figure	  1.8.a).14,15	  In	  the	  second	  possibility	  of	  the	  mechanism,	  the	  
reaction	  follows	  a	  dissociative	  mechanism.	  	  The	  leaving	  group	  is	  eliminated	  first;	  forming	  a	  met-­‐
aphosphate	  intermediate,	  then	  the	  nucleophile	  rapidly	  attacks	  (figure	  1.8.b).16,17	  Between	  these	  
two	   extreme	   mechanisms,	   a	   third	   associative	   mechanism	   with	   transition	   state	   lies	   between	  
both.	  In	  this	  model,	  the	  leaving	  group	  departure	  and	  nucleophilic	  attack	  happen	  simultaneously	  
during	   the	   transition	   state	   (figure	   1.8.c).	   Accordingly,	   the	   concerted	  mechanism	   is	   extremely	  
complicated	  since	  the	  transition	  state	  can	  be	  considered	  as	  a	  deletion,	  an	  addition	  or	  a	  combi-­‐
nation	   of	   both.	   In	   effect,	   the	   transition	   state	   as	   a	   removing	   step	   is	   similar	   to	   the	   dissociative	  
mechanism,	  while	  it	  is	  close	  to	  the	  simple	  addition-­‐elimination	  mechanism	  if	  it	  is	  deemed	  as	  an	  
addition	  step	  leading	  to	  a	  concurrent	  transition	  state	  between	  leaving	  group	  departure	  and	  ad-­‐
dition.	  To	  date,	  there	   is	  no	  strong	  evidence	  to	  suggest	  exactly	  what	  happens	  between	  starting	  
substrate	   and	   final	   product	   in	   enzymatic	   reactions.	   This	   is	   because	   this	   kind	   of	   reactions	   de-­‐
pends	   on	   many	   factors	   such	   as	   nature	   of	   the	   nucleophile,	   the	   electrophile	   and	   the	   leaving	  
group.	  Furthermore,	  the	  active	  site	  architecture	  of	  the	  enzyme	  that	  catalyses	  the	  reaction	  has	  





Figure	   1.8.	   The	   suggested	  mechanism	   of	   the	   phoshpodiester-­‐bond	   synthesis	   and	   hydrolysis	   when	   nucleophile	   (Nu)	  
attacks	  and	  leaving	  group	  eliminates	  (X).	  Nu	  is	  RO-­‐	  and	  X	  is	  OPPi-­‐	  in	  synthesis,	  but	  Nu	  is	  HO-­‐	  and	  X	  is	  RO-­‐	  in	  hydrolysis.	  
a)	  Associative	  mechanism	  with	  intermediate	  (or	  addition-­‐elimination	  mechanism)	  via	  a	  pentacoordinate	  intermediate.	  
b)	  Dissociative	  mechanism	  via	  tri-­‐coordinate	  metaphosphate	  intermediate.	  c)	  Associative	  mechanism	  with	  transition	  
state.	  
Phosphodiesterases	  are	  typically	  characterised	  by	  their	  binding	  of	  two	  metal	  ions	  such	  as	  mag-­‐
nesium	  ions	  (Mg2+)	  to	  catalyse	  hydrolysis	  of	  the	  target	  phosphate	  diester	  bond	  in	  combined	  ac-­‐
tions	  known	  as	  the	  two-­‐metal	  ion	  mechanism.	  In	  such	  way,	  one	  metal	  ion	  binds	  a	  non-­‐bridging	  
phosphate	  oxygen	  of	  the	  scissile	  phosphate	  diester	  bond	  acting	  as	  an	  electrophilic	  catalyst	  and	  
the	  nucleophilic	  hydroxide	  ion,	  and	  the	  other	  metal	  ion	  binds	  the	  same	  non-­‐bridging	  phosphate	  
oxygen	  and	  oxygen	  of	  the	  leaving	  group	  (figure	  1.9).	  One	  very	  important	  feature	  of	  these	  biolog-­‐
ical	  enzymatic	  reactions	  is	  that	  the	  electrophilic	  power	  of	  the	  phosphorus	  atom	  is	  increased	  by	  
the	  Lewis	  acid	  (electron-­‐accepting)	  effect	  of	  one	  or	  more	  Mg2+.	  
	  
Figure	  1.9.	  The	  two-­‐metal	  ion	  mechanism.	  Interaction	  of	  enzymatic	  ions	  with	  a	  non-­‐bridging	  phosphate	  oxygen	  and	  




1.3.	  FEN-­‐1	  in	  metabolism:	  
Flap	  endonuclease-­‐1	  (FEN-­‐1)	  is	  an	  important	  factor	  to	  maintain	  genetic	  stability	  in	  higher	  organ-­‐
isms.	   Previous	   studies	   have	   indicated	   an	   increase	   in	   cancer	   progression	   related	   to	   defects	   of	  
FEN-­‐1	   function.18,19	  FEN-­‐1	  has	  essential	   roles	  during	  DNA	  replication	  and	   long-­‐patch	  base	  exci-­‐
sion	  repair	  (lpBER).	  In	  both	  processes,	  FEN-­‐1	  contributes	  to	  removal	  of	  5'-­‐single	  stranded	  DNAs	  
(5'-­‐ssDNA),	  known	  as	  5'-­‐flaps,	  independently	  of	  the	  sequence	  using	  its	  phosphodiesterase	  activi-­‐
ty.5	  The	  proceeding	  sections	  describe	  the	  specific	  role	  of	  FEN-­‐1	  in	  each	  of	  DNA	  replication	  and	  
lpBER:	  	  
1.3.1.	  FEN-­‐1	  in	  DNA	  Replication:	  
Before	  a	  cell	  divides,	  DNA	  has	  to	  replicate	  so	  that	  each	  daughter	  cell	  will	  capture	  a	  copy	  of	  the	  
genome	  from	  the	  original	  DNA.20	  Because	  cells	  pack	  the	  DNA	  into	  a	  condensed	  structure	  named	  
chromatin	   under	   the	   normal	   situations,	   they	   need	   to	   unfold,	   unwind	   and	   separate	   the	   two	  
strands	  from	  each	  other	  to	  start	  replication	  at	  specific	  locations	  in	  the	  genome	  called	  replication	  
origins.	   In	   this	   case,	   each	  of	   the	   two	   strands	  works	  as	   a	  template	  for	   the	   creation	  of	   the	  new	  
strand.	  This	   structure	   is	  ordinarily	   termed	  a	   replication	   fork	   that	   is	  organised	  by	  an	  enormous	  
number	   of	   proteins.	   Each	   enzyme	   performs	   a	   core	   function	   for	   a	   specific	   purpose	   such	   as	   to	  
unwind	  the	  DNA	  strands,	  organise	   the	  ssDNA,	  prime,	  copy	   the	  DNA,	   load	  co-­‐proteins	   (such	  as	  
PCNA),	  or	  process	  the	  Okazaki	  fragments.21,22	  	  
DNA	  replication	  starts	  at	  a	  specific	  point	   in	  the	  DNA	  duplex	  known	  as	  the	  origin	  of	  replication.	  
This	  specific	  point	  is	  a	  destination	  for	  many	  enzymes	  that	  will	  bind	  specific	  binding	  sites	  on	  the	  
DNA	  to	  proceed	  with	  the	  replication.	  Initially,	  the	  DNA	  helicase	  unzips	  the	  DNA-­‐double	  helix	  by	  
breaking	  the	  hydrogen	  bonds	  between	  the	  two	  polynucleotide	  chains	  to	  generate	  a	  replication	  
fork	   (figure	  1.10).	  Each	  strand	  will	  act	  as	  a	  parental	  strand	  to	  template	  the	  synthesis	  of	  a	  new	  
strand.	  Because	  of	  the	  antiparallel	  nature	  of	  the	  DNA	  structure,	  one	  daughter	  strand	  will	  be	  syn-­‐
thesised	  continuously	  in	  the	  same	  direction	  of	  polymerase	  function	  (leading	  strand),	  on	  the	  oth-­‐
er	  hand,	  the	  other	  daughter	  strand	  will	  be	  synthesised	  discontinuously	  (lagging	  strand)	  as	  seg-­‐
ments	   named	  Okazaki	   fragments.	   Therefore,	   this	  manner	   of	   discontinuous	   synthesis	  will	   pro-­‐
duce	  further	  problems.23,24	  	  
In	   both	   cases,	   the	   polymerisation	   is	   initiated	   by	   a	   short	   complementary	   RNA	   oligonucleotide	  
(RNA	  primer),	  which	  is	  synthesised	  by	  primase	  enzyme.	  The	  RNA	  primer	  is	  then	  extended	  with	  
DNA	  primer	  synthesised	  by	  DNA	  polymerase	  α	  (Pol	  α),	  in	  order	  to	  form	  an	  RNA-­‐DNA	  primer	  (ap-­‐




and	  pol	  δ	  will	  carry	  out	  synthesis	  the	  daughter	  DNA	  strands	  on	  the	  leading	  and	  lagging	  strands,	  
respectively.	  Pol	  ε	  moves	  continuously	  along	   the	   leading	  strand	   to	  synthesize	  a	  new	  daughter	  
strand	   in	   the	  5'	   to	  3'	  direction.	  On	   the	  other	  arm	  Pol	  δ	  produces	   the	  new	  daughter	   strand	  as	  
long	  series	  of	  fragments	  known	  as	  Okazaki	  fragments.1	  	  
To	  avoid	   turning	   the	  DNA	  to	  RNA	  during	  continuation	  of	   the	   replication	  process,	   the	  previous	  
segments	  of	   the	  RNA	  primer	   should	  be	  displaced	  during	  polymerisation	  of	   the	   lagging	   strand.	  
This	  displacement	  will	  cause	  a	  flap	  in	  the	  nucleic	  acid	  polymer	  approximately	  50	  million	  times	  in	  
an	  average	  human	  cell	  replication.	  These	  flaps	  should	  be	  eliminated	  to	  allow	  DNA	  ligase	  to	  con-­‐
nect	  the	  newly	  synthesised	  DNA	  parts	  together	  to	  form	  a	  continuous	  polymer	  as	  shown	  in	  the	  
figure	  below.	  
	  	  
Figure	  1.10.	  Role	  of	  FEN-­‐1	  in	  lagging-­‐strand	  DNA	  replication.	  As	  the	  lagging	  strand	  is	  synthesised	  discontinuously,	  the	  
RNA	  primer	  and	  a	  part	  of	  the	  Okazaki	  fragment	  should	  be	  removed	  by	  FEN-­‐1	  before	  joining.	  
In	  essence,	  completion	  of	  this	  process	  requires	  joint	  enzymatic	  work	  with	  a	  complicated	  mecha-­‐
nism.	  Although	  indicating	  most	  of	  the	  proteins	  that	  constitute	  the	  central	  players	  in	  this	  process	  
solved	  the	  mystery,	  details	  are	  still	  a	  point	  of	  contention	  between	  many	  studies.	  For	  example,	  a	  
previous	  study	  suggested	  that	  the	  RNA	  primer	  is	  removed	  gradually	  by	  the	  combined	  action	  of	  
Pol	  δ	  and	  PCNA	  as	  a	  5'-­‐flap	  with	  1	  or	  2	  nucleotides	  length,	  which	  is	  removed	  directly	  by	  FEN1.	  
After	  degradation	  of	   the	  RNA	  primer,	   the	   resulting	  nicked	  DNA	  will	  be	  connected	  by	   ligase	   to	  
generate	  the	  completed	  DNA	  duplex.22	  Another	  explanation	  was	  proposed	  to	  explain	  this	  mech-­‐




ment,	  it	  will	  continue	  the	  synthesis	  by	  replace	  the	  mature	  primer	  and	  a	  part	  of	  the	  new	  DNA	  as	  
a	  30-­‐35	  nucleotides	  flap	  length.	  The	  combined	  action	  of	  RPA	  and	  Dna2	  protein	  cleaves	  the	  flap	  
to	  leave	  only	  5-­‐7	  nucleotides.	  Then	  FEN1	  cleaves	  the	  shortened	  flap	  to	  form	  a	  nicked	  DNA	  du-­‐
plex	  that	  can	  be	  sealed	  by	  ligase	  to	  generate	  the	  completed	  new	  DNA	  daughter.25	  Another	  pro-­‐
posed	  model	   offers	   a	   role	   for	   the	   ribonuclease	   (RNase)	   H2	   protein	   that	   cuts	   the	   RNA	   primer	  
leaving	  the	  last	  RNA	  nucleotide,	  which	  is	  removed	  as	  a	  5'-­‐flap	  by	  FEN1.	  At	  the	  same	  time	  the	  gap	  
is	  filled	  by	  Pol	  δ	  and	  then	  ligated	  by	  ligase	  to	  complete	  the	  new	  resulted	  DNA	  duplex.1	  
In	   some	   cases,	   the	   replication	   mechanism	   happens	   imprecisely	   forming	   some	   accidental	   ge-­‐
nomic	  lesions.	  Most	  of	  these	  changes	  will	  activate	  DNA	  repair	  mechanisms	  to	  maintain	  the	  ge-­‐
netic	  stability	  of	  the	  DNA.	  As	  a	  result,	  the	  high	  efficiency	  of	  DNA	  repair	  will	  eliminate	  mutations	  
accumulation	  in	  the	  DNA	  sequence.	  	  
1.3.2.	  FEN-­‐1	  in	  Base	  Excision	  Repair	  (BER):	  
DNA	  is	  the	  genetic	  information	  store	  in	  living	  cells;	  consequently,	  any	  DNA	  damage	  or	  instability	  
could	  be	  extremely	  deleterious.	  For	  example,	  the	  link	  between	  the	  DNA	  damage	  and	  disease	  is	  
that	  of	  mutations,	  which	  can	   lead	  to	  cancer.	  Because	  of	   this,	  DNA	  repair	  processes	  are	  neces-­‐
sary	  for	  the	  survival	  of	  all	  organisms.	  Due	  to	  different	  types	  of	  environmental	  insult,	  the	  damage	  
response	  occurs	  by	  a	  number	  of	  diverse	  pathways	  with	  participation	  of	  many	  enzymes.	  The	  ma-­‐
jor	  DNA	   repairing	  mechanism	  are	  base	  excision	   repair	   (BER),	  nucleotide	  excision	   repair	   (NER),	  
mismatch	  repair	  (MMR).	  Each	  proceeds	  by	  the	  action	  of	  subsequent	  enzymes	  to	  generate	  vari-­‐
ous	   intermediates	  by	   removing	   the	  damage	  and	   incision	  of	   the	  phosphodiester	  bond	   to	   fix	   it.	  
FEN-­‐1	  is	  one	  of	  the	  enzymes	  that	  has	  critical	  role	  in	  lpBER	  (figure	  1.11).	  
The	  first	  step	  of	  the	  BER	  pathway	  is	  initiated	  by	  recognition	  of	  then	  removing	  the	  damaged	  nu-­‐
cleobase	  via	  a	  damage-­‐specific	  DNA	  glycosylase.	  DNA	  glycosylases	  remove	  the	  damaged	  base	  by	  
flipping	   it	   into	  the	  active	  site	  and	  with	  hydrolysis	  of	   the	  glycosidic	  bond	  to	  generate	  an	  abasic	  
site	  (AP-­‐site)	  as	  a	  product.	  Some	  of	  these	  enzymes	  are	  multiple	  damaged	  bases	  removers,	  how-­‐
ever,	   others	   are	   specific	   for	  only	  one	  or	   two	  damaged	  bases.	   Interestingly,	   some	  glycosylases	  
are	  bifunctional	  enzymes.	  In	  addition	  to	  the	  glycosidic	  bond	  cleavage	  ability,	  they	  have	  less	  effi-­‐
cient	  AP	  lyase	  activity.	  Consequently,	  the	  AP	  site	  can	  be	  recognised	  by	  DNA	  glycosylase	  again	  or	  
other	  enzyme.22,25	  	  
The	  BER	  pathway	   is	   resumed	  by	   incision	   the	  deoxyribose	  phosphate	  bond	  of	   the	   resulted	  AP-­‐
site.	  Cleavage	  of	  this	  AP-­‐site	  by	  glycosylase	  with	  its	  AP-­‐lyase	  activity	  or	  endonuclease-­‐1	  (APE-­‐1)	  




deoxyribose	  phosphate	   (dRP)	  end	  to	   the	  AP	  site	   respectively.25	  The	  3'	  AP-­‐site	   intermediate	  al-­‐
ways	  follows	  the	  short	  patch	  BER	  (spBER)	  pathway	  to	  insert	  a	  single	  nucleotide,	  however	  the	  5'	  
AP-­‐site	  intermediate	  can	  follow	  either	  spBER	  or	  lpBER	  to	  incorporate	  multiple	  nucleotides.	  
	  
Figure	  1.11.	  The	  two	  ways	  of	  the	  DNA	  base	  excision	  repair	  (BER)	  the	  long-­‐patch	  (lp)	  and	  the	  short-­‐patch	  (sp)	  to	  re-­‐
move	  damaged	  base	  in	  a	  part	  of	  DNA.26	  
The	  spBER	  is	  mediated	  by	  APE1	  or	  polymerase	  β	  (pol	  β)	  to	  process	  the	  resulted	  3'	  AP-­‐site	  inter-­‐
mediate	  or	  5'	  AP-­‐site	  intermediate	  respectively.	  In	  both	  cases	  this	  leads	  to	  creation	  of	  a	  gap	  with	  
3'-­‐OH	  and	  5'-­‐phosphate	  intermediate.	  Then	  pol	  β	  fills	  the	  gap	  by	  incorporation	  of	  a	  new	  single	  
nucleotide	  to	  the	  3'-­‐OH	  termini.	  Finally	  DNA	  ligase	  seals	  the	  nick	  in	  the	  backbone	  by	  creation	  a	  
new	  phosphodiester	  bond	  between	   the	  3'-­‐OH	  of	   the	  new	  nucleotide	  and	   the	  5'-­‐phosphate	  of	  
the	  next	  nucleotide.	  
By	  contrast,	   lpBER	   is	  an	  alternative	  pathway	  of	   spBER	  when	  pol	  β	  cannot	  hydrolyse	   the	  5'dRP	  
group.	  In	  this	  case	  lpBER	  will	  be	  organised	  by	  polymerase	  β,	  δ,	  or	  ε	  to	  incorporate	  multiple	  nu-­‐
cleotides	  to	  fill	  the	  gap.	  In	  the	  meantime,	  incorporation	  of	  the	  new	  nucleotides	  displaces	  a	  sin-­‐
gle	  strand	  of	  DNA	  to	  generate	  a	   flap.	  Then	  the	  flap	   is	   removed	  by	  FEN-­‐1	  forming	  nicked	  DNA.	  




1.4.	  FEN-­‐1	  Superfamily	  (5'-­‐Nucleases):	  
FEN-­‐1	   superfamily	  members	  are	   structure	   specific	  nucleic	  acid	  hydrolysing	  enzymes	   that	  have	  
similar	  structural	  features	  and	  an	  absolute	  need	  for	  two	  central	  metal	  ions	  to	  play	  critical	  roles	  
during	  DNA	  replication,	  repair	  and	  recombination.	  In	  eukaryotic	  organisms	  the	  superfamily	  has	  
been	  divided	  to	  flap	  endonuclease-­‐1	  (FEN-­‐1);	  exonuclease-­‐1	  (EXO-­‐1);	  gap	  endonuclease-­‐1	  (GEN-­‐
1);	  and	  xeroderma	  pigmentosum	  complementation	  group	  G	  (XPG).2	  These	  enzymes	  are	  charac-­‐
terised	  with	  a	  high	  specificity	  for	  particular	  substrate	  structures	  and	  tight	  regulation	  of	  function	  
(Table	   1.1)	   (figure	   1.12).	   This	   specificity	   and	   regulation	   keep	   the	   information	   and	   function	   of	  
nucleic	  acid	  avoiding	  the	  danger	  of	  inappropriate	  phosphodiester-­‐bond	  hydrolysis.	  In	  vitro,	  the	  
superfamily	  enzymes	  hydrolyse	  various	  structures	  of	  DNA	  specifically	  to	  catalyse	  reactions	  of	  5'-­‐
bifurcated	   or	   blunt	   ended	   DNA	   substrates	   endonucleotlytically	   and	   exonucleolytically	   respec-­‐
tively.	  The	  endonuclease	  activity	  can	  cleave	  oligonucleotides	  by	  attacking	  the	  middle	  of	  the	  sub-­‐
strate	  while	  the	  exonuclease	  activity	  has	  ability	  to	  remove	  one	  nucleotide	  at	  a	  time	  by	  attacking	  
the	  end	  of	  the	  substrate.2-­‐5,12	  Each	  superfamily	  member	  has	  a	  characteristic	  structure	  to	  organ-­‐
ise	  substrate	  specifically	  and	  function.	  Although	  structural	  comparison	  between	  the	  superfamily	  
members	   shows	   a	   considerable	   sequence	   and	   structural	   similarity,	   also	   important	   structural	  
differences	  are	  identified,	  which	  cause	  variances	  in	  many	  of	  the	  superfamily	  properties	  that	  dif-­‐
ferentiate	  the	  superfamily	  members	  from	  each	  other.	  Comparison	  of	  these	  similarities	  and	  dif-­‐
ferences	  is	  very	  important	  to	  explain	  the	  substrate	  recognition	  and	  processing	  for	  the	  superfam-­‐
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Figure	  1.12.	  FEN-­‐1	  superfamily	  members	  and	  their	  substrates.	  a)	  Domain	  alignment	  of	  FEN-­‐1	  superfamily	  members	  as	  
determined	   by	   primary	   sequence	   analysis.	   b),	   c),	   d),	   and	   e)	   The	   crystal	   structures	   of	   hFEN-­‐1	   (PDB:3Q8K),	   hEXO-­‐1	  
(PDB:3QEB),	  hGEN-­‐1	  with	  other	  monomer	  (PDB:5T9J)	  and	  yeast	  XPG	  with	  other	  monomer	  (PDB:4Q0W)	  in	  complexes	  
with	  DNA,	   respectively,	   to	   show	  how	   they	   recognise	   their	   substrates	  using	   their	  active	   site	  metals	  and	  K+	   ion.	  Also	  
scheme	  of	  the	  preferred	  substrates	  of	  eachmember	  included	  and	  showing	  the	  cleavage	  site,	  released	  product	  and	  the	  
main	  product.	  The	  substrates	  shown	  are:	  FEN-­‐1	  substrates	  (double	  flap,	  3'-­‐single	  flap,	  and	  gapped	  double	  flap),	  EXO-­‐1	  
substrates	  (3'-­‐	  overhang	  and	  nick),	  GEN-­‐1	  substrate	  (Holliday	  junction),	  and	  XPG	  substrates	  (bubble).2,30,31	  	  
Flap	  endonuclease-­‐1	  (FEN-­‐1),	  which	  typifies	  the	  superfamily,	  is	  present	  in	  all	  domains	  of	  life	  as	  a	  
structure	  specific	  metallonuclease.	  It	  possesses	  phosphodiesterase	  activity	  to	  increases	  the	  rate	  
of	  phosphodiester	  bond	  hydrolysis	  at	  least	  1017	  fold.	  FEN-­‐1	  is	  essential	  in	  DNA	  replication	  and	  lp-­‐
BER	  because	  of	  its	  ability	  to	  recognize	  the	  5'-­‐flap	  of	  DF	  substrate	  that	  arises	  during	  the	  process-­‐
es	  (figure	  1.12.b).	  Participation	  of	  FEN-­‐1	  in	  DNA	  replication	  and	  repair	  provides	  important	  roles	  
to	  maintain	  genomic	  stability.	  Differently	   from	  other	  superfamily	  members,	  FEN-­‐1	  also	  has	  5'-­‐




flap	   (3'-­‐SF)	   and	   gap	   substrates	   respectively.	   This	  multi-­‐functionality	   allows	   it	   to	   participate	   in	  
several	   DNA	   processes	   to	   recognise	   a	   wide	   variety	   of	   DNA	   structures	   and	   cleave	   the	   target	  
phosphodiester-­‐bond	   specifically	   (figure	  1.12.b).	  When	  FEN-­‐1	  acts	   in	   vivo	   it	   is	  bound	   to	  PCNA	  
(Proliferating	  cell	  nuclear	  antigen).	  Interaction	  with	  PCNA	  and	  some	  other	  proteins	  is	  mediated	  
by	  a	  short	  C-­‐terminal	  extension.1,3,5	  	  
Exonuclease-­‐1	   (EXO-­‐1)	   is	   another	  member	  of	   the	   superfamily	   that	   is	   very	   close	  homologue	  of	  
FEN-­‐1	   that	   is	   detected	   in	   eukaryotic	   cells.	   EXO-­‐1	   is	   a	  much	   larger	   than	   FEN-­‐1	   although	   it	   has	  
smaller	  nuclease	  domain.	  The	  smaller	  nuclease	  domain	   is	  situated	  at	  the	  amino-­‐terminus.	  The	  
structural	  differences	  between	  EXO-­‐1	  enzyme	  and	  the	  other	  superfamily	  members	  differentiate	  
its	  functional	  specialisation.	  This	  5'-­‐structure	  specific	  nuclease	  has	  critical	  roles	  during	  mismatch	  
repair	  (MM)	  and	  double-­‐strand	  break	  repair	  (DSB).	  In	  these	  processes,	  EXO-­‐1	  can	  recognise	  the	  
5'-­‐termini	  of	  different	  substrates	  such	  as	  nicked,	  gapped,	  or	  blunt	  DNA	  and	  hydrolyse	  them	  ex-­‐
onucleolytically	   (figure	   1.12.c).	   In	   some	   cases,	   the	   EXO-­‐1	   active	   site	   can	   recognise	   single-­‐
stranded	   5'-­‐flaps,	   which	   undergo	   endonucleolytic	   cleavage.	   Deficiency	   of	   EXO-­‐1	   activity	   can	  
cause	  deep	  deleterious	  effects	  on	  human	  health	  leading	  to	  cancer.	  3,29,32	  	  	  
GEN-­‐1	  is	  a	  member	  of	  the	  superfamily	  that	  plays	  important	  roles	  recognising	  various	  substrates	  
during	  DNA	  replication	  and	  recombination	  (figure	  1.11.e).	  GEN-­‐1	  can	  cleave	  5'	  flap	  substrates	  in	  
vitro,	  but	  the	  in	  vivo	  substrate	  is	  proposed	  to	  be	  Holliday	  junctions	  (HJ).	  The	  structural	  features	  
of	  GEN-­‐1	  reveal	  its	  specificity	  for	  a	  four-­‐way	  (Holliday)	  DNA	  junction	  (figure	  1.12.d).	  To	  resolve	  
these	  HJs,	  GEN-­‐1	  acts	  in	  a	  dimeric	  form	  to	  generate	  the	  bilateral	  cleavage.	  Successful	  removal	  of	  
HJs	  averts	  appearance	  of	  chromosome	  aberrations.3,30,33	  	  
XPG	  also	  belongs	  to	  FEN-­‐1	  superfamily	  and	  is	  responsible	  for	  one	  of	  the	  steps	  of	  the	  nucleotide	  
excision	  repair	  (NER)	  process.34,35	  The	  human	  XPG	  (hXPG)	  sequence	  contains	  of	  1186	  amino	  ac-­‐
ids	  and	  it	  works	  with	  other	  proteins	  as	  a	  multi-­‐complex.2	  The	  proper	  recruitment	  of	  the	  enzyme	  
requires	  interacting	  with	  XPB,	  XPD,	  RPA	  and	  PCNA.31,34	  In	  vitro,	  XPG	  cleaves	  various	  DNA	  struc-­‐
tures	   such	   as	   single	   stranded	   5'-­‐overhangs	   and	   splayed	   arms	   DNA	   structures.	   However,	   the	  
unique	  feature	  of	  XPG	  in	  vivo	   is	  the	  recognition	  of	  the	  DNA	  repair	  bubbles	  (figure	  1.12.e).	  The	  
substrate	   specificity	  of	   the	  XPG	  protein	   could	  be	   related	   to	   the	  wide	   catalytic	   core	   that	  allow	  
egression	  of	  the	  DNA	  without	  the	  free	  5'-­‐end.3,31	  	  
Overall,	   FEN-­‐1	   superfamily	  members	   have	   ability	   to	   recognise	   the	   5'-­‐duplex	   ends,	   sometimes	  
when	   they	   are	   embedded	   in	   more	   complex	   structures	   and	   to	   hydrolyse	   the	   target	   phos-­‐
phodiester	  bond	  by	  cleaving	  the	  P-­‐O	  bridge.	  Despite	  the	  large	  structural	  similarity	  between	  the	  




chemical	  nature	  of	  the	  substrate,	  they	  are	  considerably	  stimulated	  by	  the	  substrate	  structure.36	  
Although	   individual	   superfamily	  members	  manage	   cleavage	  of	  different	  DNA	  structures,	   all	   of	  
these	  nucleases	  cleave	  at	  one	  nucleotide	   into	  a	  5'-­‐double-­‐stranded	  region	  of	   their	   target	  sub-­‐
strates.37	  	  
1.5.	  FEN-­‐1	  protein	  fold:	  
Generally,	   all	   of	   the	   superfamily	  members	   are	  a	   group	  of	  metalloenzymes	   that	  have	  a	   similar	  
common	  protein	  structure	  with	  some	  modifications	  that	  occurred	  in	  the	  higher	  life	  organisms.2	  
Primary	   sequence	  analysis	  of	  FEN-­‐1	   superfamily	   structure	  has	  characterised	  a	  number	  of	   con-­‐
served	   domains,	  which	   are	  N	   (N-­‐terminal)	   and	   C	   (C-­‐terminal)	   regions	   separated	   by	   a	   variable	  
length	  of	  intermediate	  domain	  (I).	  When	  folded,	  these	  domains	  form	  a	  complex	  structure	  con-­‐
taining	  a	  variety	  of	  different	  structural	   features.38	  The	  early	   reported	  crystal	   structures	  of	   two	  
members	  of	  the	  superfamily,	  which	  are	  FENs	  and	  EXO-­‐1,	  from	  bacteriophage	  through	  archaeal	  
to	  human	  have	  been	  highlighted	  the	  common	  FEN-­‐1	  superfamily	  architecture	   in	  figure	  1.13	  a-­‐
d.2,33	  Despite	  the	  differences	  in	  details,	  both	  members	  reveal	  monomeric	  proteins	  with	  binding	  
sites	  that	  are	  created	  by	  conserved	  amino	  acids	  to	  contain	  at	  least	  two	  metal	  ions.	  A	  part	  of	  the	  
nuclease	   domain	   feature	   orders	   as	   central	   parallel	  mixed	   and	   twisted	   β-­‐sheet	   surrounded	   by	  
secondary	  structures	  elements	  consisting	  almost	  entirely	  of	  α-­‐helices.	  Although	  these	  α-­‐helices	  
sometimes	  have	  different	  positions	   in	  proteins	   from	  different	  organisms,	   they	  are	  mostly	  pre-­‐
sented	  in	  similar	  location.	  The	  created	  central	  hall	  feature,	  which	  is	  known	  as	  the	  enzyme	  active	  
site,	  provides	  highly	  conserved	  Asp	  and	  Glu	  residues	  to	  coordinate	  the	  requisite	  divalent	  metal	  
ions.	  Moreover,	  it	  provides	  two	  sites	  on	  either	  sides	  of	  the	  β-­‐sheet	  to	  bind	  the	  target	  dsDNA.1,2	  	  
The	  very	   recent	  crystal	   structures	  of	  GEN-­‐1	  and	  XPG	  confirmed	  what	  was	  proposed	  years	  ago	  
from	  protein	  sequence	  information	  and	  showed	  high	  structural	  homology	  to	  FEN-­‐1	  in	  the	  active	  
site	  (figure	  1.13	  e.f).31,33	  The	  active	  site	  of	  FEN-­‐1	  and	  EXO-­‐1	  is	  capped	  and	  limited	  by	  helical	  arch,	  
which	   is	   shaped	  by	   two	  α-­‐helices	   from	   the	   intermediate	   domain.	   This	   spanned	   loop	  provides	  
specific	   roles	   to	   organise	   specific	   DNA	   structures,	   and	   it	   has	   been	   divided	   further	   to	   helical	  
gateway	   and	   helical	   cap	   regions	   for	   better	   understanding	   to	   their	   roles.	   In	   spite	   of	   the	   con-­‐
served	  similarity	  across	  the	  superfamily	  members	  in	  the	  gateway	  region	  (the	  base	  of	  the	  helical	  
arch)	  that	  contains	  some	  of	  the	  active	  site	  residues,	  a	  huge	  variability	  in	  the	  cap	  region	  was	  de-­‐
tected.	  Whereas	  FENs	  and	  EXO-­‐1	  have	  shown	  variation	  in	  the	  helical	  cap	  length,	  neither	  XPG	  nor	  
GEN-­‐1	  have	  helical	  cap,	  which	  makes	  their	  active	  sites	  wider	  and	  therefore	  they	  can	  recognize	  
bigger	   sizes	   of	   specific	  DNA	   structures	   including	   continuous	  DNAs	   like	   four-­‐way-­‐junctions	   and	  




homology	   is	   poor.	   In	   addition,	   the	  domain	   alignment	  of	   the	   superfamily	  members	  has	   shown	  
variation	  in	  lengths	  outside	  the	  nuclease	  core	  (the	  C-­‐terminal	  extensions’	   length)	  from	  huge	  in	  
EXO-­‐1,	  XPG,	  and	  GEN-­‐1	  to	  being	  smaller	  in	  FENs.	  Although	  it	  might	  be	  dispensable	  in	  the	  super-­‐
family	  members’	  activities,	  it	  is	  very	  important	  to	  their	  interactions	  with	  other	  proteins	  such	  as	  
PCNA.1,2,38-­‐41	  	  
Elucidation	  of	  FEN-­‐1	  structure	  and	  its	  DNA-­‐binding	  elements	  revealed	  the	  answer	  to	  many	  ques-­‐
tions	   concerned	  with	   the	  mechanism	  of	   substrate	   hydrolysis	   and	   the	   ability	   to	   cleave	   various	  
DNA	   structures	  within	   a	   single	   active	   site.2	   To	  present,	   thirteen	   crystal	   structures	  of	   FENs	  are	  
obtained	   from	   a	   wide	   range	   of	   organisms	   including	   bacteriophages,42-­‐44	   archaea,36,45	   thermo-­‐
philic	  bacteria,46	  yeast,47	  and	  human.5,29	   In	  hFEN-­‐1,	  the	  N	  and	  C	  termini	  of	  the	  protein	  that	  are	  
connected	  by	  I	  domain	  form	  the	  saddle	  like	  structure	  domain.	  The	  nuclease	  core	  domain	  archi-­‐
tecture	  consists	  of	  a	  seven	  stranded	  twisted	  β	  sheet	  supported	  with	  15	  α-­‐helices	  from	  N	  and	  C	  
domains	   creating	   the	   active	   site.	   This	   α/β	   system	   is	   connected	   by	  multiple	   loops	   ranging	   be-­‐
tween	  12	  and	  15	  Å	  to	  shape	  the	  interwoven	  fold	  of	  the	  protein.	  The	  interwoven	  loops	  allow	  res-­‐
idues	  throughout	  the	  sequence	  to	  form	  a	  carboxylate	  rich	  active	  site	  below	  a	  feature	  known	  as	  
the	  helical	   arch.5	   Seven	  acidic	   residues	   (Asp	  and	  Glu	   residues)	   that	   are	  positionally	   conserved	  
throughout	  evolution	  compose	  the	  hFEN-­‐1	  active	  site	  and	  surround	  two	  tightly	  bound	  catalytic	  
metal	  ion	  cofactors.2,5	  This	  active	  site	  is	  gated	  by	  the	  bases	  of	  helices	  α4	  and	  α2,	  and	  capped	  by	  
the	  top	  of	  α4	  and	  the	  α5	  helices	  and	  the	  flexible	  loop	  between	  helices	  to	  complete	  forming	  of	  
the	  active	  site	  hole.	  The	  resultant	  helical	  arch	  feature	  presents	  positively	  charged	  residues	  that	  
line	  the	  inner	  surface	  that	  might	  contribute	  to	  accommodation	  of	  the	  single	  stranded	  DNA	  flap.	  
Another	  binding	  feature	   is	   formed	  by	  the	  hydrophobic	  wedge,	  which	  consists	  of	  the	  top	  of	  α2	  
and	   α3	   and	   the	   loop	   between	   helices.	   The	   α2	   wedge	   bends	   the	   DNA	   at	   the	   junction	   point,	  
whereas	  the	  α3	  wedge	  and	  a	  part	  of	  the	  loop	  compose	  a	  hydrophobic	  pocket	  to	  organise	  the	  3'-­‐
terminal	   nucleotide.	   This	   3'-­‐hydrophobic	   flap	   pocket	   consists	   of	   ten	   amino	   acids	   with	  mostly	  
aliphatic	  residues.	  The	  H2TH	  region,	  which	  forms	  by	  α10	  and	  α11,	  presents	  an	  additional	  bind-­‐
ing	  site	  to	  recognise	  the	  opposite	  DNA	  duplex.	  This	  domain	  binds	  a	  potassium	  ion	  that	  interacts	  





Figure	  1.13.	  The	  crystal	  structural	  features	  of	  FEN-­‐1	  superfamily	  that	  are	  created	  by	  folding	  of	  the	  key	  domains,	  which	  
are	  indicated	  in	  a)	  using	  same	  colours,	  and	  showing	  their	  participation	  to	  recognise	  their	  preferred	  substrates	  in	  their	  
catalytic	  cores	  by	  organising	  the	  substrate	  duplex	  to	  be	  cleaved	  in	  the	  target	  (arrows).	  The	  structures	  shown	  are:	  a)	  




tive	  site	  metals	  (PDB:	  3QEB),	  c)	  T4FEN	  with	  DNA	  (PDB:	  2INH)	  d)	  T5FEN	  with	  active	  site	  metals	  (PDB:	  1UT5),	  e)	  hGEN-­‐1	  
with	  DNA	  and	  active	  site	  metals	  (PDB:5T9J),	  and	  f)	  yest	  XPG	  with	  with	  DNA	  and	  active	  site	  metals	  (PDB:4Q0W).	  The	  
crystal	  structure	  of	  each	  enzyme	  with	  DNA	  complex	  shows	  how	  the	  enzyme	  recognises	  the	  substrate	  using	  the	  main	  
features:	  the	  helical	  arch	  (cap	  and	  gateway),	  the	  wedge,	  the	  K+/H2TH,	  and	  the	  outside	  nuclease	  core	  to	  position	  the	  
target	  bond	  into	  the	  active	  site	  residues	  between	  the	  two	  metal	  ions.	  	  
1.6.	  Substrate	  specificity	  of	  hFEN-­‐1:	  
FEN-­‐1	  is	  an	  essential	  enzyme	  that	  plays	  significant	  roles	  during	  DNA	  replication	  and	  DNA	  repair	  
pathways.1	  This	  enzyme	  is	  characterised	  by	  its	  ability	  to	  recognise	  different	  DNA	  structures	  with	  
diverse	   efficiency.	   Substrate	   structure	   is	   the	   factor	   that	   differentiates	   between	   the	   so-­‐called	  
various	  activities	  of	  FEN-­‐1.	  Consequently,	  FEN-­‐1	  is	  described	  as	  a	  multifunctional	  and	  structure	  
specific	  enzyme.3,39	  The	  FENs	  of	  higher	  organisms,	  which	  require	  discontinuous	  duplex	  DNA	  with	  
free	  5'-­‐termini,	   recognise	   substrates	  with	   two	  dsDNA	   regions	   (downstream	  and	  upstream	  du-­‐
plex	   regions)	   relative	   to	   the	   cleavage	   site.	   The	   enzyme	   uses	   its	   phosphodiesterase	   activity	   to	  
carry	  out	  the	  cleavage	  that	  occurs	  at	  1-­‐nt	  into	  the	  downstream	  duplex	  (figure	  1.14).	  FEN-­‐1	  rec-­‐
ognises	  DNA	  junctions	  to	  identify	  the	  structural	  polarity.1	  	  
	  
Figure	  1.14.	  FEN-­‐1	  binds	  different	  DNA	  structures	  within	  its	  active	  site	  to	  achieve	  different	  activity	  with	  varying	  effi-­‐
ciency.1	  
Characterisation	   of	   FEN-­‐1	   specificity	   provides	   insight	   into	   its	   ability	   to	   perform	   endonuclease	  
(fen),	  exonuclease	  (exo)	  and	  gap	  endonuclease	  (gen)	  activity	  using	  a	  single	  active	  site.1,48	  FEN-­‐1	  




duced	  during	  metabolic	  pathways.	  Flap	  endonuclease	  (fen)	  activity	  is	  the	  most	  dominate	  activity	  
of	  FEN-­‐1	  that	  contributes	   in	  5'-­‐flap	  removal	  during	  DNA	  replication	  and	  in	  eukaryotes	  in	   lpBER	  
from	  various	  DNA	  structures	  for	  example	  double	  flap,	  5'-­‐single-­‐flap,	  pseudo-­‐Y	  and	  5'-­‐overhang	  
DNAs	   (figure	   1.14).	   Various	   factors	   can	   affect	   FEN-­‐1	   efficiency	   to	   cleave	   5'-­‐flaps.	   First,	   an	   in-­‐
crease	  in	  flap	  length	  of	  more	  than	  20	  nucleotides	  reduces	  FEN-­‐1	  efficiency	  in	  part	  because	  this	  
can	  cause	  flap	  secondary	  structure.46,49	  Second,	   the	  modification	  of	   the	  5'-­‐phosphate	  group	  of	  
the	   reacting	  5'-­‐duplex	  decreases	   the	   rate	  of	  FEN-­‐1	   reaction.50	  Third,	  a	  mere	  occurrence	  of	  big	  
non	  nucleotide	  molecules	  attached	  to	  the	  flap	  can	  also	  inhibit	  FEN-­‐1	  activity.51	  The	  other	  FEN-­‐1	  
activity	  is	  exo	  that	  is	  used	  to	  recognise	  several	  other	  DNA	  structures	  such	  as	  3'-­‐single-­‐flap,	  nick,	  
and	  blunt	  ended	  DNAs	  to	  remove	  1-­‐nt	   (figure	  1.14).	  The	   last	  characterised	  activity	  of	  FEN-­‐1	   is	  
gen,	  which	   is	   responsible	   for	  cleavage	  of	  DNAs	  with	  secondary	  structures	   like	   forked-­‐gap	  DNA	  
(figure	  1.14).	  In	  vivo	  it	  is	  proposed	  that	  exo	  and	  gen	  FEN-­‐1	  activities	  play	  a	  role	  in	  apoptotic	  DNA	  
fragmentation	  and	  rescue	  of	  stalled	  DNA	  replication.	  1,48	  FEN-­‐1	  is	  considered	  as	  a	  multifunction-­‐
al	   enzyme,	   in	   vitro,	   its	   efficiency	   varies	   greatly	   to	   cleave	   multiple	   structures	   of	   DNA	   (figure	  
1.14).1	  While	  the	  double	  flap	  and	  3'-­‐single-­‐flap	  substrates	  are	  the	   ideal	  DNA	  structures	  for	  eu-­‐
karyotic	  FENs,	  a	  pseudo	  Y	  DNA	  structure	  is	  the	  optimal	  substrate	  for	  the	  lower	  organisms	  such	  
as	  T4-­‐FEN	  and	  T5-­‐FEN	  bacteriophages.1,52,53	  But	  the	  question	  is	  if	  FEN-­‐1	  does	  the	  same	  chemistry	  
to	  hydrolyse	  the	  phosphodiester-­‐bond,	  how	  does	  it	  still	  have	  different	  functions	  or	  does	  it	  just	  
recognise	  different	  substrates?	  	  
1.7.	  The	  3'-­‐flap	  preference:	  
An	  early	  study	  observed	  that	  the	  upstream	  region	  was	  important	  for	  efficient	  cleavage	  by	  FEN-­‐
1s	  from	  higher	  organisms.46.	  Later,	  the	  same	  group	  used	  a	  designed	  double	  flap	  substrate	  with	  
19	  nt	  5'-­‐flap	  and	  either	  1	  nt	  or	  10	  nt	  3'-­‐flap	  lengths	  to	  demonstrate	  the	  importance	  of	  the	  single	  
nt	  3'-­‐flap	  to	  efficient	  binding	  and	  cleavage	  of	  the	  5'-­‐flap	  by	  FEN-­‐1	  in	  higher	  organisms.	  Although	  
the	  DF	  substrate	  with	  10	  nt	  3'-­‐flap	  bound	  less	  efficiently	  than	  DF	  with	  1	  nt	  3'-­‐flap	  and	  5'-­‐SF	  sub-­‐
strates,	  both	  DF	  structures	  cleaved	  more	  efficiently	  than	  5'-­‐SF	  DNA	  (figure	  1.14).	  These	  results	  
provide	  evidence	  for	  the	  importance	  of	  the	  3'-­‐flap	  and	  aid	  understanding	  of	  how	  FEN-­‐1	  recog-­‐
nises	   different	   DNA	   structures,	   although	   the	   exact	   role	   of	   3'-­‐flap	   plays	   to	   recognition	   the	   DF	  
substrate	  by	  FEN-­‐1	  still	  not	  clear.52	  Predilection	  of	  FEN-­‐1	  to	  cleave	  the	  double-­‐flap	  structure	  in-­‐
dicated	  that	  FEN-­‐1	  binds	  the	  3'-­‐flap	  specifically.54	  More	  biochemical	  results	  suggested	  that	  FEN-­‐
1	  catalysis	  requires	  conformational	  changes	  in	  the	  flexible	  loop	  domain	  as	  the	  enzyme	  binds	  its	  
substrate.55,56	  As	  a	  result	  of	  a	  scarcity	  of	  structural	  information	  about	  the	  conformational	  chang-­‐
es	  occurring	  with	  FEN-­‐1	  interactions,	  the	  modelled	  FEN1:DNA	  complex	  did	  not	  explain	  the	  FEN-­‐1	  




Generally,	   FENs	   of	   the	   higher	   organisms	   cleave	   substrates	   with	   3'-­‐flaps	   endonucleolytically	   if	  
they	  have	  a	  5'-­‐flap	  or	  exonucleolytically	  if	  they	  are	  without	  a	  5'-­‐flap	  with	  greater	  efficiency	  than	  
any	  other	  substrate	  (figure	  1.14).1	  It	  is	  of	  great	  interest	  to	  understand	  why	  FEN-­‐1	  prefers	  to	  bind	  
3'-­‐flap	  substrates.	  The	  first	  suggestion	  is	  that	  the	  3'-­‐flap	  increases	  the	  first	  order	  rate	  of	  FEN-­‐1	  
reaction	  after	   initial	   formation	  of	  FEN-­‐1:DNA	  complex.1	  Secondly,	  the	   importance	  of	  3'-­‐flap	  (1-­‐
nt)	  is	  that	  the	  single	  nucleotide	  of	  the	  flap	  is	  complementary	  to	  the	  template	  DNA	  and	  so	  it	  fills	  
and	  closes	  the	  gap	  after	  releasing	  the	  dsDNA	  product	  (figure	  1.15.a).	  Thus,	  the	  ligatable	  nicked	  
product	  will	  not	  require	  initiation	  of	  DNA	  repair	  mechanisms	  that	  are	  required	  in	  absence	  of	  the	  
3'-­‐flap	   because	   of	   the	   production	   of	   gapped	  DNA	   (figure	   1.15.b).1	   Structural	   studies	   of	   FEN-­‐1	  
showed	  that	  the	  higher	  organisms	  possess	  a	  3'-­‐extrahelical	  nucleotide	  binding	  pocket.58	  Obser-­‐
vation	  of	  this	  a	  specific	  binding	  pocket	  of	  3'-­‐flap	  (1-­‐nt)	  in	  the	  hFEN-­‐1	  structure	  underscores	  the	  
great	  importance	  of	  this	  3'-­‐flap	  for	  FEN-­‐1	  substrate	  recognition.	  Placement	  of	  the	  single	  nucleo-­‐
tide	  3'-­‐flap	  in	  this	  pocket	  stabilises	  the	  FEN-­‐1:DNA	  complex.	  Overall,	  absence	  of	  this	  3'-­‐flap	  de-­‐
creases	   the	   catalytic	   efficiency	   of	   FEN-­‐1	   and	   varies	   its	   ability	   to	   interact	   with	   different	   sub-­‐
strates.1,59	  
	  
Figure	  1.15.	  Importance	  of	  the	  3'-­‐flap	  in	  FEN-­‐1	  substrates.	  a)	  The	  double	  flap	  substrate	  produces	  a	  ligatable	  nick.	  b)	  




1.8.	  hFEN-­‐1	  binding	  elements:	  
Based	  on	  biochemical	  evidence,	  FEN-­‐1	  proteins	  of	  higher	  organisms	  prefer	  substrates	  with	  two	  
dsDNA	   regions	   (downstream	   and	   upstream	   duplex	   regions)	   with	   a	   junction	   between	   (figure	  
1.16.a).1	   These	   structures	   contact	   hFEN-­‐1	   via	   several	   positively	   charged	   side	   chains	   of	   amino	  
acids	   that	   extend	   across	   length	  of	   FEN-­‐1	  protein.	   The	  hFEN-­‐1:DNA	   interaction	   is	  mediated	  by	  
several	   binding	   elements	   that	   are	   the	   helix-­‐2-­‐turn-­‐helix	   (H2TH)	   region	  with	   bound	   potassium	  
ion,	   the	  hydrophobic	  wedge,	   the	  3'-­‐flap	  binding	  pocket,	   the	  helical	  arch	   that	   is	  divided	   to	  cap	  
and	  gateway,	  and	  the	  active	  site	  that	  component	  of	  seven	  residues	  surround	  two	  metal	  ion	  (fig-­‐
ure	  1.16.b.c).5	  Each	  binding	  element	  is	  discussed	  in	  detail	  below:	  
	  
Figure	  1.16.	   Binding	  elements	  of	  hFEN-­‐1	   to	   interact	  with	  dfDN	   .	  a)	  DNA	   substrate	  with	  upstream	  and	  downstream	  
regions	   such	  as	  dfDNA	   is	   the	  FEN-­‐1	  preferred	  substrate.	  b)	  hFEN-­‐1	  surface	   shows	   its	  key	  binding	  elements	   that	  are	  
involved	   in	   its	   complex	  with	  product	   (PDB:3QK).	   c)	   Internal	   view	  of	   hFEN1	  product	   complex	   shows	   the	  binding	   ele-­‐
ments	  and	  illustrates	  the	  active	  site	  residues	  that	  directly	  coordinate	  the	  two	  metal	  ion	  
1.8.1.	  The	  K+/H2TH	  binding	  site:	  
The	  helix-­‐two-­‐turn	  helix	  (H2TH)	  is	  a	  classical	  DNA	  binding	  site	  has	  been	  found	  in	  many	  of	  repli-­‐
cation	  and	  repair	  enzymes.	  In	  hFEN-­‐1	  this	  motif	  forms	  by	  α-­‐helices	  10	  and	  11	  and	  binds	  K+	  ion,	  




The	  backbone	  carbonyl	  oxygens	  of	  IIe238	  and	  IIe241	  and	  the	  hydroxyl	  of	  Ser237	  coordinate	  the	  
K+	  ion.	  These	  residues	  exist	  in	  the	  turns	  between	  the	  two	  helices	  (10	  and	  11).	  The	  four	  basic	  res-­‐
idues	  Arg239,	  Lys244,	  Arg245	  and	  Lys267	  from	  the	  H2TH	  region	  protrude	  from	  the	  protein	  sur-­‐
face	   creating	   a	   furrow	   in	   combination	  with	   this	  motif	   (figure	   1.17).2,5	   The	   importance	   of	   this	  
downstream	  duplex	  binding	  site	  towards	  the	  interaction	  with	  the	  substrate	  has	  been	  indicated	  
in	  human	  and	  phage	  FENs.	  Each	  of	  hFEN-­‐1	  double	  mutations	  K244A/R245A	  and	  K252A/K254A	  
impaired	  the	  cleavage	  significantly.60	  Similarly	  in	  T5FEN,	  K215A	  and	  R216A	  mutations	  of	  the	  ex-­‐
tended	  basic	  residues	  resulted	  a	  significant	  deficiency	  in	  binding	  and	  cleavage.57	  	  
	  
1.17.	  Domain	  structure	  of	  K+/H2TH	  in	  hFEN-­‐1	  shows	  the	  residues	  that	  coordinate	  the	  K+	  using	  their	  oxygenic	  atoms	  
and	  the	  residues	  that	  create	  a	  furrow	  in	  this	  region.	  
1.8.2.	  The	  hydrophobic	  wedge:	  
This	  protruding	  binding	  feature	   is	  made	  up	  from	  two	  regions:	  the	  α2-­‐helix	  and	  α2-­‐α3	   loop	  hy-­‐
drophobic	  wedges	  and	  the	  β6-­‐β7	  loop	  (β-­‐pin)	  (figure	  1.16.c).	  Conformational	  changes	  have	  been	  
observed	   in	   the	  α-­‐helices	  and	  connecting	   loop	  and	  the	  positively	  charged	  β-­‐bin	  side	  chains	  by	  
comparison	  the	  crystal	  structure	  of	  the	  enzyme	  within	  and	  without	  substrate.	  This	  motif	  binds	  





1.8.3.	  The	  3'-­‐flap	  binding	  pocket:	  
Structural	  studies	  of	  FENs	  have	  illustrated	  a	  conserved	  binding	  site	  for	  the	  3'-­‐flap	  from	  archaea	  
to	  human.	  The	  first	  crystal	  structure	  of	  Archaeoglobus	  flugidus	  FEN-­‐1	  (AfFEN-­‐1)	  in	  complex	  with	  
a	  3'-­‐overhang	  DNA	   revealed	   the	   importance	  of	   the	   single	  1	  nt	   3'-­‐flap.59	   FEN-­‐1	  possesses	   a	  3'-­‐
extrahelical	   nucleotide-­‐binding	  pocket	   (a	   3'-­‐flap	  pocket)	   that	   contacts	   the	  3'-­‐flap	   to	  open	  and	  
kink	   the	  bound	  DNA.47	  Through	  evolution,	   the	  amino	  acids	   that	   create	   this	  extrahelical	  3'-­‐flap	  
pocket	  have	  been	  observed	  in	  archaea	  and	  human	  but	  not	  in	  phage.	  In	  hFEN-­‐1	  the	  amino	  acids	  
L53,	  Q54,	  N55,	  T61,	  M65,	  K314,	  Q315,	  F316,	  S317	  and	  R320	  form	  the	  3'-­‐flap	  pocket	  region	  (fig-­‐
ure	   1.18).	   These	   ten	   residues	   surround	   the	   3'	   -­‐flap	   forming	   non-­‐sequence	   specific	   hydrogen	  
bonds	  to	  the	  3'-­‐hydroxyl	  and	  van	  der	  Waals	  interactions	  to	  the	  2-­‐deoxyribose	  sugar,	  that	  nucle-­‐
obase	  and	  the	  3'-­‐phosphate	  end.	  This	  binding	  motif	  comprises	  1/8	  of	  the	  hFEN-­‐1:DNA	  binding	  
surface.	  The	  presence	  of	  this	  flap	  besides	  the	  5'-­‐flap	  increases	  the	  reaction	  rates	  of	  FENs	  as	  this	  
binding	  to	   this	  pocket	   is	  very	   important	   to	  orient	   the	  substrate	  and	  position	  the	  scissile	  phos-­‐
phate	  close	  to	  the	  active	  site	  to	  facilitate	  the	  cleavage	  specificity.1,5,58	  	  
	  
Figure	  1.18.	  Domain	  structure	  of	  3'-­‐flap	  pocket	  shows	  their	  main	  residues	  that	  surround	  the	  3'-­‐flap	  of	  the	  substrate	  to	  




1.8.4.	  The	  helical	  arch:	  
Within	  the	  nuclease	  core	  domain,	  a	  major	  FEN-­‐1	  motif	  that	  limits	  the	  active	  site	  dimensions	  has	  
been	  conserved	  throughout	  evolution.	  This	  DNA	  binding	  motif	   is	  known	  as	  the	  helical	  arch	  re-­‐
gion.	  Its	  position	  above	  the	  active	  site	  mediates	  the	  interaction	  with	  the	  single	  stranded	  5'-­‐flap	  
of	  the	  DNA	  substrates.	  In	  hFEN-­‐1	  this	  region	  comprises	  mainly	  charged	  and	  hydrophobic	  amino	  
acid	  residues	  of	  the	  C-­‐terminal	  part	  of	  α2	  and	  all	  of	  α4	  and	  α5.	  This	  region	  has	  been	  divided	  to	  
two	  motifs	  that	  are	  the	  helical	  cap	  (a	  part	  of	  α4	  and	  all	  of	  α5)	  and	  gateway	  (parts	  of	  α4	  and	  α2)	  
(figure	  1.16.c).	  While	   the	  gateway	   is	   conserved	   in	  all	   FEN-­‐1	  superfamily	  members,	   the	  cap	   re-­‐
gion	  is	  only	  present	  in	  FEN-­‐1	  and	  EXO-­‐1.By	  forming	  secondary	  structure,	  the	  helical	  arch	  creates	  
a	  hole	   that	  allows	   ss5'-­‐terminus	  passage	  but	  not	   the	  dsDNA	  structure.	  This	  mostly	  disordered	  
region	  is	  ordered	  upon	  ss5'-­‐terminus	  threading.2,5	  	  
1.8.5.	  The	  active	  site:	  
Like	  most	  nucleases,	  FEN-­‐1	  superfamily	  members	  are	  metalloenzymes.	  They	  are	  characterised	  
with	  a	  long	  adaptable	  loop	  (arch)	  above	  a	  carboxylate	  rich	  active	  site	  that	  coordinate	  two	  essen-­‐
tial	  metal	  ions	  cofactors.	  Structural	  studies	  of	  FENs	  active	  sites	  observed	  eight	  carboxylate	  resi-­‐
dues	  in	  bacteriophages	  and	  bacteria,	  but	  only	  seven	  in	  all	  FENs	  of	  the	  higher	  organisms.	  These	  
active	  site	  residues	  of	  FENs	  provide	  coordination	  positions	  for	  divalent	  metal	  ion	  cofactors	  that	  
catalyse	  rate	  enhancement.	   Initial	   structures	   for	  crystallised	  FENs	   in	  bacteriophage	  T4	  and	  T5,	  
archaea,	   and	   human	   showed	   that	   the	   two	  metal	   ions	   bound	   to	   the	   active	   sites	   with	   varying	  
spaces	  6.3,	  8,	  5,	  and	  3.4	  Å	  respectively	  (figure	  1.19).	  The	  N-­‐terminus	  in	  higher	  organism	  proteins	  
(archaea	  and	  humans)	  seems	  to	  have	  replaced	  the	  “second”	  metal	  ion	  position	  in	  phage	  struc-­‐
tures	  with	  the	  N-­‐terminus,	  which	  seems	  to	  push	  the	  “second”	  ion	  towards	  the	  first	  metal	  ion	  in	  
higher	  organism	  FENs.	  Despite	  of	  the	  exact	  roles	  of	  this	  positive	  charged	  N-­‐terminus	  remaining	  
unknown,	  their	  occurrence	  in	  the	  active	  site	  of	  the	  higher	  organism	  enzyme	  may	  suggest	  an	  im-­‐
portant	  role	  during	  catalysis.	  Some	  studies	  suggest	  a	  third	  metal	  ion	  is	  transferred	  to	  the	  active	  







Figure	  1.19.	  The	  observed	  two	  metal	  ions	  in	  active	  sites	  of	  FENs.	  a)	  T5FEN	  (PDB:	  1UT5).	  b)	  T4FEN	  (PDB:	  1TFR).	  c)	  hFEN-­‐
1	  (PDB:1UL1).	  d)	  mjFEN-­‐1	  (Methanococcus	   jannaschii	  FEN)	  (PDB:	  1A77).	  Black	  arms	   illustrate	  positions	  of	  the	  active	  
site	  carboxylate	  groups,	  and	  grey	  spheres	  (1	  &	  2)	  show	  the	  two	  metal	  ions	  of	  FENs	  active	  site.	  FENs	  of	  the	  lower	  or-­‐
ganisms	  phage	  and	  bacterial	  (a	  &	  b)	  have	  an	  extra	  active	  site	  residue	  (T5	  Asp201,	  T4	  Asp197),	  while,	  the	  N-­‐terminus	  of	  
the	  protein	  in	  the	  higher	  organisms	  human	  and	  archaeal	  (c	  and	  d)	  engages	  a	  similar	  position	  to	  metal	  ion	  2.	  However,	  
M1	  is	  bound	  in	  a	  similar	  location	  in	  all	  structures,	  M2	  position	  is	  changeable	  to	  vary	  the	  space	  between	  the	  two	  metal	  
ions.	  The	  spaces	  between	  M	  1	  and	  M2	  in	  the	  structures	  are	  a)	  8,	  b)	  6.3,	  c)	  3.4	  and	  d)	  5	  Å.3	  
In	  hFEN-­‐1	  the	  two	  metal	  ions	  are	  coordinated	  by	  D86,	  E160,	  D179	  and	  D181	  to	  make	  the	  inner	  
sphere,	  thus	  the	  other	  three	  residues	  of	  the	  active	  site	  D34,	  E158	  and	  D233	  and	  Y234	  interact	  
with	  the	  water	  molecules	  to	  make	  the	  outer	  sphere.	  All	  of	  these	  features	  with	  either	  N-­‐terminus	  
or	  a	  third	  metal	  ion	  specify	  the	  target	  phosphodiester	  bond	  to	  start	  the	  hydrolysis.	  Besides	  that,	  
later	  studies	  suggest	  more	   interactions	  with	  the	  gateway	  aromatic	  residue	  Y40	  from	  helix	  two	  
and	  the	  gateway	  basic	  residues	  K93	  and	  R100	  from	  helix	  four	  stabilise	  the	  substrate	  during	  and	  
after	  the	  chemistry	  (figure	  1.20).	  Consequently,	  they	  are	  presented	  as	  an	  active	  site	  residues	  in	  





Figure	  1.20.	  The	  main	  seven	  active	  site	  residues	  of	  hFEN-­‐1	  in	  product	  complex	  and	  their	  oxygen	  atoms	  to	  coordinate	  
two	  Sm3+	  metal	   ion	   and	   to	   form	   the	   sphere	   (PDB:3QK).	  Also	   includes	   the	   three	  basic	   residues	  K93,	  R100	  and	  R104	  
from	  α4,	  and	  an	  aromatic	  residue	  Y40	  from	  α2	  that	  have	  roles	  to	  organise	  the	  5'-­‐end	  using	  their	  oxygen	  and	  nitrogen	  
atoms.	  	  
A	  variety	  of	  divalent	  metal	  ions	  have	  been	  observed	  in	  living	  organisms	  such	  as	  Mg2+,	  Ca2+,	  Mn2+,	  
Fe2+,	  Ni2+,	  Cu2+	  and	  Zn2+,	  with	  Mg2+	  at	  the	  highest	  concentration	  inside	  cells.	  Each	  is	   involved	  in	  
specific	  enzymatic	   catalysis.	  Nucleases	  active	   sites	  are	  usually	  associated	  with	  Mg2+.12,52,63	   This	  
preferred	  binding	  of	  Mg2+	  by	  nucleases	  possibly	  refers	  to	  its	  availability,	  solubility,	  redox	  stability	  
compared	  to	  Mn2+,	  Fe2+	  and	  Cu2+,	  its	  stringent	  coordination	  geometry	  compared	  to	  Fe2+,	  Ni2+	  and	  
Cu2+,	   small	   size	   compared	   to	  Ca2+	   and	   its	   unusual	   hydration	  properties.12	  As	   indicated	  before,	  
the	  divalent	  metal	  ion	  Mg2+	  is	  essential	  for	  the	  nuclease	  function	  of	  FEN-­‐1	  superfamily	  as	  both	  
an	  exonuclease	  and	  a	  structure	  specific	  endonuclease.	  Similar	   in	  vivo,	  Mg2+	   is	  used	  to	  catalyse	  
the	  phosphodiester	  bond	  hydrolysis	  to	  study	  these	  essential	  roles	  in	  vitro.	  However,	  the	  bigger	  
sized	  ion	  Ca2+	  is	  used	  to	  inhibit	  the	  hydrolysis.12	  For	  the	  structural	  study	  of	  FEN1,	  it	  is	  crystalized	  





1.9.	  FEN-­‐1:DNA	  interaction	  features:	  
The	  FEN-­‐1	   superfamily	   contains	  multifunctional	   enzymes	  with	   similar	   active	   site	  domains	   that	  
are	  involved	  in	  nearly	  all	  DNA	  pathways	  (replication,	  recombination	  and	  repair).	  Binding	  of	  the	  
enzyme	  to	  the	  favoured	  substrate	  ensures	  that	  the	  hydrolysis	  occurs	  strictly	  in	  the	  right	  position	  
so	  that	  the	  product	  can	  be	  used	  for	  downstream	  processes.64	  The	  hydrolysis	  mechanism	  of	  FEN-­‐
1	  in	  each	  organism	  requires	  a	  specific	  distance	  between	  the	  two	  metal	  ions	  (from	  their	  closest	  
sites).3	   Although	   the	   absence	   of	   the	   two	   metal	   ions	   does	   not	   inhibit	   formation	   of	   the	  
T4FEN:DNA	  complex	  as	  seen	  in	  a	  structure	  of	  this	  protein-­‐substrate	  in	  the	  presence	  of	  EDTA,	  the	  
target	  site	  of	  FEN	  hydrolysis	  (1nt	  into	  the	  downstream	  duplex)	  is	  not	  close	  enough	  to	  the	  active	  
site	  for	  the	  hydrolysis	  to	  occur	   (figure	  1.13.c).2,44	  This	  suggests	  that	  the	  two	  metal	   ions	  are	  re-­‐
quired	  to	  achieve	  better	  contact	  between	  the	  target	  phosphodiester	  bond	  and	  the	  active	  site.	  
Historically,	   several	   different	   mechanisms	   were	   proposed	   for	   FEN-­‐1	   substrate	   recognition.	   In	  
spite	   of	   the	   variation	   between	   FENs	   in	   terms	   of	   favoured	   substrates,	   binding	   method,	   and	  
mechanistic	  details,	  all	  of	   them	  share	   the	  common	  mechanism	  of	  phosphodiester	  bond	  selec-­‐
tion	  using	  the	  two	  metal	  ions	  active	  site.	  Models	  of	  FEN-­‐1	  mechanism	  were	  proposed	  in	  previ-­‐
ous	   studies	   to	   address	   how	   FEN-­‐1	   recognizes	   substrate.	   In	   one	   model	   of	   FEN-­‐1	   mechanism,	  
which	  known	  as	  a	  tracking	  model,	  FEN-­‐1	  recognizes	  the	  5'-­‐flap	  end	  to	  push	  it	  self	  towards	  the	  
ss/ds	  junction.50	  However,	  this	  mechanism	  was	  ruled	  out	  by	  the	  observations	  that	  beside	  double	  
flap	   substrate,	   FEN-­‐1	   possesses	   3'-­‐SF	   and	   gap	   substrates	  with	   comparable	   efficiencies	   (figure	  
1.12.a).5,29,58	  A	  second	  model	   is	  known	  as	  the	  threading	  model	  suggested	  that	  FEN-­‐1	  binds	  the	  
DNA	  junction	  first	  then	  threads	  the	  flap.	  But	  also	  this	  mechanism	  raises	  concerns	  about	  the	  abil-­‐
ity	  of	   flap	   threading	   through	  a	  small	  hole	  especially	  when	  accommodating	  gapped	   flaps.58,65	  A	  
third	  clamping	  model	  suggested	  that	  FEN-­‐1	  folds	  its	  helical	  arch	  over	  the	  5'-­‐flap	  allowing	  inter-­‐
action	  with	   the	   gateway	   residues.29	  However,	   the	   clamping	  model	   is	   not	   compatible	  with	   the	  
need	  to	  confine	  reaction	  to	  free	  (discontinuous)	  5'-­‐ends.	  	  
An	  alternative	  disorder-­‐thread-­‐order	  mechanism	   is	  currently	   the	  preferred	  one.	   In	   this	  model,	  
binding	  of	  the	  upstream	  and	  downstream	  double	  strand	  regions	  of	  dfDNA	  first,	  followed	  by	  5'-­‐
flap	   threading	   through	  the	  disordered	  helical	  arch	  and	  3'-­‐flap	  engagement	   into	  3'-­‐flap	  pocket.	  
Then,	  following	  ordering	  of	  the	  helical	  arch	  and	  3'-­‐flap	  pocket	  the	  scissile	  phosphate	  bond	  will	  
be	  positioned	  into	  the	  active	  site.2	   In	  fact,	  many	  specific	  details	  about	  this	  mechanism	  are	  still	  
unknown,	   for	  example,	  no	  evidence	  can	  suggest	  which	  of	   the	  flaps	   is	  organized	  first	  or	   if	   they	  
are	  organized	  simultaneously.	  The	  overall	  disorder-­‐thread-­‐order	  mechanism	  as	  shown	  in	  figure	  





Figure	  1.21.	  A	  diagram	  of	  the	  disorder-­‐thread-­‐order	  mechanism	  of	  FEN-­‐1	  (E)	  and	  DF	  substrate	  (S)	  interaction	  deduced	  
from	  FENs	  studies	  to	  date	  and	  there	  may	  be	  more	  steps	  in	  the	  reaction	  than	  illustrated.	  1)	  E	  binds	  S	  to	  bend	  S	  and	  to	  
form	  the	  ES	  complex.	  2)	  To	  cleave	  the	  substrate,	  ES	  complex	  undergoes	  conformational	  changes	  creating	  a	  cleavage	  
competent	  complex	  ES’.	  3)	  Catalysis	  creates	  5’-­‐flap	  (P)	  and	  dsDNA	  (Q)	  products.	  As	  the	  flap	  product	  releases	  the	  com-­‐
plex	   immediately	  upon	  cleavage,	   the	  Q	  product	   results	  as	  EQ	  complex.	  4)	  Dissociation	  of	   the	  EQ	  complex	   results	   in	  
nicked	  DNA	  (Q)	  and	  free	  FEN1	  enzyme.	  
1.9.1.	  Binding:	  
FEN-­‐1	  binds	   the	  downstream	  portion	  of	   the	  DNA	  that	  undergoes	   reaction	  via	   the	  non-­‐specific	  
dsDNA	  interaction	  motif	  K+/H2TH	  (figure	  1.22.a).	  The	  majority	  of	  DNA	  interactions	  occur	  at	  the	  
template	  strand	  via	  this	  region.	  The	  interaction	  occurs	  through	  a	  direct	  contact	  between	  the	  K+	  
ion	   and	   the	   four	   protruding	   basic	   residues	   of	   this	  motif	   and	   the	   phosphate	   backbone	   of	   the	  
complementary	  strand	  of	  the	  DNA	  (figure	  1.22.b).	  This	  interaction	  may	  allow	  fluid	  slide	  for	  the	  
DNA	  minor	  groove	  through	  the	  furrow	  created	  by	  four	  protruding	  basic	  residues	  within	  the	  pro-­‐




the	  protein	  surface	  introducing	  the	  substrate	  to	  more	  binding	  interactions	  that	  allow	  for	  bend-­‐
ing	  of	  the	  DNA.2,5	  
	  
Figure	  1.22.	  Binding	  of	  the	  DF	  substrate	  by	  H2TH	  motif	  of	  hFEN1.	  a).	  Structure	  of	  hFEN1	  product	  complex	  (PDB:3QK)	  
shows	  binding	  of	  the	  downstream	  region	  of	  DF	  DNA	  by	  H2TH	  region	  and	  its	  fluid	  slide	  through	  the	  furrow	  of	  the	  re-­‐
gion.	  b).	  Front	  view	  of	   the	  H2TH	   region	  shows	   interaction	  of	  The	  K+	   ion	  with	  the	  back	  bond	  of	   the	  complementary	  
strand	  of	  the	  DNA	  and	  the	  basic	  residues	  that	  create	  the	  furrow	  within	  protein	  surface.	  c)	  Back	  view	  of	  the	  H2TH	  re-­‐
gion	  shows	  its	  basic	  residues	  that	  create	  the	  furrow	  within	  protein	  surface	  and	  its	  residues	  that	  coordinate	  the	  K+	  ion.	  	  
1.9.2.	  Bending:	  
Beyond	  the	  K+/H2TH	  motif,	  arcs	  of	  the	  template	  strand	  become	  free	  from	  the	  protein	  surface.	  
They	  re-­‐join	  close	  to	  the	  active	  site	  by	  hydrophobic	  wedge	  motif.	   Introducing	  the	  substrate	  in-­‐
duces	  disorder-­‐to-­‐order	  transition	  of	  the	  α2-­‐α3	  loop	  and	  moves	  the	  β-­‐pin	  to	  position	  the	  tem-­‐
plate.	  The	  reacting	  strand	  interacts	  with	  a	  basic	  residue	  that	  is	  provided	  by	  β-­‐pin	  to	  pass	  under	  




stacks	  between	  the	  base	  pairs	  of	  either	  side	  of	  the	  dsDNA	  junction.	  The	  hydrophobic	  wedge	  (β-­‐
pin	  and	  α	  helix	  amino	  acids	  residues)	  also	  binds	  the	  upstream	  template	  by	  an	  interaction	  with	  
the	  last	  three	  base	  pairs	  (next	  to	  the	  3'-­‐flap)	  to	  bend	  the	  substrate	  (figure	  1.23.a.b).	  This	  binding	  
feature	  bends	  the	  substrate	  markedly	  at	  a	  single	  phosphodiester	  bond	  with	  ~100°	  between	  up-­‐
stream	  and	  downstream	  regions	  of	  reacted	  DNA	  (figure	  1.23.a).	  The	  bent	  conformation	  at	  the	  
DNA	  junction	  is	  stabilised	  by	  an	  extra	   interaction	  between	  the	  last	  base	  pair	  face	  and	  some	  of	  
the	   hydrophobic	  wedge	   residues.	   The	   bent	   substrate	   forms	  what	   looks	   like	   an	   arch	   from	   the	  
template	  strand.2,5	  Ensemble	  FRET	  experiments	  confirmed	  that	  this	  bent	  conformational	  change	  
of	  the	  DF	  substrate	  is	  stabilised	  by	  hFEN-­‐1	  binding.47	  The	  big	  conformational	  change	  of	  this	  bind-­‐
ing	   interaction	  presents	  the	  two	  flaps	  of	  the	  DF	  DNA	  to	  the	  next	  two	  binding	  elements,	  which	  
are	   the	  helical	  arch	  and	  the	  3'-­‐flap	  binding	  pocket.5	  There	   is	  currently	  no	  evidence	  confirming	  
which	  accommodation	  of	  the	  3'-­‐flap	  and/or	  5'-­‐flap	  occurs	  after	  this	  initial	  binding	  and	  bending	  
or	   even	   at	   what	   point	   the	   DNA	   is	   threaded	   nor	   whether	   there	   is	   equilibrium	   with	   a	   non-­‐
threaded	  form.	  	  
	  
Figure	  1.23.	  Bending	  of	  the	  DF	  substrate	  by	  hFEN1	  wedge.	  a)	  hFEN1	  product	  complex	  (PDB:3QK)	  shows	  bent	  product	  
at	   the	   junction	  between	   the	  upstream	   and	  downstream	  DNA	   regions	  by	  hydrophobic	  wedge	  motif.	  b)	   View	  of	   the	  




1.9.3.	  The	  5'-­‐flap	  threading:	  
It	  is	  known	  that	  the	  5'-­‐flap	  is	  threaded	  through	  the	  helical	  arch.	  After	  the	  5'-­‐flap	  is	  threaded,	  the	  
arch	   residues	   (cap	   and	   gateway)	   go	   from	   a	   disordered-­‐to-­‐ordered	   helical	   state.	   The	   disorder-­‐
thread-­‐order	  transition	  structures	  the	  cap	  and	  the	  gateway	  to	  limit	  the	  dimensions	  of	  the	  helical	  
arch.	  The	  ordered	  gateway	  width	  allows	  only	  ssDNA	  passage	  while	  prevents	  entry	  of	  the	  dsDNA	  
and	   this	   is	   could	   be	   another	   FEN-­‐1	   technique	   to	   organise	   specific	   DNA	   structures	   (figure	  
1.24.a.b).5	   Any	   bulky	   addition	   to	   the	   5'-­‐flap	   such	   as	   streptavidin	   (SA)	   prevents	   the	   threading	  
through	  the	  structured	  or	  unstructured	  helical	  arch	  resulting	  in	  a	  drastically	  slowed	  FEN-­‐1	  reac-­‐
tion.50	  	  
The	   requirement	   of	   ss-­‐flap	   for	   the	   disordered-­‐to-­‐ordered	   threading	   mechanism	   raised	   many	  
questions	  regarding	  the	  processing	  of	  3'-­‐SF	  substrate	  (without	  5'-­‐flap)	  and	  gapped	  DNA	  (5'-­‐flap	  
containing	  secondary	  structure)	  with	  FEN-­‐1.	  Biological	  results	  are	  related	  to	  ss5'-­‐flap	  length	  ef-­‐
fects	   demonstrated	   that	   the	   5'-­‐flap	   length	   does	   not	   affect	   the	   binding	   affinity	   of	   the	  DF	   sub-­‐
strate.51	  However,	   the	   total	   removal	   of	   this	   5'-­‐flap	   creating	   an	  exo	   substrate	   (3'-­‐SF)	   has	   small	  
effects	  on	  substrate	  binding	  and	  cleavage,66	  which	  suggested	  that	  the	  5'-­‐flap	  is	  not	  required	  for	  
disorder-­‐to-­‐order	  transition	  as	  this	  could	  be	  brought	  about	  by	  the	  first	  two	  downstream	  nucleo-­‐
tides.	  More	  evidence	  relating	  to	  gapped	  DNA	  clarified	  that	  a	  5'-­‐flap	  with	  secondary	  structure	  is	  
excised	  efficiently	  by	  the	  gen	  activity	  of	  FEN-­‐1	  via	  the	  same	  mechanism	  of	  fen	  activity.51,60	  Theo-­‐
retically,	  the	  binding	  of	  the	  complementary	  strand	  of	  the	  gap	  substrate	  orients	  the	  dsDNA	  struc-­‐
ture	  of	   the	  5'-­‐flap	   into	  the	  disordered	  archway	  region.	  Consequently,	   the	  arch	  region	  must	  be	  
reordered	  after	  threading	  of	  the	  ss-­‐flap	  section.51	  	  
Regardless	  of	  the	  5'-­‐flap	  length	  or	  the	  presence	  of	  a	  short	  duplex	  within	  the	  5'-­‐flap,	  the	  mostly	  
disordered	  region	  is	  ordered	  upon	  substrate	  binding	  and	  threading.	  This	  ordered	  region	  is	  stabi-­‐
lised	  through	  the	  interactions	  with	  the	  residues	  M37	  and	  Y40	  in	  α2	  gateway,	  K93	  and	  R100	  in	  α4	  
gateway	  region,	  R103	  and	  R104	  in	  α4	  gateway/cap	  region,	  and	  K125,	  K128,	  and	  R129	  in	  α5	  cap	  
region.2,5	  Threading	  of	  the	  5'-­‐termini	  into	  the	  disordered	  helical	  arch	  positions	  the	  scissile	  phos-­‐
phate	  near	  the	  active	  site	  with	  neither	  direct	  contact	  to	  the	  two	  metal	  ions	  nor	  the	  amino	  acid	  
residues	  of	  the	  active	  site	  to	  undergo	  hydrolysis	  (figure	  1.24.c.d).1,5	  Accordingly,	  an	  extra	  force	  is	  





Figure	  1.24.	  Threading	  of	  5'-­‐end	  of	  substrate	  by	  hFEN1.	  a)	  and	  b)	  Front	  and	  back	  view,	  respectively,	  of	  hFEN1	  3'-­‐flap	  
substrate	  complex	  (PDB:3Q8L)	  shows	  threading	  of	  5'-­‐end	  through	  the	  helical	  arch	  (cap	  and	  gateway).	  c)	  and	  d)	  Front	  
and	  back	  view,	  respectively,	  of	  the	  helical	  arch	  shows	  its	  residues	  from	  the	  gateway	  that	  may	  interact	  with	  the	  5'-­‐end	  
of	  the	  substrate.	  	  
1.9.4.	  The	  3'-­‐flap	  engagement:	  
Along	  with	  two-­‐way	  dsDNA	  junction	  bending	  by	  the	  hydrophobic	  wedges,	  the	  upstream	  duplex	  
places	  the	  1nt	  3'-­‐flap	  of	  the	  DF	  substrate	  near	  the	  3'-­‐flap	  binding	  pocket	  of	  FEN-­‐1	  (figure	  1.25.a).	  
The	   ten	  amino	  acid	   residues	  of	   the	  3'-­‐flap	  binding	  pocket	   surround	  and	   interact	  with	   the	   last	  
nucleotide	  of	   the	  upstream	  DNA	   region	   (1nt	  3'-­‐flap).	  Amazingly,	   this	   cleft	   can	  only	   fit	   a	   single	  
unpaired	  nucleotide	  of	   the	  3'-­‐flap	   and	   recognises	   the	   single	  nucleotide	   regardless	  of	   base	   se-­‐
quence	   (figure	  1.25.b).	   Therefore,	  most	  of	   the	  3'-­‐flap	   strand	  does	  not	   interact	  with	  FEN-­‐1	  alt-­‐
hough	   it	   is	  base-­‐paired	  with	  the	  template	  strand.	  The	  3'-­‐flap	  specificity	  allows	  FEN-­‐1	  to	  recog-­‐
nise	   different	   DNA	   structures,	   which	   have	   1nt	   3'-­‐flap	   such	   as	   double	   flap,	   3'-­‐single	   flap	   and	  




the	  FEN-­‐1:DNA	  complex	  and	  prevent	  flap	  migration	  and	  cause	  FEN-­‐1	  to	  be	  structure	  specific	  for	  
dfDNA.1,5	  Recognition	  of	  the	  two-­‐way	  DNA	  junction	  and	  threading	  of	  the	  two	  flaps	  capture	  the	  
substrate	  initially	  to	  place	  the	  selected	  scissile	  phosphate	  close	  to	  the	  active	  site	  but	  not	  in	  the	  
exact	  required	  position	  for	  hydrolysis	  (figure	  1.25.c.d).	  	  
	  
Figure	  1.25.	  Threading	  of	  3'-­‐flap	  of	  double	  flap	  substrate	  by	  hFEN1.	  a)	  Total	  view	  for	  threading	  of	  the	  5'-­‐end	  and	  3'-­‐
flap	  of	  df-­‐substrate	  in	  hFEN1	  product	  complex	  (PDB:3QK)	  into	  the	  helical	  arch	  and	  the	  3'-­‐flap	  flap	  pocket	  respectively.	  
b)	  View	  of	  the	  3'-­‐flap	  pocket	  and	  its	  residues	  (oxygen	  and	  nitrogen	  atoms	  shown)	  that	  surround	  the	  3'-­‐flap.	  c)	  and	  d)	  
Front	  and	  back	  view,	  respectively,	  of	  the	  helical	  arch	  show	  the	  different	  position	  of	  the	  5'-­‐end	  between	   its	  residues	  




1.9.5.	  Shifting	  of	  the	  scissile	  phosphate	  bond	  to	  reach	  the	  active	  site	  metal	  ion:	  	  
In	  fact,	  all	  the	  suggested	  models	  of	  FEN-­‐1	  mechanism	  (tracking,	  threading	  and	  clamping)	  did	  not	  
explain	  how	  FEN-­‐1	  specifies	  the	  target	  incision	  site	  and	  moves	  it	  onto	  the	  metal	  ion	  active	  site.	  
This	  led	  to	  a	  focus	  on	  the	  molecular	  active	  site	  changes	  that	  occur	  during	  the	  chemistry	  by	  com-­‐
paring	  between	  the	  enzyme	  substrate	  and	  enzyme	  product	  complexes.	  As	  a	  result	  a	  Double	  Nu-­‐
cleotide	  Unpairing	  mechanism	  (DNU)	  was	  proposed	  (figure	  1.26.a).	  
A	   structural	   study	   of	   EXO-­‐1	   and	   hFEN-­‐1	   enzyme	   substrate	   (ES)	   and	   product	   (EP)	   complexes	  
showed	  base	  pairing	  of	  the	  +1nt	  and	  -­‐1nt	  in	  the	  substrate	  complex.	  However,	  the	  product	  com-­‐
plex	  showed	  unpairing	  of	   the	   -­‐1nt	  and	  small	  differences	   in	   the	  positions	  of	   -­‐1nt	  and	  template	  
strand	  (figure	  1.26.b).5,29	  The	  two	  metal	  ion	  sites	  in	  the	  crystal	  structure	  of	  hFEN-­‐1	  are	  occupied	  
by	  Sm3+	  ions	  that	  support	  binding	  but	  prevent	  cleavage.	  Despite	  neutralisation	  of	  the	  active	  site	  
negative	  charge	  in	  hFEN-­‐1	  complexes,	  the	  target	  phosphate	  diester	  bond	  in	  the	  substrate	  com-­‐
plex	  was	  around	  5.2	  Å	  from	  either	  metal	   ion,	  however,	  the	  unpaired	  -­‐1nt	  of	  the	  product	  com-­‐
plex	  was	   coordinated	   directly	   with	   the	   active	   site	  metal	   ions	   (figure	   1.26.c).	   In	   the	   substrate	  
complex	  Y40	  was	  stacked	  with	  the	  +1	  nt,	  but	  in	  the	  product	  complex	  it	  was	  stacked	  with	  the	  un-­‐
paired	  and	  rotated	  -­‐1	  nt	  (≈25°).	  The	  template	  strand	  showed	  a	  slight	  difference	  in	  the	  position	  in	  
both	   the	   substrate	   and	   product	   complexes	   because	   of	   its	   interaction	   with	   the	   hydrophobic	  
wedge	   (α2	   and	   β	   pin).5	   These	   differences	   between	   the	   substrate	   and	   the	   product	   complexes	  
suggested	  a	  double	  nucleotide	  unpairing	  mechanism	  occurs	  at	  +1	  and	  -­‐1	  nts.5	  	  
This	  DNU	  mechanism	  was	  suggested	  to	  promote	  localisation	  of	  the	  target	  phosphate	  bond	  (one	  
nucleotide	  into	  the	  downstream)	  between	  the	  two	  metal	  ions	  and	  toward	  the	  carboxylate	  rich	  
region	  that	  stabilises	  this	  unpaired	  state	  (figure	  1.26.a).3,44,64	  Thus,	  there	  is	  no	  evidence	  to	  sug-­‐
gest	  if	  the	  disorder-­‐to-­‐order	  transition	  step	  is	  a	  prerequisite	  for	  the	  double	  nucleotide	  unpairing.	  
Furthermore,	  it	  is	  unknown	  if	  this	  duplex	  end	  unpairing	  is	  necessary	  for	  the	  chemistry	  to	  release	  
the	  5'-­‐flap	  by	  locating	  the	  scissile	  phosphate	  bond	  into	  the	  right	  position	  or	   is	   it	  a	  step	  to	  pre-­‐
vent	  hFEN-­‐1	  reaction	  with	  the	  duplex	  DNA.2,5,37	  	  
More	  recently,	  collaborative	  structural	  studies	  have	  revealed	  that	  unpairing	  does	  not	  take	  place,	  
but	  the	  DNA	  becomes	  untwisted.	  This	  is	  dealt	  with	  in	  further	  detail	  later,	  nevertheless	  there	  is	  a	  





Figure	  1.26.	  Double	  Nucleotide	  Unpairing	  (DNU)	  mechanism	  is	  conserved	  across	  FEN	  superfamily.	  a)	  Cartoon	  of	  the	  
DNU	  mechanism	  represents	  orientation	  of	  the	  target	  phosphodiester	  bond	  in	  the	  enzyme	  active	  site	  between	  the	  two	  
metal	   ion	   sites.	  b)	   Complexes	   of	   hFEN-­‐1	  with	   substrate	   (PDB:3Q8L)	   and	   product	   (PDB:3QK)	   that	   support	   the	   DNU	  
mechanism.	   In	   the	  ES	   complex	   the	   two	  nucleotides,	  +1	   and	   -­‐1	   that	  are	  on	  either	   side	  of	   the	   target	  phosphodiester	  
bond,	  are	  still	  paired.	  In	  the	  EP	  complex	  the	  terminal	  -­‐1	  nucleotide	  is	  unpaired.	  Therefore,	  the	  +1	  and	  -­‐1	  nucleotides	  
are	  assumed	  to	  be	  unpaired.	  The	  helical	  gateway	  is	  the	  base	  of	  α4	  and	  α2,	  and	  the	  helical	  cap	  is	  top	  of	  α4	  and	  α5.	  c)	  
Comparison	  of	  the	  substrate	  and	  product	  DNA	  near	  the	  active	  sites	  shows	  that	  double	  nucleotide	  unpairing	  (+1	  and	  -­‐1	  
nucleotides)	  allows	  direct	  interaction	  between	  the	  scissile	  phosphate	  and	  two	  metal	  ion	  active	  site.67	  
1.9.6.	  Catalysis	  and	  product	  release:	  
The	  initial	  binding	  of	  FEN-­‐1	  to	  the	  dsDNA	  two-­‐way	  junction	  by	  the	  H2TH	  and	  wedge	  regions,	  the	  
consequent	  bending	  at	  the	  DNA	  junction,	  accommodation	  of	  the	  two	  flaps,	  and	  the	  double	  nu-­‐
cleotide	  unpairing	  or	  untwisting	  are	  conformational	  changes	  that	  position	  the	  scissile	  phosphate	  
bond	   into	   the	   active	   site.	   As	   DNA	   conformational	   change	   is	   proposed	   to	   localize	   the	   target	  




active	   site,	   one	  metal	   ion	   faces	   the	  5'	   side	   and	   the	  other	  one	   faces	   the	  3'	   side	  of	   the	   scissile	  
phosphate.	  The	  active	  site	   residues	  Y40	   (in	  α2),	  K93	  and	  R100	   (in	  α4)	  are	   the	  key	   for	  efficient	  
DNA	   positioning	   to	   start	   the	   hydrolysis	   reaction	   and	   stabilise	   the	   resulted	   cleavage	   (figures	  
1.27.a.b).	  Structural	  data	  position	  the	  two	  metal	  ions	  in	  coordination	  variously	  with	  the	  attack-­‐
ing	  nucleophile,	  leaving	  group	  and	  phosphate	  oxygens	  to	  start	  the	  chemistry.68	  	  
	  
Figure	  1.27.	  The	  key	  residues	  of	  the	  active	  site	  and	  helical	  gateway	  of	  hFEN-­‐1.	  a)	  and	  b)	  The	  different	  positions	  of	  the	  
terminal	  nucleotides	  +1	  and	  -­‐1	   in	  hFEN1	  substrate	  and	  product	  complexes	  respectively.	  This	  illustrates	  the	  coordina-­‐
tion	  of	  key	  residues	  with	  the	  respective	  nucleotides	  in	  the	  different	  states.	  The	  oxygen	  and	  nitrogen	  atoms	  of	  the	  side	  
chains	  were	  shown.	  
The	   presence	   of	   the	   two	  metal	   ions	   active	   site	   is	   the	   common	   and	   significant	   feature	   of	   the	  
phosphodiesterases.	  It	  has	  been	  suggested	  that	  hFEN-­‐1	  uses	  the	  two	  metal	  ion	  mechanism	  pro-­‐
posed	  previously	  for	  3'-­‐5'exonuclease.12,69	  In	  this	  mechanism,	  the	  phosphodiester	  bonds	  are	  hy-­‐
drolysed	  using	  an	  addition-­‐elimination	  type	  mechanism	  in	  harmony	  leading	  to	  inversion	  of	  con-­‐
figuration	  at	  the	  central	  phosphorus	  (figure	  1.7).12,70	  The	  two	  metal	  ion	  chemistry	  is	  claimed	  to	  
have	  the	  advantage	  of	  high	  substrate	  specificity	  and	  efficient	  product	  release.12	  The	  active	  site	  
metal	   ions	   interact	  with	   the	  non-­‐bridging	  phosphate	  oxygens	  of	   the	   substrate.	   In	   such	  a	  way,	  
they	  may	  catalyse	  the	  reaction	  by	  acting	  as	  a	  Lewis	  acid	  factor	  (electron-­‐accepting).	  The	  Lewis	  
acid	  effect	  of	  one	  or	  more	  Mg2+	  increases	  the	  electrophilic	  power	  of	  the	  phosphorus	  atom	  of	  the	  
scissile	  bond	   (figure	  1.28.a).	  This	  environment	  maybe	  catalyses	   the	   reaction	  by	  enhancing	   the	  
nucleophile	  formation,	  by	  locating	  the	  nucleophile	  in-­‐line	  with	  the	  target	  bond	  or	  by	  stabilising	  
the	   leaving	   group.61,68	   Another	  mechanism	   suggests	   a	   direct	   interaction	  with	   only	   one	   of	   the	  




one	  is	  exposed	  to	  the	  solvent	  (figure	  1.28.b).12	  At	  all	  events,	  the	  direct	  and	  indirect	  interactions	  
between	  the	  active	  site	  metal	   ions	  and	  the	  non-­‐bridging	  oxygen	  are	  suggested	  to	  develop	  the	  
positive	  charge	  on	  the	  phosphorus	  with	  simultaneous	  with	  nucleophilic	  attack	  and	  breakage	  of	  
the	  P−O	  bond	  to	  the	  leaving	  group.12,68	  
	  
Figure	  1.28.	  Active	   site	  metal-­‐ion-­‐	   dependent	  mechanism	  of	   the	  phosphodiesterases.	  a)	   The	   two	  metal	   ion	  mecha-­‐
nism.	  Both	  metal	  ions	  coordinate	  the	  OSP	  of	  the	  scissile	  phosphate	  bond	  from	  both	  sides	  5'	  and	  3'.	  b)	  The	  one	  metal	  ion	  
mechanism.	  While	  one	  metal	  ion	  coordinates	  the	  OSP	  of	  the	  scissile	  phosphate	  bond,	  the	  metal	  ion	  A	  is	  eliminated.
12	  
1.10.	  FEN-­‐1	  mutations	  and	  their	  link	  to	  cancer:	  
Unrepaired	   damaged	   DNA	   causes	   accumulation	   of	   genetic	  mutations	   and	   genomic	   instability	  
that	  together	  can	  result	  in	  or	  exacerbate	  human	  cancers.71,72	  Genetic	  mutations	  are	  any	  change	  
or	  alteration	  in	  the	  composition	  of	  DNA	  sequence	  other	  than	  recombination	  that	  arise	  from	  ei-­‐
ther	  outside	  factors	  (induced)	  or	  natural	  processes	  (spontaneous).	  Gene	  mutations	  can	  be	  mani-­‐
fest	   at	   two	   categories	   that	   are	   insertion/deletion	   mutations	   and	   point	   mutations.6	   18	   Earlier	  
studies	   focused	  on	   the	  cause	  of	  mutations	  due	   to	  external	  effects.	   For	  example,	   smoking	  and	  
asbestos	  exposure	  were	  suggested	  as	  main	  causes	  to	  increase	  the	  risk	  of	  lung	  cancer.	  Eventually	  
it	  was	  found	  that	  the	  tobacco	  smoke	  and	  the	  asbestos	  fibres	  contained	  a	  large	  amount	  of	  DNA-­‐
damaging	  agents	  and	  mutagens	  that	  increase	  cell	  mutations.73	  Later	  studies	  focused	  on	  alterna-­‐
tive	   causes	   of	   genetic	   instability	   that	   underlie	   increased	  mutations	   in	   cells	   and	   cause	   cancer.	  
DNA	  mutations	  can	  mutate	  proteins	  by	  altering	  their	  amino	  acids	  sequence	  and	  this	  may	  affect	  
on	  protein	  function.74	  	  
Protein	  expression	   is	   the	  means	  by	  which	   cells	   synthesise	   the	  needed	  particular	  protein	   from	  
appropriate	  nucleotide	  sequence	  of	  DNA.	  The	  DNA	  sequence	  contains	  the	  genetic	   information	  
that	  is	  needed	  for	  protein	  synthesis,	  but	  it	  is	  used	  indirectly	  when	  it	  is	  transcribed	  into	  RNA	  and	  




molecule	  of	  DNA,	  which	  consists	  of	  both	  coding	   (exons)	  and	  non-­‐coding	   (introns)	   regions.	  Via	  
RNA	  splicing,	  it	  is	  modified	  to	  remove	  introns	  and	  produce	  the	  mature	  mRNA	  that	  is	  then	  trans-­‐
ported	  to	  the	  cytoplasm	  to	  start	  translation	  in	  ribosomes.	  Each	  triplet	  codon	  is	  translated	  to	  one	  
amino	  acid	  to	  produce	  the	  final	  protein.6	  DNA	  mutations	  affect	  protein	  expression	   in	  different	  
ways.	   An	   insertion/deletion	   mutation	   could	   change	   the	   amino	   acids	   and	   produce	   either	   too	  
short	  or	  too	  long	  as	  the	  reading	  shift	  can	  code	  the	  stop	  codon	  too	  early	  or	  too	  late,	  or	  it	  could	  
lead	  to	  a	  frame	  shift	  mutation	  if	  the	  inserted	  or	  deleted	  base	  pairs	  are	  not	  a	  multiple	  of	  three	  
nucleotides	  and	   lose	  protein	   function	   (non-­‐functional	  proteins).	  Missense	  and	  nonsense	  point	  
mutations	  affect	  the	  resultant	  protein	  by	  changing	  one	  amino	  acid	  to	  another	  or	  stop	  its	  transla-­‐
tion	   respectively,	   however,	   a	   silent	   point	  mutation	   does	   not	   affect	   the	   produced	   protein	   se-­‐
quence	  but	  it	  can	  affect	  its	  synthesis	  limiting	  its	  amount.74,75	  Indeed,	  mutated	  genes	  are	  present	  
in	  all	  cancer	  cells.74	  Thus,	  a	  single	  event	  such	  as	  a	  mutation’s	  effect	  on	  function	  of	  protein	  can	  
increase	  the	  rate	  of	  accumulation	  and	  cause	  tumour	  progression.76,77	  
Identification	  of	  mutations	  in	  enzymes	  that	  have	  no	  impact	  on	  gene	  expression	  in	  cancer	  cells,	  
but	   that	   alter	   enzyme	  activity	   and	  produce	  mutations	  due	   to	   the	   impact	  on	  DNA	  metabolism	  
strongly	  suggest	  a	  link	  between	  altered	  DNA	  repair/replication	  and	  cancer.18,76	  FEN-­‐1	  is	  an	  indis-­‐
pensable	  factor	  to	  maintain	  genome	  stability	  and	  integrity	  because	  of	  its	  important	  roles	  in	  DNA	  
metabolism.78,79	  Because	  FEN-­‐1	  mutations	  such	  as	  I39T,	  Q112R	  and	  S317F	  have	  been	  indicated	  
in	  many	  human	  cancer	  specimens,	  it	  becomes	  very	  important	  to	  understand	  the	  exact	  relation-­‐
ship	   between	   FEN-­‐1	  mutations	   and	   cancer	   susceptibility.18	   In	   fact,	   not	   all	   of	   FEN-­‐1	  mutations	  
observed	  in	  cancer	  patients	  can	  cause	  cancer	  progression,	  but	  only	  those	  effect	  the	  FEN-­‐1	  activ-­‐
ities	  and	  protein-­‐protein	  interactions	  appear	  to	  produce	  effects	  on	  DNA	  replication	  and	  repair.48	  
Functional	  defects	   in	  FEN-­‐1	  have	  been	   suggested	   to	  affect	  genomic	   stability	  and	   the	  develop-­‐
ment	  of	  cancer.18,76,80	  More	  evidence	  was	  suggested	  from	  mice	  models	  to	  identify	  the	  relation-­‐
ship	   between	  mutant	   FEN-­‐1	   and	   tumourgenesis	   of	   the	   gastrointestinal	   tract.	  Mice	   containing	  
E160D	  mutation	  showed	  rapid	  progression	  of	  cancer	  and	  decreased	  life	  expectancy.	  According-­‐
ly,	   defects	   of	   FEN1	   function	  does	  not	   alter	   cancer	   initiation	  process	   but	   has	   a	   deep	  effect	   on	  
cancer	  progression	  because	  of	  its	  important	  roles	  in	  DNA	  repair.76	  This	  defect	  of	  FEN-­‐1	  function	  
was	  highlighted	  as	  a	  main	  cause	  of	  accumulation	  of	  mutations	  that	  underlie	  cancer.80	  Contrary	  
to	  the	  previous	  findings,	  a	  later	  study	  did	  not	  indicate	  any	  mutations	  of	  FEN-­‐1	  or	  a	  decrease	  in	  
protein	  expression	   in	  human	   lung	  cancer	  cells.	   In	  this	  case,	  defects	  of	  FEN-­‐1	  function	  were	   in-­‐
volved	   in	  progression	  of	  human	   lung	  cancer.	  Otherwise,	  cancer	  cells	  showed	   increase	  of	  FEN1	  
expression	   that	   attributed	   to	   the	   response	   to	   the	   increase	  of	  DNA	  damage.81	   Further	   support	  




cells.	  By	  indicating	  of	  FEN-­‐1mRNA,	  the	  enzyme	  showed	  over	  expression	  in	  most	  cases	  of	  cancer	  
and	  this	  could	  be	  an	  indication	  of	  genomic	  instability	  in	  human	  cancer.82	  In	  spite	  of	  the	  wide	  ac-­‐
ceptance	   that	   accumulation	   of	   mutations	   in	   the	   genes	   that	   directly	   control	   genome	   stability	  
causes	  cancer,	  mechanisms	  of	  mutation	  generation	  remain	  the	  subject	  of	  continuing	  debate.	  
Attempts	  to	  understand	  the	  implications	  of	  FEN-­‐1	  mutations	  have	  focused	  on	  consideration	  of	  
FEN-­‐1	   as	   a	  multifunctional	   enzyme	  with	   fen,	   exo	   and	   gen	   activities	   (section	   1.6).48	  One	   study	  
proposed	  that	  an	  E160DmFEN-­‐1	  point	  mutation,	  which	  results	  in	  lung	  cancer	  in	  mouse	  models	  
abrogates	  the	  exo	  and	  gen	  activities	  of	  FEN-­‐1	  while	  retaining	  fen	  activity	  to	  cleave	  flapped	  sub-­‐
strates.	  Thus,	  deficiency	  in	  the	  minor	  activities	  of	  FEN-­‐1	  is	  claimed	  to	  increase	  spontaneous	  mu-­‐
tations	   and	   accumulation	   of	   unprocessed	  DNA	   fragments	   in	   cells.	   It	   is	   suggested	   that,	   conse-­‐
quently,	  cells	  will	  be	  predisposed	  to	  chronic	  inflammation	  that	  promotes	  tumour	  progression.18	  
In	   another	   study	  of	   the	   E160DmFEN-­‐1	  point	  mutation,	   reduction	  of	   fen	   activity	   of	   FEN-­‐1	  was	  
claimed	  to	  be	  the	  result	  of	  the	  protein	  alteration.	  Accordingly,	  decreased	  flap	  cleavage	  capabil-­‐
ity	  was	  claimed	  to	  increase	  the	  incidence	  of	  cancer,	  especially	  lymphoma,	  due	  to	  resulting	  prob-­‐
lems	  with	   DNA	   replication.19	   A	   later	   study	   identified	   that	   E359KmFEN-­‐1	  mutation,	   which	   has	  
been	  indicated	  in	  human	  breast	  cancer,	  in	  mouse	  models	  affects	  the	  protein-­‐protein	  interaction	  
and	   reduces	   gen	   activity	   of	   FEN-­‐1	   and	   this	   leads	   to	   defective	   FEN-­‐1	   ability	   to	   process	   bubble	  
structures	  that	  are	  formed	  during	  replication.83	  Furthermore,	  a	  recent	  study	  claims	  to	  show	  that	  
L209PhFEN-­‐1,	  which	  was	   identified	   in	  human	  colon	  cancer,	  point	  mutation	  develops	  cancer	   in	  
humans	  because	  of	  the	  deficiency	  in	  fen,	  exo	  and	  gen	  activities	  of	  FEN-­‐1.84	  	  
Despite	  the	  substantial	  knowledge	  of	  that	  FEN-­‐1	  mutations	  affect	  its	  function	  and	  this	  leads	  an-­‐
imal	  models	  to	  develop	  cancer,	  many	  issues	  such	  as	  the	  exact	  effects	  of	  FEN-­‐1	  mutations	  remain	  
to	  be	  addressed.	  	  
1.11.	  Aims	  of	  project:	  
Although	  FEN-­‐1	  structure	  and	   function	  have	  studied	  widely,	   still	   lots	  of	  outstanding	  questions	  
that	  need	  explanation.	   For	  example	  how	   the	  enzyme	  can	   recognise	  different	   substrates	  using	  
the	   same	   active	   site,	   how	   FEN-­‐1	   recognises	   the	   substrate	   and	   achieves	   reaction	   at	   a	   specific	  
bond,	  how	  mutations,	  which	  were	  indicated	  in	  many	  cancer	  cells,	  affect	  FEN-­‐1	  ability	  to	  recog-­‐
nise	   any	   substrates.	  Many	   answers	   have	   emerged	   through	   the	   previous	   studies.	  While	  many	  





In	  the	  previous	  studies,	  FEN-­‐1	  was	  considered	  as	  a	  multifunctional	  enzyme	  with	  different	  activi-­‐
ties.	  By	  observing	  FEN-­‐1	  mutations	   in	  numerous	  different	  human	  cancer	  kinds,	  many	  of	   them	  
were	  studied	  to	  indicate	  their	  effects	  on	  these	  different	  activities.	  In	  2007,	  effect	  of	  FEN-­‐1	  muta-­‐
tions	  in	  cancers	  was	  tested	  on	  FEN-­‐1	  point	  mutation	  generated	  in	  mice	  by	  using	  a	  gene	  targeting	  
approach.	  As	  a	  result,	  most	  of	  mice	  with	  E160D	  point	  mutation	  spontaneously	  developed	  can-­‐
cers,	  mainly	  in	  the	  lungs.	  In	  addition,	  above	  60	  %	  of	  cancers	  in	  these	  E160D	  mice	  have	  other	  mu-­‐
tations	   in	  Kras,	  p53,	  Apc	  or	  Egfr.	  According	   to	   the	  nuclease	  activity	  assay,	   it	  was	  claimed	   that	  
many	  of	  these	  mutations	  such	  as	  A159V	  and	  E160D	  led	  to	  loss	  of	  exo	  and	  gen	  cleavage	  abilities,	  
but	  had	  no	  effect	  on	  fen	  cleavage	  ability	  of	  mFEN-­‐1	  (figure	  1.29.a.b).	  Consequently,	  this	  could	  
be	   the	  main	  reason	  that	   lead	  to	   increase	   incidence	  of	  cancer	  especially	   lung	  cancer.	   18	  A	   later	  
study	  in	  2008	  showed	  that	  the	  E160DmFEN-­‐1	  point	  mutation	  leads	  to	  reduced	  fen	  nuclease	  ac-­‐
tivity	  (figure	  1.29.c.d).	  Accordingly,	  decreased	  flap	  cleavage	  capability	  was	  proposed	  as	  the	  main	  
cause	  of	  increasing	  incidence	  of	  cancer,	  especially	  lymphoma	  due	  to	  resulting	  in	  problems	  with	  
DNA	   replication.19	   To	   facilitate	   studying	   of	  mutations’	   effects,	  many	   FEN-­‐1	  mechanisms	  were	  
suggested.	  The	  disorder-­‐thread-­‐order	  mechanism	  was	  the	  preferred	  one	  that	   facilitates	  study-­‐
ing	  of	  FEN-­‐1.	  Although	  many	  details	  remain	  to	  be	  understood,	  the	  mechanism	  was	  summarized	  
in	  simple	  steps,	  which	  are	  binding,	  bending,	  5'-­‐flap	  threading,	  and	  3'-­‐flap	  engagement,	  and	  scis-­‐
sile	  phosphate	  bond	  possition.2	  	  
	  
Figure	  1.29.	  From	  2007	  study	  on	  mFEN-­‐1:	  a)	  hFEN-­‐1	  mutations	  that	  were	  observed	  in	  numerous	  cancer	  using	  direct	  
DNA	  sequencing.	  b)	  The	  profiles	  of	  FEN-­‐1	  activities	  and	  its	  mutant	  variants:	  1	  is	  WT,	  2	  is	  E160D	  and	  7	  is	  A159V.	  Both	  
mutations	  reduced	  exo	  and	  gen	  activities	  without	  effect	  on	  fen	  activity.18	  From	  2008	  study	  on	  mFEN-­‐1:	  c)	  Left:	  Struc-­‐
ture	  and	  cutting	  of	  5'-­‐flap	  DNA.	  Right:	  Comprisal	  the	  endonuclease	  activity	  of	  WT	  and	  E160D.	  d)	  Left:	  The	  prolifera-­‐




Based	  on	  the	  previous	  mentioned	  observations;	  this	  project	  aims	  to	  study	  both	  mouse	  and	  hu-­‐
man	   FEN-­‐1.	   In	   mFEN-­‐1	   study,	   WTmFEN-­‐1	   will	   be	   first	   studied	   kinetically	   with	   different	   sub-­‐
strates	   to	  verify	   if	   the	  enzyme	  actually	  has	  different	  activities	  or	   just	   recognises	  different	  sub-­‐
strates	  using	  same	  chemistry.	  In	  addition,	  the	  two	  active	  site	  mutations	  A159V	  and	  E160D	  muta-­‐
tions,	  which	   have	  been	   shown	   to	   have	   contradictory	   effects	   on	   the	   enzyme	   activities,	  will	   be	  
studied	   to	   indicate	   their	   effects	   on	   the	   enzyme	   efficiency,	   substrate	   conformational	   changes	  
and	  substrate	  bending.	  Finally,	  this	  combined	  kinetic	  and	  structural	  study	  may	  also	  help	  to	  illus-­‐
trate	  some	  other	  points	  such	  as	  the	  preferred	  substrate	  of	  FEN-­‐1	  and	  the	  main	  requirements	  for	  
the	  enzyme	  mechanism.	  A	  study	  of	  hFEN-­‐1	  will	  focus	  on	  effects	  of	  some	  different	  mutated	  resi-­‐
dues	   from	  the	  arch	  and	  3'-­‐flap	  pocket	  on	   the	   local	  DNA	  conformational	  change	  and	  substrate	  
bending.	  This	  hFEN-­‐1	  study	  will	  be	  done	  to	  complete	  the	  kinetic	  study,	  which	  has	  been	  done	  by	  
our	  group	  members	  Dr.	  Nikesh	  Patel,	  Dr.	  Jack	  Exell	  and	  Dr.	  Mark	  Thompson.	  As	  in	  mFEN-­‐1,	  also	  
this	  combined	  study	  can	  help	  to	  add	  some	  explanations	  to	  the	  general	  proposed	  hFEN-­‐1	  mech-­‐
anism.	  	  




Chapter	  2:	  Methodology:	  
2.1.	  WT	  and	  mutant	  mFEN-­‐1	  site-­‐directed	  mutagenesis	  and	  protein	  expression:	  	  
Buffers,	  media	  &	  gels	  required:	  
2X	  YT	  media	  (1	  L)	   16	  g	  tryptone,	  10	  g	  yeast	  extract,	  5	  g	  NaCl,	  H2O,	  adjust	  pH	  to	  7.5	  with	  5N	  NaOH.	  
SOC	  media	  (1	  L)	  
20	  g	  trypton,	  5	  g	  yeast	  extract,	  0.584	  g	  NaCl,	  0.186	  g	  KCl,	  1.20	  g	  MgSO4,	  3.60	  g	  
glucose,	  H2O.	  
TY	  media	  (928	  ml)	   12	  g	  Tryptone,	  24	  g	  yeast	  extract,	  H2O.	  
50X	  5052	  media	  (100	  ml)	   2.5	  g	  glucose,	  25	  g	  glycerol,	  10	  g	  α-­‐lactose,	  H2O.	  
AI	  media	  (500	  ml)	  
464	  ml	  TY	  media,	  25	  ml	  20XP,	  10	  ml	  50X	  5052	  media,	  1	  ml	  1	  M	  MgSO4,	  100	  ul	  10
3X	  
Trace	  metals,	  supplemented	  with	  500	  µl	  of	  chloramphenicol	  (34mg/ml)	  and	  4	  ml	  of	  
kanamycin	  (50	  mg/ml).	  
LB/Agar	  plate’s	  media	  (1	  L)	  
10	  g	  Tryptone,	  5	  g	  yeast	  extract,	  10	  g	  NaCl,	  15	  g	  agar,	  H2O.	  (+	  Antibiotic:	  50	  µg/ml	  
kanamycin	  or	  kanamycin	  +	  chloramphenicol).	  
Cell	  lysis	  buffer	  (100	  ml)	  
100	  ml	  IMAC	  buffer	  A	  with	  a	  dissolved	  tablet	  of	  SIGMAFAST	  Protease	  Inhibitor	  
Cocktail	  (EDTA	  free).	  
1X	  PBS	  (1	  L)	   8	  g	  NaCl,	  0.2	  g	  KCl,	  1.44	  g	  Na2HPO4,	  0.24	  g	  KH2PO4,	  adjust	  pH	  to	  7.4.	  
50X	  TAE	  buffer	  (1	  L)	  
242	  g	  Tris	  base,	  57.1	  ml	  glacial	  acetic	  acid,	  100	  ml	  500	  mM	  EDTA	  (adjust	  pH	  to	  8),	  
H2O.	  
Resolving	  gel	  buffer	   1.5	  M	  tris	  (pH	  8.8),	  0.4	  %	  SDS	  (w/v).	  
Stacking	  gel	  buffer	   0.5	  M	  tris	  (pH	  6.8),	  0.4	  %	  SDS	  (w/v).	  
Agarose	  gel	  (100	  ml)	   1	  g	  agarose,	  100	  ml	  1X	  TAE,	  10	  µl	  SYBR	  safe	  DNA	  gel	  stain	  (10,000X).	  
Acrylamide	  gel	  
Resolving	  (12	  %):	  3.4	  ml	  H2O,	  4	  ml	  Acrylamide/bis-­‐Acrylamide	  (30	  %	  solution),	  2.5	  
ml	  resolving	  gel	  buffer,	  100	  µl	  APS	  (10	  %),	  10	  µl	  TEMED,	  50	  µl	  TCE.	  Stacking	  (4	  %):	  
3.4	  ml	  H2O,	  830	  µl	  Acrylamide/bis-­‐Acrylamide	  (30%	  solution),	  680	  µl	  stacking	  gel	  




2.1.1.	  Site-­‐directed	  mutagenesis:	  
All	   of	   the	   DNA	   sequences	  with	   the	   target	  mutant	   codons	  were	   generated	   using	   site-­‐directed	  
mutagenesis.	  The	  WT,	  E160D,	  and	  A159V	  mFEN-­‐1	  were	  generated	  by	  PCR	  using	  a	  specific	  pair	  of	  
primers,	   designed	  with	  mismatching	   nucleotides,	   for	   each	  mutation.	   The	  WTmFEN-­‐1	   plasmid	  
(pet-­‐28b-­‐mFEN1)	  was	   sequenced	   (University	   of	   Sheffield	  Genomic	   sequencing	   facility)	   to	   con-­‐
firm	  that	  it	  is	  a	  free	  of	  mutations	  and	  a	  completed	  sequence	  to	  be	  used	  in	  the	  expression.	  First,	  
this	  WT	  plasmid	  was	  used	  to	  prepare	  E160DmFEN-­‐1.	  Second,	  this	  mutated	  plasmid	  was	  used	  to	  
prepare	   more	   WTmFEN-­‐1.	   Finally,	   the	   new	   WTmFEN1	   plasmid	   was	   used	   to	   prepare	   the	  
A159VmFEN-­‐1	  plasmid.	  
2.1.1.1.	  PCR	  reaction:	  
The	   E160DmFEN-­‐1	   primers	   were	   designed	   with	   the	   Agilent	   QuickChange	   Primer	   Design	   tool	  
(http://www.genomics.agilent.com/primerDesignProgram.jsp).	   For	   each	  mutation	  point	   (inser-­‐
tion	  or	  deletion)	  a	  different	  pair	  of	  primers	  was	  used,	  as	  shown	  in	  (Table	  2.1).	  















25	   WT	   A159V	  
Table	  2.1.	  The	  primers	  were	  used	  for	  site	  directed	  mutagenesis	  of	  mFEN-­‐1	  contain	  the	  mutated	  bases.	  
Mismatched	   primer	   solutions	   for	   the	   required	   mutation	   (100	   µM)	   were	   prepared	   by	   re-­‐
suspending	  the	  dehydrated	  primers	  in	  Milli-­‐QTM	  water.	  The	  Pair-­‐primer	  (PP)	  solutions	  (100	  µl,	  3	  
µM)	  were	  prepared	  by	  mixing	  3	  µl	  of	  each	  of	  the	  forward	  and	  reverse	  primer	  solution	  with	  94	  µl	  
of	  H2O.	  The	  PP	  solutions	  were	  used	  for	  PCR	  mutagenesis	  reactions,	  along	  with	  the	  reagents	  de-­‐
scribed	   in	   table	  2.2.	  The	   reactants	  were	  mixed	   together	  and	   thermo-­‐coupled	  using	  a	  PCR	  ma-­‐




ed	  at	  37	   oC	   for	  1.5	  hours	  after	   adding	  1	  µl	  of	  DPN1.	  Mutagenesis	   reactions	  were	  analysed	  by	  
running	  5	  µl	  on	  an	  agarose	  gel	  and	  staining	  with	  Sybr	  Safe	  stain.	  	  
Ingredient	   Volume	  (µl)	   Ingredient’s	  role	  
Pair-­‐primer	  solution	  (3	  µM)	   2.5	   Needed	  to	  amplify	  the	  target	  DNA	  fragment.	  
10X	  PfuUltra	  HF	  Reaction	  
Buffer	  (bought	  from	  Agilent)	   2.5	  
To	  create	  an	  environment	  for	  optimum	  activity	  of	  Taq	  DNA	  poly-­‐
merase.	  
PfuUltra	  Hotstart	  DNA	  poly-­‐
merase	  (2.5U/µl)	   0.5	  
Enzyme	  helps	  catalyse	  the	  polymerisation	  of	  the	  deoxynucleo-­‐
tides	  into	  a	  DNA	  strand.	  
Template	  plasmid	  (79	  ng/µl)	   1	   Contains	  the	  target	  fragment	  to	  be	  amplified.	  
dNTP	  (10	  mM)	   2	   Mix	  of	  nucleotides	  to	  build	  the	  new	  DNA	  strands.	  
Milli-­‐Q	  water	   16.5	   To	  adjust	  the	  concentration	  of	  each	  component.	  
Total	   25	   /	  
Table	  2.2.	  PCR	  reaction	  mixture	  and	  role	  of	  each	  ingredient.	  
	  
Figure	  2.1.	  The	  PCR	  mutagenesis	  reaction	  program.	  
2.1.1.2.	  Transformation	  of	  cells:	  
After	  monitoring	   the	  DNA	   formation	  using	   an	   agarose	   gel,	   2.5	  µl	   of	   the	  mutagenesis	   solution	  
was	  added	  to	  50	  µl	  of	  DH5α	  cells,	  which	  had	  been	  thawed	  on	  ice	  for	  10	  minutes.	  The	  cells	  were	  
incubated	  on	  ice	  for	  45	  minutes.	  Then	  the	  cells	  were	  heat	  shocked	  in	  a	  water	  bath	  at	  42	  oC	  for	  
90	  seconds,	  and	  then	  incubated	  on	  ice	  for	  5	  minutes.	  1ml	  of	  SOC	  media	  was	  added	  to	  the	  trans-­‐
formed	  cells,	  which	  were	  incubated	  at	  37	  oC,	  200	  rpm	  for	  1	  hour.	  Subsequently,	  the	  cells	  were	  
centrifuged	  at	  13,400	  rpm	  for	  5	  minutes.	  Next,	  the	  media	  was	  removed	  and	  the	  cells	  were	  re-­‐




plemented	   with	   50	   µg/ml	   of	   kanamycin.	   The	   plates	   were	   incubated	   at	   37	   oC	   overnight.	   The	  
transformed	  cells	  were	  observed	  on	  plates	  as	  single	  colonies.	  
2.1.1.3.	  Plasmid	  preparation:	  
A	  single	  colony	  of	  cells	  was	  added	  to	  10	  ml	  of	  2XYT	  media	  supplemented	  with	  10	  µl	  of	  50	  mg/ml	  
of	  kanamycin	  (3	  tubes	  for	  each	  plasmid)	  and	  left	  to	  grow	  for	  14-­‐16	  hours	  overnight	  at	  37	  oC,	  200	  
rpm.	  The	  starter	  cultures	  were	  grown	  until	  an	  OD	  at	  600	  nm	  ranging	  from	  0.5	  to	  1.5	  of	  1:10	  dilu-­‐
tion	  was	  achieved.	  
The	   starter	   culture	   from	  each	   tube	  was	  divided	   into	  6	  of	  1.5	  ml	   tubes	  and	   centrifuged	   for	  10	  
minutes	  at	  room	  temperature	  to	  pellet	  the	  cells.	  A	  mini-­‐prep	  kit	  (Qiagen)	  was	  used	  to	  collect	  the	  
plasmids.	  First,	  the	  pelleted	  cells	  were	  re-­‐suspended	  in	  250	  µl	  of	  P1	  buffer.	  Then,	  250	  µl	  of	  buff-­‐
er	  P2	  was	  added	  and	  the	  tube	  was	  mixed	  slowly	  by	  inverting	  until	  the	  solution	  turned	  blue.	  350	  
µl	  of	  buffer	  N3	  was	  added	  and	  the	  tube	  again	  was	  mixed	  slowly	  by	  inverting	  until	  the	  solution	  
turned	   colourless.	   The	  mixture	  was	   centrifuged	   for	   10	  minutes	   to	   separate	   the	   insoluble	  por-­‐
tions.	  
The	   supernatant	  was	   applied	   to	   the	  QIA-­‐prep	   spin	   column,	  which	  was	   then	   centrifuged	   for	   1	  
minute	  and	  the	  flow-­‐through	  was	  discarded.	  The	  QIA-­‐prep	  spin	  column	  was	  washed	  by	  adding	  
500	  µl	  of	  PB	  buffer,	  and	  then	  centrifuged	  for	  1	  minute	  and	  the	  flow-­‐through	  was	  discarded.	  This	  
step	  was	  repeated	  again	  by	  washing	  the	  column	  with	  750	  µl	  of	  PE	  buffer.	  The	  column	  was	  cen-­‐
trifuged	  again	  for	  1	  minute	  to	  remove	  all	  remaining	  wash	  buffers.	  
The	  QIA-­‐prep	  spin	  column	  was	  placed	   in	  a	  clean	  1.5	  ml	  centrifuge	   tube.	  50	  µl	  of	  MilliQ	  water	  
was	  added,	  and	  the	  plasmid	  was	  collected	  by	  centrifugation	  for	  2	  minutes.	  The	  plasmid	  concen-­‐
trations	  were	  determined	  by	  absorbance	  at	  260	  nm	  using	  the	  Nanodrop	  UV	  spectrophotometer.	  
The	   prepared	   plasmid	   solutions	   were	   then	   sent	   for	   sequencing.	   The	   sequencing	   results	   are	  
shown	  in	  the	  appendix	  from	  section	  7.1.1	  to	  7.1.6.	  	  
2.1.2.	  Protein	  expression:	  
BL21DE	  cells	  were	  transformed	  using	  2	  µl	  of	  the	  chosen	  plasmid	  solution	  using	  the	  same	  proto-­‐
col	  described	  above.	  	  
A	  single	  colony	  of	  cells	  transformed	  with	  each	  plasmid	  was	  added	  to	  25	  ml	  of	  2XYT	  media	  sup-­‐
plemented	  with	  25	  µl	  of	  chloramphenicol	  (34	  mg/ml)	  and	  12.5	  µl	  of	  Kanamycin	  (50	  mg/ml)	  and	  
left	  to	  grow	  for	  14-­‐16	  hours	  overnight	  at	  37	  oC,	  200	  rpm.	  The	  culture	  was	  grown	  until	  an	  OD	  at	  




5	  ml	  of	  each	  overnight	  culture	  was	  added	  to	  in	  500	  ml	  of	  AI	  media	  supplemented	  with	  500	  µl	  of	  
chloramphenicol	  (34	  mg/ml)	  and	  4	  ml	  of	  kanamycin	  (50	  mg/ml)	  (2	  flasks	  for	  each	  plasmid).	  The	  
cultures	  were	  grown	  at	  37	  oC,	  255	  rpm	  for	  3	  or	  4	  hours.	  The	  cultures	  were	  then	  incubated	  at	  18	  
oC	  overnight	  until	  an	  OD	  at	  600	  nm	  of	  10	  %	  of	  the	  solution	  at	  around	  10	  was	  achieved.	  
The	  6	  cultures	  were	  put	  in	  3	  of	  1	  L	  centrifuge	  bottles,	  and	  pelleted	  by	  centrifugation	  (9000	  x	  g,	  
30	  min,	  3	  oC).	  After	  removing	  the	  supernatant,	  each	  cell	  pellet	  was	  re-­‐suspended	  in	  30	  ml	  of	  ice-­‐
cold	  PBS.	  The	  cells	  were	  transferred	  to	  50	  ml	  tubes,	  and	  pelleted	  once	  more	  by	  centrifugation	  
(4000	  x	  g,	  1	  hour,	  4	  oC).	  After	  removing	  the	  supernatant,	  each	  cell	  pellet	  was	  suspended	  in	  25	  ml	  
of	  lysis	  buffer	  and	  then	  3ml	  of	  lysis	  buffer	  containing	  2	  %	  lysozyme	  from	  chicken	  was	  added.	  The	  
cells	  were	  shaken	  gently	  at	  4	  oC	  for	  1	  hour,	  and	  100	  µl	  from	  each	  was	  retained	  for	  analysis	  by	  
SDS	  PAGE.	  All	  the	  lysates	  were	  frozen	  at	  -­‐20	  oC.	  	  
2.2.	  WT	  and	  mutant	  mFEN-­‐1	  protein	  purification:	  
Buffers	  required:	  	  
IMAC	  A1	   20	  mM	  tris	  (pH	  7),	  1	  M	  NaCl,	  5	  mM	  imidazole,	  0.02	  %	  NaN3.	  
IMAC	  A2	   20	  mM	  tris	  (pH	  7),	  500	  mM	  NaCl,	  40	  mM	  imidazole,	  0.02	  %	  NaN3,	  0.1	  %	  (v/v)	  Tween-­‐20.	  
IMAC	  B1	   500	  mM	  NaCl,	  250	  mM	  imidazole	  (pH	  7.2),	  0.02	  %	  NaN3	  
Anion	  exchange	  A1	   20	  mM	  tris	  (pH	  8),	  1mM	  EDTA,	  0.02	  %	  NaN3.	  
Anion	  exchange	  B1	   20	  mM	  tris	  (pH	  8),	  1	  mM	  EDTA,	  1	  M	  NaCl,	  0.02	  %	  NaN3.	  
Heparin	  A1	   25	  mM	  tris	  (pH	  7.5),	  1	  mM	  CaCl2,	  0.02	  %	  NaN3.	  
Heparin	  B1	   25	  mM	  tris	  (pH	  7.5),	  1	  mM	  CaCl2,	  1	  M	  NaCl,	  0.02	  %	  NaN3.	  
PS/A1	   25	  mM	  tris	  (pH	  7.5),	  10	  %	  glycerol,	  1	  mM	  CaCl2,	  0.02	  %	  NaN3.	  
PS/B1	   25	  mM	  tris	  (pH	  7.5),	  2M	  (NH4)2SO4,	  2	  mM	  CaCl2,	  0.02	  %	  NaN3.	  
SEC	  buffer	   100	  mM	  HEPES	  (pH	  7.5),	  200	  mM	  KCl,	  2	  mM	  CaCl2,	  10	  mM	  DTT,	  0.04	  %	  NaN3.	  




Initially,	  the	  presence	  of	  the	  target	  protein	  was	  tested	  by	  carrying	  out	  SDS	  PAGE	  using	  the	  100	  µl	  
samples	  that	  were	  taken	  previously	  from	  the	  cells	   lysates.	  Accordingly,	  each	  enzyme	  was	  puri-­‐
fied	  separately	  in	  the	  order	  E160D,	  A159V,	  and	  then	  WT	  mFEN-­‐1.	  
The	   cell	   lysate	  was	  prepared	   for	  protein	  purification	  by	   incubating	   the	   suspension	   in	   cold	   tap	  
water	   until	   it	   was	   completely	   thawed.	   Then,	   the	   viscous	   suspension	   was	   sonicated	   on	   ice	   3	  
times	  at	  75	  %	  power	  with	  5	  seconds	  bursts	  with	  at	  least	  25	  seconds	  between	  each	  burst	  until	  it	  
became	   liquid.	   Then,	   the	   cell	   lysate	   was	   washed	   by	   adding	   buffer	   IMAC	   A1	   containing	   10	   %	  
Tween	  20	  to	  obtain	  a	  final	  mixture	  containing	  1	  %	  Tween	  20.	  The	  lysate	  was	  centrifuged	  in	  50	  ml	  
tubes	  for	  30	  minutes	  (30,000	  X	  g,	  4	  oC)	  and	  then	  the	  supernatant	  was	  collected.	  	  
All	  proteins	  were	  purified	  at	  4	  oC	   in	  the	  cold	  room	  by	  using	  an	  AktaFPLC	  (GE	  Lifesciences).	  Ac-­‐
cording	  to	  the	  protocol	  of	  the	  manufacturer,	  the	  Chelating	  Sepharose	  Fast	  Flow	  (GE	  Lifescienc-­‐
es)	  column	  (1.6	  cm	  ID,	  10	  cm	  length)	  was	  charged	  with	  Ni2+	   ions.	  The	  column	  was	  equilibrated	  
with	  5	  column	  volumes	  (CV)	  of	  buffer	  IMAC	  A1.	  The	  previously	  collected	  supernatant	  (~100	  ml)	  
was	  then	  applied	  to	  the	  column,	  which	  was	  subsequently	  washed	  with	  7	  CV	  of	  buffer	  IMAC	  A1	  
and	  5	  CV	  of	  buffer	  IMAC	  A2.	  The	  target	  protein	  was	  eluted	  as	  a	  single	  fraction	  with	  5	  CV	  of	  buff-­‐
er	   IMAC	  B1.	  10	  µl	  of	   the	  eluate	  was	   retained	   for	  SDS	  PAGE	   for	  detecting	   the	  presence	  of	   the	  
protein.	   The	  eluted	   fraction	  was	   then	  diluted	  with	  an	  equal	   volume	  of	  a	  mixture	  of	  anion	  ex-­‐
change	  buffers	  A1	  and	  B1	  (70	  %	  of	  A1	  and	  30	  %	  of	  B1).	  
The	  diluted	  eluate	  was	  applied	  directly	  to	  a	  Hitrap	  Ionic	  Exchange	  column	  (5	  ml)	  using	  anion	  ex-­‐
change	  buffers	  A1	  and	  B1.	  Fractions	  containing	  the	  target	  protein	  were	  pooled,	  and	  10	  µl	  of	  the	  
fraction	   were	   retained	   for	   analysis	   by	   SDS	   PAGE.	   The	   ionic	   strength	   of	   the	   solution	   was	   in-­‐
creased	  by	  the	  slow	  addition	  of	  a	  cold	  solution	  of	  3	  M	  of	  (NH4)2SO4	  with	  stirring	  to	  approximate-­‐
ly	  2	  M	  final	  concentration.	  	  
The	  final	  solution	  was	  injected	   directly	   to	   a	   HiTrap	   Phenyl	   Sepharose	   HP	   column	   (20	   ml)	   and	  
then	  applied	  using	  PS/A1	  buffer.	  The	  protein	  was	  eluted	  from	  the	  column	  by	  an	   inverse	   linear	  
salt	  gradient	  generated	  using	  buffers	  PS/A1	  and	  PS/B1	  and	  was	  collected	  in	  10	  ml	  fractions.	  Pro-­‐
tein-­‐containing	   fractions	  were	  pooled,	  and	  10	  µl	  were	   retained	   for	  analysis	  by	  SDS	  PAGE.	  The	  
pooled	  fractions	  were	  concentrated	  by	  ultra-­‐filtration	  using	  a	  250	  ml	  Amicon	  Ultra-­‐filtration	  cell	  
with	  10,000	  MWCO	  PES	  membrane	   (Millipore)	  pressurised	  with	  NR	  R	   (40	  PSI).	   The	  volume	  of	  




The	  concentrated	  fraction	  was	  injected	  into	  the	  super-­‐loop	  using	  a	  syringe,	  and	  then	  applied	  to	  
a	  HiPrep	  26/10	  Desalting	  column	  (1X	  53	  ml)	  using	  heparin	  buffers	  A1	  and	  B1.	  The	  protein	  was	  
eluted	  using	  1CV	  of	  heparin	  buffers	  A1	  (95	  %)	  and	  B1	  (5	  %),	  and	  NaCl	  (5	  mM).	  	  
The	  mixture	  of	  collected	  fractions	  was	  applied	  directly	  to	  a	  HiTrap	  Heparin	  HP	  column	  (3X	  5	  ml	  
in	  tandem)	  using	  buffer	  heparin	  A1.	  The	  protein	  was	  eluted	  using	  a	  50	  CV	  linear	  NaCl	  gradient	  (0	  
to	   1	   M	   NaCl)	   using	   heparin	   buffers	   A1	   and	   B1	   and	   collected	   as	   2.5	   ml	   fractions.	   Protein-­‐
containing	  fractions	  were	  pooled	  and	  10	  µl	  of	  the	  elate	  was	  retained	  for	  analysis	  by	  SDS	  PAGE.	  
The	  collected	  fractions	  were	  concentrated	  using	  an	  ultra-­‐filtration	  system	  (Millipore)	  (as	  previ-­‐
ously	  described)	  to	  collect	  about	  10	  ml.	  The	  volume	  of	  the	  concentrated	  fractions	  mixture	  was	  
reduced	  to	  about	  5	  ml	  by	  using	  a	  Vivaspin	  (10,000	  MWCO)	  spin	  columns	  (4000	  X	  g,	  30min,	  4	  oC).	  	  
The	  retentate	  from	  the	  spin	  columns	  was	  then	  applied	  to	  a	  Sephacryl	  S-­‐100	  (1.6	  cm	  ID	  x	  60	  cm)	  
size	  exclusion	  column	  (GE	  Lifesciences)	  and	  isocratically	  eluted	  using	  SEC	  buffer	  and	  collected	  in	  
2.5	  ml	  fractions.	  Protein	  containing	  fractions	  were	  pooled,	  and	  20	  µl	  of	  the	  eluate	  was	  retained	  
for	  analysis	  by	  SDS	  PAGE.	  The	  fractions	  were	  concentrated	  using	  a	  Vivaspin	  (10,000	  MWCO)	  spin	  
column	  (4000	  X	  g,	  30min,	  4	  oC).	  	  
2.3.	  Determination	  of	  protein	  concentration	  and	  protein	  folding	  test:	  	  
Initially,	  the	  protein	  concentrations	  were	  measured	  by	  absorbance	  at	  280	  nm	  using	  a	  Nanodrop	  
UV	  spectrophotometer.	  The	  volume	  of	   the	  mFEN-­‐1	  sample	  was	  adjusted	  with	  the	  appropriate	  
volume	  of	  100	  %	  glycerol	  (chelexed	  and	  filtered)	  and	  SEC	  buffer	  to	  adjust	  the	  final	  concentration	  
to	  100	  µM	  protein,	  50	  %	  (v/v)	  glycerol,	  50	  mM	  HEPES,	  100	  mM	  KCl,	  1	  mM	  CaCl2,	  10	  mM	  DTT,	  
0.02	  %	  (w/v)	  NaN3.	  	  
Protein	   concentrations	  of	   glycerol	   stocks	  were	   confirmed	  using	  a	  Bradford	  assay	  according	   to	  
the	  Microtiter	   Plate	   protocol	   (Bradford	   assay).85	   Eight	   dilutions	   of	   protein	   standard	   (BSA)	   (43	  
mg/ml)	  were	  prepared	  in	  water	  with	  concentrations	  ranging	  from	  0.05	  mg/ml	  to	  0.5	  mg/ml.	  1X	  
Bradford	  Reagent	  was	  also	  prepared	  by	  dilution	  5X	  stock	  in	  water.	  From	  the	  enzyme	  stock	  solu-­‐
tion,	  four	  different	  enzyme	  concentrations	  were	  prepared	  in	  water	  (2.5,	  5,	  10,	  and	  20	  µM	  based	  
on	  the	  concentration	  measured	  using	  the	  Nanodrop).	  Into	  separate	  microtiter	  plate	  wells,	  10	  µl	  
of	  each	  protein	  standard	  and	  protein	  solution	  were	  pipetted.	  Then	  200	  µl	  of	  1X	  of	  Bradford	  Re-­‐
agent	  was	  added	  to	  each	  well,	  mixed,	  and	  centrifuged	  for	  few	  minutes	  to	  remove	  any	  bubbles.	  
Finally,	   the	   absorbance	  was	  measured	   at	   595	  nm	  using	   a	   Cary	  Bio	  UV-­‐Vis	   spectrophotometer	  




The	  secondary	  structure	  and	  folding	  properties	  of	  FEN-­‐1	  protein	  (WT,	  A159V	  and	  E160D)	  were	  
analysed	  using	  ECCD	  technique.	  First,	  each	  buffer	  of	  enzyme	  was	  exchanged	  to	  another	  buffer	  
contains	   0.1	  M	  potassium	  phosphate,	   3	  M	   ammonium	   sulphate,	   99	  mg	  magnesium	   sulphate,	  
500	  mM	  EDTA	  and	  1	  M	   tris	   (hydroxypropyl)	   phosphine	   (THPP)	  using	  micro	  biospin6	   columns-­‐
buffer	   exchange.	   Each	   enzyme’s	   concentration	   in	   the	   new	   buffer	   was	   determined	   using	   a	  
Nanodrop	  UV	  spectrophotometer.	  From	  each	  enzyme,	  a	   sample	  of	  300	  µl	   containing	  6	  µM	  of	  
protein	  in	  the	  exchanged	  buffer	  was	  prepared	  and	  analysed	  in	  the	  ECCD	  machine.	  The	  spectrum	  
of	  each	  protein	  was	  collected	  between	  190	  and	  260	  and	  nm.	  	  	  
2.4.	  Kinetic	  based	  assays	  to	  compare	  WT	  and	  mutated	  mFEN-­‐1	  (A159V	  &	  E160D):	  
Buffers	  and	  solutions	  were	  required:	  
10X	  RB	  (50	  ml)	   1	  M	  KCl,	  0.5	  M	  HEPES	  (pH	  7.5),	  80	  mM	  MgCl2,	  1	  mg/ml	  BSA	  
10X	  FB	  (50	  ml)	   1	  M	  KCl,	  0.5	  M	  HEPES	  (pH	  7.5).	  
5X	  RRB	  (1	  ml)	   500	  µl	  10XRB,	  5	  µl	  DTT	  (1	  M),	  495	  µl	  H2O.	  
1X	  RRB	  (2	  ml)	   400	  µl	  5XRRB,	  1600	  µl	  H2O.	  
MM	  (1.6	  ml)	   360	  µl	  5XRRB,	  1240	  µl	  H2O.	  
1X	  FB	  (10	  ml)	   9	  ml	  H2O,	  1	  ml	  10X	  FB.	  
ST	  quench	  (1	  L)	   1.5	  M	  NaOH,	  50	  mM	  EDTA.	  
10X	  RB	  quench	  using	  (1	  L)	   1	  M	  KCl,	  0.5	  M	  HEPES	  pH=7.5,	  80	  mM	  MgCl2,	  1mg/ml	  BSA,	  0.02	  %	  NaN3.	  
1X	  RRB	  quench	  using	  (1.5	  L)	   150	  ml	  10X	  RB	  quench	  using,	  1350	  ml	  H2O.	  
1X	  RB	  quench	  using	  (1	  L)	   110	  mM	  KCl,	  55	  mM	  HEPES	  (pH	  7.5),	  8	  mM	  MgCl2,	  15%	  glycerol,	  0.02	  %	  NaN3	  
Wave	  buffer	  A	  (5	  L)	   0.1	  %	  MeCN,	  1	  mM	  EDTA,	  2.5	  mM	  tbab,	  H2O.	  
Wave	  buffer	  B	  (5	  L)	   70	  %	  MeCN,	  1	  mM	  EDTA,	  2.5	  mM	  tbab,	  H2O.	  
Wave	  buffer	  C	  (5	  L)	   8	  %	  MeCN,	  H2O.	  	  




2.4.1.	  Kinetic	  substrates	  design:	  	  
The	  kinetic	  based	  assays	  (multiple	  turnover	  and	  single	  turnover)	  were	  conducted	  using	  oligonu-­‐
cleotides	   to	   form	   static	   substrates	   as	   shown	   in	   figure	   2.2	   to	   enhance	   formation	   of	   the	   non-­‐
productive	  complexes	  and	  simplify	  the	  kinetic	  analysis.	  The	  5'-­‐terminus	  of	  the	  single	  strands	  F1,	  
E3,	  G1	  and	  2'OH	   is	   labelled	  with	   fluorescein	   fluorophore	  connection	  to	  be	   indicated	  by	  dHPLC	  
machine.	  After	  dissolving	  the	  oligonucleotide	  stock	  in	  appropriate	  amount	  of	  water,	  the	  mass	  of	  
each	  oligonucleotide	  was	  determined	  by	  Mass	  Spectrometer	  (MS)	  to	  be	  compared	  with	  the	  ac-­‐
tual	  mass	  (table	  2.4).	  The	  concentration	  of	  the	  final	  oligonucleotide	  solution	  was	  determined	  by	  
UV	  using	  Nanodrop	  at	  260	  nm	  and	  20	  °C	  using	  extinction	  coefficients	  generated	  by	  IDT	  oligo	  an-­‐
alyser	  3.1	  tool	  (https://www.idtdna.com/calc/analyzer)	  (table	  2.4).	  	  
The	   50	   µM	   of	   each	   substrate	   stock	   solution	   comprised	   50	   µM	   fluorescently	   labelled	   single	  
strand	  DNA	  (F1,	  E3,	  G1	  or	  2'OH)	  and	  55	  µM	  T1	  template	  strand	  in	  1X	  FB	  (figure	  2.2)	  (table	  2.3).	  
Before	  substrate	  addition	  to	  any	  subsequent	  reaction	  mixture,	  it	  was	  annealed	  by	  heating	  to	  95	  
oC	  for	  3	  minutes	  and	  then	  leaving	  to	  cool	  at	  room	  temperature	  for	  10	  minutes	  to	  allow	  correct	  
substrate	  folding	  and	  annealing.	  All	  the	  kinetic	  substrates),	  which	  are	  double	  flap	  DNA	  (DF),	  3'-­‐
single	  flap	  DNA	  (3'-­‐SF),	  forked	  gap	  substrate	  (gap)	  and	  double	  flap	  2'OH	  (DF2'OH),	  have	  a	  junc-­‐
tion	  between	  tow	  duplexes	  (up-­‐stream	  and	  down-­‐stream)	  (figure	  2.2).	  While	  the	  5'-­‐terminal	  of	  
the	   junction	   is	   the	   structural	  difference	  between	   the	  DF	   (5'-­‐flap),	  3'-­‐SF	   (no	   flap)	  and	  gen	   sub-­‐
strates	  (5'-­‐flap	  with	  secondary	  structure),	  the	  DF2'OH	  substrate	  similar	  to	  DF	  but	  has	  RNA	  fea-­‐
ture	  in	  the	  +1	  nt	  possition.	  In	  addition,	  all	  these	  substrates	  had	  labelled	  5'-­‐terminuse	  with	  fluo-­‐
rescein	  fluorophore	  to	  indicate	  the	  product	  and	  unreacted	  substrate	  using	  dHPLC	  that	  equipped	  
with	  a	  fluorescein	  detector.	  In	  the	  kinetic	  study,	  all	  these	  substrates	  (DF,	  3'-­‐SF,	  gap	  and	  DF2'OH)	  
were	   used	   to	   study	   WTmFEN-­‐1	   activities	   and	   DF,	   gap	   and	   DF2'OH	   substrates	   used	   to	   study	  





Figure	   2.2.	   Schematic	   structures	   of	   the	   synthetic	   oligonucleotides	   used	   to	   prepare	  DF,	   3'-­‐SF,	   bap	   and	  DF2'OH	   sub-­‐
strates	  that	  used	  for	  the	  kinetic	  study	  of	  WT	  and	  mutated	  mFEN-­‐1.	  Each	  substrate	  structure	  was	  formed	  from	  a	  single	  
strand	  (F1,	  E3,	  G1	  or	  2'OH)	  and	  a	  T1	  template.	  mFEN-­‐1	  attack	  the	  substrate	  into	  one	  nucleotide	  down	  stream	  to	  re-­‐
lease	  the	  product	  that	  is	  labelled	  with	  fluorescein	  fluorophore	  (presented	  as	  a	  yellow	  ball)	  connection	  to	  be	  indicated	  








Construct	   Composition	  
DF	   F1	  +	  T1.	  
3'-­‐SF	   E31+	  T1.	  
Gap	   G1+	  T1.	  
DF2'OH	   2'OH	  +	  T2.	  
Table	  2.3.	  Oligonucleotide	  combinations	  used	  to	  make	  the	  substrate	  constructs	  for	  MT	  and	  ST	  experiments	  to	  study	  
mFEN-­‐1	  kinetic.	  Each	  substrate	  structure	  was	  formed	  from	  T1	  and	  another	  single	  strand.	  
Oligonucleotide	  code	   Actual	  Mass	  (g.mol-­‐1)	   Calculated	  Mass	  (g.mol-­‐1)	   ε260	  (L.mol
-­‐1.cm-­‐1)	  
F1	   7536.1	   7536	   236760	  
E3	   6015.1	   6013	   196360	  
G1	  	   11885.9	   11886.12	   373960	  
2'OH	   7552.1	   7552.1	   237260	  
T1	   10474.8	   10475	   323200	  
Table	  2.4.	  Details	  of	  the	  kinetic	  oligonucleotides	  synthesised	  and	  purified	  for	  work	  with	  mFEN-­‐1.	  
2.4.2.	  The	  multiple	  turnover	  kinetic	  (MT):	  
The	  multiple	  turnover	  assays	  for	  WT,	  E160D,	  and	  A159V	  mFEN-­‐1	  were	  conducted	  under	  similar	  
conditions:	  110	  mM	  KCl,	  55	  mM	  HEPES	  (pH	  7.5),	  8	  mM	  MgCl2,	  0.1	  mg/ml	  BSA	  and	  1	  mM	  DTT.	  
The	   same	   range	   of	   substrate	   concentrations	  was	   used	   for	   all	   enzymes.	   However,	   in	   order	   to	  
reach	  the	  same	  initial	  rate,	  different	  concentrations	  of	  each	  enzyme	  were	  used	  at	  each	  specific	  
substrate	  concentration	  (table	  2.5).	  While	  WTmFEN-­‐1	  was	  reacted	  with	  all	  substrates,	  the	  mu-­‐
tated	  enzymes	  were	  reacted	  with	  all	  substrates	  except	  3'-­‐SF	  substrate,	  which	  was	  expected	  to	  
be	  exactly	  as	  DF	  according	   to	   the	  WT	  results.	  The	  MT	  experiments	   tables	  of	  WT	  and	  mutated	  
mFEN-­‐1	  are	  shown	  in	  the	  appendices	  (from	  table	  7.1	  to	  table	  7.10).	  
Each	  substrate	  stock	  solutions	  were	  made	  up	  from	  the	  50	  µM	  fluorescently	  labelled	  stock	  (DF,	  
3'-­‐SF,	  gap	  or	  DF2'OH)	  annealed	  as	  described	  before.	  Buffer	  components	  were	  derived	  from	  MM	  
solution	  to	  maintain	  the	  same	  final	  concentration	  between	  all	   the	  reaction	  mixtures.	  For	  each	  
experiment	  an	  appropriate	  amount	  of	  5X	  RRB	  was	  prepared	  by	  adding	  a	  fresh	  5	  mM	  DTT	  to	  di-­‐




quired.	  All	   the	  enzyme	  dilutions	  were	  prepared	   in	  1X	  RRB	  using	  the	  stocks	  of	  WT,	  E160D,	  and	  
A159V	  mFEN1	  enzymes,	  which	  had	  concentrations	  of	  100	  µM	  in	  50	  %	  (v/v)	  glycerol.	  
The	  multiple	  turnover	  assay	  was	  performed	  by	  site	  up	  12	  micro	  centrifuge	  tubes	  (1.5	  ml)	  con-­‐
tain	  the	  substrate,	  MM,	  and	  1X	  FB	  in	  ice.	  A	  control	  tube	  was	  prepared	  by	  taking	  4.5	  µl	  from	  the	  
6	  first	  tubes	  and	  18	  µl	  from	  the	  other	  ones.	  The	  first	  6	  samples	  were	  incubated	  in	  a	  water	  bath	  
(37oC)	  for	  8	  minutes.	  The	  reactions	  were	  initiated	  by	  adding	  the	  enzyme	  for	  each	  tube	  every	  20	  
S	   (and	  mixing	  by	  pipetting	   the	   solution	  up	  and	  down).	  Then,	   the	   reactions	  were	  quenched	  by	  
removing	  5	  µl	   at	  each	   time	  point	  and	  adding	   it	   to	  250	  mM	  of	  EDTA	   (pH	  7.5).	   The	  volumes	  of	  
EDTA	  used	  were	  determined	   to	  give	  an	  overall	   substrate	   concentration	  of	  700	  pM.	  The	   same	  
previous	   steps	   were	   repeated	   with	   the	   other	   6	   samples	   except	   that	   the	   amount	   of	   the	  
quenched	  reaction	  was	  20	  µl.	  	  
For	  each	  reaction,	  aliquots	  were	  taken	  at	  0	  (the	  control),	  2,	  4,	  6,	  8,	  and	  20	  minutes	  time	  points.	  
The	  positive	   control	  was	   taken	   in	   the	  absence	  of	  enzyme	   to	  detect	   any	  baseline	   fluorescence	  
that	  occurred	  before	  enzyme	  substrate	  binding.	  These	  time	  points	  were	  chosen	  so	  that	  about	  
10	  %	  of	   product	  was	   formed	   in	   10	  minutes	   to	   allow	   true	   initial	   rates	   to	  be	  determined.	   	   The	  
product	  was	  detected	  by	  measuring	   fluorescence	  at	  λ510	  coupled	  to	  reversed-­‐phase	  high	  pres-­‐
sure	   liquid	  chromatography	   (dHPLC).	  The	  wave	  buffers	   (A,	  B,	  C,	  and	  D)	  were	  used	  to	  separate	  
the	   product	   from	   starting	  material	   on	   a	  DNAseq.	  While	   the	   retention	   time	   of	   the	   5'-­‐terminal	  
product	   varied	   depending	   on	   its	   size,	   the	   remaining	   substrate	   (23	   mer)	   always	   at	   around	   8	  
minutes.	  
All	  of	   the	  reactions	  were	   independently	  repeated	  3	  times.	  The	   initial	   rates	   (Vo,	  nMmin-­‐1)	  were	  
measured	  by	  plotting	  the	  amount	  of	  product	  against	  time	  for	  the	  first	  10	  %	  of	  product	  formed	  
during	   the	   reaction.	   The	  measured	   initial	   rates	   were	   normalized	   to	   the	   concentration	   of	   en-­‐
zyme.	  The	  kinetic	  parameters	  kcat	  and	  KM	  were	  determined	  by	  applying	  the	  Michaelis	  and	  Men-­‐
ten	   Equation	   (equation	   3.2)	   by	   plotting	   the	   normalized	   initial	   rates	   versus	   the	   different	   initial	  
substrate	   concentrations.	   All	   graphs	   and	   statistics	   were	   fitted	   and	   analysed	   using	   GraphPad	  
Prism	  6	  Software.	  
2.4.3.	  The	  single	  turnover	  kinetic	  (ST):	  
A	  RQF-­‐63	   quench	   flow	  device	   (Hi-­‐Tech	   Sci	   Ltd,	   Sailsbury,	  UK)	  was	   used	   to	   perform	   the	   single	  
turnover	  assays	  discontinuously	  with	  a	  huge	  excess	  of	  enzyme	  at	  37	  oC.	  Triplicate	  sets	  of	  assays	  
were	  carried	  out	  with	  small	  timeframes	  using	  quench	  flow	  machinery.	  The	  assays	  were	  carried	  




10X	  and	  1/40X	  the	  corresponding	  KM	   that	  was	  determined	  previously	   in	   the	  multiple	   turnover	  
assays	   (table	  2.5).	   The	  enzyme	  and	  substrate	  concentrations	  were	   initially	  prepared	  at	  2X	   the	  
final	  concentrations	  by	  using	  5X	  RRB	  and	  1X	  FB	   (8	  mM	  MgCl,	  110	  mM	  KCl,	  55	  mM	  HEPES	   (pH	  
7.5),	  0.1	  mg/ml	  BSA	  and	  1	  mM	  DTT)	  and	  kept	  on	  ice.	  	  
Table	  2.5.	  The	  substrate	  (S)	  and	  enzyme	  (E)	  concentrations	  that	  used	  in	  MT	  and	  ST	  assays.	  a)	  Ranges	  of	  mFEN-­‐1	  en-­‐
zyme	  concentrations	  that	  used	  for	  each	  MT	  reaction,	  while	  the	  substrate	  concentrations	  always	  ranges	  from	  5000	  nM	  
to	  5	  nM.	  b)	  The	  initial	  concentrations	  of	  S	  and	  E	  for	  each	  ST	  reaction.	  
The	  enzyme	  substrate	   reactions	  were	   carried	  out	  using	   the	   range	  of	   time	  points.	  All	   the	   time	  
points	  for	  each	  enzyme	  can	  be	  found	  in	  the	  appendices	  (from	  table	  7.11	  to	  table	  7.13).	  At	  each	  
time	  point	  100	  µl	  of	   the	  enzyme	  solution	  was	   injected	  with	  an	  equal	  volume	  of	   the	  substrate	  
solution.	  Reactions	  were	  quenched	  with	  80	  µl	  of	  the	  standardised	  quench	  solution	  (ST	  quench).	  
170	  µl	  of	  each	  quenched	  reaction	  was	  placed	  in	  a	  small	  tube.	  All	  the	  samples	  were	  analysed	  us-­‐
ing	  HPLC	  as	  described	  for	  the	  steady	  state	  measurements.	  The	  kinetic	  parameter	  kST	  max	  was	  de-­‐
termined	  by	  plotting	  percentage	  of	  product	  formed	  versus	  time	  point	  initially	  by	  the	  one	  phase	  
exponential	   (equation	  3.3),	  but	   they	  had	  better	   fitted	  with	  the	  two	  phases	  exponential	   (equa-­‐
tion	  3.4).	  All	  graphs	  and	  statistics	  were	  fitted	  and	  analysed	  by	  using	  GraphPad	  Prism	  6	  Software.	  
2.5.	  Observation	  of	  local	  conformational	  changes	  of	  substrate	  reacted	  duplex	  in	  the	  
WT	  and	  mutated	  FEN-­‐1	  by	  circular	  dichroism	  of	  2-­‐aminopurine	  (ECCD):	  




a)	  Concentrations	  in	  MT	  (PM)	   b)	  Concentrations	  in	  ST	  (nM)	  
[WT]	  	   [A159V]	  	   [E160D]	  	   WT	   A159V	   E160D	  
From	   To	   From	   To	   From	   To	   [s]	   [E]	   [s]	   [E]	   [s]	   [E]	  
DF	   150	   2	   40000	   400	   1200	   64	   5	   680	   5	   1820	   5	   2100	  
3'-­‐SF	   800	   20	   -­‐	   -­‐	   -­‐	   -­‐	   2.5	   680	   -­‐	   -­‐	   -­‐	   -­‐	  
Gap	  	   300	   3	   80000	   1200	   1800	   100	   2.5	   920	   7	   2620	   7	   2820	  




10X	  buffer	  (Ca+2)	   100	  mM	  CaCl2,	  1	  M	  KCl,	  0.5	  M	  HEPES	  (pH	  7.5).	  
10X	  FB	   1	  M	  KCl,	  0.5	  M	  HEPES	  (pH	  7.5).	  
Storage	  buffer	  (SB)	   1X	  FB,	  50%	  glycerol,	  0.02%	  NaN3.	  
DTT	  stock	   1	  M	  chelexed	  DTT	  solution.	  
Master	  mix	  (MM)	   	  1X	  buffer	  (Ca+2),	  1	  mM	  DTT.	  
2.5.1.	  ECCD	  substrates	  design	  using	  2-­‐AP	  substitution:	  
The	  aim	  of	  this	  ECCD	  experiments	  to	  probe	  specific	  structural	  changes	  of	  adjacent	  basis	  at	  the	  
ss-­‐ds	   junction	   of	   FEN-­‐1	   substrates.	   Accordingly,	   substrates	   containing	   2-­‐AP	   dimers	   were	   de-­‐
signed	  carefully	  from	  oligonucleotides	  to	  have	  structures	  as	  shown	  in	  figure	  2.3.	  ECCD	  of	  FEN-­‐
1:substrate	  complexes	  were	  recorded	  using	  3'-­‐SF,	  5'OH3'-­‐SF	  or	  DF	  substrates	  that	  constructs	  of	  
a	  1	  nt	  3'-­‐flap,	  1	  nt	  3'-­‐flap	  with	  5'OH	  or	  5	  nt	  5'-­‐flap	  and	  1	  nt	  3'-­‐flap	  respectively,	  analogues	  to	  the	  
substrates	  construct	  that	  used	  for	  kinetic	  study.	  2-­‐AP	  dimer	  was	  placed	  at	  +1,-­‐1	  and	  -­‐1,-­‐2	  posi-­‐
tions.	  The	  positions	  numbers	  of	  2-­‐AP	  dimer	  are	  relative	  to	  the	  scissile	  phosphate.	  All	  substrates	  
had	  static	  nature	  construction	  and	  that	  was	  important	  to	  eliminate	  flap	  migration	  and	  allowing	  
the	  ECCD	   spectrum	   to	  be	  definitely	   assigned	   to	   a	   specific	   position	  of	   2-­‐AP	  dimer	  within	  DNA.	  
Each	  substrate	  was	  bio-­‐molecularly	   formed	  from	  a	   template	  strand	   (T1	  or	  T2),	  which	  contains	  
the	  1	  nt	  3'-­‐flap,	  and	  a	  single	  strand	  with	  or	  without	  flap	  have	  or	  lack	  a	  5'-­‐phosphate	  (figure	  2.3)	  
(table	  2.6).	  Each	  oligonucleotide	  was	  dissolved	   in	  chelexed	  Milli-­‐Q	  water	  to	  prepare	  a	  500	  µM	  
stock	  solution.	  Their	  molecular	  weights	  confirmed	  using	  mass	  spectrometry,	  and	  the	  exact	  con-­‐
centration	  of	   the	   final	  oligonucleotide	  solution	  was	  determined	  by	  UV	  using	  Nanodrop	  at	  260	  
nm	   and	   20	   °C	   using	   extinction	   coefficients	   generated	   by	   IDT	   oligo	   analyser	   3.1	   tool	  
(https://www.idtdna.com/calc/analyzer)	  (table	  2.7).	  
For	   the	   ECCD	  experiment,	   each	   substrate	   and	   free	  non-­‐template	  oligonucleotide	  mixture	  was	  
prepared	  as	  a	  100	  µM	  solution	  in	  chelexed	  1X	  FB	  using	  the	  500	  µM	  oligonucleotide	  stocks.	  Be-­‐
fore	   the	   substrate	  addition	  of	  any	  enzyme	  mixture,	   it	  was	  annealed	  by	  heating	   to	  95	   oC	   for	  3	  






Figure	  2.3.	  Schematic	  structures	  of	  the	  ECCD	  synthetic	  oligonucleotides	  used	  to	  study	  the	  conformational	  changes	  of	  
mFEN-­‐1.	  Each	  substrate	  structure	  was	  formed	  from	  a	  single	  strand	  and	  a	  template.	  A	  represents	  2-­‐aminopurine	  nu-­‐
cleotide,	  (P)	  represents	  a	  5'-­‐monophosphate,	  and	  (OH)	  represents	  a	  5'-­‐hydroxyl.	  The	  scissile	  phosphate	  connects	  the	  






Construct	   Composition	  
3'-­‐SF+1-­‐1	   ss3'-­‐SF+1-­‐1	  +	  T1.	  
3'-­‐SF-­‐1-­‐2	   ss3'-­‐SF+1-­‐1+T2.	  
5'OH3'-­‐SF+1-­‐1	   ss5'OH3'-­‐SF+1-­‐1+	  T1.	  
5'OH3'-­‐SF-­‐1-­‐2	   ss5'OH3'-­‐SF-­‐1-­‐2+T2.	  
DF+1-­‐1	   ssDF+1-­‐1+	  T1.	  
DF-­‐1-­‐2	   ssDF-­‐1-­‐2+T2.	  
Table	   2.6.	  Oligonucleotide	   combinations	   used	   to	  make	   the	   substrate	   constructs	   for	   ECCD	  experiments	   to	   study	   the	  
conformational	  changes	  of	  FEN-­‐1.	  Each	  substrate	  structure	  was	  formed	  from	  T1	  and	  a	  +1-­‐1	  single	  strand	  or	  T1	  and	  a	  -­‐
1-­‐2	  single	  strand.	  
Oligonucleotide	  code	   Actual	  Mass	  (g.mol-­‐1)	   Calculated	  Mass	  (g.mol-­‐1)	   ε260	  (L.mol
-­‐1.cm-­‐1)	  
ss3'-­‐SF+1-­‐1	   4152.7	   4152.71	   118500	  
ss3'-­‐SF+1-­‐1	   4152.7	   4151.7	   118500	  
ss5'OH3'-­‐SF+1-­‐1	  	   4072.7	   4071.74	   118500	  
ss5'OH3'-­‐SF-­‐1-­‐2	   4072.7	   4073	   118500	  
ssDF+1-­‐1	   5593.7	   5593.96	   158400	  
ssDF-­‐1-­‐2	   5593.7	   5593.96	   158400	  
T1	   8789.7	   8789.9	   257500	  
T2	   8789.7	   8793	   258100	  
Table	  2.7.	  Details	  of	  the	  ECCD	  oligonucleotides	  synthesised	  and	  purified	  for	  work	  with	  FEN-­‐1.	  
2.5.2.	  ECCD	  experiment	  technique:	  	  
2-­‐aminopurine	   (2-­‐AP)	  absorbs	   light	   in	  a	  different	  region	   from	  bases	  and	  proteins.	  Accordingly,	  
correlation	  of	  this	  group	  with	  the	  terminal	  nucleotides	  can	  provide	  a	  typical	  spectrum.	  This	  typi-­‐
cal	  absorption	  can	  be	  affected	  by	  the	  presence	  of	  the	  5'-­‐terminal	  phosphate	  group	  and	  enzyme	  
mutations.	  	  
Carefully	  designed	  substrates	  containing	  2-­‐AP	  dimers	  (3'-­‐SF+1-­‐1,	  3'-­‐SF-­‐1-­‐2,	  5'OH3'-­‐SF+1-­‐1,	  5'OH3'-­‐SF-­‐




E160D	  mFEN-­‐1	  binding	  in	  ±Ca2+	  as	  shown	  in	  table	  2.8.	  Same	  substrates	  except	  the	  DF	  were	  used	  
to	   study	   the	   structural	   changes	  upon	  WT,	   Y40A,	  K93A,	  R100A,	   L130P,	  D181A	  and	  K93AR100A	  
hFEN-­‐1	  binding	  in	  ±Ca2+	  as	  shown	  in	  table	  2.8.	  Samples	  containing	  10	  µM	  of	  DNA,	  100	  mM	  KCl,	  1	  
mM	  DTT,	  12	  µM	  FEN-­‐1	  protein	  (mWT,	  mA159V,	  mE160D,	  hWT,	  hY40A,	  hK93A,	  hR100A,	  L130P,	  
hD181A	  or	   hK93AR100A)	   and	   either	   10	  mM	  CaCl2	   or	   10	  mM	  CaCl2	   +	   25	  mM	  EDTA	  were	   pre-­‐
pared.	  More	  details	  about	   the	  reaction	  conditions	  can	  be	   found	   in	   the	  appendices	   (table	  7.14	  
and	  table	  7.15).	  CD	  spectra	  (300-­‐480	  nm)	  were	  acquired	  at	  20	  oC	  using	  a	  JASCO	  J-­‐810	  CD	  spec-­‐
trophotometer	  with	  hFEN-­‐1	  and	  chirascan	  plus	  CD	  spectrophotometer	  with	  mFEN-­‐1.	  CD	  spectra	  
were	  an	  average	  of	  5	  scans	  recorded	  in	  0.5	  nm	  steps	  (0.5	  S	  response	  time).	  The	  base	   line	  was	  
corrected	   using	   spectra	   recorded	   on	   samples	   containing	   the	   same	   components,	   but	   storage	  
buffer	  rather	  than	  FEN-­‐1	  or	  1X	  FB	  rather	  than	  DNA.	  The	  baseline-­‐subtracted	  spectra	  were	  then	  
smoothed	  using	  the	  Means-­‐Movement	  option	  with	  a	  convolution	  width	  of	  5	  using	  JASCO	  Spec-­‐
tra	   analysis	   software	   (version	   1.53.07)	   or	   chirascan	   plus	   analysis	   software	   depending	   on	   the	  
used	   CD	   spectrophotometer.	   All	   of	   the	   processed	   data	   were	   normalised	   and	   then	   fitted	   and	  
analysed	  using	  GraphPad	  Prism	  6	  Software.	  
E	   3'-­‐SF+1-­‐1	   3'-­‐SF-­‐1-­‐2	   5'OH3'-­‐SF+1-­‐1	   5'OH3'-­‐SF-­‐1-­‐2	   DF+1-­‐1	   DF-­‐1-­‐2	  
mFEN-­‐1	  
WT	   ✓	   ✓	   ✓	   ✓	   ✓	   ✓	  
A159V	   ✓	   ✓	   ✓	   ✓	   ✓	   ✓	  
E160D	   ✓	   ✓	   ✓	   ✓	   ✓	   ✓	  
hFEN-­‐1	  
WT	   ✓	   ✓	   ✓	   ✓	   	   	  
Y40A	   ✓	   ✓	   ✓	   ✓	   	   	  
K93A	   ✓	   ✓	   ✓	   ✓	   	   	  
R100A	   ✓	   ✓	   ✓	   ✓	   	   	  
L130P	   ✓	   ✓	   ✓	   ✓	   	   	  
D181A	   	   ✓	   ✓	   ✓	   	   	  
K93A	  R100A	   ✓	   ✓	   ✓	   ✓	   	   	  
Table	  2.8.	  Details	  of	  ECCD	  experiments	  to	  illiterate	  which	  substrates	  were	  studied	  with	  WT	  and	  mutated	  mouse	  and	  
human	  FEN-­‐1.	  
2.6.	  Measuring	  substrate	  bending	  upon	  FEN-­‐1	  binding	  by	  Fluorescence	  Resonance	  En-­‐
ergy	  Transfer	  analysis	  (FRET):	  




10X	  Ca+2	  buffer	   100	  mM	  CaCl2,	  1	  M	  KCl,	  1	  mg/ml	  BSA,	  0.5	  M	  HEPES	  (pH	  7.5).	  
10X	  EDTA	  buffer	   20	  mM	  EDTA,	  1	  M	  KCl,	  1	  mg/ml	  BSA,	  0.5	  M	  HEPES	  (pH	  7.5).	  
1X	  FB	  	   100	  µM	  KCl,	  50	  mM	  HEPES	  (pH	  7.5).	  
DTT	  stock	   1	  M	  chelexed	  DTT	  solution.	  
2.6.1.	  FRET	  substrates	  design	  using	  donor	  and	  acceptor	  connection:	  	  
DNA	  constructs-­‐oligonucleotide	  sequences	  are	  shown	  in	  figure	  2.4	  and	  table	  2.9.	  DNA	  oligonu-­‐
cleotides	  including	  those	  containing	  internal	  TAMRA	  and	  fluorescein	  were	  purchased	  with	  HPLC-­‐
purification	  from	  DNA	  Technology	  A/S.	  The	  phosphoramidite	  synthons	  used	  for	  5'-­‐biotin,	  inter-­‐
nal	   TAMRA	   dT	   and	   internal	   fluorescein	   dT	   modifications	   were	   N-­‐DMT-­‐biotinyl-­‐2-­‐
aminoethoxyethanol	  amidite,	  5-­‐DMT-­‐T(TEG-­‐TAMRA)	  and	  fluorescein	  T	  amidite	  respectively,	  and	  
purchased	  from	  Biosearch	  Technologies	  Inc.	  After	  dissolving	  the	  oligonucleotide	  stock	  in	  appro-­‐
priate	  amount	  of	  water,	  the	  mass	  of	  each	  oligonucleotide	  was	  determined	  by	  Mass	  Spectrome-­‐
ter	  (MS)	  to	  be	  compared	  with	  the	  actual	  mass	  (table	  2.10).	  The	  concentration	  of	  the	  final	  oligo-­‐
nucleotide	  solution	  was	  determined	  by	  UV	  using	  Nanodrop	  at	  260	  nm	  and	  20	  °C	  using	  extinction	  
coefficients	   generated	   by	   IDT	   oligo	   analyser	   3.1	   tool	   (https://www.idtdna.com/calc/analyzer)	  
(table	  2.10).	  	  
FRET	  substrates	  have	  labelling	  sites	  are	  chosen	  to	  maximise	  the	  FRET	  change	  upon	  enzyme	  bind-­‐
ing	   (figure	   2.4).	   These	   substrates	  were	   assembled	   by	   heating	   3-­‐flap,	   5-­‐flap/exo	   and	   template	  
strands	  in	  1:1.1:1	  ratio	  in	  50	  mM	  HEPES	  pH	  7.5	  and	  100	  mM	  KCL	  (1X	  FB)	  to	  80	  °C	  for	  5	  minutes	  
and	   then	  cooling	  at	   room	   temperature.	  DNA	  duplex	   created	  as	  above	  with	  Tcdonor	  and	   tem-­‐
plate	  strands	  in	  a	  1:1	  ratio	  (figure	  2.4)	  (table	  2.9).	  The	  DF	  substrate	  used	  in	  this	  study	  has	  similar	  
structure	  to	   that	  used	  previously,	  however,	   it	  differs	   in	  donor	  and	  acceptor	  positions.	   In	  addi-­‐
tion,	  substrate	  lacking	  5'-­‐flap	  with	  5'-­‐phosphate	  was	  used	  for	  first	  time.	  All	  substrates	  containing	  
internal	  TAMRA	  and	  fluorescein	  in	  sites	  that	  were	  selected	  to	  maximise	  the	  FRET	  change	  upon	  
bending	  resulted	  from	  FEN-­‐1	  binding	  (figure	  2.4).	  The	  FRET	  substrates	  (3'-­‐SF	  and	  DF)	  assembled	  
by	  3'-­‐flap	  (contains	  donor),	  5'-­‐flap/exo	  and	  template	  (contains	  acceptor)	  strands	  (table	  2.9).	  All	  
FRET	  changes	  were	  compared	  with	  DNA	  duplex	  FRET	  that	  created	  from	  Tcaccept	  and	  TcdonorD	  
(figure	  2.4	  &	  table	  2.9).	  The	  donor	  and	  acceptor	  were	  attached	  to	  the	  thymine	  of	  the	  5th	  nt	  and	  




static	  and	  similar	  to	  the	  other	  substrates	  in	  this	  thesis	  except	  the	  DF	  substrate	  has	  6	  nts	  flap	  ra-­‐
ther	  than	  5	  nts.	  
	  
Figure	  2.4.	   Schematic	   structures	  of	   the	  FRET	   synthetic	  oligonucleotides	  and	   substrates	   that	  were	  used	   to	   study	   the	  
substrate	  bending	  upon	  FEN-­‐1	  binding.	  Each	  DAL,	  which	   is	  donor	   (Fluor)	  and	  acceptor	   (TAMRA)	   labelled	  substrate,	  
structure	  was	  formed	  from	  two	  or	  three	  single	  strands.	  Fluor	  represents	   internal	  fluorescein,	  TAMRA	  represents	  tet-­‐
ramethylrhodamine,	  B	  represents	  biotin,	  P	  represents	  a	  5'-­‐monophosphate,	  OH	  represents	  a	  5'-­‐hydroxyl,	  and	  AA	  rep-­‐




Construct	   Composition	  
DF	  (NL)	   Tcflap	  +	  Tcca	  +Tccd.	  
DF	  (DOL)	   Tcflap	  +Tcca	  +Tcdonor.	  
DF	  (AOL)	  	   Tcflap	  +	  Tccd	  +	  Tcaccept.	  
DF	  (DAL)	   Tcflap	  +	  Tcdonor	  +	  Tcaccept.	  
3'-­‐SF	  (NL)	   EP-­‐Fret	  +	  Tcca	  +Tccd.	  
3'-­‐SF	  (DOL)	   EP-­‐Fret	  +Tcca	  +Tcdonor.	  
3'-­‐SF	  (AOL)	   EP-­‐Fret	  +	  Tccd	  +	  Tcaccept.	  
3'-­‐SF	  (DAL)	   EP-­‐Fret	  +	  Tcdonor	  +	  Tcaccept.	  
5'OH3'-­‐SF	  (NL)	   EO-­‐Fret	  +	  Tcca	  +Tccd.	  
5'OH3'-­‐SF	  (DOL)	   EO-­‐Fret	  +Tcca	  +Tcdonor.	  
5'OH3'-­‐SF	  (AOL)	   EO-­‐Fret	  +	  Tccd	  +	  Tcaccept.	  
5'OH3'-­‐SF	  (DAL)	   EO-­‐Fret	  +	  Tcdonor	  +	  Tcaccept.	  
MM+1DF	  (NL)	   MM+1-­‐Fret	  +	  Tcca	  +Tccd.	  
MM+1DF	  (	  DOL	  )	   MM+1-­‐Fret	  +Tcca	  +Tcdonor.	  
MM+1DF	  (AOL)	   MM+1-­‐Fret	  +	  Tccd	  +	  Tcaccept.	  
MM+1DF	  (DAL)	   MM+1-­‐Fret	  +	  Tcdonor	  +	  Tcaccept.	  
5'-­‐SF	  (NL)	   Tcflap	  +	  Tccd2	  +	  Tcca.	  
5'-­‐SF	  (DOL)	   Tcflap	  +	  Tcdonor2	  +	  Tcca.	  
5'-­‐SF	  (AOL)	   Tcflap	  +	  Tccd2	  +	  Tcaccept.	  
5'-­‐SF	  (DAL)	   Tcflap	  +	  Tcdonor2	  +	  Tcaccept.	  
Nicked	  DNA	  (NL)	   EP-­‐Fret	  +	  Tcca	  +	  Tccd2.	  
Nicked	  DNA	  (DOL)	   EP-­‐Fret	  +	  Tcca	  +	  Tcdonor2.	  	  
Nicked	  DNA	  (AOL)	   EP-­‐Fret	  +	  Tcaccept	  +	  Tccd2.	  
Nicked	  DNA	  (DAL)	   EP-­‐Fret	  +	  Tcaccept	  +	  Tcdonor2.	  
DNA	  duplex	  (DOL)	   TcdonorD	  +Tcca.	  
DNA	  duplex	  (DAL)	   TcdonorD	  +	  Tcaccept.	  
Table	  2.9.	  Oligonucleotide	  combinations	  used	  to	  make	  the	  substrate	  constructs	  for	  FRET	  experiments.	  NL	  is	  non-­‐
labelled	  substrate	  DOL	  is	  donor	  only	  labelled	  substrate	  AOL	  is	  acceptor	  only	  labelled	  substrate,	  DAL	  is	  donor	  and	  ac-­‐
ceptor	  labelled	  substrate,	  ,	  and.	  AA	  represents	  2-­‐aminopurine	  nucleotides,	  (P)	  represents	  a	  5'-­‐monophosphate,	  and	  




Oligonucleotide	  code	   Actual	  Mass	  (g.mol-­‐1)	   Calculated	  Mass	  (g.mol-­‐1)	   ε260	  (L.mol
-­‐1.cm-­‐1)	  
Tcaccept	   11570.8	   11571	   352000	  
Tcdonor	   6271.3	   6271	   190000.	  
Tcdonor2	   5982.1	   5982.09	   182800	  
Tcflap	  	   7819.3	   7807	   231500	  
Tcca	   11004.1	   11004	   322900	  
Tccd	   5758.8	   5759	   176300	  
Tccd2	   5469.6	   5468.95	   169100	  
Ep-­‐Fret	   5668.7	   5668.83	   182900	  
EO-­‐Fret	   5588.7	   5588.84	   182900	  
MM+1-­‐Fret	   7422.9	   7422.24	   237400	  
TcdonorD	   11632.7	   11632.5	   364800	  
Table	  2.10.	  Details	  of	  the	  FRET	  oligonucleotides	  synthesised	  and	  purified	  for	  work	  with	  FEN-­‐1.	  
2.6.2.	  FRET	  experimental	  technique	  to	  characterise	  DNA	  bending	  upon	  FEN-­‐1	  binding:	  	  
Florescence	  Resonance	  Energy	  Transfer	  (FRET)	  efficiencies	  (E)	  were	  measured	  using	  the	  (ratio)A	  
method	  86	  by	  determining	  the	  enhanced	  acceptor	  fluorescence	  at	  37	  °C.	  The	  steady	  state	  fluo-­‐
rescent	  spectra	  of	  10	  nM	  non-­‐labelled	  (NL)	  trimolecular,	  donor-­‐only-­‐labelled	  (DOL)	  and	  douply-­‐
labelled	   (DAL)	   substrates	   (figure	   2.4)	  were	   recorded	   using	   a	   Horiba	   Jobin	   Yvon	   FluoroMax-­‐3®	  
fluorometer.	  For	  direct	  excitation	  of	   the	  donor	   (fluorometer,	  DOL)	  or	  acceptor	   (TAMRA,	  AOL),	  
the	  sample	  was	  excited	  at	  490	  nm	  or	  560	  nm	  (2	  nm	  slit	  width)	  and	  the	  emission	  signal	  collected	  
from	  515-­‐650	  nm	  or	  575-­‐650	  nm	  (5	  nm	  slit	  width).	  Emission	  spectra	  were	  corrected	  for	  buffer	  
and	  enzyme	  background	  signal	  by	  substracting	  the	  signal	  from	  the	  non-­‐labelled	  (NL)	  DNA	  sam-­‐
ple.	  In	  addition	  to	  10	  nM	  of	  the	  appropriate	  DNA	  construct,	  samples	  contained	  10	  mM	  CaCl2	  or	  
2	  mM	  EDTA,	  110	  mM	  KCL,	  55	  mM	  HEPES	  pH	  7.5,	  0.1	  mg/mL	  bovine	  serum	  albumin	  (BSA)	  and	  1	  
mM	  DTT.	   The	   first	  measurement	  was	   taken	   prior	   to	   the	   addition	   of	   protein	  with	   subsequent	  
readings	  taken	  on	  the	  cumulative	  addition	  of	  the	  appropriate	  enzyme	  in	  the	  same	  buffer	  (table	  
2.11).	  With	  corrections	  made	  for	  dilution.	  Transfer	  efficiencies	  (E)	  were	  determined	  according	  to	  
equation	   3.8.	   Energy	   transfer	   efficiency	   (E)	   was	   fitted	   by	   non-­‐linear	   regression	   in	   the	   Kalei-­‐




Donor	  (fluorescein)	  was	  excited	  at	  490	  nm	  with	  emission	  sampled	  as	  the	  average	  value	  of	  the	  
signal	  between	  515-­‐525	  nm,	  and	  acceptor	  (TAMRA)	  was	  excited	  at	  560	  nm	  with	  emission	  aver-­‐
age	   between	   580-­‐590	   nm.	   For	   FRET	   experiments	   involving	   substrate	   bound	   to	   streptavidin,	   5	  
molar	   equivalent	   of	   streptavidin	  were	  pre-­‐incubated	  with	   the	  biotinylated	   substrate	   in	   buffer	  
containing	  10	  mM	  CaCl2,	  55	  mM	  HEPES	  pH	  7.5,	  110	  mM	  KCl,	  1	  mg/ml	  BSA	  and	  1	  mM	  DTT	  for	  10	  
minutes	  at	  room	  temperature	  before	  proceeding	  as	  above.	  	  
E	   DF	   MMDF	   3'-­‐SF	   5'OH3'-­‐SF	   SADF	   5'-­‐SF	   Nicked	  
mFEN-­‐1	  
WT	   ✓	   -­‐	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	  
A159V	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	  
E160D	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   	  -­‐	  
hFEN-­‐1	  
WT	   ✓	   ✓	   ✓	   ✓	   ✓	   ✓	   ✓	  
Y40A	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	  
L53A	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   	  -­‐	  
K93A	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	  
R100A	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	  
R104A	   -­‐	   -­‐	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	  
L130P	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	  
K132A	   -­‐	   -­‐	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	  
D181A	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	  
K93AR100A	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	  
R103AR129A	   ✓	   -­‐	   ✓	   -­‐	   -­‐	   -­‐	   	  
R103ER129E	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   	  
R104AK132A	   ✓	   -­‐	   ✓	   -­‐	   -­‐	   -­‐	   	  
R104EK132E	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   	  
Quad	  E	   ✓	   -­‐	   -­‐	   -­‐	   -­‐	   -­‐	   	  
Table	  2.11.	  Details	  of	  FRET	  experiments	  to	  illiterate	  which	  substrates	  were	  studied	  with	  each	  WT	  and	  mutated	  mouse	  




Chapter	  3:	  Results	  and	  Discussion	  of	  mFEN-­‐1:	  	  
As	  indicated	  in	  chapter	  1,	  the	  FEN-­‐1	  enzyme	  can	  best	  be	  described	  as	  a	  multifunctional	  enzyme	  
with	  different	  activities	  to	  recognise	  different	  substrates.	   In	  previous	  studies,	  FEN-­‐1	  mutations	  
have	  been	  connected	  to	  cancer	  because	  of	  the	  presence	  mutations	  reduce	  enzyme	  efficiency	  by	  
affecting	   FEN-­‐1	   activities.18,19,87	   FEN-­‐1	   catalysis	   has	   been	   suggested	   to	   proceed	   by	   a	   specific	  
mechanism	  and	  it	   is	  therefore	  possible	  that	  mutations	  alter	  specific	  reaction	  steps.	  In	  this	  part	  
of	  project,	  wild-­‐type	  mouse	  FEN-­‐1	  (WTmFEN-­‐1)	  will	  be	  studied	  with	  different	  substrates	  kinet-­‐
ically	   to	  verify	   the	   impact	  on	  different	  activities	  and	  the	  ability	   to	  recognise	  the	  different	  sub-­‐
strates.	   In	   addition,	  mFEN-­‐1	  active	   site	  mutations	   (A159V	  and	  E160D)	  were	   studied	  and	   com-­‐
pared	  to	  WTmFEN-­‐1	  to	  illustrate	  if	  these	  mutations	  affect	  protein	  chemistry,	  substrate	  confor-­‐
mational	  change	  and/or	  substrate	  bending.	  	  
3.1.	  WT	  and	  mutant	  mFEN-­‐1	  expression,	  purification,	  adjustment	  concentration	  and	  
folding	  test:	  
WT,	  A159V	  and	  E160D	  mFEN-­‐1	  enzymes	  expressed,	  purified,	  adjusted	  to	  100	  µM	  concentration	  
and	  their	  secondary	  structure	  was	  tested.	  The	  obtained	  results	  are	  summarised	  as	  below:	  
3.1.1.	  PCR	  reaction,	  cells	  transformation	  and	  plasmid	  preparation:	  
Site-­‐directed	  mutagenesis	  was	  used	   to	  create	  a	  mutation	  at	  a	  defined	  site	  of	   the	  known	  tem-­‐
plate	  sequence	  using	  PCR.	  As	  the	  primers	  were	  extended	  to	  replace	  the	  original	  sequence,	  the	  
resulting	  amplified	  product	   incorporated	  the	  mutation.	  A159V,	  E160D	  and	  D160E	  primer	  pairs	  
were	  used	   to	  produce	  A159V,	  E160D	  and	  WT	  mFEN-­‐1	  plasmids,	   respectively.	   The	  exponential	  
amplification	   in	   PCR	   produced	   a	   fragment	   containing	   the	   desired	   mutation	   (E160D,	   WT	   and	  
A159V	  mFEN-­‐1)	  in	  sufficient	  quantity.	  This	  was	  tested	  by	  observing	  separation	  from	  the	  original	  
(non-­‐mutant)	  plasmid	  on	  an	  agarose	  gel	  electrophoresis	  stained	  with	  Sybr	  Safe.	  The	  target	  DNA	  
for	  each	  protein	  was	  seen	  as	  a	  band	  using	  the	  ChemDocTM	  MP	  Imaging	  System	  (figure	  3.1).	  	  
DH5α	   cells	   were	   transformed	  with	   pET-­‐28b-­‐mFEN-­‐1	   plasmids	   containing	   the	  WT	   and	  mutant	  
DNA	  sequences.	  The	   transformed	  cells	  were	   spread	  on	  agar	  gel	  plates	  and	  observed	  as	   single	  
colonies.	  
The	   starter	   culture	   for	   each	   enzyme,	  which	  was	   obtained	  by	   inoculation	  of	   a	   single	   colony	   in	  
2XYT	  media,	  grew	  successfully	  and	  cloudy	  solutions	  after	  overnight	  growth	  were	  obtained.	  The	  
plasmids	   for	   each	  protein	  were	   collected	  using	   a	  mini-­‐prep	   kit	   (Qiagen),	   and	   their	   concentra-­‐




tained	  were	  higher	  than	  50	  ng/µl	  (table	  3.1).	  All	  of	  the	  prepared	  plasmid	  solutions	  were	  sent	  for	  
sequencing.	   The	   sequencing	   data	   indicated	   that	   the	   mutagenesis	   had	   worked	   correctly	   as	  
shown	  in	  the	  appendix	  (section	  7.1.1	  to	  7.1.6).	  	  
	   	  
Figure	  3.1.	  Bands	  corresponding	  to	  target	  DNA	  for	  each	  enzyme	  on	  agarose	  gels	  in	  the	  second	  lane,	  and	  the	  molecular	  
weight	  markers	  are	  in	  the	  first	  lane	  of	  each	  gel	  photo.	  The	  gels	  were	  visualised	  using	  Bio	  RAD	  chemiDocTMMP	  imaging	  
system.	  
mFEN-­‐1	  Plasmid	   A159V	   E160D	   WT	  
The	  concentration	  obtained	  (ng/µl)	   60	   114	   78	  
Table	  3.1.	  The	  concentrations	  of	  the	  obtained	  plasmids	  measured	  using	  Nanodrop	  Spectrophotometer.	  
3.1.2.	  Protein	  expression:	  
BL21DE	  cells	  were	  transformed	  with	  the	  plasmids.	  Transformed	  cells	  were	  spread	  on	  agar	  plates	  
and	  grew	  as	  single	  colonies.	  A	  single	  colony	  containing	  each	  plasmid	  was	  used	  for	  initial	  growth	  
in	  2XYT	  media,	  followed	  by	  grow-­‐up	  in	  AI	  media.	  The	  cultures	  were	  pelleted	  by	  centrifugation,	  
washed	  with	  PBS,	  and	  re-­‐suspended	  into	  lysis	  buffer.	  	  
The	  protein	  synthesis	  was	  tested	  by	  running	  samples	   from	  the	  pellet	  and	  supernatant	  of	  each	  
culture	  on	  SDS	  gel.	  A	  band	  corresponding	  to	  the	  correct	  molecular	  weight	  each	  target	  protein	  
(WT,	  A159V	  and	  E160D)	  was	  seen	  with	  most	  of	  the	  protein	  in	  the	  supernatant	  lane	  (figure	  3.2).	  
The	  bacterial	  cell	  supernatants	  were	  frozen	  at	  -­‐20	  oC,	  and	  after	  that,	  they	  were	  subjected	  to	  lysis	  





Figure	  3.2.	  The	  supernatant	  and	  pellet	  samples	  of	  WT,	  A159V,	  and	  E160D	  mFEN-­‐1	  overexpression	  analysed	  by	  SDS-­‐
PAGE.	  The	  gel	  was	  visualised	  using	  Bio	  RAD	  chemiDocTMMP	  imaging	  system.	  
3.1.3.	  Protein	  purification:	  
Purification	  of	  all	  mFEN-­‐1	  proteins	  (WT,	  A159V	  and	  E160D)	  was	  performed	  as	  described	  in	  sec-­‐
tion	  2.2.	  Each	  purification	  system	  required	  six	  chromatography	  media	  columns	  (IMAC,	  Ionic	  Ex-­‐
change,	  Phenyl	  Sephorose,	  Desalting,	  Heparin,	  and	  Size	  Exclusion).	  The	  presence	  of	   the	   target	  
protein,	  which	  was	   tested	  by	  SDS	  PAGE	  using	  10	  µl	   samples	   that	  were	  taken	   from	  the	  elution	  
after	  each	  of	  the	  first	  four	  columns,	  was	  indicated	  as	  a	  band	  on	  the	  SDS	  gel.	  Purity	  of	  the	  final	  
collected	  protein	  was	  indicated	  from	  the	  SDS	  gel	  of	  different	  concentrations	  of	  the	  final	  elution	  
(SEC	  column	  eluate)	  as	  shown	  in	  figure	  3.3.	  	  
	  
Figure	  3.3.	   The	   SDS	  gels	   of	   purified	  mFEN-­‐1	  proteins	   (WT,	  A159V	  and	  E160D).	   In	   each	  gel:	   the	   first	   lane	   is	   protein	  
marker	  with	  molecular	  weights	  bands	  shown	  in	  KD,	  and	  the	  other	  lanes	  correspond	  to	  different	  protein	  concentrations	  




3.1.4.	  Adjustment	  of	  the	  protein	  concentration	  and	  protein	  folding	  test:	  	  
By	   using	   a	   Nanoview	   spectrophotometer	   and	   the	   calculated	   extinction	   coefficient	   (mFEN-­‐1:	  
22920	  M-­‐1cm-­‐1),	  each	  protein	  concentration	  was	  determined	  by	  absorbance	  at	  280	  nm.	  The	  pro-­‐
tein	  concentration	  was	  adjusted	  with	  the	  appropriate	  volume	  of	  100	  %	  glycerol	   (chelexed	  and	  
filtered)	  and	  SEC	  buffer	  to	  adjust	  the	  final	  concentration	  to	  100	  µM	  FEN1,	  50%	  (v/v)	  glycerol,	  50	  
mM	  HEPES,	  100	  mM	  KCl,	  1mM	  CaCl2,	  10	  mM	  DTT,	  0.02	  %	  (w/v)	  NaN3.	  Then,	  the	  proteins’	  con-­‐
centrations	   were	   confirmed	   using	   a	   Bradford	   assay,	   in	   which	   the	   measured	   absorbance	   was	  
compared	  with	  a	  standard	  curve	  (figure	  3.4.a).	  
Examining	  the	  structure	  of	  proteins	  in	  solution	  (WT,	  A159V	  and	  E160D)	  using	  CD	  technique	  ob-­‐
tained	  complementary	  structural	  information	  to	  show	  that	  the	  WTmFEN-­‐1	  and	  mutant	  enzymes	  
have	  similar	   secondary	  structures	   (figure	  3.4.b).	  Therefore,	   loss	  of	  FEN-­‐1	  efficiency	   in	   the	  mu-­‐
tant	  cannot	  be	  due	  to	  an	  incorrectly	  folded	  structure.	  
	  
Figure	  3.4.	  Protein	  concentration	  and	  folding	  tests.	  a)	  The	  Bradford	  assay	  for	  WT,	  A159V	  and	  E160D.	  BSA	  standard	  
curve	  used	  to	  determine	  the	  concentration	  of	  protein	  in	  the	  storage	  buffer.	  b)	  The	  protein	  fold	  test	  of	  WT,	  A159V	  and	  
E160D	  mFEN-­‐1	  using	  CD	  machine.	  
3.2.	  Kinetic	  analysis	  of	  WT	  and	  mutant	  mFEN-­‐1:	  	  
Kinetic	   information	   is	  useful	   to	  understand	  how	  FEN-­‐1	   interacts	  with	  DNA	  and	  how	  the	  muta-­‐
tions	  can	  affect	  its	  activity.	  In	  fact,	  it	  is	  impossible	  to	  understand	  enzymes	  without	  understand-­‐
ing	  the	  kinetic	  properties	  of	  their	  reactions.	   In	  vivo	  FEN-­‐1	  specifically	   interacts	  with	  DNAs	  that	  
have	  a	  junction	  between	  two	  duplexes	  to	  hydrolyse	  the	  phosphate	  bond	  that	  is	  located	  1nt	  into	  
downstream	  duplex	  of	  the	  5'	  end	  of	  the	  DNA.	  Based	  on	  this,	  FEN-­‐1	  can	  be	  described	  as	  an	  en-­‐
zyme	  with	  different	   activities	   to	   recognise	  a	  double	   flap	   (DF)	   substrate	  with	   fen	   activity,	   a	   3'-­‐




With	  DF	  substrate,	  the	  5'	  end	  will	  be	  released	  as	  a	  smaller	  product	  (P)	  as	  shown	  in	  figure	  3.6.c.	  
The	  single	  strand	  product	  (P)	  is	  released	  directly	  after	  the	  hydrolysis	  chemistry.	  However,	  under	  
multiple	  turnover	  conditions	  (substrate	  saturating	  [E]	  <	  [S]	  >	  [KM])	  release	  of	  the	  double	  strand	  
product	  (Q)	  is	  rate	  limiting	  (figure	  3.5).66	  Previous	  studies	  compared	  the	  catalytic	  activity	  of	  WT	  
and	  mutant	  FENs	  under	  kcat/KM	   conditions.5	  Since	  substrate-­‐limiting	  conditions	  are	   likely	   to	  be	  
diffusion-­‐controlled	   reactions	   and	   substrate-­‐saturating	   conditions	   are	   rate	   limited	   by	   product	  
release,	  multiple	  turnover	  (MT)	  reactions	  may	  underestimate	  the	  effects	  of	  mutations.	  	  
On	  the	  other	  hand,	  determination	  of	  maximal	  rate	  of	  single	  turnover	  (ST)	  reactions	  can	  be	  more	  
useful	  when	  characterising	  mutation,	  as	  this	  does	  not	  measure	  product	  release	  or	  substrate	  as-­‐
sociation.	  Accordingly,	   the	  effect	  of	  mutations	   that	  are	  associated	  with	  cancer	  on	   the	  enzyme	  
activities	  was	  studied	  under	  MT	  and	  ST	  conditions.	  Previous	  studies	  on	  E160D	  and	  A159V	  mFEN-­‐
1	  differed	  on	  how	  active	  site	  mutations	  affect	   the	  enzyme	  activity.18,19	  This	  catalysis	  study	  has	  
two	  purposes.	   First,	   to	   ascertain	  whether	  WTmFEN-­‐1	  has	  different	   activities	   or	   just	   recognise	  
different	   substrates	  by	  using	  DF,	   3'SF,	   gap,	   and	  DF2'OH	   substrates.	   Secondly,	   to	   study	   the	  ef-­‐
fects	  of	  A159V	  and	  E160D	  active	  site	  mutations	  on	  mFEN-­‐1	  activities	  compared	  with	  the	  WT	  us-­‐
ing	  different	  substrates.	  
	  
Figure	  3.5.	  The	  proposed	  reaction	  mechanism	  of	  FEN-­‐1	  and	  DF	  substrate.	  The	  used	  relative	  rate	  constants	  are	  enzyme	  
(E)	  and	  substrate	  (S)	  association	  (kon),	  ES	  complex	  dissociation	  (koff),	  reversible	  conformational	  change	  (kCC	  and	  kRCC),	  
the	   chemistry	   step	   (kchem)	  and	  product	   release	   step	   (krelease).	   The	  parameters	  of	  Michaelis-­‐Menten	   (kcat	   and	  KM)	  and	  
maximal	  single	  turnover	  (kST)	  presenters	  are	  presented.	  
For	   the	   catalysis	   study	   analogous	   experiments	   (multiple	   and	   single	   turnover)	  were	   conducted	  
for	  WT,	  A159V	  and	  E160D	  of	  mFEN-­‐1.	  All	  of	  these	  enzymes	  were	  prepared	  within	  one	  month	  to	  
make	   sure	   they	  have	   similar	  ages	  and	   rule	  out	  any	   impacts	  of	  protein	  degradation	  with	   time.	  
Kinetic	   assays	   were	   determined	   using	   static	   substrates	   (no	   flap	   migration)	   to	   minimise	   the	  
chance	  of	  non-­‐productive	  complexes	  and	  hence	  simplify	  the	  kinetic	  analysis.	  All	  the	  substrates	  
are	  partly	   structurally	   similar,	   as	   they	  have	   two	  double	   strands	  of	  DNA	  up-­‐stream	  and	  down-­‐




strates.	  While	  the	  3'-­‐SF	  introduces	  a	  mononucleotide	  to	  FEN-­‐1,	  DF	  and	  gap	  substrates	  introduce	  
flap	  and	  flap	  with	  secondary	  structure	  respectively	  (figure	  3.5.a).	  All	  of	  the	  substrates	  were	  con-­‐
structed	  from	  a	  template	  strand	  (T1)	  with	  specific	  sequence	  to	  avoid	  homodimer	  formation.	  T1	  
was	  annealed	  with	   labelled	  5'-­‐end	  strand	  (F1)	  that	  differs	  from	  one	  substrate	  to	  another.	  As	  a	  
result,	  the	  substrates	  will	  have	  some	  differences	  in	  their	  5'-­‐flap	  sequence.	  All	  the	  substrates	  are	  
labelled	  with	  a	  fluorescein	  fluorophore	  at	  the	  5'-­‐end.	  This	  allowed	  the	  products	  of	  mFEN-­‐1	  and	  
DNA	  reaction	  to	  be	  analysed	  using	  dHPLC	  equipped	  with	  a	  fluorescence	  detector	  after	  separa-­‐
tion	  of	  the	  fluorescent	  product	  and	  unreacted	  substrate	  (figure	  3.6.b.c).	  
	  
Figure	  3.6.	  Substrates	  used	  for	  kinetic	  analysis	  of	  mFEN-­‐1.	  a)	  Cartoon	  structure	  of	  substrates	  that	  used	  for	  this	  kinetic	  
study.	  b)	  The	  double	   flap	  substrate	   (DF)	  structure	  with	   fluorescein	   fluorophore	  connection.	  c)	  The	  HPLC	  trace	  of	   the	  
substrate	  (S),	  the	  6	  nt	  flap	  product	  (P)	  and	  the	  dsDNA	  product	  (Q),	  which	  cannot	  be	  obtained	  by	  dHPLC	  machine.	  
Multiple	  turnover	  reactions	  (MT)	  were	  performed	  as	  discontinuous	  assays	  when	  [E]	  <<	  [S]	  for	  a	  
valid	  Michaelis-­‐Menten	  relationship.	  Each	  reaction,	  which	  is	  triplicate,	  is	  measured	  with	  12	  dif-­‐
ferent	   substrate	   concentrations	  allowing	  10	  %	  of	   the	   final	  product	   to	   form	  within	   the	   first	  10	  
minutes	  of	  the	  reaction	  time	  to	  make	  sure	  that	  the	  measured	  rate	  is	  the	  initial	  rate	  of	  the	  prod-­‐
uct	   formation.	   Importantly,	   this	   avoids	   effects	   of	   the	   product	   accumulation.	   As	   the	   substrate	  
concentration	  ranges	  from	  5000	  nM	  at	  the	  first	  point	  to	  5	  nM	  at	  the	  last	  point,	  enzyme	  concen-­‐




for	   analysis	   all	   derived	   rates	   were	   normalised	   for	   enzyme	   concentration.	   All	   reactions	   were	  
quenched	  using	  250	  mM	  EDTA	  solution.	  The	  quenched	  reactions	  and	  control	  sample	  containing	  
only	   substrate	  were	  analysed	  using	  dHPLC.	  Product	   concentration	   [P]	  was	   calculated	  by	  using	  
equation	  3.1	  where	  Po	  and	  So	  are	  the	  total	  areas	  under	  the	  product	  peak	  and	  substrate	  peak	  re-­‐
spectively,	  and	   [S]	   is	   the	   substrate	  concentration.	  The	   initial	   rates	  of	   the	   reaction	  were	  meas-­‐
ured	  when	  about	  10	  %	  of	  product	  had	  formed	  at	  10	  minutes.	  For	  an	  extended	  period	  ranging	  
from	   2	   to	   20	  minutes,	   the	   product	   concentration	   increased	   linearly	  with	   time	   (an	   example	   is	  
shown	   in	   figure	   3.7).	   The	   slope	   in	   the	   initial	   rate	   period	   is	   the	   initial	   rate	   of	   the	   reaction	   (Vo,	  
nM.min-­‐1).	  To	  avoid	  the	  effect	  of	  substrate	  diminution	  or	  product	  accumulation,	  only	  initial	  rates	  
were	  measured	  for	  each	  reaction.	  The	  initial	  rates	  were	  used	  to	  calculate	  the	  kinetic	  parameters	  
kcat	  (Vmax)	  and	  Km	  by	  fitting	  the	  Michaelis-­‐Menten	  equation	  3.2,	  where	  Vo	  is	  the	  initial	  rate,	  [S]	  is	  
the	  substrate	  concentration,	  and	   [E]	   is	   the	  total	  enzyme	  concentration.	  Using	  GraphPad	  Prism	  
software,	   the	   normalized	   initial	   rates	   (Vo/[E]o,	  min-­‐1)	   were	   fitted	   against	   substrate	   concentra-­‐
tions	  [S]	  (nM).	  The	  multiple	  turnover	  reactions	  were	  performed	  in	  appropriate	  buffers	  contain-­‐
ing	  Mg2+	  ions	  at	  pH	  7.5	  (section	  2.4.2).	  For	  each	  protein,	  the	  data	  sets	  represent	  three	  or	  more	  
experimental	  repeats.	  
𝑃 = !°  !"#!!°  !"#!!!°!"#! ×[𝑆]	  	   	   Equation	  3.1	  
!°!° = !!"#[!]!!![!]	   	   	   Equation	  3.2	  
	  
Figure	  3.7.	  An	  example	  of	  the	  initial	  rate	  curve	  for	  E160DmFEN-­‐1	  when	  [E]=480pM	  and	  [S]=750nM.	  
Maximal	  single	  turnover	  rates	  (ST)	  were	  determined	  on	  WT	  and	  mutant	  mFEN-­‐1s.	  These	  exper-­‐
iments	   used	   quench-­‐flow	  machinery	   or	  manual	   sampling	   on	   bench	   for	   slower	   reactions.	   The	  
conditions	   chosen	  were	  where	   [E]	  >>	  KM	  >>	   [S]	   to	   reduce	   the	   chance	  of	   non-­‐productive	   com-­‐
plexes	  and	  so	  that	  at	   the	  beginning	  of	  reaction	  all	  substrate	  would	  be	   in	  the	  productive	   inter-­‐
y	  =	  6.3671x	  -­‐	  0.9289	  


















mediate	  form	  [ES].	  While	  DF	  and	  3'-­‐SF	  reactions	  were	  quenched	  using	  solution	  with	  1.5	  M	  NaOH	  
and	   50	  mM	   EDTA	   concentrations,	   gap	   and	   DF2'-­‐OH	   substrates	   were	   quenched	   using	   80	  mM	  
EDTA	  solution.	  NaOH	  was	  not	  used	  to	  quench	  the	  DF2'-­‐OH	  reaction	  to	  avoid	  transesterifcation	  
of	   the	   substrate.	   The	   quenched	   reactions	   and	   control	   sample	   containing	   only	   substrate	  were	  
analysed	  using	  dHPLC.	  As	  wll,	   the	  use	  of	  an	  EDTA	  quench	   (without	  NaOH)	  was	  used	  with	  gap	  
substrate	   to	  produce	  better	  dHPLC	   separation	  of	   the	  gapped	  DNA	  product	   from	   its	   substrate.	  
Although	  all	  ST	  data	  were	  initially	  fitted	  using	  a	  one	  phase	  exponential	  (equation	  3.3),	  they	  were	  
better	  fitted	  using	  a	  two	  phase	  exponential	  (equation	  3.4),	  where	  Pt	  is	  the	  amount	  of	  product	  at	  
time	  t,	  P∞	  is	  the	  amount	  of	  product	  at	  time	  ∞,	  and	  kSTmax	  is	  the	  single	  turnover	  rate	  of	  reaction.	  
The	  single	  turnover	  rate	  was	  measured	  at	  [WTmFEN-­‐1]	  10-­‐fold	  higher	  and	  [S]	  40-­‐fold	  lower	  than	  
the	  respective	  KM	  value	  for	  each	  substrate.	  For	  each	  protein,	  all	  data	  sets	  represented	  three	  or	  
more	  experimental	  repeats.	  
𝑃! = 𝑃!(1 − 𝑒!!!"#$%!)	   	   	   	   Equation	  3.3	  
𝑃! = 𝑃!"#!(1 − 𝑒!!!"!!) + 𝑃!"#!(1 − 𝑒!!!"!!)	   	   Equation	  3.4	  
3.2.1.	  WTmFEN-­‐1	  catalysis	  upon	  binding	  of	  different	  substrates:	  	  
Based	  on	  the	  previous	  description	  of	  FEN-­‐1	  as	  an	  enzyme	  with	  different	  activities,	  which	  are	  fen,	  
exo	  and	  gen	  activities,	  WTmFEN-­‐1	  was	  reacted	  with	  different	  substrates	  (figure	  3.8.a).	  MT	  and	  
ST	  assays	  were	  used	  to	  test	  WTmFEN-­‐1	  ability	  to	  hydrolyse	  all	  these	  5'-­‐ends.	  Curves	  of	  the	  MT	  
and	  ST	  assays	  for	  the	  WT	  with	  DF,	  3'-­‐SF,	  gap	  and	  DF2'-­‐OH	  substrates	  that	  were	  produced	  using	  
GraphPad	   Prism	   6	   software	   showed	   slight	   differences	   between	   the	   substrates	   in	   each	   graph	  
(figure	  3.8).	  	  
The	  MT	  curves	  are	  the	  result	  of	  fitting	  of	  the	  normalized	  initial	  rates	  (Vo/[E]o,	  min-­‐1)	  against	  the	  
substrate	   concentrations	   (nM)	   of	   each	   reaction	   of	  WTmFEN-­‐1	   (figure	   3.8.b).	   Results	   auditing	  
showed	  that	  interaction	  of	  WTmFEN-­‐1	  with	  all	  of	  the	  substrates	  (DF,	  3'-­‐SF,	  gap	  and	  DF2'OH)	  fol-­‐
lows	   the	   classic	  Michaelis-­‐Menten	   behaviour.	   In	   all	   curves,	  Vo/[E]o	   increased	   linearly	   with	   in-­‐
crease	   in	   the	   substrate	   concentration	   in	   the	   low	   range.	   At	   sufficiently	   high	   [S]	   (≈50	   nM),	   the	  
normalized	  initial	  rate	  followed	  saturation	  kinetics	  and	  tended	  towards	  a	  limiting	  value	  with	  re-­‐
spect	  to	  [S].	  This	   limiting	  value,	  which	  is	  known	  as	  kcat	  or	  the	  turnover	  number,	  was	  calculated	  
for	  all	  of	  the	  substrates	  and	  summarized	  in	  figure	  3.8.f	  and	  table	  3.2.	  When	  [S]	  <<	  KM	  the	  slope	  
of	   the	   curve	   equals	  kcat/KM	   that	   represents	   the	   rate	   constant	   of	   the	   second	  order	   reaction	   to	  
convert	  free	  E	  and	  S	  to	  free	  E	  and	  P.	  While	  curves	  of	  the	  gap	  and	  DF2'OH	  substrates	  were	  very	  
close	  and	  slightly	  lower	  than	  DF	  substrate’s	  curve,	  3'-­‐SF	  substrate’s	  curve	  was	  slightly	  lower	  than	  





Figure	  3.8.	  Multiple	  and	   single	   turnover	   kinetic	  analysis	  of	  WTmFEN-­‐1	  upon	  different	   substrates.	  a)	   Cartoon	  of	  DF,	  
3'SF,	  gap	  and	  DF2'OH	  substrates	  that	  reacted	  with	  WTmFEN-­‐1.	  The	  minor	  product	  is	  coloured	  differently	  in	  each	  sub-­‐
strate.	  b)	  Comparison	  of	  Michaelis-­‐Menten	  plots	  for	  cleavage	  of	  DF,	  3-­‐'SF,	  gap	  and	  DF2'OH	  substrates	  by	  WTmFEN-­‐1.	  
c)	  Result	  of	  non-­‐linear	  regression	  of	  the	  MT	  data	  when	  variance	   is	  weighted	  1/Y2.	  d)	  Comparison	  of	  single	  turnover	  
rate	  profiles	  for	  DF,	  3'SF,	  gap	  and	  DF2'OH	  substrates	  by	  WTmFEN-­‐1.	  e)	  Residual	  plot	  of	  the	  ST	  un-­‐weighted	  data.	  f)	  





showed	  disordered	  scatter	  plot	  (figure	  3.8.c).	  The	  variance	  of	  the	  normalized	  initial	  rate	  (Y-­‐axis)	  
changed	  randomly	  and	  independently	  on	  the	  substrate	  concentration	  (X-­‐axis).	  In	  total	  the	  nor-­‐
malized	  initial	  rate	  variance	  was	  small	  and	  this	  suggests	  high	  quality	  of	  non-­‐linear	  regression	  of	  
the	  MT	  curve.	  
The	  ST	  curves	  result	   from	  fitting	  of	  the	  product	  percentage	  (%	  P)	  against	  time	  (min-­‐1)	   for	  each	  
reaction	  of	  WTmFEN-­‐1.	  Results	  processing	  showed	  that	  interaction	  of	  WTmFEN-­‐1	  with	  all	  of	  the	  
substrates	  (DF,	  3'-­‐SF,	  gap	  and	  DF2'OH)	  follows	  the	  two-­‐phase	  exponential	  fitting	  (figure	  3.8.d).	  
Rate	  curves	  of	  all	  substrates	  appeared	  time	  dependent.	  While	  the	  curve	  of	  the	  3'-­‐SF	  substrate	  
showed	  a	  slight	  difference	  in	  the	  first	  phase,	  all	  of	  the	  substrates	  showed	  significant	  similarity	  in	  
the	  second	  phase.	  Curves	  showed	  that	  the	  overall	  product	  amount	  is	  linear	  with	  time	  reaching	  
to	   around	  75	  %	   in	   the	   early	   phase	   of	   each	   reaction.	   The	   amount	   of	   product	   continued	   to	   in-­‐
crease	  with	   time	  and	  reached	  a	   final	   stable	  state	   in	   the	  second	  phase	  where	  the	  product	  was	  
around	  90	  %.	  It	  can	  be	  seen	  that	  the	  amplitude	  of	  the	  first	  phase	  is	  bigger	  so	  most	  of	  the	  prod-­‐
uct	   forms	   in	  the	  first	  phase	  of	  each	  curve.	  The	  obtained	  single	  turnover	  rates	  of	   the	  reactions	  
(kSTmax)	  were	  compared	  to	  MT	  parameters	  and	  summarized	  in	  figure	  3.8.f	  and	  table	  3.2.	  The	  re-­‐
siduals	   plot	   of	   the	   non-­‐linear	   regression	   plot	   of	   the	   single	   turnover	   data	   showed	   disordered	  
scatter	  plot	   (figure	  3.8.e).	  The	  normalized	   initial	   rate	  (Y-­‐axis)	  had	  random	  variance	  by	   increase	  
the	   substrate	   concentration	   (X-­‐axis).	   Generally,	   this	   variance	  was	   small	   especially	  with	   higher	  
[S],	  which	  suggests	  the	  high	  quality	  of	  the	  non-­‐linear	  regression	  of	  the	  ST	  curves.	  	  
Overall,	   the	   kinetic	   parameters	   for	   ST	   and	  MT	   of	  WTmFEN-­‐1	   enzyme	  with	   the	   different	   sub-­‐
strates	   (DF,	   gap,	   3'-­‐SF,	   and	  DF2'OH),	  which	  were	   summarized	   in	   table	   3.2,	  were	   compared	   to	  
confirm	  existing	  details	  about	   the	  enzyme	   interaction.	   In	  combination,	   they	  showed	  small	  dif-­‐
ferences	   in	   catalytic	  parameters	  between	   the	  various	   substrates.	   The	  greatest,	   albeit	  modest,	  
impact	  was	  seen	  with	  3'-­‐SF	  where	  the	  catalytic	  efficiency	  was	  seen	  to	  be	  9-­‐fold	  lower.	  	  
Substrate	   kcat	  (min
-­‐1)	   KM	  (nM)	   kcat/KM	  (nM
-­‐1.min-­‐1)	   kST	  max	  (min
-­‐1)	   kST	  max/kcat	  	  
DF	   308	  ±	  18	   34	  ±	  5	   9	  ±	  1	   1229	  ±	  74	   4	  
3'-­‐SF	   65	  ±	  5	   100	  ±	  13	   1	  ±	  0.1	   353	  ±	  26	   5	  
Gap	  	   121	  ±	  6	   46	  ±	  5	   3	  ±	  0.3	   2522	  ±	  120	   21	  
DF2'OH	   135	  ±	  8	   36	  ±	  5	   4	  ±	  0.5	   1847	  ±	  45	   14	  




From	  the	  data	  in	  figure	  3.8.f	  and	  table	  3.2	  it	  is	  clear	  that	  mFEN-­‐1	  accommodates	  all	  of	  the	  sub-­‐
strates	  (DF,	  gap,	  3'-­‐SF,	  and	  DF2'OH)	  with	  similarity	  in	  both	  the	  affinity	  (KM)	  and	  the	  catalytic	  effi-­‐
ciency	  (kcat/KM),	  except	  the	  3'-­‐SF	  substrate	  that	  showed	  slightly	  lower	  affinity	  (~3-­‐fold)	  and	  lower	  
catalytic	  efficiency	  (~9-­‐fold)	  compared	  to	  DF	  substrate.	  Under	  saturating	  multiple	  turnover	  con-­‐
ditions	  ([S]	  >>	  KM	  >>	  [E]),	  WTmFEN-­‐1	  showed	  similar	  turnover-­‐limiting	  rates	  (kcat	  values)	  with	  all	  
substrates,	  except	  the	  3'-­‐SF	  substrate	  that	  showed	  ~5-­‐fold	  decrease	  compared	  to	  DF	  substrate.	  
Hence,	  this	  confirms	  the	  similar	  biological	  efficiency	  of	  the	  enzyme	  towards	  the	  substrates	  DF,	  
gap	  and	  DF2'OH,	  and	  the	  slightly	   lower	  affinity	  and	  the	  catalytic	  efficiency	  with	  the	  3'-­‐SF.	  Fur-­‐
thermore,	  WTmFEN-­‐1	  appears	  possibly	  subject	  to	  diffusion	  control	  (catalytic	  perfection	  –	  kcat/Km	  
~107-­‐109	  M-­‐1.sec-­‐1)	  with	  all	  of	  the	  substrates.	  The	  exact	  values	  of	  the	  measured	  maximal	  single	  
turnover	  rates	  (kSTmax)	  of	  the	  four	  substrates	  complement	  the	  steady	  state	  parameters	  to	  identi-­‐
fy	   the	   rate-­‐limiting	   step	  of	   the	  WTmFEN-­‐1.	  The	   single	   turnover	   rate	   (kSTmax)	  of	   the	  WTmFEN-­‐1	  
was	  higher	  than	  the	  corresponding	  multiple-­‐turnover	  rate	  (kcat)	  with	  all	  of	  the	  substrates	  espe-­‐
cially	  with	  gap	  and	  DF2'OH	  substrates.	  As	  a	  result,	  the	  enzyme	  is	  rate	  limited	  by	  dsDNA	  product	  
release,	  because	  the	  single	  turnover	  rates	  of	  all	  substrates	  hydrolysis	  are	  faster	  than	  MT	  rates.	  
Hence,	  this	  is	  consistent	  with	  kinetic	  data	  on	  T5FEN-­‐1	  and	  hFEN-­‐1.64,67	  Furthermore,	  under	  sin-­‐
gle	   turnover	   conditions,	   only	   the	   3'-­‐SF	   substrate	   showed	   3-­‐fold	   decrease	   of	   the	   kSTmax	   value	  
compared	  to	  the	  DF	  substrate.	  In	  addition,	  the	  enzyme	  uses	  the	  same	  active	  site	  and	  the	  same	  
chemistry	  to	  interact	  with	  all	  of	  the	  substrates,	  which	  means	  that	  FEN-­‐1	  does	  not	  have	  different	  
activities.	   This	   conclusion	   contradicts	   the	   earlier	   studies	   that	   suggested	   that	   FEN-­‐1	   is	   a	  multi-­‐
functional	  enzyme.1,3,39	  
3.2.2.	  Effects	  of	  mFEN-­‐1	  active	  site	  mutations	  (A159V	  &	  E160D)	  on	  substrate	  catalysis:	  	  
As	  two	  previous	  results	  from	  2007	  and	  2008	  about	  how	  FEN-­‐1	  mutations	  affect	  its	  various	  activi-­‐
ties	  and	  cause	  cancer	  contradict	  each	  other,	  the	  two	  mutated	  mFEN-­‐1	  (A159V	  and	  E160D)	  that	  
correspond	  to	  the	  previous	  studies	  were	  evaluated	  kinetically.	  According	  to	  WTmFEN-­‐1	  results	  
from	  the	  previous	  section	  (section	  3.2.1),	  FEN-­‐1	  is	  not	  a	  multifunctional	  enzyme	  as	  thought	  pre-­‐
viously,	  but	  it	  just	  can	  recognise	  different	  substrates	  using	  same	  chemistry.	  The	  individual	  active	  
site	  mutations	  A159VmFEN-­‐1	  and	  E160DmFEN-­‐1	  were	  reacted	  with	  DF,	  gap,	  and	  DF2'OH	  to	  be	  
compared	  with	  the	  WTmFEN1	  (figure	  3.9.a).	  MT	  and	  ST	  assays	  were	  used	  to	  test	  the	  effect	  of	  
the	  mutations	   on	  WTmFEN-­‐1’s	   ability	   to	   hydrolyse	   the	   5'-­‐terminus	   1-­‐nt	   into	   the	   downstream	  
duplex	  of	  these	  substrates.	  Curves	  of	  the	  MT	  and	  ST	  assays	  for	  the	  A159V	  and	  E160D	  mutations	  
with	  DF,	  gap	  and	  DF2'-­‐OH	  substrates,	  which	  were	  produced	  using	  GraphPad	  Prism	  6	  software,	  




The	  MT	   curves	   resulted	   from	   fitting	   of	   the	   normalized	   initial	   rates	   (Vo/[E]o,	  min-­‐1)	   against	   the	  
substrate	  concentrations	  (nM)	  for	  A159V	  and	  E160D	  with	  DF,	  gap,	  and	  DF2'-­‐OH	  substrates	  and	  
were	  combined	  with	  WTmFEN-­‐1	  results	  from	  the	  previous	  section	  (figure	  3.9.b,d,f).	  Results	  au-­‐
diting	  showed	  that	   the	   interaction	  of	   the	  mutant	  mFEN-­‐1	   (A159V	  &	  E160D)	  with	  the	  different	  
substrates	   follows	   the	   classic	   Michaelis-­‐Menten	   behaviour	   similar	   to	   the	   WT.	   In	   all	   curves,	  
Vo/[E]o	   increased	  with	   increase	   in	   the	  substrate	  concentration	   in	   the	   low	  range.	  At	  sufficiently	  
high	  [S]	  (≈50	  nM),	  the	  normalized	  initial	  rate	  followed	  saturation	  kinetics	  and	  tended	  towards	  a	  
limiting	   value	  with	   respect	   to	   [S].	  However,	  WTmFEN-­‐1	  always	  has	  greater	   response	   than	   the	  
mutated	   mFEN-­‐1s.	   With	   DF	   and	   gap	   substrates	   the	   rate	   decreased	   significantly	   from	  WT	   to	  
E160D	  to	  A159V	  mFEN-­‐1,	  while	  with	  the	  DF2'OH	  both	  of	  E160D	  and	  A159V	  appeared	  similar	  and	  
slightly	  lower	  than	  WT.	  This	  variance	  affected	  the	  turnover	  number	  (kcat	  value)	  and	  kcat/KM	  num-­‐
ber	   that	   represents	   the	   rate	  constant	  of	   the	  second	  order	   reaction	   to	  convert	   free	  E	  and	  S	   to	  
free	  E	  and	  P	  (figure	  3.9.h.i.j)	  (table	  3.3).	  All	  of	  the	  residual	  plots	  of	  the	  weighted	  non-­‐linear	  re-­‐
gression	  plot	  of	  the	  multiple	  turnover	  data	  showed	  disordered	  scatter	  plot	  (figure	  7.1.b.d.f).	  The	  
variance	  of	  the	  normalized	  initial	  rate	  (Y-­‐axis)	  changed	  randomly	  and	  independently	  on	  the	  sub-­‐
strate	   concentration	   (X-­‐axis).	   In	   total,	   the	   normalized	   initial	   rate	   variance	   was	   small	   and	   this	  
suggests	  high	  quality	  non-­‐linear	  regression	  of	  the	  MT	  curves.	  
The	  ST	  curves	  resulted	  from	  fitting	  of	  the	  product	  percentage	  (%	  P)	  against	  time	  (min-­‐1)	  of	  each	  
reaction	  of	  mFEN-­‐1.	  Results	  processing	  showed	  that	  similarly	  to	  WTmFEN-­‐1	  interaction,	  mutant	  
mFEN-­‐1	  also	  followed	  the	  two-­‐phase	  exponential	  fitting	  with	  all	  of	  the	  different	  substrates	  (fig-­‐
ure	  3.9.c.e.g).	  Rate	  curves	  of	  all	  mFEN-­‐1	  enzymes	  (WT,	  A159V,	  and	  E160D)	  with	  the	  three	  sub-­‐
strates	  (DF,	  gap,	  and	  DF2'-­‐OH)	  appeared	  time	  dependent	  and	  %	  P	  reached	  to	  around	  90	  %	  in	  the	  
final	   stable	   state.	   The	   obtained	   kSTmax	   values	   were	   compared	   to	   the	   MT	   parameters	   (figure	  
3.9.h.i.j)	   (table	  3.3).	  However,	   velocity	  of	  product	   formation	   significantly	   reduced	   from	  WT	   to	  
E160D	  to	  A159V	  similarly	  with	  both	  DF	  and	  gap	  substrates,	  while	  DF2'OH	  showed	  less	  variation	  
in	  the	  rate	  decrease.	  The	  residuals	  plot	  of	  the	  non-­‐linear	  regression	  plot	  of	  the	  single	  turnover	  
data	  showed	  disordered	  scatter	  plot	  (figure	  7.1.c.e.g).	  The	  %	  P	  (Y	  axis)	  had	  random	  variance	  by	  
increase	  the	  time	  (X-­‐axis).	  Generally,	  this	  variance	  was	  small	  especially	  with	  higher	  %	  P,	  which	  





Figure	  3.9.	  Multiple	  and	  single	  turnover	  kinetic	  analysis	  of	  WT,	  A159V,	  and	  E160D	  mFEN-­‐1	  upon	  different	  substrates.	  
a)	  Cartoon	  of	  DF,	  gap	  and	  DF2'OH	  substrates	  that	  reacted	  with	  mFEN-­‐1	  to	  product	  minor	  product.	  b)	  d)	  and	  f)	  Com-­‐
parison	  of	  Michaelis-­‐Menten	  plots	   for	   cleavage	  of	  DF,	  gap,	  and	  DF2'OH	  substrates	   respectively	  by	  WT,	  A159V,	  and	  




by	  WT,	  A159V,	  and	  E160D	  mFEN-­‐1.	  Comparison	  between	  the	  obtained	  parameters	   from	  MT	  and	  ST	  kinetics	  of	  WT,	  
A159V,	  and	  E160D	  mFEN-­‐1	  interaction	  are	  shown	  in	  h)	  DF	  substrate.	  i)	  Gap	  substrate.	  j)	  DF2'OH	  substrate.	  	  	  
S	   E	   kcat	  (min
-­‐1)	   KM	  (nM)	   kcat/KM	  (nM
-­‐1.min-­‐1)	   kST	  max	  (min
-­‐1)	   kST	  max/kcat	  
DF	  
WT	   308	  ±	  18	   34	  ±	  5	   9	  ±	  1	   1229	  ±	  74	   4	  
A159V	   1	  ±	  0.06	   91	  ±	  8	   0.01	  ±	  0.001	   34	  ±	  25	   34	  
E160D	   16	  ±	  1	  	   105	  ±	  13	   0.2	  ±	  0.02	  	   93	  ±	  7	   6	  
Gap	  
WT	   121	  ±	  6	   46	  ±	  5	   3	  ±	  0.3	   2522	  ±	  120	   21	  
A159V	   1	  ±	  0.05	   131	  ±	  13	   0.01	  ±	  0.001	   19	  ±	  2	   21	  
E160D	   13	  ±	  1	   141	  ±	  14	   0.1	  ±	  0.01	   193	  ±	  12	   14	  
DF2'OH	  
WT	   135	  ±	  8	   36	  ±	  5	   4	  ±	  0.5	   1847	  ±	  45	   14	  
A159V	   15	  ±	  1	  	   72	  ±	  8	   0.2	  ±	  0.03	  	   83	  ±	  3	  	   5	  
E160D	   50	  ±	  2	  	   166	  ±	  14	  	   0.3	  ±	  0.02	  	   336	  ±	  12	  	   7	  
(Table	  3.3).	  The	  obtained	  MT	  and	  ST	  parameters	  for	  WT	  and	  mutant	  mFEN-­‐1.	  
Comparison	  all	  of	  the	  ST	  and	  MT	  kinetic	  parameters	  of	  A159V	  and	  E160D	  to	  WTmFEN-­‐1	  show	  
that	  these	  active	  site	  mutations	  affect	  enzyme	  efficiency	  when	  acting	  upon	  DF,	  gap	  and	  DF2'OH	  
substrates	  (figure	  3.9.h.i.j	  and	  table	  3.3).	  Comparison	  of	  the	  multiple	  turnover	  numbers	  (kcat)	  of	  
A159V	   and	   E160D	  mutant	   proteins	   to	  WTmFEN-­‐1	   showed	   rate	   decrease	   of	   300-­‐	   and	   20-­‐fold	  
with	  DF,	  120-­‐	  and	  10-­‐fold	  with	  gap,	  and	  10-­‐	  and	  3-­‐fold	  with	  DF2'OH,	  respectively.	  Surprisingly,	  
both	  mutations	  increased	  the	  KM	  values	  of	  all	  substrates	  very	  slightly	  (~3-­‐fold)	  compared	  to	  the	  
WTmFEN-­‐1.	   Furthermore,	   the	   kcat/KM	   ratio	   of	   A159V	   and	   E160D	  mutant	   proteins	   showed	   de-­‐
creases	  900-­‐	  and	  40-­‐fold	  with	  DF,	  300-­‐	  and	  30-­‐fold	  with	  gap,	  and	  20-­‐	  and	  10-­‐fold	  with	  DF2'OH	  
compared	  to	  the	  WT	  protein,	  respectively.	  In	  addition,	  the	  exact	  values	  of	  the	  measured	  maxi-­‐
mal	  single	  turnover	  rates	  (kSTmax)	  of	  A159V	  and	  E160D	  mutations	  showed	  decreases	  in	  their	  rate	  
of	   reactions	   of	   30-­‐	   and	   10-­‐fold	   with	   DF,	   100-­‐	   and	   10-­‐fold	   with	   gap,	   and	   20-­‐	   and	   5-­‐fold	   with	  
DF2'OH	  compared	  to	   the	  WT	  protein,	   respectively.	  According	   to	   the	  MT	  parameters	   it	   is	  clear	  
that	  these	  active	  site	  mutations	  decrease	  protein	  turnover	  rates	  (kcat)	  and	  enzyme	  substrate	  af-­‐
finity	  (KM	  values).	  Unlike	  WTmFEN-­‐1,	  mutant	  proteins	  are	  outside	  the	  usual	  range	  for	  diffusion	  
control	  (catalytic	  perfection	  –	  kcat/KM	  ~107-­‐109	  M-­‐1.sec-­‐1),	  which	  could	  means	  that	  the	  formation	  
of	  the	  ES	  complex	  can	  be	  the	  quickest	  step	  with	  the	  mutated	  mFEN-­‐1s	  because	  the	  mutations	  
presence	  reduce	  the	  catalytic	  efficiency	  of	  the	  enzyme.	  The	  measured	  kSTmax	  values	  complement	  
the	  steady	  state	  parameters	  to	  identify	  the	  rate-­‐limiting	  step	  of	  mutant	  mFEN-­‐1s.	  Although	  both	  
mutations	   decreased	   the	   kSTmax	   values,	   it	   is	   still	   higher	   than	   the	   corresponding	  kcat	   to	   confirm	  




between	  all	  of	  the	  kinetic	  parameters,	  A159V	  and	  E160D	  mutations	  reduce	  the	  mouse	  enzyme	  
efficiency	  by	  altering	  the	  enzyme	  substrate	  affinity,	  diffusion	  control	  property,	  and	  rate	  of	  the	  
final	  product	  release.	  Overall,	  the	  enzymatic	  activity	  of	  the	  A159V	  and	  E160D	  mutations	  report-­‐
ed	  here	  casts	  doubt	  on	  reports	   that	   this	  mutant	  had	   increased	   incidence	  of	  cancer	   (especially	  
lung	  cancer)	  due	  only	  to	  the	  loss	  of	  exo	  and	  gen	  cleavage	  abilities.18	  Instead,	  this	  study	  supports	  
the	   previous	   study19	   that	   concluded	   that	   the	   increased	   incidence	   of	   cancer	   was	   due	   to	   de-­‐
creased	  flap	  cleavage	  capability	  resulting	  in	  problems	  with	  DNA	  replication.	  Interestingly,	  A159V	  
mutation	   has	   greater	   effect	   than	   E160D	  mutation.	   Both	  mutations	   reduce	  mFEN-­‐1	   efficiency	  
towards	  all	  substrates	  similarly,	  except	  DF2'OH	  substrate	  that	  reduced	  the	  effects	  of	  the	  muta-­‐
tions	  especially	  with	  the	  A159V	  mutation.	  
Although	  the	  differences	  observed	  are	  not	  well	  understood,	  one	  can	  speculate	  that	  substitution	  
of	  glutamic	  acid	  with	  aspartic	  acid	   (E160D)	  or	  alanine	  with	  valine	   (A159V)	  affects	   the	  mFEN-­‐1	  
active	   site	   structure,	   which	  means	   that	   the	   substrates	   (DF,	   gap,	   DF2'OH	   and	   expected	   3'-­‐SF)	  
cannot	  be	  precisely	  positioned	  into	  FEN-­‐1	  active	  site	  to	  allow	  efficient	  catalysis	  especially	  with	  
A159V	  mutation.	  Although	  A159V	  and	  E160D	  mutations	  do	  not	  affect	  the	  chemical	  environment	  
as	  both	  still	  have	  aliphatic	  and	  acidic	  residues	  respectively,	  they	  result	  in	  longer	  and	  shorter	  side	  
chains	   respectively.	   Considering	   the	   positions	   of	   the	  mutations,	   E160	   has	   direct	   contact	  with	  
active	  site	  metal	  ions,	  presumably	  the	  shorter	  side	  chain	  of	  E160D	  impairs	  the	  direct	  interaction	  
with	  the	  active	  site	  metal	   ion	  and	   increases	  the	  spacing	  of	  the	  requisite	  divalent	  metal	   ions	   in	  
catalysis.	  Although	  A159V	  does	  not	  have	  direct	   contact	  with	   the	   two	  metal	   ions	  active	   site	  as	  
E160D,	   it	   has	   stronger	   effect	   to	   reduce	   mFEN-­‐1	   activity	   than	   E160D.	   This	   could	   be	   because	  
A159V	  has	  bigger	  side	  chain	  than	  E160D	  and	  this	  can	  cause	  higher	  steric	  hindrance	  and	  affect	  
the	  enzyme	  secondary	   structure	   that	   can	   influence	   substrate	  entrance	  and	  positioning	   (figure	  
3.10).	   It	  seems	  unlikely	  that	  changes	   in	  the	  metal	   ion	  positions	  or	  steric	  hindrance	  would	  only	  
affect	  exo	  and	  gap	  or	  only	  DF	  substrate	  scissile	  phosphate-­‐diester	  placement	  and	  not	  affect	  scis-­‐
sile	   phosphate-­‐bond	   hydrolysis	   of	   the	   other	   substrates,	   which	   casts	   doubt	   on	   previous	  
reports.18,19	  
Decreases	   in	   the	   effects	   of	  mutations	   towards	  DF2'OH	   relate	   to	   the	   chemical	   features	   of	   the	  
enzyme	  active	  site.	  The	  ribonucleotide	  of	  the	  +1	  nt	  possesses	  an	  extra	  2'OH	  and	  mimic	  the	  sub-­‐
strate	   encountered	   in	   vivo	   during	   RNA	   primer	   removal.	   Although,	   the	   presence	   of	   this	   extra	  
2'OH	  did	  not	  affect	  WTmFEN-­‐1	  reaction	  compared	  to	  DF	  substrate	   (section	  3.2.1),	   it	  enhances	  
the	  mutant	  enzyme	  catalysed	  reaction,	  particularly	  with	  A159V	  mutation.	  Accordingly,	  the	  2'OH	  
produces	  a	  chemical	  environment	   that	  potentially	   facilitates	  reaction	  by	  decreasing	  the	  pKa	  of	  




deoxyuridine).88	   These	   results	   suggest	   that	   the	   slower	  mutant	   reactions	  are	  more	   sensitive	   to	  
this	  substrate	  change.	  A	  potential	  explanation	  of	  this	  is	  that	  the	  rate	  limiting	  step	  in	  the	  mutant	  
is	   solely	   or	   partially	   chemical,	  whereas	   in	   that	   of	   the	  WT	   reaction	   is	   not.	   These	   findings	   have	  
some	  implications	  for	  the	  consequences	  of	  mutation	  in	  vivo,	  where	  RNA	  primer	  removal	  might	  
be	   expected	   to	   be	  more	  modestly	   impaired	   compared	   to	   function	   of	   FEN-­‐1	   that	   involve	   sub-­‐
strates	  that	  are	  solely	  composed	  of	  DNA	  (alpha	  segment	  editing	  and	  repair	  processes).	  
	  
Figure	  3.10.	  Effects	  of	  hFEN-­‐1	  active	  site	  mutations	  on	  its	  structure.	  a)	  The	  hFEN-­‐1	  active	  site	  involved	  in	  its	  complex	  
with	  product	  (PDB:3QK)	  to	  show	  the	  position	  of	  A159	  and	  E160	  residues.	  b)	  E160D	  mutation	  reduces	  the	  side	  chain	  
length	  and	  increases	  the	  distance	  between	  the	  two	  metal	  ions	  of	  the	  active	  site.	  C)	  A159V	  mutation	  increases	  the	  side	  
chain	  length	  causing	  higher	  steric	  hindrance	  that	  influences	  substrate	  iterance	  and	  position	  by	  effect	  the	  enzyme	  sec-­‐
ondary	  structure	  comparing	  to	  A159	  residue.	  
3.2.3.	  Summary	  and	  conclusion	  of	  the	  kinetic	  study	  of	  mFEN-­‐1:	  
The	  kinetic	  experiments	  revealed	  that	  FEN-­‐1	  accommodates	  DF,	  gap	  and	  DF2'OH	  substrates	  en-­‐




slight	   lower	   efficiency.	   The	  enzyme	  performs	  with	   similar	   properties	   such	   as	   affinity,	   catalytic	  
efficiency,	  diffusion	  controlled	  reactions	  and	  rate	  limited	  by	  dsDNA	  product	  release	  towards	  all	  
the	  substrates,	  except	  the	  3'-­‐SF	  substrate	  that	  is	  recognised	  with	  slightly	  lower	  affinity	  and	  cata-­‐
lytic	  efficiency.	  In	  addition,	  mFEN-­‐1	  interacts	  with	  all	  of	  these	  substrates	  using	  same	  chemistry	  
(phosphodiester	  bond	  hydrolysis)	  at	  the	  same	  active	  site,	  which	  means	  that	  FEN-­‐1	  can	  recognise	  
different	  substrates	  but	  not	  different	  activities.	  	  
Active	  site	  mutations	  such	  as	  A159V	  and	  E160D	  reduce	  the	  enzyme	  efficiency	  by	  affecting	  the	  
active	  site	  structure	   that	   reduces	   the	  enzyme	  ability	   to	  precisely	  position	  DF,	  gap	  and	  DF2'OH	  
substrates	  in	  the	  active	  site	  to	  allow	  efficient	  catalysis.	  This	  is	  especially	  so	  with	  the	  A159V	  mu-­‐
tation.	  Because	  A159V	  and	  E160D	  mutations	  result	  in	  longer	  and	  shorter	  side	  chains	  respective-­‐
ly,	  presumably	  E160D	  increases	  the	  spacing	  of	  the	  requisite	  divalent	  metal	  ions	  in	  catalysis	  and	  
A159V	   causes	   higher	   steric	   hindrance	   that	   influence	   substrate	   positioning.	   Accordingly,	   these	  
active	  site	  structural	  changes	  cannot	  only	  affect	  on	  3'SF	  and	  gap	  substrates	  or	  only	  DF	  substrate	  
recognition	   without	   affecting	   the	   other	   substrates,	   which	   casts	   doubt	   on	   previous	   reports.	  
DF2'OH	  reduces	  the	  impact	  of	  mFEN-­‐1	  mutations,	  particularly	  with	  the	  A159V	  mutation.	  
3.3.	  Investigation	  local	  conformational	  changes	  of	  substrate	  reacted	  duplex	  in	  mFEN-­‐1	  
active	  site	  by	  low	  energy	  circular	  dichroism	  of	  2-­‐aminopurine	  (ECCD):	  	  
Since	  analysis	  of	  the	  impact	  of	  the	  mutations	  using	  crystal	  structures	  suggest	  that	  they	  may	  pro-­‐
duce	  impacts	  on	  substrate	  positioning	  it	  was	  decided	  to	  study	  the	  ability	  of	  substrate	  to	  deform	  
in	  response	  to	  FEN-­‐1	  and	  divalent	  metal	  ions.	  Circular	  dichroism	  (CD)	  of	  2-­‐aminopurine	  (2-­‐AP)	  is	  
used	  to	  study	  the	  local	  nucleic	  acid	  structural	  distortions.	  Because	  many	  of	  the	  DNA	  interactions	  
implicate	  local	  conformational	  changes	  at	  specific	  junctions,	  only	  the	  conformational	  changes	  of	  
the	  nucleotides	  of	  these	  junctions	  are	  of	  relative	  importance.	  The	  normal	  CD	  of	  any	  polynucleo-­‐
tide	  structure	  reveals	  the	  total	  summation	  of	  all	  base-­‐base	  interactions.	  However,	  exciton	  cou-­‐
pling	  circular	  dichroism	  (ECCD)	  spectrum	  of	  2-­‐AP,	  more	  specifically	  two	  adjacent	  2-­‐APs,	  shows	  a	  
positive	  CD	   signal	   at	  326	  nm	   that	  only	   reflects	   the	   interaction	  of	   the	   substituted	   residues	  be-­‐
cause	  no	  natural	  nucleic	  acids	  or	  proteins	  absorb	  in	  this	  region.	  This	  method	  can	  be	  used	  to	  de-­‐
tect	   the	   conformational	   changes	   that	  depend	  on	   the	  exciton	   coupling	  between	  2-­‐AP	  bases	  of	  
two	  nucleotides.89	  
Fluorescent	  2-­‐AP	  is	  readily	  incorporated	  into	  DNA	  constructs	  in	  place	  of	  adenine.89	  This	  substitu-­‐
tion	   of	   2-­‐AP,	  which	   is	   an	   adenine	   structural	   isomer,	   does	   not	   significantly	   alter	   structure	   and	  
stability	  of	  DNA	  in	  spite	  of	  the	  difference	  of	  the	  hydrogen	  bond	  pattern	  that	  results	  from	  reposi-­‐




	  	  	  
Figure	  3.11.	  Positions	  of	  the	  hydrogen	  bonds	  between	  adenine:thymine	  and	  2-­‐aminopurine:thymine.92	  
Each	  2-­‐AP	  molecule	  has	  an	  electric	  dipole	  transition	  moment	  (EDTM).	  Substitution	  of	  two	  adja-­‐
cent	  nucleotides	  in	  a	  DNA	  structure	  with	  two	  2-­‐AP	  molecules	  leads	  to	  interaction	  between	  the	  
chromophores	  that	  result	  from	  exciton	  coupling	  of	  the	  electronic	  fields	  and	  splitting	  of	  the	  en-­‐
ergy	  levels	  (figure	  3.12.a).	  The	  high	  sensitivity	  of	  this	  interaction	  to	  the	  magnitude,	  of	  separation	  
and	  orientation	  of	  the	  2-­‐AP	  molecules	  is	  used	  to	  monitor	  the	  base	  stacking	  and	  conformational	  
changes	  of	  the	  replaced	  dinucleotide	  with	  two	  2-­‐APs	  in	  the	  protein-­‐DNA	  complex	  spectroscopi-­‐
cally.	  For	  illustration,	  a	  non-­‐interacting	  dimer	  of	  2-­‐APs	  (such	  as	  non-­‐adjacent	  two	  2-­‐APs	  mono-­‐
mers)	  has	  similar	  one	  monomer	  absorption	  frequency	  but	  with	  doublet	  intensity.	  However,	  the	  
tandem	  dimer	   (2-­‐AP)2	   in	   a	  DNA	   structure	   has	   two	   different	   energies	   of	   absorption	   frequency	  
with	  singly	  excited	  electronic	  transitions	  (figure	  3.12.b).92	  	  
	  
Figure	  3.12.	  Two	  adjacent	  2-­‐APs	  in	  DNA	  structure.	  a)	  The	  molecular	  structure	  of	  the	  2-­‐AP	  dinucleotide.	  b)	  Energy	  level	  
diagram	  of	  two	  chemically	  identical	  two-­‐level	  molecules.92	  
Any	  two	  adjacent	  2-­‐APs	  have	  a	  significant	  CD	  signal	  caused	  by	  a	  transfer	  of	  excitation	  that	  re-­‐
sulted	  from	  the	  interaction	  between	  the	  fluctuations	  in	  electric	  field	  in	  one	  monomer	  with	  the	  




relative	  orientation	  of	  the	  2-­‐AP	  electric	  dipole	  transition	  moments	  (EDTMs),	  and	  magnitude	  of	  
the	  excitation.92	  In	  addition,	  this	  ECCD	  spectra	  of	  two	  adjacent	  2-­‐AP	  residues	  is	  sensitive	  to	  the	  
base	  stacking	  or	  unstaking	  in	  a	  DNA	  duplex.89	  The	  maximum	  stacking	  between	  two	  adjacent	  2-­‐
APs	  depends	  on	  the	  twist	  angle	  to	  induce	  the	  maximum	  surface	  occlusion	  of	  the	  bases	  using	  the	  
hydrophobic	   forces.	   Increasing	   twist	   angle	   reduces	   the	   degree	   of	   stacking	   (surface	   occlusion)	  
between	  the	  two	  adjacent	  bases	  (figure	  3.13).	  92	  
	  
Figure	  3.13.	  Schematic	  representation	  of	  the	  stacking	  surfaces	  degree	  of	  two	  neighboring	  nucleic	  acid	  bases	  in	  DNA.	  
a)	  The	  closely	  maximal	  stacking	  with	  twist	  angle	  θ12=5°.	  b)	  Much	  less	  stacking	  degree	  with	  twist	  angle	  ϑ12=36°.
92	  
The	  spectra	  of	  two	  adjacent	  two	  2-­‐APs	  in	  the	  context	  of	  single	  strand	  (ss)	  and	  double	  strand	  (ds)	  
of	   DNA	   have	   been	   characterised	   previously.	   The	   absorption	  maximum	   of	   ds-­‐DNA	   showed	   at	  
326-­‐328	  nm	  with	   intensity	  of	  Δε	  =	  3.2	  ±	  0.4	   (M	  AP)-­‐1.cm-­‐1.	  Comparatively,	   the	  ss-­‐DNA	  showed	  
2.5-­‐fold	  decrease	   in	  this	   intensity.	  Depending	  on	  the	  2-­‐AP	  dimer	  position	  within	  the	  DNA	  con-­‐
struct,	   its	   interaction	  can	  be	  used	  to	   indicate	   the	   local	  conformational	  changes	  of	   the	  DNA	  by	  
affording	   base	   stacking	   and	   probably	   base	   pairing	   information.89	   In	   addition,	   the	   ECCD	   tech-­‐
nique	  had	  been	  used	  to	  indicate	  effects	  of	  hFEN-­‐1	  mutations	  on	  the	  local	  structural	  changes	  of	  
DNAs.	  Accordingly,	  hFEN-­‐1	  was	  proposed	  to	  carry	  out	  selective	  hydrolysis	  of	  DNA	  structures	  us-­‐
ing	  a	  novel	  double	  nucleotide	  unpairing	  mechanism,	  which	  was	  thought	  to	  be	  required	  to	  place	  
the	   scissile	  phosphate	  diester	  bond	  on	  active	   site	  metal	   ions.	   Support	   for	   the	  hypothesis	   that	  
the	  terminal	  nucleotides	  were	  unpaired	  came	  from	  structural	  studies	  which	  showed	  that	  the	  5'-­‐
phosphate	  monoester	  product	  was	  directly	  coordinated	  to	  the	  metal	  ions	  within	  the	  active	  site	  
of	   hFEN-­‐1.37	   More	   recent	   studies	   of	   FEN-­‐1:substrate	   complexes	   where	   the	   scissile	   phos-­‐




stead	  untwisted	   introducing	   significant	  distortion	   to	   the	  base	   stacking	  arrangements.93	  Never-­‐
theless,	  ECCD	  spectra	  reflect	  the	  change	  that	  occurs	  as	  substrate	  transfers	  to	  the	  active	  site	  up-­‐
on	  addition	  of	  divalent	  metal	  ions.	  	  
According	  to	  the	  kinetic	  results	  (section	  3.2),	  A159V	  and	  E160D	  mFEN-­‐1	  mutations	  reduced	  the	  
enzyme	  efficiency	  to	  recognise	  of	  DF,	  gap,	  2'OH-­‐DF	  and	  also	  expected	  3'-­‐SF	  substrates.	  In	  addi-­‐
tion,	  the	  A159V	  mutation	  had	  a	  greater	  effect	  than	  E160D	  mutation.	  Thus	  the	  ECCD	  technique	  
was	   used	   to	   further	   illuminate	   two	  main	   points.	   First,	   ECCD	  measurements	   of	  WT	   complexes	  
with	  3'-­‐SF,	   5'OH3'-­‐SF,	   and	  DF	   substrates	  were	   compared	   to	   indicate	   importance	  of	   active	   site	  
metal	   ion(s),	  5'-­‐flap,	  and	  5'-­‐phosphate	  of	  the	  exo	  substrate.	  These	   illustrated	  the	  substrate	  re-­‐
quirements	   for	   the	   ideal	   structural	   change.	   Second,	   ECCD	   measurements	   of	   mutant	   mFEN-­‐1	  
bound	  to	  substrate	  were	  used	  to	  obtain	  information	  about	  the	  local	  structural	  changes	  that	  oc-­‐
cur	  in	  the	  reacting	  duplex,	  and	  compared	  to	  those	  with	  the	  corresponding	  WT	  complex	  to	  find	  
out	  any	  differences	  can	  explain	  the	  kinetic	  results.	  	  
To	  establish	  analogue	  2-­‐AP	  conformations	  in	  +1,-­‐1	  and	  -­‐1,-­‐2	  positions	  in	  mFEN-­‐1:DNA	  complex-­‐
es,	   ECCD	   spectra	   of	   free	   ss	   and	   ds	   DNA	   and	   bound	   substrates	   were	   investigated	   for	   3'-­‐SF,	  
5'HO3'-­‐SF	  and	  DF	  substrates.	  All	  substrates	  have	  a	  static	  construction	  to	  eliminate	  flap	  migration	  
and	  allow	  the	  ECCD	  spectrum	  to	  be	  definitely	  assigned	  to	  a	  specific	  position	  of	  2AP	  dimer	  within	  
DNA.	  Each	  substrate	  was	  formed	  from	  two	  oligomers,	  T1	  (for	  +1,-­‐1)	  or	  T2	  (for	  -­‐1,-­‐2)	  templates,	  
which	  also	  contain	  the	  1nt	  3'-­‐flap	  and	  the	  upstream	  duplex,	  and	  a	  single	  strand	  with	  or	  without	  
flap	  that	  have	  or	  lack	  a	  5'-­‐phosphate	  (figure	  2.3)	  (table	  2.6).	  	  
The	  experiments	  were	  performed	  using	  samples	  containing	  10	  µM	  DNA	  and	  when	  present	  12.5	  
µM	  mFEN-­‐1	  protein	  (WT,	  A159V,	  or	  E160D)	  in	  Ca2+	  and	  in	  EDTA.	  Like	  the	  reactions	  of	  many	  nu-­‐
cleases	  that	  use	  metal	  ion,	  Ca2+	  does	  not	  support	  FEN-­‐1	  catalysis.	  However,	  Ca2+	  ions	  have	  been	  
shown	   to	   be	   a	   competitive	   inhibitor	   of	   FEN	   reactions,	   demonstrating	   they	   can	  occupy	   similar	  
sites	  to	  viable	  cofactors	  like	  Mg2+.	  ECCD	  spectra	  were	  recorded	  between	  300–480	  nm.	  Proteins	  
and	  natural	  DNA	  bases	  do	  not	  absorb	  in	  this	  region	  of	  the	  CD	  spectrum.	  However,	  no	  2-­‐AP	  ab-­‐
sorbance	  was	  observed	  above	  360	  nm	  with	  any	  unbound	  or	  bound	  DNA	  containing	  the	  spectral	  
probe,	  (2-­‐AP)2.	  Therefore,	  only	  the	  signal	  between	  300-­‐360	  nm	  is	  shown.	  Furthermore,	  to	  sim-­‐
plify	  and	  complement	  the	  analysis	  of	  the	  CD	  traces	  the	  ellipticity	  differences	  per	  (2-­‐AP)2	  residue	  
at	  326	  nm	  was	  calculated	  from	  three	  independent	  repetitions.	  The	  CD	  traces	  and	  the	  ellipticity	  




3.3.1.	  Base-­‐pair	  effects	  on	  local	  conformational	  changes	  of	  free	  ss	  and	  ds	  DNAs:	  
The	  ECCD	  spectra	  of	  (2-­‐AP)2	  inserted	  into	  single	  strand	  and	  double	  strand	  of	  3'-­‐SF,	  5'OH3'-­‐SF	  and	  
DF	  substrates,	  which	  were	  analysed	  without	  enzyme	  as	  a	  basis	  for	  comparison	  with	  the	  subse-­‐
quent	  experiments,	  were	  similar	  to	  those	  previously	  published	  of	  ss	  and	  ds	  DNAs.37	  ECCD	  traces	  
of	   both	   ss	   and	   ds	   DNAs	   containing	   neighbouring	   (2-­‐AP)2	   in	   Ca2+	   were	   not	   changed	   by	   adding	  
EDTA	  (figure	  3.14.a.b).	  In	  addition,	  comparison	  the	  ECCD	  intensity	  at	  326	  nm	  of	  three	  repeats	  of	  
each	  ss	  and	  ds	  DNAs	  in	  Ca2+	  (figure	  3.14.c)	  and	  in	  EDTA	  (figure	  3.14.d)	  were	  also	  consistent	  with	  
typical	  ECCD	  traces.	  However,	  ssDNA	  traces	  had	  weaker	  ECCD	  signals	  than	  dsDNAs.	  All	  ss	  traces	  
showed	  small	  blue	  shifts	  resulted	  lower	  λmax	  values	  (figure	  3.14.a.b).	  	  
Reviewing	  and	  comparing	  the	  free	  ss	  and	  ds	  ECCD	  results	  allows	  assessment	  of	  the	  juxtaposition	  
of	  the	  adjacent	  2-­‐APs	  interaction	  in	  absence	  of	  the	  enzyme,	  which	  can	  be	  used	  later	  as	  a	  basis	  to	  
interpret	   the	   impact	   of	   the	   enzyme	   interaction.	   Therefore,	   the	   impact	   of	   metal	   ions,	   5'-­‐flap	  
presence,	   5'-­‐phosphate	   monoester,	   the	   position	   of	   the	   adjacent	   (2-­‐AP)2	   in	   the	   DNA	   and	   the	  
presence	  or	  absence	  of	  basepairing	   could	  be	  assessed.	  The	   similar	  ECCD	   response	   in	  Ca2+	   and	  
EDTA	  suggests	  similar	   interactions	  between	  the	  adjacent	   two	  2-­‐APs	  with	  and	  without	  divalent	  
metal	   ion	  present.	   Furthermore,	  no	  differences	  on	  ECCD	   response	  have	  been	   indicated	   to	   re-­‐
flect	   any	  effect	  of	   adjacent	  2-­‐APs	  positions,	   5'-­‐flap,	   or	   5'-­‐phosphate	  monoester.	  On	   the	  other	  
hand,	   the	  observed	  enhanced	  exciton	   coupling	  between	   the	  neighbouring	  2-­‐APs	  by	   transition	  
from	  ss	  to	  ds	  indicates	  that	  the	  2-­‐AP	  nucleobases	  are	  restricted	  to	  fewer	  conformations	  in	  dsD-­‐
NA	  compared	  with	  ssDNA.	  The	  base-­‐pair	  opening	  reduces	  the	  interaction	  between	  two	  adjacent	  
2-­‐APs	   as	   a	   result	   of	   the	  weaker	   alignment	  of	   electronic	   transition	  dipoles	   in	   the	   single	   strand	  
DNA,	  and	   this	   is	   in	  good	  agreement	  with	  previous	   spectra	  of	   ssDNA	  having	  2-­‐APs.89	  Taken	   to-­‐
gether,	   these	   results	   show	   that	   base-­‐pair	   opening	   is	   the	   only	   influence	   that	   can	   increase	   the	  







Figure	  3.14.	  ECCD	  spectra	  of	  free	  single	  strands	  (ss)	  and	  double	  strands	  (ds)	  of	  DNAs	  containing	  2-­‐AP	  dimer.	  a)	  and	  b)	  
The	   ECCD	   traces	   in	   Ca2+	   of	   the	   unbound	   ds	   represented	   in	   solid	   lines,	   while	   their	   corresponding	   ss	   represented	   in	  
dashed	  lines	  in	  Ca2+	  and	  EDTA	  respectively.	  The	  colours	  as	  matched	  as	  in	  c	  and	  d.	  c)	  and	  d)	  Ellipticity	  changes	  at	  326	  
nm	  for	  ss	  and	  ds	  in	  Ca2+	  and	  EDTA	  respectively.	  All	  data	  sets	  are	  three	  experimental	  repeats	  and	  standard	  errors	  are	  
shown.	  DNA	  constructs	  are	  shown	  schematically.	  2-­‐AP	  was	  represented	  in	  red,	  a	  5'-­‐monophosphate	  was	  represented	  




3.3.2.	  Importance	  of	  mFEN-­‐1	  metal	  ion	  active	  site,	  the	  5'-­‐flap	  and	  the	  5'-­‐phosphate	  
monoester	  for	  local	  conformational	  changes	  of	  the	  DNA	  reacting	  duplex	  upon	  WT	  pro-­‐
tein	  binding:	  	  
The	  kinetic	   study	  of	  WTmFEN-­‐1,	  which	   required	  Mg2+,	   illustrated	   that	   the	  absence	  of	  a	  5'-­‐flap	  
reduced	  the	  protein	  catalytic	  efficiency	  slightly	  (~10-­‐fold)	  compared	  to	  the	  DF	  substrate	  (table	  
3.2).	  In	  addition,	  other	  early	  reports	  (from	  our	  group)	  concentrated	  on	  the	  importance	  of	  the	  5'-­‐
phosphate	   indicated	   that	   lack	   of	   the	   5'-­‐phosphate	  monoester	   of	   the	   exonucleolytic	   substrate	  
decreased	   hFEN-­‐1	   catalytic	   efficiency.5	   To	   indicate	   the	   importance	   of	   the	   5'-­‐flap	   and	   the	   5'-­‐
phosphate	  monoester	   for	   local	  conformational	  changes	  of	   the	  DNA	  reacting	  duplex	  upon	  pro-­‐
tein	  binding,	  ECCD	  was	  used	  to	  probe	  the	  specific	  conformational	  changes	  of	  WTmFEN-­‐1	  com-­‐
plexes	  with	  DF,	  3'-­‐SF	  and	  5'OH3'-­‐SF.	  
WTmFEN-­‐1	  showed	  an	  analogous	  response	  with	  either	  3'-­‐SF	  or	  DF	  complexes.	  In	  Ca2+,	  WT	  com-­‐
plexes	   with	   either	   3'-­‐SF	   or	   DF	   substrate	   within	   (2-­‐AP)2	   in	   +1	   and	   -­‐1	   positions	   showed	   higher	  
ECCD	   signals	   than	   corresponding	   complexes	   within	   (2-­‐AP)2	   in	   -­‐1	   and	   -­‐2	   positions	   (figure.3.15	  
a,b,e,f).	  The	  calculated	  ECCD	  intensity	  at	  326	  nm	  identified	  the	  total	  differences	  for	  three	  repeti-­‐
tions	   (figure	  3.15.g).	  While	   the	  ECCD	  spectrum	  of	  WT:3'SF+1-­‐1	  and	  WT:DF+1-­‐1	   complexes	   in	  Ca2+	  
had	  an	  exciton-­‐coupling	  intensity	  at	  326	  nm	  of	  Δε	  =	  1.7	  ±	  0.1	  and	  1.2	  ±	  0.3	  (M	  AP)-­‐1.cm-­‐1	  respec-­‐
tively,	  the	   lower	  ECCD	  intensity	  at	  326	  nm	  of	  both	  WT:3'SF-­‐1-­‐2	  and	  WT:DF-­‐1-­‐2	  complexes	   in	  Ca2+	  
were	  0.3	  ±	  0.2	  (M	  AP)-­‐1.cm-­‐1.	  The	  ECCD	  signal	  of	  the	  3'-­‐SF	  and	  DF	  complexes	  with	  WT	  were	  no-­‐
ticeably	  enhanced	  in	  EDTA.	  The	  signals	  of	  the	  3'-­‐SF	  and	  DF	  complexes	  with	  (2-­‐AP)2	  in	  +1	  and	  -­‐1	  
positions	   resembled	   the	   corresponding	   free	   ds3'-­‐SF+1-­‐1	   and	   dsDF+1-­‐1	   respectively	   (figure	  
3.15.a.e).	  However,	  signals	  of	  same	  complexes	  with	  (2-­‐AP)2	   in	   -­‐1	  and	  -­‐2	  positions	   increased	  to	  
have	   a	   similar	  magnitude	   to	   that	   observed	   for	   corresponding	   unbound	   ss3'-­‐SF-­‐1-­‐2	   and	   ssDF-­‐1-­‐2	  
respectively	  (figure	  3.15.b.f).	  	  
However,	  when	  the	  3'-­‐single	  flap	  lacked	  a	  5'-­‐phosphate	  the	  resultant	  complexes	  were	  not	  able	  
to	   fully	   reproduce	   the	   required	   DNA	   conformational	   change.	   The	   5'OH3'-­‐SF	   complex	   showed	  
similar	   ECCD	   signal	   to	   the	   analogous	   response	   of	   both	   corresponding	   3'-­‐SF	   complex	   and	   DF	  
complex	  with	  (2AP)2	  in	  -­‐1	  and-­‐2	  positions,	  however,	  the	  5'OH3'-­‐SF	  complex	  displayed	  a	  greater	  
ECCD	   signal	   with	   (2AP)2	   in	   +1	   and	   -­‐1	   positions.	   Similarly,	   this	   substrate	   complex	   in	   Ca2+	   also	  
showed	  a	  higher	  ECCD	  signal	  within	  (2-­‐AP)2	  in	  +1,-­‐1	  position	  than	  corresponding	  complex	  within	  
(2AP)2	   in	   -­‐1,-­‐2	   positions	   (figure	   3.15.c.d).	   ECCD	   intensity	   at	   326	   nm	   in	   Ca2+	   showed	   that	  
WT:5'OH3'-­‐SF+1-­‐1	  complex	  had	  similar	   intensity	  to	  the	  corresponding	  free	  ds,	  while	  WT:5'OH3'-­‐




dramatically	  by	  adding	  EDTA.	  While	   intensity	  of	  the	  5'OH3'-­‐SF+1-­‐1	  complex	  exceeded	  the	  corre-­‐
sponding	  free	  ds,	  the	  5'OH3'-­‐SF-­‐1-­‐2	  intensity	  identified	  the	  corresponding	  free	  ds	  (figure	  3.15.g).	  	  
Consideration	  of	  all	  of	  the	  WT	  protein	  complexes	  with	  3'-­‐SF,	  5'OH3'-­‐SF	  or	  DF	  substrates	  allows	  
identification	   of	   the	   importance	   of	   the	   two	   metal	   ion	   active	   site,	   the	   5'-­‐flap,	   and	   the	   5'-­‐
phosphate	  for	  the	  local	  conformational	  changes	  of	  the	  DNA	  reacting	  duplex.	  First,	  in	  accord	  with	  
what	   is	   already	   known	   about	   the	   importance	   of	   FEN-­‐1	  metal	   ion	   active	   site,	   increase	   of	   the	  
ECCD	  intensity	  at	  326	  nm	  of	  all	  WT:DNA	  complexes	  upon	  adding	  EDTA	  suggests	  that	  the	  pres-­‐
ence	  of	  the	  metal	  ion(s)	  in	  the	  active	  site	  (Ca2+)	  is	  essential	  for	  the	  local	  conformational	  changes	  
of	  all	  substrates.	  This	  increase	  indicates	  the	  conformational	  changes	  with	  Ca2+	  result	  from	  a	  de-­‐
crease	  in	  the	  stacked	  population	  of	  +1	  and	  -­‐1	  nucleotides	  also	  -­‐1	  and	  -­‐2	  nucleotides.	  Together	  
the	  data	  imply	  the	  divalent	  metal	  ion	  dependence	  for	  local	  conformational	  changes.	  Second,	  the	  
similar	  behaviour	  of	  WT	  complexes	  with	  either	  3'-­‐SF	  or	  DF	  substrates	  in	  Ca2+	  and	  EDTA	  demon-­‐
strates	  that	   lack	  of	  the	  5'-­‐flap	  does	  not	  affect	  the	  local	  conformational	  changes	  of	  the	  reacted	  
duplex.	  This	  means,	  the	  5'-­‐flap	   is	  not	  required	  for	   ideal	   local	  conformational	  changes.	  This	  be-­‐
haviour	   is	   consistent	  with	  what	  was	   observed	   previously	   from	   a	   DNA	   conformational	   change	  
study	  with	  DF-­‐1-­‐2	  and	  P-­‐1-­‐2.37	   In	  addition,	   this	   result	   is	   in	  agreement	  with	   the	  slight	  decrease	  of	  
the	  catalytic	  efficiency	  of	  mFEN-­‐1	  with	  3'-­‐SF	  substrate	  compared	  to	  DF	  substrate	  that	  observed	  
kinetically	  (table	  3.2).	  Third,	  the	  different	  ECCD	  response	  of	  5'OH3'-­‐SF+1,1	  substrate	  from	  both	  3'-­‐
SF+1,1	   substrate,	   which	   has	   a	   terminal	   5'-­‐phosphate,	   and	   DF+1,1	   substrate,	   which	   has	   a	   5'-­‐
phosphate	  diester	   in	   the	  corresponding	  position	   indicates	   the	   importance	  of	   the	  5'-­‐phosphate	  
monoester	  of	  the	  +1	  nt	  to	  produce	  the	  ideal	  local	  conformational	  change	  of	  +1	  and	  -­‐1	  nts	  upon	  
mFEN-­‐1	  binding.	  The	  higher	  ECCD	  response	  of	  the	  substrate	  complex	  (WT:5'OH3'-­‐SF+1,1)	  in	  Ca2+,	  
which	   is	   further	   increased	   when	   EDTA	  was	   added,	   suggests	   that	   lacking	   of	   the	   5'-­‐phosphate	  
monoester	  causes	  only	   imperfect	  conformational	  change	  of	  the	  +1	  nt	   leading	  to	  reduced	  elec-­‐
tronic	   interaction	   between	   the	   two	  nucleotides	   +1	   and	   -­‐1	   nts,	   but	   not	   as	   required.	  However,	  
lack	   of	   this	   5'-­‐phosphate	   does	   not	   effect	   the	   conformational	   change	  of	   -­‐1	   and	   -­‐2	   nts	   as	   their	  
electronic	   interaction	  reduced	   ideally	  as	  3'-­‐SF	  and	  DF	  substrates.	  This	  provides	  an	  explanation	  
for	  what	  was	  previously	  reported	  about	  5'OH3'-­‐SF	  (that	  lacks	  a	  5'-­‐phosphate	  monoester)	  where	  








Figure	  3.15.	  ECCD	   spectra	  of	  WTmFEN-­‐1	   complexes	   in	  Ca2+	  and	  EDTA	   besides	   the	   corresponding	  ss	   and	  ds	  of	  each	  
substrate.	  a)	  WT:3'-­‐SF+1-­‐1	  complex.	  b)	  WT:3'-­‐SF-­‐1-­‐2	  complex.	  c)	  WT:5'OH3'-­‐SF+1-­‐1	  complex.	  d)	  WT:5'OH3'-­‐SF-­‐1-­‐2	  complex.	  
e)	  WT:DF+1-­‐1	  complex.	  f)	  WT:DF-­‐1-­‐2	  complex.	  g)	  Ellipticity	  changes	  at	  326	  nm	  for	  WT	  complexes	  and	  their	  correspond-­‐
ing	   ss	   and	   ds-­‐DNAs	   containing	   2-­‐AP	   dimer.	   All	   data	   sets	   are	   three	   experimental	   repeats	   and	   standard	   errors	   are	  
shown.	  DNA	  constructs	  are	   shown	   schematically	  with	  a	  5'-­‐monophosphate	  was	   represented	  as	  *	  and	  a	  5'-­‐hydroxyl	  
was	  represented	  as	  (OH).	  	  
Clearly,	  mFEN-­‐1	  requires	  its	  metal	  ion	  active	  site	  and	  a	  substrate	  where	  the	  +1	  nucleotide	  is	  5'-­‐
phosphorylated	  to	  produce	  ideal	  conformational	  changes	  to	  position	  the	  scissile	  phosphate	  for	  
hydrolysis.	  Additionally,	   lack	  of	  a	  5'-­‐flap	  does	  not	  affect	  the	  conformational	  changes.	  Based	  on	  
these	  results,	  it	  is	  possible	  to	  represent	  the	  similar	  conformational	  changes	  of	  both	  3'-­‐SF	  and	  DF	  
substrates	  as	  the	  typical	  conformational	  changes	  that	  are	  required	  for	  mFEN-­‐1	  catalytic	  efficien-­‐




changes	  reduce	  the	  degree	  of	  the	  electronic	  interaction	  between	  +1	  and	  -­‐1	  nts	  also	  between	  -­‐1	  
and	   -­‐2	   nts.	   In	   fact,	   this	   reduced	   exciton-­‐coupling	   may	   result	   from	   different	   origins	   such	   as	  
change	  of	  relative	  orientation	  of	  the	  +1	  and	  -­‐1	  bases	  with	  different	  angles	  and/or	  distance	  the	  
+1	  and	  -­‐1	  nucleotides	  (unstacking)	  (figure	  3.16).	  Furthermore,	  the	  higher	  ECCD	  response	  of	  (2-­‐
AP)2	  in	  +1,-­‐1	  position	  than	  -­‐1,-­‐2	  positions	  shows	  that	  the	  electronic	  interaction	  between	  -­‐1	  and	  -­‐
2	  nucleotides	  are	  reduced	  further	  than	  +1	  and	  -­‐1	  nucleotides.	  However,	  these	  results	  alone	  are	  
not	   enough	   to	   accept	   or	   refute	   the	   previous	   suggestion	   about	   the	  DNU	  mechanism	   that	  was	  
formulated	  based	  upon	  on	  the	  obtained	  unpaired	  -­‐1	  nt	  in	  product	  complex.1,37	  This	  mechanism	  
suggested	  that	  this	  local	  DNA	  conformational	  change	  was	  restricted	  to	  being	  double	  nucleotide	  
unpairing	  and	  may	  be	  combined	  with	  reorientation	  of	  +1	  and	  -­‐1	  nts	  to	  position	  the	  phosphate	  
bond	  into	  the	  active	  site.1,2,37	  However,	  combined	  hFEN-­‐1	  ECCD	  results,	  which	  will	  be	  discussed	  
in	  section	  4,	  with	  later	  results	  indicated	  that	  the	  scissile	  phosphate	  bond	  was	  positioned	  into	  the	  
active	  site	  with	  fully	  base-­‐paired	  DNA.	  These	  data	  suggested	  that	  Y40	  and	  positive	  side	  chains	  of	  
the	  helical	  arch	  untwist	  the	  dsDNA.	  This	  reorientation	  alters	  the	  base	  overlap	  and	  the	  base	  pair-­‐
ing	   strength	  of	  +1	  and	   -­‐1	  nts	  and	  affect	   the	  ECCD	  signals.93	   Taken	   together,	   the	  DNU	  and	  un-­‐
twisting	  mechanisms	   leads	  us	   to	   rethink	   the	   total	  mechanical	  events.	   It	   is	  possible	   to	   imagine	  
that	   an	   interaction	   force	  between	   the	  enzyme	  and	   the	  DNA	   leads	   to	  untwisted	  DNA	  with	   full	  
base	  pairing	  (but	  nucleobase	  unstacking)	  to	  position	  the	  target	  phosphate	  bond	  into	  the	  active	  
site.	  Completion	  of	  the	  hydrolysis	  chemistry	  causes	  disappearance	  of	  the	  +1nt	  forcing	  structural	  
changes	   that	  may	   cause	   -­‐1	   nt	   unpairing.	   Accordingly,	   the	   conformational	   changes	   are	   consid-­‐
ered	  as	  reorientation	  of	  +1	  and	  -­‐1	  nucleotides.	  
	  
Figure	  3.16.	  Cartoon	  to	  illustrate	  different	  DNA	  conformational	  changes	  that	  lead	  to	  changes	  in	  the	  electronic	  interac-­‐
tion	  between	  +1	  and	   -­‐1	  nts	  and	  between	   -­‐1	  and	   -­‐2	  nts.	  a)	  Normal	  DNA.	  b)	  DNA	  with	  reoriented	  +1	  and	   -­‐1	  nts	  with	  
different	  angles	  without	  effect	  on	  the	  base	  pairing	  and	  stacking	  of	  both	  nts.	  c)	  DNA	  with	  distanced	  +1	  and	  -­‐1	  nts	  caus-­‐




3.3.3.	  Effects	  of	  mFEN-­‐1	  mutations	  (A159V	  &	  E160D)	  on	  local	  conformational	  changes	  
of	  reacting	  duplex	  upon	  their	  complexes	  with	  DF,	  3'-­‐SF	  or	  5'OH3'-­‐SF	  compared	  with	  
the	  WT:	  
The	  effects	  of	  A159V	  and	  E160D	  mutations	  on	  the	  local	  conformational	  changes	  of	  exonucleo-­‐
lytic	   and	   DF	   substrates	   were	   investigated	   by	   comparison	   of	   their	   complexes	   with	   the	   corre-­‐
sponding	  WT	  complex	  to	  indicate	  any	  differences.	  Furthermore,	  both	  mutations	  were	  compared	  
to	  each	  other	  to	   investigate	   if	   they	  differ	   in	  their	  effects.	  Overall,	  both	  mutations	  affected	  the	  
ECCD	  response	  of	  3'-­‐SF,	  5'OH3'-­‐SF	  and	  DF	  complexes.	  
Compared	   with	  WT:3'-­‐SF	   complex,	   A159V	   and	   E160D	  mutations	   affected	   the	   ECCD	   traces	   of	  
their	  complexes	  with	  3'-­‐SF	  substrate.	  In	  Ca2+,	  both	  mutant	  mFEN-­‐1	  complexes	  with	  3'-­‐SF+1-­‐1	  sub-­‐
strate	  increased	  the	  ECCD	  signal	  analogously	  further	  than	  the	  comparable	  WT	  complex	  and	  the	  
identical	   free	   substrate	   (figure	  3.17.a.).	   By	   adding	   EDTA,	   the	   calculated	  ECCD	   intensity	   at	   326	  
nm	   in	   Ca2+	   increased	   slightly	   to	   approach	   the	  WT	   signal	   (figure	   3.17.g.h).	   A159V	   and	   E160D	  
mFEN-­‐1	  complexes	  with	  3'-­‐SF-­‐1-­‐2	  showed	  a	  diverse	  response	  that	  also	  differed	  from	  WT	  complex	  
in	   the	   presence	   of	   the	   divalent	  metal	   ion.	  While	   A159V	   caused	   a	   deeper	  minimum	   than	  WT,	  
E160D	  led	  to	  higher	  signal	  than	  WT	  at	  326	  nm	  (figure	  3.17.b.g).	  ECCD	  intensity	  at	  326	  nm	  of	  the-­‐
se	   3'-­‐SF-­‐1-­‐2	  mutant	   complexes	   increased	   to	   approach	   the	   corresponding	  WT	   complex	   and	   the	  
single	  strand	  signals	  (ss3'-­‐SF-­‐1-­‐2)	  upon	  adding	  EDTA	  (figure	  3.17.h).	  
Similarly	   to	  mutant	  mFEN-­‐1:3'-­‐SF	  complexes,	  more	  variations	  also	  were	  detected	  with	  mutant	  
enzyme:5'OH3'-­‐SF	  complexes	  compared	  to	  the	  corresponding	  WT	  complex.	  Both	  mutations	  af-­‐
fected	  the	  ECCD	  signals	  of	  their	  complexes	  with	  5'OH3'-­‐SF	  similarly	  to	  their	  complexes	  with	  3'-­‐
SF.	  The	  ECCD	  signal	  associated	  with	  5'OH3'-­‐SF+1-­‐1	  complex	  with	  either	  A159V	  or	  E160D	  increased	  
analogously,	  but	  further	  than	  WT	  complex	  and	  the	   identical	   free	  substrate	   in	  presence	  of	  Ca2+	  
(figure	  3.17.c.).	  Both	  of	  these	  complexes	  produced	  only	  a	  very	  slight	  increase	  in	  the	  ECCD	  inten-­‐
sity	   at	   326	   nm	   by	   adding	   EDTA	   to	   approach	   the	   corresponding	   WT	   complex	   signal	   (figure	  
3.17.g.h).	  In	  addition,	  the	  signals	  that	  associated	  with	  A159V	  and	  E160D	  complexes	  of	  a	  (2-­‐AP)2	  
in	  -­‐1	  and	  -­‐2	  positions	  were	  lower	  and	  higher	  than	  WT:5'OH3'-­‐SF-­‐1-­‐2	  complex	  in	  Ca2+	  respectively	  
(figure	  3.17.d).	  The	  calculated	  intensity	  at	  326	  nm	  increased	  slightly	  to	  similar	  extent	  of	  WT	  sig-­‐
nal	  in	  EDTA	  (figure	  3.17.g.h).	  
Less	  marked	  effects	  of	  mutations	  on	  ECCD	  response	  were	  observed	  with	  complexes	  involving	  DF	  
substrate.	  The	  ECCD	  traces	  of	   the	  WT:DF	  complexes	  were	  altered	  with	   the	  presence	  of	  either	  
A159V	  or	  E160D	  mutation,	  but	  not	  with	  the	  same	  impact	  as	  seen	  with	  exonucleolytic	  complex-­‐




and	  EDTA	  significantly,	  however,	  A159V	  mutation	  increased	  the	  intensity	  in	  Ca2+	  slightly,	  which	  
was	   increased	  more	  by	  adding	  EDTA	  to	  approach	  the	  WT	  and	  E160D	  intensity	  on	  EDTA	  (figure	  
3.17.e.g.h).	  With	  DF-­‐1-­‐2	  substrate,	  both	  mutations	  reduced	  the	  ECCD	  signal,	  but	  more	  significant-­‐
ly	  with	  A159V	  than	  E160D	  (figure	  3.17.f).	  By	  adding	  EDTA,	  intensity	  of	  both	  mutations	  complex-­‐
es	  increased	  to	  reach	  intensity	  of	  the	  corresponding	  WT	  complex	  (figure	  3.17.g.h).	  	  
	  
Figure	  3.17.	  ECCD	  spectra	  of	  WT,	  A159V	  and	  E160D	  mFEN-­‐1	  complexes	  with:	  a)	  3'-­‐SF+1-­‐1.	  b)	  WT:3'-­‐SF-­‐1-­‐2.	  c)	  5'OH3'-­‐
SF+1-­‐1.	  d)	  5'OH3'-­‐SF-­‐1-­‐2.	  e)	  DF+1-­‐1.	  f)	  DF-­‐1-­‐2.	  Besides	  that	  the	  corresponding	  ss	  and	  ds	  of	  each	  substrate	  also	  represented.	  
Ellipticity	  changes	  at	  326	  nm	  for	  WT,	  A159V	  and	  E160D	  mFEN-­‐1	  complexes	  and	  their	  corresponding	  ss	  and	  ds-­‐DNAs	  
containing	  2AP	  dimer	  are	  shown	  g)	  in	  Ca2+	  and	  h)	  in	  EDTA.	  All	  data	  sets	  are	  three	  experimental	  repeats	  and	  standard	  
errors	  are	  shown.	  DNA	  constructs	  are	  shown	  schematically	  with	  a	  5'-­‐monophosphate	  was	  represented	  as	  *	  and	  a	  5'-­‐




According	   to	   the	   results	   of	  mutant	  mFEN-­‐1	   complexes	   with	   either	   exonucleolytic	   or	   DF	   sub-­‐
strate,	   some	   differences	   from	   the	   corresponding	  WTmFEN-­‐1	   complexes	   were	   observed.	   This	  
suggests	   unfavourable	   effects	   of	   A159V	   and	   E160D	   mutations	   on	   the	   local	   conformational	  
changes	  of	   reacting	  duplex	  of	   each	   substrate,	   reflecting	  positioning	  of	   the	   scissile	   phosphate-­‐
bond	  in	  the	  active	  site.	  
First,	  with	  all	  substrates	  (3'-­‐SF,	  5'OH3'-­‐SF	  and	  DF),	  A159V	  mutation	  similarly	  affects	  mFEN-­‐1	  abil-­‐
ity	  to	  produce	  the	   ideal	   local	  conformational	  changes.	  Compared	  to	  the	  ECCD	  response	  of	  the	  
analogous	  WT	  complex,	  A159V	  effects	  on	  ECCD	  response	  may	  reflect	  differences	  in	  a	  partition	  
between	  oriented	  and	  not	  oriented	  and/or	  imperfect	  orientation	  of	  the	  2-­‐AP	  nucleobases	  in	  +1	  
and	  -­‐1	  positions.	  However,	  the	  contrary	  effect	  of	  mutation	  on	  the	  interaction	  of	  (2-­‐AP)2	  in	  +1,-­‐1	  
positions,	   which	   had	   higher	   response	   than	   corresponding	   WT	   complex,	   and	   -­‐1,-­‐2	   positions,	  
which	  had	  lower	  response	  than	  corresponding	  WT	  complex,	  may	  support	  the	  possibility	  of	  the	  
imperfect	  reorientation	  of	  +1	  and	  -­‐1	  nts.	  This	   imperfect	  reorientation	  decreases	  the	  electronic	  
interaction	  between	  +1	  and	  -­‐1	  also	  between	  -­‐1	  and	  -­‐2,	  but	  higher	  and	  lower	  than	  required	  re-­‐
spectively.	  Second,	  the	  E160D	  mutation	  affects	  local	  conformations	  of	  3'-­‐SF	  and	  5'OH3'-­‐SF	  sub-­‐
strates	  analogously,	  whereas	  the	  effect	  on	  DF	  is	  slightly	  different.	  The	  higher	  ECCD	  response	  of	  
E160D	  complexes	  with	  either	  3'-­‐SF	  or	  5'OH3'-­‐SF,	  compared	  to	  the	  corresponding	  WT	  complex,	  
may	  reflect	  increase	  a	  partition	  of	  the	  not	  oriented	  forms	  and/or	  imperfect	  orientation	  of	  the	  2-­‐
AP	  nucleobases.	   The	  DF	   complexes	   that	  appears	  equal	   and	   lower	   signals	  with	   (2-­‐AP)2	   in	  +1,-­‐1	  
and	  -­‐1,-­‐2	  positions	  respectively	  lead	  to	  suggest	  that	  the	  +1	  and	  -­‐1	  nucleotides	  are	  oriented	  im-­‐
perfectly.	   As	   a	   result,	   the	   electronic	   interaction	   between	   +1	   and	   -­‐1	   nucleotides	   is	   decreased	  
from	  the	  ideal	  seen	  with	  the	  WT	  complex;	  however,	  the	  electronic	  interaction	  between	  -­‐1	  and	  -­‐
2	  nucleotides	  is	  decreased	  further	  than	  required.	  	  
Taken	  together,	  both	  mutations	  alter	  the	  conformational	  changes	  of	  the	  WT	  complexes	  of	  three	  
of	   the	   substrates	   (3'-­‐SF,	  5'OH3'-­‐SF	  and	  DF),	  however,	   they	  differ	   slightly	   in	   their	  effects	   (table	  
3.4).	  A159VmFEN-­‐1	   twists	   all	   the	   substrates	   similarly	   and	  decreases	   the	  electronic	   interaction	  
between	  +1	  and	  -­‐1	  also	  between	  -­‐1	  and	  -­‐2	   less	  and	  more	  than	  corresponding	  WT	  complex	  re-­‐
spectively.	  E160DmFEN-­‐1	  twists	  both	  exo	  substrates	  similarly	  decreasing	  the	  electronic	  interac-­‐
tion	  between	  the	  three	  nucleotides,	  but	  still	  less	  than	  the	  corresponding	  WT	  complex.	  With	  DF	  
substrate,	  E160D	  mutation	  only	  alters	  the	  -­‐1	  and	  -­‐2	  nts	  conformational	  changes	  by	  decreasing	  
their	  electronic	   interaction	  more	  than	  the	  corresponding	  WT	  complex.	  As	  a	  result	  of	  these	  im-­‐
perfect	   conformational	   changes,	   both	   mutations	   do	   not	   have	   ability	   to	   position	   the	   scissile	  
phosphate	  bond	  between	  the	  two	  metal	  ions	  active	  site	  to	  the	  same	  extent	  as	  the	  WT	  protein.	  




greater	   impact	   of	   A159V	   on	   the	   rate	   of	   reaction	   of	   DF	   substrate	   (also	   expected	   of	   3'-­‐SF	   sub-­‐
strate)	   than	  E160D,	  which	  has	  been	  demonstrated	  kinetically	   in	   section	  3.2.1.	   In	  addition,	   the	  
lower	  efficiency	  of	  WThFEN-­‐1	  to	  cleave	  5'OH3'-­‐SF,	  which	  was	  shown	  previously,5	  is	  expected	  to	  
be	  worst	   in	  presence	  of	   these	  mutations.	  As	  was	  expected	   in	   the	   kinetic	   study,	   these	   altered	  
conformational	   changes	  may	   result	   from	   the	   higher	   steric	   hindrance	  of	  A159V	   and	   the	   direct	  
contact	  between	  E160D	  and	  metal	  ion	  active	  site,	  which	  can	  influence	  substrate	  positioning	  and	  
the	  distance	  between	  divalent	  ions	  respectively.	  
Substrate	  
A159V	   E160D	  
+1,-­‐1	   -­‐1,-­‐2	   +1,-­‐1	   -­‐1,-­‐2	  
3'-­‐SF	   +	   -­‐	   +	   +	  
5'OH3'-­‐SF	   +	   -­‐	   +	   +	  
DF	   +	   -­‐	   =	   -­‐	  
Table	  3.4.	  Strength	  of	   the	  electronic	   interaction	  between	  the	  two	  adjacent	  2-­‐Aps	  of	  +1,-­‐1	  and	  -­‐1,-­‐2	  positions	  of	   the	  
mutated	  mFEN-­‐1	  complexes	  comparing	  to	  the	  corresponding	  WT	  complex	  of	   the	  three	  studied	  substrates.	  The	  used	  
symbols	  mean	  that	  (+)	  higher	  interaction	  (-­‐)	  less	  interaction	  (=)	  similar	  interaction	  to	  the	  corresponding	  WT	  complex.	  
The	  data	  were	  summarised	  from	  figure	  3.18.	  
3.3.4.	  Summary	  and	  conclusion	  of	  the	  local	  conformational	  changes	  of	  WT	  and	  mutant	  
mFEN-­‐1:	  
Base-­‐pair	  opening	  of	  free	  DNA	  is	  the	  only	  effect	  that	  increases	  the	  freedom	  of	  movement	  of	  2-­‐
AP	  bases	  and	  changes	  the	  electronic	  interaction	  strength	  between	  them.	  However,	  without	  un-­‐
pairing,	  enzyme	  binding	  introduces	  other	  effects	  on	  this	  electronic	  interaction	  that	  are	  depend-­‐
ent	   on	   its	   metal	   ions	   active	   site,	   5'-­‐phosphate	   monoester	   of	   exo	   substrate,	   and	   mutations.	  
WTmFEN-­‐1	   induces	   specific	   substrate	   conformational	   changes	   in	   the	   presence	   of	   Ca2+	   and	   5'-­‐
phosphate	  monoester	   of	   +1	   nt	   that	   position	   the	   scissile	   phosphate	   bond	   into	   the	   active	   site.	  
These	   structural	   changes	   cause	   reorientation	  of	   the	   +1	   and	   -­‐1	   nts	   differently	   by	   reducing	   the	  
electronic	   interaction	   between	   -­‐1	   and	   -­‐2	   nts	   also	   between	   +1	   and	   -­‐1	   nts	   by	   DNA	   twisting.	  
WTmFEN-­‐1	  complex	  with	  either	  DF	  or	  3'-­‐SF	  substrate	  produces	  an	  ideal	  conformational	  change	  
that	   produces	   rapid	   reaction	   in	   the	   presence	   of	   viable	   cofactor	   and	   prior	   to	   this	   reduces	   the	  
electronic	  interaction	  between	  -­‐1	  and	  -­‐2	  nts	  more	  than	  +1	  and	  -­‐1	  nts.	  However,	  without	  the	  5'-­‐
phosphate	   of	   the	   3'-­‐SF	   the	   enzyme’s	   ability	   to	   reorient	   +1	   nt	   is	   decreased.	   This	   explains	  why	  




and	  E160D	  mutant	  residues	  reduce	  the	  enzyme	  ability	  to	  produce	  ideal	  conformational	  changes.	  
The	  contrary	  effect	  of	  mutations	  on	  +1	  and	  -­‐1	  interactions	  in	  most	  cases	  supports	  the	  possibility	  
of	   the	   imperfect	   reorientation	  of	  +1	  and	   -­‐1.	  However,	  A159V	  effects	  are	   stronger	   than	  E160D	  
effects.	  The	  much	  more	  marked	  imperfect	  conformational	  change	  with	  A159V	  explains	  the	  ca-­‐
talysis	  view	  that	  A159V	  decreases	  cleavage	  ability	  of	  mFEN-­‐1	  more	  than	  E160D	  (section	  3.2).	  
3.4.	  Measuring	   substrate	   bending	   upon	   enzyme	  binding	   by	   Fluorescence	  Resonance	  
Energy	  Transfer	  analysis	  (FRET):	  
Kinetic	  studies	  reported	  at	  the	  beginning	  of	  this	  chapter	  suggest	  that	  the	  FEN-­‐1	  mutations	  asso-­‐
ciated	  with	  cancer,	  A159V	  and	  E160D,	  may	  have	  modestly	  altered	  substrate	  binding	  properties.	  
To	  test	  this	  a	  substrate	  binding	  assay	  that	  measures	  the	  ability	  of	  the	  enzyme	  to	  bend	  the	  two	  
duplexes	  of	  substrate	  towards	  each	  other	  was	  set	  up	  exploiting	  fluorescence	  resonance	  energy	  
transfer	  (FRET).	  FRET	  is	  nonradiative	  physical	  process	  that	  transfers	  energy	  from	  an	  excited	  do-­‐
nor	  fluorophore	  to	  another	  acceptor	  fluorophore.94	  The	  energy	  transfer	  efficiency	  (E)	  is	  a	  sepa-­‐
ration	   distance	   (R)	   dependent	   between	  donor	   and	   acceptor	   coupling,	   and	   is	   very	   sensitive	   to	  
small	   changes	   in	   this	  distance	   (equation	  3.5).	   The	  R0	   (Foster	  distance)	  value,	  which	   is	   typically	  
the	  distance	  of	  donor	  and	  acceptor	  pair	  at	  which	  the	  energy	  transfer	  efficiency	  is	  50	  %,	  depends	  
on	  the	  overlap	  integral	  between	  the	  spectrum	  of	  the	  donor	  emission	  and	  the	  acceptor	  absorp-­‐
tion,	   their	  molecular	  orientation,	  quantity	  of	   the	  donor	   fluorescence,	   the	  acceptor	  absorption	  
coefficient,	   and	   the	   refractive	   index	  of	   the	   solution.86,95	   Therefore,	   labelling	  DNA	   strands	  with	  
donor	   and	   acceptor	   fluorophores	   are	   used	   to	  measure	   the	  DNA	   conformational	   changes	   that	  
occur	  upon	  protein	  binding	  by	  reporting	  change	  of	  the	  energy	  transfer	  efficiency	  (E).	  	  
A	  previous	  study	  showed	  that	  a	  protein	  and	  labelled-­‐DNA	  binding	  can	  affect	  the	  donor	  and/or	  
acceptor	   fluorescence	   intensity,	  which	   reflected	  DNA	  bending	  around	  protein	  surface.96	  Other	  
later	   studies	  measured	   the	   FRET	   efficiency	  of	   a	  DF	   substrate	   attached	   to	   donor	   and	   acceptor	  
molecules	  at	  different	  positions	  to	  indicate	  the	  substrate	  bending	  upon	  FEN-­‐1	  binding.47,67,97-­‐99	  	  
𝐸 = 𝟏𝟏! 𝑹 𝑹𝟎 𝟔 	  	   	   Equation	  3.5	  
In	   this	   study,	   the	   induced	  emission	  of	   the	   acceptor	  was	  used	   to	  measure	   the	  energy	   transfer	  
efficiency	  (E),	  which	  was	  calculated	  using	  the	  (ratio)A	  method	  (equation	  3.6).	  The	  (ratio)A	  is	  de-­‐
termined	  from	  fluorescent	  signal	  of	  the	  donor-­‐only	  labelled	  molecule	  (DOL)	  and	  doubly-­‐labelled	  
molecule	  (DAL)	  at	  two	  specific	  wavelength	  pairs	  (equation	  3.6),	  and	  N	  the	  normalization	  factor	  
(equation	   3.7).86	   Fluorescence	   measurements	   were	   made	   by	   direct	   excitation	   of	   the	   donor	  




at	   515-­‐650	  nm	  or	   575-­‐650	  nm	   (5	  nm	   slit	  width).	   Additionally,	   spectra	   of	   unlabelled	   (NL)	  DNA	  
sample	  was	  deducted	  from	  the	  appropriate	  emission	  spectra	  of	  the	  labelled	  DNAs	  in	  order	  to	  be	  
corrected	  from	  effects	  of	  buffer	  and	  enzyme	  conditions.	  Because	  of	  the	  overlap	  between	  TAM-­‐
RA	  excitation	  and	  FAM	  emission	  spectra,	  donor	  excitation	   (𝜆!"! )	  of	  double-­‐labelled	  DNA	   (DAL)	  
causes	  the	  acceptor	  emission	  (𝜆!"! )	  resulting	  FRET	  signal	   (𝐹!"   𝜆!"! , 𝜆!"! ).	   In	  short,	   this	  FRET	  
signal	   is	  composed	  of	  three	  fluorescent	  spectra,	  which	  are	  acceptor	  emission	  due	  to	  FRET,	  ac-­‐
ceptor	  emission	   from	  direct	  excitation,	  and	  donor	  emission	   from	  direct	  excitation.	  To	  achieve	  
pure	   FRET	   with	   acceptor	   emission	   from	   FRET	   and	   direct	   excitation	   only,	   donor	   emission	  𝐹! 𝜆!"! , 𝜆!"! 	  that	  is	  measured	  by	  donor	  only–labelled	  DNA	  (DOL)	  and	  normalised	  to	  match	  do-­‐
nor	  peak	  of	  DAL	  molecule	  should	  be	  subtracted	  from	  the	  FRET	  signal	  of	  DAL	  molecule.	  As	  well,	  
the	  resultant	  pure	  FRET	  after	  subtraction	  is	  normalised	  by	  the	  acceptor	  maximum	  emission	  by	  
its	  direct	  excitation	  in	  DAL	  molecule	  𝐹!" 𝜆!"! , 𝜆!"! .	  Where	  FDA	  and	  FD	  represent	  the	  fluorescent	  
signal	  of	  the	  doubly-­‐labelled	  molecule	  (DAL)	  and	  donor-­‐only-­‐labelled	  molecule	  (DOL)	  at	  the	  giv-­‐
en	  wavelengths	  respectively.	  	  
𝑟𝑎𝑡𝑖𝑜 ! = !!"   !!"! ,!!"! !!.!! !!"! ,!!"!   !!" !!"! ,!!"! 	  	  	   Equation	  3.6	  
𝑁 = !!" !!"! ,!!"!!! !!"! ,!!"! 	  	   	   	   	   Equation	  3.7	  
The	  determined	  (ratio)A	  then	  was	  used	  to	  calculate	  energy	  transfer	  efficiency	  (E).	  Functionally,	  E	  
depends	  on	  (ratio)A	  and	  the	  molar	  absorption	  extinction	  coefficients	  of	  donor	  (εD)	  and	  acceptor	  
(εA)	   at	   the	  given	  excitation	  and	  emission	  wavelengths	   (equation	  3.8).	   εD	   (490)/	   εA(560)	   and	  εA	  
(490)/	  εA(560)	  were	  determined	  from	  absorbance	  spectra	  of	  DAL	  substrate	  and	  excitation	  spec-­‐
tra	  of	  AOL	  substrate	  respectively.	  
𝐸 = !"#$%   !!! !"#!! !"#   !   !! !"#!! !"# 	  	   	   Equation	  3.8	  
Data	  were	  fitted	  by	  nonlinear	  squares	  regression	  by	  KaleidaGraph	  version	  4.5.2	  using	  equation	  
3.9	  below:	  
𝐸 = 𝐸!"# + !!"#!!!"#! !    𝑆 + 𝑃 + 𝐾!"#$ − 𝑆 + 𝑃 + 𝐾!"#$ ! − 4 𝑆 𝑃 	  	   	   Equation	  3.9	  
Accordingly,	  the	  dissociation	  constant	  (Kbend)	  value	  is	  calculated	  using	  the	  measured	  E	  at	  a	  spe-­‐
cific	  total	  enzyme	  concentration	  [P]	  and	  substrate	  concentration	  [S],	  minimum	  energy	  transfer	  
efficiency	  of	  the	  free	  substrate	  in	  absence	  of	  any	  enzymes	  (Emin)	  and	  the	  maximum	  energy	  trans-­‐




For	  mFEN-­‐1	  FRET	  experiments,	  only	  DF	  and	  3'-­‐SF	   labelled	  with	  donor	  and	  acceptor	  were	  used	  
(figure	  3.18).	  Using	   (ratio)A	  method,	   E	  were	  determined	  by	  measuring	   the	  enhanced	  acceptor	  
fluorescence	  at	  37	  °C	  of	  10	  nM	  of	  NL,	  DOL	  and	  DAL	  of	  DNA	  substrates.	  The	  experiments	  were	  
carried	  out	  with	  and	  without	  catalytically	  non-­‐viable	  Ca2+	  ions	  to	  allow	  substrate	  bending	  with-­‐
out	  reaction.	  The	  donor	  or	  acceptor	  was	  excited	  at	  490	  nm	  or	  560	  nm	  and	  the	  emission	  signals	  
were	   collected	   from	   515-­‐650	   nm	   or	   575-­‐650	   nm.	   These	   emission	   signals	   were	   corrected	   for	  
buffer	   and	   enzyme	  background	   signal	   by	   subtracting	   the	   signal	   from	  NL	   substrate	   signal.	   The	  
overall	  substrates	  conformations	  were	  compared	  to	  duplex	  DNA.	  	  
	  
Figure	  3.18.	  Schematic	  of	  double	  flap	  (DF),	  3'-­‐single	  flap	  (3'-­‐SF)	  and	  duplex	  DNA	  used	   in	  mFEN-­‐1	  FRET	  studies.	  Each	  
DAL	  substrate	  contains	  donor	  (fluorescein)	  and	  acceptor	  (TAMRA).	  Non-­‐labelled	  (NL),	  donor	  only	  labelled	  (DOL)	  and	  
acceptor	  only	  labelled	  (AOL)	  substrates	  have	  versions	  of	  these	  constructs	  were	  also	  used.	  	  
3.4.1.	  The	  5'-­‐flap	  is	  not	  required	  for	  DNA	  bending	  upon	  addition	  of	  WTmFEN-­‐1:	  	  
The	  data	  observed	  with	  free	  DF	  and	  3'-­‐SF	  reported	  that	  the	  energy	  transfer	  efficiency	  (E)	  of	  the	  
DF	  alone	  was	  similar	  ±Ca2+	  (0.26-­‐0.28),	  but	  was	  slightly	  higher	  than	  the	  E	  of	  the	  free	  3'-­‐SF,	  which	  
also	  had	  similar	  E	  ±Ca2+	  (0.19-­‐0.20)	  (figure	  3.19.a).	  However,	  both	  of	  the	  free	  substrates	  had	  sig-­‐
nificantly	  greater	  E	  than	  the	  corresponding	  free	  duplex	  (0.1)	  (figure	  3.19.d).	  The	  calculated	  max-­‐
imum	   distances	   (without	   protein)	   between	   donor	   and	   acceptor	   pair	   using	   equation	   3.5	   were	  
consistent	  with	  the	  above	  E	  details	  (figure	  3.19.e).	  The	  free	  DF,	  3'-­‐SF	  and	  DNA	  duplex	  substrates	  
had	  similar	  rmax	  ±Ca2+	  and	  around	  65	  Å,	  70	  Å	  and	  80	  Å	  respectively.	  This	  indicates	  that	  the	  DF	  and	  
3'-­‐SF	   substrates	  have	  an	  overall	   similar	   conformation	   that	   are	  more	  bent	   than	  a	  DNA	  duplex,	  
even	  before	  adding	  protein.	  This	  is	  in	  agreement	  with	  the	  previous	  suggestion	  derived	  from	  sin-­‐
gle	  molecule	  experiments	  in	  which,	  a	  DF	  substrate	  was	  proposed	  to	  rapidly	  fluctuate	  between	  a	  
bent	  and	  a	   linear	  extended	  conformation.97	  Furthermore,	  the	  slightly	   lower	  E	  of	  the	  free	  3'-­‐SF	  
substrate	  indicates	  an	  overall	  bigger	  bending	  angle	  of	  the	  substrate	  than	  the	  free	  DF	  substrate,	  
which	  might	  be	  expected	  as	  the	  number	  of	  flaps	  is	  reduced.	  
The	  gradual	  addition	  of	  WTmFEN-­‐1	  to	  doubly-­‐labelled	  DF	  or	  3'-­‐SF	  substrate	  increased	  the	  ener-­‐
gy	   transfer	  efficiency	   (E)	   significantly	  by	   increasing	  enzyme	  concentration	  until	  each	   substrate	  




not	  (figure	  3.19.a).	  When	  both	  substrates	  were	  saturated	  and	  fully	  bound	  to	  mFEN-­‐1	  (E	  at	  end-­‐
point),	  DF	  (DAL)	  substrate	  showed	  slightly	  lower	  E	  at	  the	  endpoints	  (≈5	  %)	  than	  the	  correspond-­‐
ing	  3'-­‐SF	  ±Ca2+	  (figure	  3.19.a.d).	  In	  addition,	  each	  substrate	  showed	  slightly	  higher	  E	  values	  that	  
were	   reproducibly	  observed	  with	  Ca2+	   ions	  present	   than	   the	  corresponding	  substrate	   signal	   in	  
EDTA,	  which	  showed	  ≈10	  %	  decrease	  (figure	  3.19.d).	  Surprisingly,	  these	  small	  differences	  of	  the	  
E	  values	  at	  the	  end	  points	  were	  not	  enough	  to	  reflect	  any	  effect	  on	  the	  calculated	  minimum	  dis-­‐
tance	   (at	   saturating	   protein)	   between	   donor	   and	   acceptor	   pair	   using	   equation	   3.5	   (figure	  
3.19.e).	  	  
Both	  substrates	  (DF	  and	  3'-­‐SF)	  showed	  gradual	  decrees	  of	  distance	  to	  reach	  rmin	  values	  were	  es-­‐
timated	  with	  ≈	  54	  Å.	  The	  derived	  equilibrium	  dissociation	  constants	  Kbend	  were	  similar	  for	  both	  
substrates	  in	  Ca2+,	  however,	  it	  increased	  by	  a	  factor	  of	  two	  in	  EDTA	  for	  both	  substrates	  (DF:	  8	  ±	  1	  
nM	  and	  27	  ±	  2	  nM	  /	  3'-­‐SF:	  10	  ±	  1	  nM	  and	  21	  ±	  1	  nM)	  (figure	  3.19.f)	  (table	  3.5).	  The	  main	  cause	  
of	  the	  endpoint	  variance	  at	  ±Ca2+	  and	  between	  DF	  and	  3'-­‐SF	  is	  unknown.	  However,	  this	  variance	  
does	  not	  affect	  DNA	  bending	  according	  to	  the	  similar	  rmin	  of	  both	  substrates	  ±Ca2+.	  The	  Kbend	  val-­‐
ues	  reflect	   that	  mFEN-­‐1	  has	  ability	   to	  bend	  DF	  and	  3'-­‐SF	  substrates	  similarly	  with	  and	  without	  
metal	  ions	  presence	  (table	  3.5).	  This	  establishes	  that	  presence	  of	  the	  5'-­‐flap	  is	  not	  necessary	  for	  
the	  global	  substrate	  bending.	  Relying	  on	  the	  previous	  indication	  of	  the	  importance	  of	  the	  diva-­‐
lent	  metal	  ions	  for	  5'-­‐flap	  threading51	  and	  position	  of	  the	  scissile	  phosphate	  bond	  into	  the	  active	  
site,37	   these	   results	  mean	   that	   the	  DF	  and	  3'-­‐SF	   substrates	  bind	  and	  bend	  with	   similar	  affinity	  
regardless	  either	  of	  these	  features	  have	  taken	  place.	  This	  is	  also	  consistent	  with	  kinetic	  (section	  
3.2.1)	  and	  ECCD	   (section	  3.3.3)	   results	  of	  WTmFEN-­‐1,	  which	   indicated	   that	   the	  divalent	  metal	  
ions	  of	  WTmFEN-­‐1	  are	  necessary	  to	  induce	  specific	  conformational	  changes	  of	  the	  substrate	  to	  





Figure	  3.19.	  FRET	  data	  in	  Ca2+	  and	  EDTA.	  FRET	  binding	  curves	  of	  a)	  3'-­‐SF	  (dots)	  and	  DF	  (solid)	  to	  WTmFEN-­‐1.	  b)	  DF	  to	  
A159V.	  c)	  DF	  to	  E160D.	  The	  data	  points	  were	  fit	  to	  equation	  3.9.	  d)	  The	  measured	  Emin	  and	  Emax.	  e)	  The	  calculated	  rmax	  
and	  rmin	  using	  equation	  3.5.	  f)	  The	  observed	  Kbend	  values.	  Each	  DAL	  substrate	  structure	  is	  shown	  and	  contains	  donor	  
and	  acceptor.	  	  	  
	  Substrate	   mFEN-­‐1	   Kbend	  (nM)	  (Ca
2+)	   Kbend	  (nM)	  (EDTA)	  
3'-­‐SF	   WT	   10	  ±	  0.8	   21	  ±	  1.6	  
DF	   WT	   8	  ±	  0.8	  	   27	  ±	  2	  	  
A159V	   20	  ±	  2	  	   21	  ±	  2	  	  
E160D	   57	  ±	  5	  	   13	  ±	  1	  
	  
Table	  3.5.	  Kbend	  parameters	  for	  3'-­‐SF	  bound	  to	  WT	  and	  DF	  bound	  to	  WT,	  A159V	  and	  E160D	  mFEN-­‐1	  that	  were	  deter-­‐
mined	  by	  FRET.	  
3.4.3.	  Active	  site	  mutations	  (A159V	  &	  E160D)	  do	  not	  prevent	  bending	  but	  produce	  
raised	  Kbend:	  
To	  investigate	  the	  requirements	  for	  DF	  substrate	  bending,	  A159V	  and	  E160D	  mFEN-­‐1	  were	  also	  
tested.	   The	  mFEN-­‐1	   conserved	   residues	  A159	  and	  E160	  are	   located	   in	  α7	   forming	  part	  of	   the	  




mutated	  proteins	  increased	  FRET	  signals	  of	  DF	  (DAL)	  ±Ca2+	  upon	  increasing	  their	  concentrations	  
until	   the	   substrate	   plateau	   was	   reached	   at	   saturating	   protein	   	   (figure	   3.19.b.c).	   As	   with	   the	  
WTmFEN-­‐1,	  only	   subtle	  variations	   in	   the	  energy	   transfer	  efficiency	   (E)	  at	  end	  points	  were	  ob-­‐
served	  with	  and	  without	  divalent	  metal	  ions.	  A159V	  and	  E160D	  proteins	  showed	  10	  %	  and	  5	  %	  
decrease	  of	   the	  E	  at	  end	  points	   in	  EDTA	  respectively	  compared	  to	  metal	   ions	  presence	   (figure	  
3.19.b.c.d).	   Increasing	   mutated	   protein	   concentrations	   showed	   gradual	   decreasing	   of	   the	   DF	  
(DAL)	  distance	  between	  donor	  and	  acceptor	  pair,	  which	  was	  calculated	  using	   equation	  3.5,	   to	  
reach	   similar	   ±Ca2+	   rmin	   of	  WT	   (≈	   55	   Å)	   (figure	   3.19.e).	   In	   contrast,	   the	   calculated	  Kbend	   values	  
showed	  differences	  from	  WT	  (figure	  3.19.f)	  (table	  3.5).	  In	  Ca2+,	  A159V	  and	  E160D	  showed	  3-­‐fold	  
and	  7-­‐fold	  increase	  of	  Kbend	  values	  compared	  to	  WT,	  respectively.	  However,	  in	  EDTA,	  both	  muta-­‐
tions	  only	  decreased	  the	  Kbend	  values	  slightly	  compared	  to	  WT,	  as	  might	  be	  predicted	  as	  the	  sub-­‐
strate	  would	  not	  be	  expected	  to	  access	  the	  active	  site	  without	  divalent	  metal	  ions	  present	  (table	  
3.5).	  Notably,	  all	  of	  the	  E	  and	  rmin	  changes	  demonstrate	  that	  DF	  (DAL)	  substrate	  adopts	  a	  bent	  
conformational	  change	  with	  both	  mutated	  mouse	  proteins	  (A159V	  &	  E160D).	  According	  to	  the	  
WT	  mutant	  mFEN-­‐1	  Kbend	  values,	  A159V	  mutation	  reduces	  the	  protein	  stability	  upon	  DNA	  bind-­‐
ing	   and	   bending	   slightly,	   while	   E160D	  mutation	   decreased	   it	   more	   significantly.	   This	   demon-­‐
strates	  that	  A159V	  mutation	  may	  not	  be	  as	  critical	  as	  E160D	  mutation	  to	  DNA	  binding	  and	  bend-­‐
ing.	  This	  may	  explain	  the	  low	  efficiency	  of	  these	  mutations	  in	  the	  kinetic	  study	  and	  proves	  that	  
the	  lower	  catalytic	  efficiency	  of	  A159V	  is	  not	  because	  of	  worse	  bending	  (section	  3.2.2).	  In	  addi-­‐
tion,	  one	  possibility	   is	  that	  failure	  to	  bend	  the	  substrate	  as	  efficiently	  as	  for	  wild	  type	  also	   im-­‐
pacts	  on	  the	  ECCD	  signal	  for	  the	  mutations	  (section	  3.3.4).	  
3.4.4.	  Summary	  and	  conclusion	  of	  the	  substrate	  bending	  upon	  WT	  and	  mutant	  mFEN-­‐1	  
binding:	  
Collectively,	  FRET	  assays	  suggest	   that	  WTmFEN-­‐1	  has	  nanomolar	  affinity	   for	  DF	  and	  3'-­‐SF	  sub-­‐
strates,	  as	  summarized	  in	  table	  3.2.	  Although	  differences	  in	  the	  bend	  angle	  were	  indicated	  with	  
both	   substrates	  without	  protein	  compared	   to	   the	   free	  duplex,	   the	  measured	  dissociative	  con-­‐
stants	   (±Ca2+)	   were	   very	   similar	   for	   both	   substrates	   and	   in	   accordance	   with	   the	   previous	   DF	  
measurements.	   Accordingly,	   the	   absence	   of	   the	   5'-­‐flap	   does	   not	   affect	   WTmFEN-­‐1	   ability	   to	  
bend	  3'-­‐SF	  substrate	  to	  reach	  similar	  rmin	  and	  Emax	  of	  DF	  substrate.	  Interestingly,	  despite	  the	  pre-­‐
vious	  evidence	  of	   the	   importance	  and	   requirement	  of	  divalent	  metal	   ions	  bound	   in	   the	  active	  
site	   for	   5'-­‐flap	   threading	   and	   scissile	   phosphate	   bond	   position,	   their	   absence	   does	   not	   affect	  
WTmFEN-­‐1	  ability	  to	  produce	  the	  global	  substrate	  bending.	  Hence,	   it	   is	  clear	  that	  bending	  can	  
occur	  without	  metal	   ions	   active	   site	   presence	   (in	   EDTA)	   or	   FEN-­‐1	   reaction	   features	   that	   need	  




importance	  of	  the	  A159	  and	  E160	  residues	  for	  DF	  substrate	  bending	  are	  inferred	  from	  their	  ef-­‐
fect	  on	  FRET	  assay.	  The	  data	  of	  these	  mutated	  residues	  of	  A159V	  and	  E160D	  proteins	  suggest	  
that	  while	  A159V	  mutation	  reduces	  mFEN-­‐1	  ability	  to	  bend	  DF	  substrate	  slightly	  (3-­‐fold),	  E160D	  
mutation	  has	  a	  much	  greater	  effect	  (7-­‐fold).	  Thus,	  A159V	  mutation	  may	  not	  as	  critical	  as	  E160D	  
mutation	  to	  DNA	  binding	  and	  bending.	  	  
3.5.	  Summary	  and	  conclusion	  of	  mFEN-­‐1	  (kinetic,	  ECCD	  and	  FRET):	  
The	  work	  described	  in	  this	  chapter	  has	  used	  different	  approaches	  to	  study	  mFEN-­‐1	  mechanism	  
and	  the	  effect	  of	  active	  site	  mutations.	  Previous	  biochemical	  studies	  have	  described	  FEN-­‐1	  as	  a	  
multifunctional	   enzyme	   with	   fen,	   exo	   and	   gen	   activities	   that	   preferred	   to	   interact	   with	   sub-­‐
strates	   that	   have	   a	   junction	   between	   two	   duplexes.1,3,39	   Despite	   the	   scarcity	   of	   many	   details	  
about	   FEN-­‐1	  mechanism,	  many	  previous	   studies	   agree	  on	   the	   general	   features	  of	   the	  mecha-­‐
nism,	  which	  are	  substrate	  binding	  and	  bending,2,5,47,97	  5'-­‐flap	   threading,5,50	  and	  double	  nucleo-­‐
tide	  unpairing3,44,64	  or	  untwisting93	  to	  start	  chemistry	  in	  the	  active	  site.	  The	  existence	  of	  mutated	  
FEN-­‐1	  proteins	   in	  cancer	  cells	  highlighted	  studying	  their	  effects	  on	  the	  enzyme	  efficiency.	  Two	  
previous	  studies	  have	  reached	  conflicting	  results	  regarding	  the	  effects	  of	  mFEN-­‐1	  active	  site	  mu-­‐
tations.	  While	  one	  study	  indicated	  decreases	  of	  exo	  and	  gen	  activities	  of	  A159V	  and	  E160D	  mu-­‐
tated	  mFEN-­‐1	  with	  retention	  of	  fen	  activity,18	  a	   later	  study	  indicated	  reduced	  of	  fen	  activity	  of	  
E160D	  mFEN-­‐1.19	  Accordingly,	  this	  chapter	  used	  several	  approaches	  to	  first	  verify	  the	  validity	  of	  
the	  enzyme	  possession	  of	  different	  activities,	  and	  second	  to	  confirm	  which	  of	  the	  previous	  stud-­‐
ies	  around	  A159V	  and	  E160D	  active	  site	  mutations	  effects	  is	  more	  acceptable.	  
The	  kinetic	  study	  of	  WTmFEN-­‐1	  with	  different	  substrates	  proved	  that	  the	  enzyme	  interacts	  with	  
different	  substrate	  structures,	  which	  have	  a	  junction	  between	  two	  duplexes	  and	  1nt	  3'-­‐flap,	  sim-­‐
ilarly	  except	   the	  slight	   lower	  catalytic	  efficiency	  with	  3'-­‐SF	  substrate.	   In	  contradiction	  with	  the	  
previous	   enzyme	   characterisation,	  WTmFEN-­‐1	   does	   not	   have	   different	   activities,	   but	   has	   the	  
ability	   to	   recognise	   different	   substrates	   using	   the	   same	   chemistry.	   Both	   ECCD	   and	   FRET	  
WTmFEN-­‐1	  results	  monitored	  the	  same	  structural	  changes	  and	  bending	  ability	  of	  DF	  and	  3'-­‐SF	  
substrates	  upon	  the	  enzyme	  binding.	  Taken	  all	  together,	  substrate	  without	  5'-­‐flap	  can	  be	  bent	  
and	  structurally	  changed	  ideally	  upon	  FEN-­‐1	  binding,	  but	  the	  chemistry	  can	  be	  affected	  leading	  
to	  reduced	  enzyme	  catalytic	  efficiency.	  
The	  mutated	   residues	   proposed	   to	   be	   involved	   in	  mFEN-­‐1	   active	   site	   (A159V	  &	   E160D)	  were	  
used	  in	  this	  study	  to	   investigate	  the	  effect	  of	  mFEN-­‐1	  active	  site	  mutations.	  Each	  mutation	  re-­‐
duces	  the	  enzyme’s	  ability	  to	  interact	  with	  all	  substrates	  similarly.	  The	  mutated	  A159V	  residue	  




causes	   steric	   hindrance	   can	   influence	   substrate	   entry.	   The	   E160D	  mutation	   showed	   a	   smaller	  
rate	  reduction	  related	  to	  the	  shorter	  aspartic	  acid	  side	  chain.	  Because	  of	   the	  direct	  contact	  of	  
this	  residue	  with	  the	  metal	   ions	  in	  the	  active	  site,	  this	  mutation	  may	  increase	  the	  distance	  be-­‐
tween	  them	  and	  decreases	  enzyme	  ability	  to	  hydrolyse	  the	  scissile	  phosphate	  bond.	  In	  addition,	  
both	   mutations	   have	   hindered	   mFEN-­‐1	   ability	   to	   produce	   ideal	   conformational	   changes	   and	  
bending	  angle	  that	  are	  required	  for	  enzyme	  interaction	  with	  all	  substrates.	  In	  contradiction	  with	  
the	  previous	  studies	  of	  mFEN-­‐1	  mutations	  effect,	  which	  indicated	  decreasing	  of	  one	  or	  two	  ac-­‐
tivities	  of	  mFEN-­‐1,	  these	  mutations	  affect	  the	  enzyme	  ability	  to	  organise	  all	  substrates	  similarly	  
(DF,	  3'-­‐SF,	  and	  gap).	  	  
Interestingly,	  DF2'OH	  substrate	  decreases	  mFEN-­‐1	  mutations	  effects	  on	  chemistry,	  particularly	  
A159V.	  The	  presence	  of	  the	  2'OH	  effects	  the	  chemical	  environment	  producing	  a	  more	  reactive	  
substrate	   that	   appears	   to	   overcome	   the	   steric	   hindrance	   and	   alterations	   to	   the	   distance	   be-­‐




Chapter	  4:	  Results	  and	  Discussion	  of	  hFEN-­‐1:	  	  
As	  indicated	  before,	  FEN-­‐1	  biological	  function	  requires	  the	  enzyme	  to	  be	  able	  to	  recognise	  the	  
correct	  DNA	  substrate	  and	  efficiently	  carry	  out	  a	  specific	  reaction,	  but	  to	  exclude,	  or	  drastically	  
slow,	  the	  reaction	  of	  unsuitable	  DNAs.	  In	  turn,	  this	  relies	  on	  the	  interactions	  of	  enzyme	  and	  cor-­‐
rect	   substrate	   both	   of	  which	   undergo	   conformational	   change	   during	   the	   recognition	   process.	  
Thus	  both	  substrate	  structure	  and	  FEN-­‐1	  mutations	  can	  affect	  the	  enzyme	  efficiency.	  Substrate	  
conformational	  changes	  involve	  bending	  of	  the	  DNA	  that	  identifies	  the	  presence	  of	  a	  DNA	  junc-­‐
tion	  and	  allows	  the	  DNA-­‐protein	  complex	  to	  form	  and	  a	  local	  DNA	  conformational	  change	  that	  
permits	   the	   substrate	   to	   transfer	   to	   the	   active	   site.	   Studying	   the	   impact	   of	   DNA	   and	   protein	  
structure	  on	  the	  ability	  of	  substrates	   to	  undergo	  these	  conformational	  changes	  will	   reveal	   the	  
features	  of	  the	  protein	  that	  allow	  FEN-­‐1	  to	  discriminate	  between	  potential	  substrates.	  
A	  number	  of	  WT	  and	  different	  single,	  double	  and	  quadruple	  hFEN-­‐1	  mutations	  were	  chosen	  to	  
study	  their	  effects	  on	  local	  substrate	  conformational	  changes	  and	  DNA	  bending	  (figure	  4.1).	  All	  
these	  hFEN-­‐1	  mutations	  were	  expressed,	  purified,	   tested	   for	   folding	  and	  kinetically	   character-­‐
ised	  by	  other	  members	   in	  the	  group	  (Dr.	  Nikesh	  Patel,	  Dr.	  Jack	  Exell	  and	  Dr.	  Mark	  Thompson).	  
The	  effects	  of	  different	  mutations	  which	  will	  be	   studied	  on	   the	  maximal	   single	   turnover	   rates	  
(kSTmax)	   are	   summarised	   in	   table	   4.1.93,100,101.	   Most	   of	   these	   mutations	   K93A,	   R100A,	   R104A,	  
L130P,	  K132A,	  K93AR100A,	  R103AR129A,	  R103ER129E,	  R104AK132A,	  R104EK132E,	  and	  Quad	  E	  
(R103ER104ER129EK132E)	  were	  within	  the	  hFEN-­‐1	  helical	  arch.	  Some	  of	  these	  mutations	  are	  of	  
residues	  that	  are	  conserved	  across	  the	  5'	  nuclease	  superfamily	  (K93A	  and	  R100A)	  and	  in	  the	  so-­‐
called	  gateway	  that	  surrounds	  the	  active	  site.	  The	  mutation	  L130P	  was	  designed	  to	  test	  whether	  
the	  non-­‐superfamily	  conserved	  helical	  cap	  structure	  was	  important	  for	  FEN-­‐1	  catalytic	  processes	  
and	   substitutes	  a	   secondary	   structure	  disrupting	   for	  a	   leucine	   residue.	  Others	   (R104A,	  K132A,	  
K93AR100A,	   R103AR129A,	   R103ER129E,	   R104AK132A,	   R104EK132E,	   and	   Quad	   E	  
(R103ER104ER129EK132E))	  were	  identified	  on	  the	  basis	  of	  the	  later	  D86N	  hFEN-­‐1	  threaded	  sub-­‐
strate	  structure	  (PDB	  code	  5UM9)	  as	  candidates	  for	  electrostatic	  interactions	  between	  the	  sub-­‐
strate	  +1	  phosphate	  diester	  and	  the	  helical	  cap.	  FEN-­‐1-­‐conserved	  Y40	  was	  also	  included	  in	  the	  
study,	  at	   this	  α-­‐2	   residues	   from	  the	  other	  half	  of	   the	  gateway.	   In	  addition,	  active	   site	   carbox-­‐







Figure	  4.1.	  Position	  of	  the	  studied	  mutated	  hFEN-­‐1	  residues.	  a)	  Schematic	  of	  DNU	  mechanism	  to	  position	  the	  scissile	  
phosphodiester	  bond	  between	  +1	  and	  -­‐1	  nts	  between	  the	  active	  site	  metal	  ions.	  b)	  Cartoon	  represents	  the	  active	  site	  
of	  hFEN-­‐1:product	  structure	  to	  show	  the	  -­‐1	  nt	  in	  contact	  with	  metal	  ions	  active	  site	  and	  the	  studied	  mutated	  residues	  
from	  the	  helical	  gateway	  (base	  α2-­‐α4),	  cap	  (top	  of	  α4	  and	  a5)	  and	  3'-­‐flap	  pocket.	  
hFEN-­‐1	   With	  DF	  rate	  decrease	  by-­‐-­‐-­‐fold	  	   With	  3'-­‐SF	  rate	  decrease	  by-­‐-­‐-­‐fold	  
Y40A	  (2)	   100	   -­‐	  
L53A	  (3)	   1000	   -­‐	  
K93A	  (2)	   2000	   -­‐	  
R100A	  (2)	   7000	   -­‐	  
R104A	  (3)	   40	   -­‐	  
L130P	  (1)	   2000	   -­‐	  
K132A	  (3)	   4	   2	  
D181A	  (2)	   10,000	   -­‐	  
K93AR100A	  (2)	   6000	   -­‐	  
R103AR129A	  (3)	   65	   40	  
R103ER129E	  (3)	   1500	   -­‐	  
R104AK132A	  (3)	   220	   40	  
R104EK132E	  (3)	   4000	   -­‐	  
Quad	  E	  (3)	   3000	   -­‐	  
Table	  4.1.	  Decrease	  of	   single	   turnover	   rates	   (KSTmax	   values)	   for	   cleavage	  of	  DF	  and	  3'-­‐SF	   substrates	  by	   the	  different	  
studied	  mutations	  relative	  to	  WThFEN-­‐1.	  The	  superscript	  numbers	  to	   indicate	  the	  person	  that	  performed	  the	  kinetic	  




Accordingly,	   the	  arginine	   (R)	  and	   lysine	   (K)	  basic	   residues	  were	  mutated	   to	  alanine	   (A)	  or	  glu-­‐
tamic	  acid	  (E)	  to	  remove	  the	  attractive	  positive	  charge	  that	  effects	  the	  interaction	  with	  the	  DNA,	  
the	  aliphatic	  leucine	  side	  chain	  (P)	  was	  mutated	  to	  proline	  (P)	  or	  alanine	  (A)	  to	  reduce	  the	  side	  
chain	  length	  that	  has	  roles	  to	  maintain	  the	  protein	  secondary	  structure,	  tyrosine	  side	  chain	  was	  
mutated	  to	  alanine	  to	  remove	  its	  aromatic	  ring	  that	  effect	  the	  interaction	  with	  the	  -­‐1	  nt	  of	  the	  
DNA,	  and	  finally	  aspartic	  acid	  side	  chain	  (D)	  was	  mutated	  to	  alanine	  (A)	  to	  remove	  the	  attractive	  
negative	  side	  chain	  that	  effect	  active	  site	  metal	   ions	  position.	  By	  comparison	  between	  the	  WT	  
and	  mutated	  hFEN-­‐1,	  the	  enzymes	  studied	  allowed	  the	  impact	  of	  helical	  arch	  mutations	  such	  as	  
Y40A,	  K93A,	  R100A,	  K93AR100A	  and	  L130P,	  and	  active	   site	  mutation	  D181A	  on	   the	   local	   sub-­‐
strate	  structural	  changes	  to	  be	  studied	  (using	  ECCD).	  Using	  FRET	  technique,	  wild	  type	  and	  mu-­‐
tated	   hFEN-­‐1	   with	   helical	   arch	   mutations	   Y40A,	   K93A,	   R100A,	   R104A,	   L130P,	   K132A,	  
K93AR100A,	   R103AR129A,	   R103ER129E,	   R104AK132A,	   R104EK132E	   and	   Quad	   E	  
(R103ER104ER129EK132E),	  active	  site	  mutation	  D181A,	  and	  3'-­‐flap	  pocket	  mutation	  L53A	  were	  
studied	  to	  indicate	  their	  effects	  on	  substrate	  bending	  upon	  protein	  binding.	  	  
4.1.	  Investigation	  of	  local	  conformational	  changes	  of	  substrate	  reacted	  duplex	  in	  hFEN-­‐
1	  active	  site	  by	  low	  energy	  circular	  dichroism	  of	  2-­‐aminopurine	  (ECCD):	  
The	   ECCD	   experiments	   that	  were	   used	   to	   study	  mutated	   hFEN-­‐1	   proteins	  were	   based	   on	   the	  
same	  theoretical	  basis	  as	  described	  before	  in	  chapter	  3	  (section	  3.3)	  and	  used	  (2-­‐AP)2	  containing	  
substrates.	  First,	  WThFEN-­‐1	  was	  studied	  with	  3'-­‐SF	  and	  5'OH3'-­‐SF	  substrates	  in	  the	  presence	  and	  
absence	  of	  EDTA	  to	   investigate	   the	   importance	  of	   the	  active	  site	  metal	   ions	  and	  5'-­‐phosphate	  
monoester	  that	  were	  indicated	  previously	  with	  mFEN-­‐1	  in	  section	  3.3.2.	  Second,	  the	  ECCD	  tech-­‐
nique	  was	  also	  used	   to	   illustrate	  effects	  of	   some	  helical	   arch	  mutated	   residues	   such	  as	   Y40A,	  
K93A,	  R100A,	   L130P	  and	  K93AR100A,	  and	   the	  active	   site	  mutated	   residue	  D181A	  on	   the	   local	  
DNA	  conformational	  change	  of	  3'-­‐SF	  and	  5'OH3'-­‐SF	  substrates	  upon	  protein	  binding	  compared	  
to	  WThFEN-­‐1.	  As	  summarized	  in	  table	  4.1,	  previous	  studies	  have	  shown	  that	  under	  maximal	  sin-­‐
gle	  turnover	  conditions	  the	  mutations	  K93A,	  R100A,	  K93AR100A	  and	  L130P	  reduce	  the	  rate	  of	  
the	   hFEN-­‐1	   reaction	   by	   factors	   of	   at	   least	   2000,51,100	   and	   later	   studies	   showed	   that	   Y40	   and	  
D181A	  cause	  102	  and	  104	  rates	  decrease	  of	  hFEN-­‐1	  under	  single	  turnover	  conditions,	  respective-­‐
ly.101	  As	   a	   result,	   studying	  effects	  of	   such	  mutations	   can	  help	   to	   investigate	   the	   requirements	  
and	  the	  importance	  of	  these	  local	  DNA	  conformational	  changes	  for	  an	  ideal	  hFEN-­‐1	  interaction.	  	  
4.1.1.	  Base-­‐pair	  effects	  on	  local	  conformational	  changes	  of	  free	  ss	  and	  ds	  DNA:	  
The	  ECCD	  spectra	  of	  (2-­‐AP)2	  inserted	  into	  the	  ss	  DNAs	  and	  ds	  substrate	  constructs	  of	  3'-­‐SF	  and	  




3.3.1.	  These	  results	  were	  obtained	  without	  enzyme	  to	  indicate	  base-­‐pair	  effects	  and	  to	  be	  used	  
as	  a	  basis	  for	  comparison	  with	  the	  subsequent	  experiments.	  The	  ECCD	  signals	  of	  the	  free	  DNAs	  
(ss	  and	  ds)	  containing	  neighbouring	  2-­‐APs	  in	  Ca2+	  did	  not	  change	  by	  adding	  EDTA	  (figure	  4.2.a.b).	  
Furthermore,	  comparison	  of	  the	  ECCD	  intensity	  at	  326	  nm	  of	  three	  repeats	  of	  each	  free	  DNA	  (ss	  
and	   ds)	   in	   Ca2+	   and	   in	   EDTA	   (figure	   4.2.c)	   also	   consistent	  with	   the	   typical	   ECCD	   traces	   (figure	  
4.2.a.b).	  ssDNAs	  gave	  weaker	  ECCD	  signals	  and	  lower	  intensity	  at	  326	  nm	  combined	  with	  small	  
blue	  shifts	  resulting	  in	  lower	  λmax	  values	  compared	  to	  the	  free	  dsDNAs	  (figure	  4.2).	  Variance	  of	  
the	   inserted	  adjacent	  2-­‐AP,	  whether	   in	  +1,-­‐1	  or	   -­‐1,-­‐2,	  did	  not	  affect	  either	  ECCD	  traces	  or	   the	  
intensity	  at	  326	  nm	  	  of	  the	  single	  strand	  (figure	  4.2).	  
Accordingly,	  the	  base-­‐pairing	  is	  the	  only	  effector	  on	  the	  adjacent	  2-­‐APs	  interaction	  in	  absence	  of	  
the	   enzyme.	  While	   absence	   of	   the	   5'-­‐phosphate	   monoester	   did	   not	   affect	   the	   ECCD	   signals,	  
base-­‐pairing	  of	  the	  DNA	  increased	  the	  ECCD	  response	  significantly	  from	  ss	  to	  ds	  DNAs.	  Hence,	  
the	  base-­‐pair	  opening	  is	  the	  only	  effect	  that	  can	  increase	  freedom	  of	  movement	  of	  the	  adjacent	  
2-­‐APs	  and	  reduce	  their	  interaction	  because	  of	  the	  weaker	  alignment	  of	  electronic	  transition	  di-­‐
poles	  in	  the	  ssDNA.	  This	  is	  in	  good	  agreement	  with	  the	  previous	  spectra	  of	  ssDNA	  having	  2-­‐APs89	  
and	   the	   previous	   finding	  with	  mFEN-­‐1	   results	   (section	   3.3.1).	   In	   spite	   of	   this	   finding,	   the	   evi-­‐
dences	  from	  these	  results	  are	  not	  enough	  to	  identify	  the	  nature	  of	  this	  force	  in	  presence	  of	  en-­‐
zyme,	  which	  could	  be	  reoriention	  and/or	  alteration	  of	  the	  distance	  of	  the	  adjacent	  bases	  with	  or	  






Figure	  4.2.	  ECCD	  spectra	  of	  free	  single	  strands	  (ss)	  and	  double	  strands	  (ds)	  of	  DNAs	  containing	  2-­‐AP	  dimer.	  a)	  and	  b)	  
The	  ECCD	  traces	  of	  the	  unbound	  ds	  represented	  in	  solid	  lines,	  while	  their	  corresponding	  ss	  represented	  in	  dashed	  lines	  
in	  Ca2+	  and	  EDTA	  respectively.	  c)	  Ellipticity	  changes	  at	  326	  nm	  for	  ss	  and	  ds	  in	  Ca2+	  and	  EDTA.	  All	  data	  sets	  are	  three	  
experimental	  repeats	  and	  standard	  errors	  are	  shown.	  DNA	  constructs	  are	  shown	  schematically.	  2-­‐AP	  was	  represented	  





4.1.2.	  Importance	  of	  hFEN-­‐1	  active	  site	  metal	  ions	  and	  the	  5'-­‐phosphate	  monoester	  for	  
local	  conformational	  changes	  of	  the	  DNA	  reacting	  duplex	  upon	  WT	  protein	  binding:	  
An	  earlier	  report5	  indicates	  the	  importance	  of	  the	  5'-­‐phosphate	  of	  the	  +1	  nt	  of	  the	  exo	  substrate	  
kinetically	  for	  efficient	  hFEN-­‐1	  reactions.	  In	  addition,	  experiments	  with	  mFEN-­‐1	  demonstrate	  its	  
importance	  for	  substrate	  binding	  and	  for	  producing	  ideal	  conformational	  changes	  upon	  mFEN-­‐1	  
binding	  (section	  3.3.2).	  To	  test	  the	  universality	  of	  this	  earlier	  observation,	  ECCD	  results	  of	  WTh-­‐
FEN-­‐1	  with	  3'-­‐SF	  and	  5'OH3'-­‐SF	   substrates	  were	  used	   to	  probe	   the	   specific	   structural	   changes	  
upon	   human	   protein	   binding.	   These	   studies	   revealed	   the	   importance	   of	   the	   active	   site	  metal	  
ions	  and	  the	  5'-­‐phosphate	  for	  hFEN-­‐1	  to	  produce	  ideal	  conformational	  changes.	  
WThFEN-­‐1	   showed	   similar	   results	   to	  mFEN-­‐1	   complexes	   with	   3'-­‐SF	   and	   5'OH3'-­‐SF	   substrates.	  
Both	  3'-­‐SF-­‐1-­‐2	  and	  5'OH3'-­‐SF-­‐1-­‐2	  substrates	  showed	  similar	  dramatic	  change	  in	  the	  ECCD	  response	  
with	  a	  deep	  minimum	  ECCD	  signal	  at	  around	  310	  nm	  and	  low	  ECCD	  intensity	  at	  326	  nm	  in	  Ca2+	  
(figure	  4.3.c.g	  and	  figure	  4.4.b.d).	  However,	  when	  the	  conformational	  change	  was	  studied	  with	  
2Aps	  at	  +1	  and	  -­‐1	  position	  there	  were	  marked	  differences	  between	  substrates	  ±phosphate.	  At	  
326	  nm	  with	  FEN-­‐1-­‐	  Ca2+3'-­‐SF+1-­‐1	  produced	  an	  ECCD	  signal	  of	  1.5	  ±	  0.4	  (M	  AP)-­‐1.cm-­‐1,	  close	  to	  that	  
of	   free	  ssDNA.	   In	  contrast,	  5'OH3'-­‐SF+1-­‐1	  had	  much	  greater	  signal	  close	  to	  that	  of	  dsDNA	  when	  
bound	   to	   the	  enzyme	   in	  Ca2+.	   The	  ECCD	  signals	  and	   the	   intensity	  at	  326	  nm	   for	   the	   four	   sub-­‐
strates	  increased	  significantly	  by	  adding	  EDTA	  (figure	  4.3	  and	  figure	  4.4).	  	  
As	  the	  3'-­‐SF	  substrate	  is	  one	  of	  the	  preferred	  substrates	  of	  hFEN-­‐1	  enzyme,	  its	  structural	  change	  
upon	  addition	  of	  metal	  ions	  is	  presumed	  to	  be	  as	  an	  ideal	  conformational	  change.	  Based	  on	  the	  
ECCD	  changes	  of	  the	  human	  WT	  complexes	  with	  3'-­‐SF+1-­‐1	  and	  3'-­‐SF-­‐1-­‐2	  substrates,	  the	  ideal	  con-­‐
formational	  changes	  in	  Ca2+	  suggested	  decreasing	  the	  electronic	  interaction	  between	  +1	  and	  -­‐1	  
nucleotides	  also	  between	  -­‐1	  and	  -­‐2	  nucleotides.	  This	  may	  result	   from	  different	  origins	  such	  as	  
reorientation	  and/or	  changes	   in	   the	  distance	  of	   the	  adjacent	  bases	  +1	  and	  -­‐1.	   In	  addition,	   the	  
comparison	   between	   the	   +1,-­‐1	   and	   -­‐1,-­‐2	   substrates	   showed	   that	   the	   electronic	   interaction	   is	  
reduced	  between	   -­‐1	   and	   -­‐2	  nucleotides	   further	   than	  +1	   and	   -­‐1	  nucleotides.	   This	   result	   of	   the	  
ideal	  conformational	  changes	  is	  in	  consistent	  with	  the	  previous	  result	  that	  obtained	  with	  mFEN-­‐





Figure	  4.3.	  ECCD	  spectra	  of	  WT	  and	  mutated	  hFEN-­‐1	  complexes	  in	  Ca2+	  and	  EDTA	  beside	  the	  corresponding	  ss	  and	  ds	  
of	   each	   substrate.	   a)	   hFEN-­‐1:3'-­‐SF+1-­‐1	   complexes	   in	   Ca
2+.	   b)	   hFEN-­‐1:3'-­‐SF+1-­‐1	   complexes	   in	   EDTA.	   c)	   hFEN-­‐1:3'-­‐SF-­‐1-­‐2	  
complexes	  in	  Ca2+.	  d)	  hFEN-­‐1:3'-­‐SF-­‐1-­‐2	  complexes	  in	  EDTA.	  e)	  hFEN-­‐1:5'OH3'-­‐SF+1-­‐1	  complexes	  in	  Ca
2+.	  f)	  hFEN-­‐1:5'OH3'-­‐
SF+1-­‐1	  complexes	   in	  EDTA.	  g)	  hFEN-­‐1:5'OH3'-­‐SF-­‐1-­‐2	  complexes	   in	  Ca




constructs	  are	  shown	  schematically	  with	  2-­‐APs	  were	  represented	   in	  red,	  a	  5'-­‐monophosphate	  was	  represented	  as	  *	  
and	  a	  5'-­‐hydroxyl	  was	  represented	  as	  (OH).	  	  
	  
Figure	  4.4.	  ECCD	  intensity	  at	  326	  nm	  of	  free	  ssDNAs	  and	  dsDNAs,	  and	  hFEN-­‐1	  complexes	  with	  substrates	  containing	  2-­‐
AP	  dimer	  in	  Ca2+	  and	  EDTA.	  a)	  The	  ss,	  ds	  and	  complexes	  of	  3'-­‐SF+1-­‐1.	  b)	  The	  ss,	  ds	  and	  complexes	  of	  3'-­‐SF-­‐1-­‐2.	  c)	  The	  ss,	  
ds	  and	  complexes	  of	  5'OH3'-­‐SF+1-­‐1.	  a)	  The	  ss,	  ds	  and	  complexes	  of	  5'OH3'-­‐SF-­‐1-­‐2.	  All	  data	  sets	  are	  three	  experimental	  
repeats	  and	  standard	  errors	  are	  shown.	  DNA	  constructs	  are	  shown	  schematically.	  2-­‐AP	  was	  represented	  in	  red,	  a	  5'-­‐
monophosphate	  was	  represented	  as	  *	  and	  a	  5'-­‐hydroxyl	  was	  represented	  as	  (OH).	  	  
According	  to	  these	  ECCD	  results,	  the	  two	  metal	  ions	  active	  site	  (Ca2+)	  and	  the	  5'-­‐phosphate	  are	  
also	   essential	   for	   the	   local	   structural	   change	   of	   the	   exo	   substrates	   upon	  WThFEN-­‐1	   binding.	  
First,	   increased	  ECCD	  signals	  upon	  addition	  of	  EDTA	  confirms	  the	  importance	  of	  the	  active	  site	  
metal	  ions	  to	  produce	  the	  local	  conformational	  changes	  of	  3'-­‐SF	  and	  5'OH3'-­‐SF	  substrates	  upon	  
hFEN-­‐1	  binding,	  even	  if	  these	  changes	  are	  not	  ideal	  for	  the	  enzyme	  efficiency.37	  Second,	  the	  dif-­‐
ferent	  behaviour	  of	   the	  WT:5'OH3'-­‐SF+1-­‐1	   complex	   compared	   to	   the	  corresponding	  complex	  of	  




duce	  an	  ideal	  structural	  changes	  upon	  hFEN-­‐1	  binding	  involving	  +1	  and	  -­‐1	  nts,	  however,	  it	  is	  not	  
required	  for	  -­‐1	  and	  -­‐2	  structural	  changes.	  In	  the	  case	  of	  the	  5'OH3'-­‐SF	  substrate,	  its	  loss	  of	  ability	  
to	  direct	  the	  +1	  nt	  correctly	  as	  required	  as	  in	  3'-­‐SF	  substrate	  suggests	  it	  to	  be	  closer	  to	  -­‐1	  nt	  than	  
the	  ideal	  situation.	  This	  result	  is	  in	  line	  with	  and	  may	  explain	  the	  previous	  report	  about	  decrease	  
of	  hFEN-­‐1	  reaction	  efficiency	  as	  a	  result	  of	  the	  lacking	  of	  the	  5'-­‐phosphate	  of	  the	  exo	  substrate.5	  
Both	  results	  of	  the	   importance	  of	  the	  metal	   ions	  active	  site	  and	  the	  5'-­‐phosphate	  for	  the	  DNA	  
conformational	   changes	   upon	   hFEN-­‐1	   binding	   are	   consistent	   with	   what	   were	   previously	   ob-­‐
served	  for	  DNA	  conformational	  changes	  upon	  mFEN-­‐1	  binding	  (section	  3.3.2).	  The	  importance	  of	  
the	  metal	   ions	  active	  site	  is	  also	  in	  line	  with	  what	  was	  previously	  observed	  for	  DNA	  conforma-­‐
tional	  changes	  study	  of	  DF-­‐1-­‐2	  and	  P-­‐1-­‐2.37	  As	   indicated	  before	  (section	  3.3.2)	  (figure	  3.17),	  more	  
details	  about	  the	  nature	  of	  this	  conformational	  change	  were	  derived	  by	  combining	  WT	  and	  mu-­‐
tated	  hFEN-­‐1	  results	  with	  other	  later	  results.93	  
4.1.3.	  Effects	  of	  hFEN-­‐1	  helical	  arch	  mutations	  and	  active	  site	  mutation	  on	  local	  con-­‐
formational	  changes	  of	  reacting	  duplex	  upon	  their	  complexes	  with	  3'-­‐SF	  and	  5'OH3'-­‐SF	  
compared	  with	  WT:	  	  
To	  investigate	  the	  requirements	  and	  the	  importance	  of	  the	  ideal	  DNA	  conformational	  changes,	  
effects	  of	  helical	  arch	  mutations	  K93A,	  R100A,	  K93AR100A,	  L130P	  and	  Y40A,	  and	  active	  site	  mu-­‐
tation	  D181A	  were	  studied	  with	  3'-­‐SF	  and	  5'OH3'-­‐SF	  (figure	  4.5).	  The	  residues	  K93	  and	  R100	  are	  
located	  at	  the	  base	  of	  α4	  forming	  a	  part	  of	  the	  hFEN-­‐1	  helical	  gateway5	  from	  where	  they	  pro-­‐
trude	  into	  the	  hFEN-­‐1	  active	  site	  and	  are	  not	  predicted	  to	  be	  involved	  in	  substrate	  interactions	  
until	  the	  DNA	  is	  positioned	  to	  react.	  L130	  is	  a	  component	  of	  the	  helical	  cap	  (α5)	  so	  it	  is	  far	  from	  
the	   active	   site,	   but	   the	   L130P	  mutation	   is	   presumed	   to	   affect	   the	   secondary	   structure	   of	   the	  
cap.100	  Y40	  is	  a	  part	  from	  the	  gateway	  (α2)	  and	  close	  to	  the	  active	  site	  seen	  to	  interact	  with	  the	  
+1	  nucleotide	  of	   the	  substrate	  complex,	  whereas	   it	   stacks	  on	  the	  -­‐1	  nucleotide	   in	   the	  product	  
complex	  structure.1,5	  D181	  is	  an	  active	  site	  residue	  with	  direct	  contact	  with	  the	  catalytic	  metal	  
ions	  in	  hFEN-­‐1	  structure.5	  D181A	  mutation	  could	  alter	  the	  number	  of	  metal	  ions	  bound	  and/or	  





Figure	  4.5.	  Cartoon	  represents	  the	  active	  site	  of	  hFEN-­‐1:product	  structure	  during	  the	  DNU	  mechanism	  to	  show	  the	  -­‐1	  
nt	  in	  contact	  with	  metal	  ions	  active	  site	  and	  the	  studied	  mutated	  residues	  from	  the	  gateway	  (base	  α2-­‐α4),	  cap	  (top	  of	  
α4	  and	  a5)	  and	  the	  active	  site.	  The	  oxygen	  and	  nitrogen	  atoms	  of	  the	  side	  chains	  were	  shown.	  
3'-­‐SF-­‐1-­‐2	  substrate	  was	  bound	  to	  WT	  and	  mutated	  hFEN-­‐1	  to	  investigate	  mutations	  effects	  on	  the	  
substrate	   conformational	   changes.	   K93A	   and	   D181A	   were	   able	   to	   bring	   an	   analogous	   ECCD	  
spectrum	  and	  so	  close	  ECCD	  intensity	  at	  326	  nm	  to	  WT	  protein	  with	  Ca2+	  (figure	  4.3.c	  and	  figure	  
4.4.b).	  In	  fact,	  it	  is	  surprising	  for	  D181A	  brought	  about	  a	  similar	  ECCD	  response	  to	  WT.	  This	  sug-­‐
gests	  that	  this	  mutation	  does	  not	  affect	  the	  metal	  dependent	  ideal	  local	  conformational	  chang-­‐
es	  of	  hFEN-­‐1,	  which	  is	  in	  contrary	  to	  the	  previous	  observation	  of	  no	  active	  site	  metal	  ions	  visible	  
in	  an	  X-­‐ray	  structure	  of	  D181A	  bound	  to	  3'-­‐SF	  substrate	  in	  the	  presence	  of	  Ca2+	  where	  the	  DNA	  
remained	  base	  paired	  and	  not	  within	  the	  active	  site.5	  	  
As	  seen	  previously	  with	  hFEN-­‐1:DF-­‐1-­‐2	  complexes37,100	  and	  mFEN-­‐1:	  DF-­‐1-­‐2	  complexes	  (figure	  3.16.f	  
in	  section	  3.3.3),	  spectra	  of	  3'-­‐SF-­‐1-­‐2	  produced	  by	  R100A	  and	  Y40A	  with	  Ca2+	  contained	  an	  addi-­‐
tional	  minimum	  at	  310	  nm	  (figure	  4.3.c)	  and	  lower	  ECCD	  intensity	  at	  326	  nm	  than	  WT.	  In	  con-­‐
trast,	  the	  double	  mutant	  (K93AR100A)	  showed	  higher	  ECCD	  intensity	  at	  326	  nm	  than	  WT	  (figure	  
4.4.b).	   This	   suggests	   that	   these	  mutations	   (Y40A,	   R100A	   and	   double	  mutant)	   have	   an	   altered	  
conformational	  change	  of	  the	  -­‐1	  and	  -­‐2	  nts	  from	  that	  produced	  by	  WT,	  D181A	  and	  K93A	  hFEN-­‐1.	  
According	  to	  the	  ECCD	  changes,	  R100A,	  Y40A	  and	  double	  mutant	  reduce	  the	  electronic	  interac-­‐
tion	   between	   the	   two	   adjacent	   2-­‐APs	   of	   the	   DNA	   compared	   to	   the	   corresponding	   free	   DNA,	  
which	   reflects	   increasing	   distance	   and/or	   an	   alternative	   orientation	   of	   them.	   However,	   com-­‐




quired	  as	   in	  WT,	  K93AR100A	   increases	   it	  but	   still	   less	   than	   required	  as	   in	  WT.	  Thus,Tyr40	  and	  
Arg100	  are	  required	  to	  correctly	  position	  the	  substrate	  for	  reaction.	  In	  contrast,	  the	  ECCD	  trace	  
and	  the	  ECCD	  intensity	  at	  326	  nm	  with	  L130P	  were	  similar	  ±Ca2+and	  close	  to	  the	  corresponding	  
free	  dsDNA	  indicating	  that	  this	  mutation	  that	  alters	  the	  structure	  of	  the	  helical	  cap	  prevents	  the	  
local	  conformational	  changes	  of	  3'-­‐SF-­‐1-­‐2	  completely.	  	  
When	  the	  same	  mutated	  hFEN-­‐1s	  were	  employed	  with	  3'-­‐SF+1-­‐1	  substrate,	  only	  K93A	  most	  close-­‐
ly	   resembled	   the	   behaviour	   of	   the	   WT	   protein.	   However,	   Y40A,	   R100A,	   L130P,	   D181A	   and	  
K93AR100A	  did	  not	  significantly	  alter	  the	  signal	  with	  3'-­‐SF+1-­‐1	  at	  326	  nm	  ±Ca2+.	  This	  reflects	  that	  
these	  mutated	   helical	   arch	   residues	   produce	   imperfect	   or	   prevent	   the	   protein	   form	   bringing	  
about	   changes	  of	   +1	   and	   -­‐1	  nts	   compared	   to	   the	  WT	  protein.	   Thus,	   the	  basic	   residues	  of	   the	  
arch,	  the	  intact	  structure	  of	  the	  cap	  and	  the	  proper	  positioning	  of	  metal	   ions	  by	  D181A	  are	  all	  
required	  to	  produce	  the	  substrate	  conformation	  presumed	  to	  be	  required	  for	  reaction.	  
The	   conformational	   changes	   of	   the	   5'OH3'-­‐SF	   substrate	   was	   studied	   with	   WT	   and	   mutated	  
hFEN-­‐1	  to	  indicate	  effects	  of	  the	  mutations	  and	  absence	  of	  the	  5'-­‐phosphate	  monoester	  on	  the	  
local	  DNA	  conformational	  changes.	  According	  to	  the	  results	  in	  section	  4.1.2,	  the	  absence	  of	  the	  
5'-­‐phosphate	  of	  exo	  substrate	  affects	  the	  WThFEN-­‐1	  ability	  to	  bring	  about	  ideal	  local	  DNA	  con-­‐
formational	   change	   involving	   the	   +1	   and	   -­‐1	   nts	   in	   substrate	   DNAs	   unlike	   the	   conformational	  
change	  involving	  the	  -­‐1	  and	  -­‐2	  nts,	  which	  are	  not	  affected	  at	  all.	  In	  addition	  to	  the	  similarity	  of	  
the	  WThFEN-­‐1	  interaction	  with	  3'-­‐SF-­‐1-­‐2	  and	  5'OH3'-­‐SF-­‐1-­‐2,	  all	  the	  mutated	  proteins	  had	  also	  the	  
same	   response	   to	  5'OH3'-­‐SF-­‐1-­‐2	   as	  3'-­‐SF-­‐1-­‐2	  with	   the	  exception	  of	  D181A,	  where	  hFEN-­‐1	   in	  Ca2+	  
reduced	  the	  ECCD	  signal	  to	  a	  lesser	  extent	  (figure	  4.4.d).	  Hence,	  the	  absence	  of	  a	  5'-­‐phosphate	  
does	  not	  prevent	  the	  WT	  and	  mutated	  hFEN-­‐1	  proteins	  bringing	  about	  a	   local	  DNA	  conforma-­‐
tional	  change	  involving	  the	  -­‐1	  and	  -­‐2	  nts	  as	   in	  3'-­‐SF	  substrate	  (except	  D181A),	  but	  the	  orienta-­‐
tion	  of	  2-­‐APs	  may	  differ	  from	  that	  adopted	  by	  the	  5'-­‐phosphorylated	  form	  (figure	  2.15).	  Howev-­‐
er,	   the	  absence	  of	   the	  5'-­‐phosphate	  monoester	  prevents	  D181AhFEN-­‐1	  enzyme	  ability	   to	  pro-­‐
duce	  the	  ideal	  local	  conformational	  change	  within	  -­‐1	  and	  -­‐2	  nts	  as	  in	  3'-­‐SF	  substrate.	  	  
On	  the	  other	  hand,	  when	  the	  5'-­‐phosphate	  was	  removed	  from	  the	  3'-­‐SF	  substrate	  involving	  +1	  
and	  -­‐1	  of	  2-­‐APs	  (5'OH3'-­‐SF+1-­‐1),	  ECCD	  signals	  of	  the	  hFEN-­‐1s	  were	  significantly	  altered	  compared	  
to	  5'OH3'-­‐SF-­‐1-­‐2	   complexes	  as	   they	  were	   for	   the	  WT	  protein.	  All	   showed	  a	   smaller	  decrease	   in	  
ECCD	  signal	   at	  326	  nm	   in	   the	  presence	  of	  divalent	   ions	   relative	   to	   the	   same	   samples	   in	  EDTA	  
(figure	   4.3.e.f	   and	   figure	   4.4.c).	   Moreover,	   the	  maximum	   of	   the	   signal	   with	   hFEN-­‐1:Ca2+	   was	  
blue-­‐shifted	  relative	  to	  free	  corresponding	  dsDNA.	  This	  demonstrates	  the	  importance	  of	  the	  5'-­‐




ing	  the	  +1	  and	  -­‐1	  nts.	  Earlier	  literature	  observed	  a	  20-­‐fold	  decrease	  in	  reaction	  efficiency	  of	  a	  3'-­‐
SF	   substrate	   lacking	   the	   5'-­‐phoshate	   monoester	   measuring	   kcat/KM,	   but	   even	   larger	   impacts	  
(~200-­‐fold)	  on	  the	  rate	  of	  reaction	  at	  higher	  substrate	  concentration	  were	  measured	  recently.	  It	  
seems	  likely	  that	  these	  rate	  decelerations	  can	  be	  assigned	  to	  the	  imperfect	  local	  conformational	  
changes.	  Furthermore,	   the	  crystal	   structure	  of	   the	  substrate	   (without	  5'-­‐phoshate	  monoester)	  
remained	  base-­‐paired	  and	  did	  not	  move	  the	  active	  site	  despite	  the	  presence	  of	  active	  site	  metal	  
ions.	  In	  combination,	  all	  these	  results	  suggest	  that	  the	  local	  DNA	  conformational	  change	  neces-­‐
sary	  for	  reaction	  requires	  a	  5'-­‐phosphate	  in	  the	  3'-­‐SF	  substrate	  or	  a	  5'-­‐phosphate	  diester	  in	  the	  
DF	  substrate.5	  	  
4.1.4.	  Summary	  and	  conclusion	  of	  the	  local	  conformational	  changes	  of	  WT	  and	  mutant	  
hFEN-­‐1:	  
Taken	  together	  changes	  of	  the	  +1,-­‐1	  and	  -­‐1-­‐2	  of	  3'-­‐SF	  substrate	   (table	  4.2)	   indicate	  that	  when	  
the	  hFEN-­‐1	  protein	  was	  altered	  to	  K93A,	  there	  was	  no	  effect	  on	  the	  structural	  change	  of	  the	  3'-­‐
SF	   substrate	   in	   the	  presence	  of	   the	  divalent	  metal	   ions	   compared	   to	   its	   absence.	  Hence,	   K93	  
residue	  does	  not	  play	  a	  role	   in	  substrate	  positioning	  and	  the	   impact	  of	   its	  mutation	  to	  alanine	  
seems	  to	  be	  entirely	  related	  to	  catalysis.88	  	  
In	  contrast,	  all	  other	  mutations	  affected	  the	  ideal	  conformational	  change.	  Although,	  D181A	  mu-­‐
tation	  produces	  an	  ideal	  conformational	  change	  within	  -­‐1	  and	  -­‐2	  as	  in	  WT,	  it	  prevents	  the	  ideal	  
conformational	  change	  of	  the	  +1	  and	  -­‐1	  nts.	  The	  ECCD	  changes	  suggest	  that	  the	  +1	  nt	  may	  be	  
stacked	  to	  -­‐1	  nt	  and	  moved	  analogously	  causing	  an	  increase	  in	  the	  ECCD	  signal.	  The	  lack	  of	  the	  
perfect	  reorientation	  of	  the	  nucleobases	  in	  this	  instance	  may	  be	  related	  to	  metal	  ion	  positioning	  
in	  the	  mutated	  protein	  (since	  D181	  is	  directly	  coordinated	  to	  one	  of	  the	  active	  site	  M2+	  ions).	  	  
On	  the	  other	  hand,	  Y40A,	  R100A	  and	  K93AR100A	  appear	  to	  play	  a	  role	  in	  reorientation	  of	  the	  +1	  
and	  -­‐1	  nts	  also	  -­‐1	  and	  -­‐2	  nts.	  Y40A	  and	  R100A	  reduced	  the	  ECCD	  signal,	  and	  the	  double	  mutant	  
(K93AR100A)	  increased	  the	  signal	  with	  3'-­‐SF-­‐1,2	  in	  presence	  of	  Ca2+	  compared	  to	  WThFEN-­‐1.	  This	  
may	  reflect	  the	  single	  mutations	  effect	  to	  increase	  the	  distance	  between	  the	  -­‐1	  and	  -­‐2	  nts	  fur-­‐
ther	  than	  required	  as	  with	  WThFEN-­‐1,	  while	  double	  mutation	  increased	  it	  but	  still	  lesser	  extent	  
than	  with	  WThFEN-­‐1.	  Though,	  these	  single	  and	  double	  mutations	  affect	  differently	  on	  +1	  and	  -­‐1	  
nts	  by	  stacking	  and	  orient	  them	  similarly	  to	  keep	  the	  distance	  between	  them	  as	  in	  dsDNA.	  The	  
data	  presented	  here	  support	  the	  idea	  that	  the	  Y40	  and	  R100	  residues	  play	  an	  important	  role	  in	  
optimal	  substrate	  positioning,	  and	  their	  mutations	  to	  alanine	  were	  found	  to	  reduce	  the	  rate	  of	  




and	  R100)	  contact	  the	  cleaved	  phosphate	  monoester	  in	  product	  structures,	  they	  may	  well	  posi-­‐
tion	  the	  scissile	  phosphate	  diester	  in	  active	  site	  positioned	  substrate	  complex	  (figure	  4.5).	  
	  In	  contrast,	  perturbation	  of	   the	  secondary	  structure	  of	   the	  helical	  cap	  (L130P)	  does	  not	   facili-­‐
tate	  the	  local	  DNA	  conformational	  change	  when	  divalent	  metal	  ions	  are	  added,	  and	  prevent	  the	  
inclusion	  of	  a	  +1	  nt.	  This	  difficulty	  with	  the	  local	  DNA	  conformational	  change	  is	  consistent	  with	  
the	  indicated	  3000-­‐fold	  decrease	  of	  the	  mutated	  enzyme	  ability	  to	  incise	  a	  5'-­‐flap	  substrate	  (ta-­‐
ble	  4.1).	  In	  theory	  this	  mutation	  could	  alter	  the	  positioning	  of	  all	  the	  other	  helical	  arch	  residues	  
that	  have	  been	  studied	  here	  so	  this	  drastic	  impact	  could	  well	  be	  explained	  by	  a	  lack	  of	  a	  helical	  
cap	  structure.	  	  
According	  to	  the	  +1,-­‐1	  and	  -­‐1,-­‐2	  changes	  of	  5'OH3'-­‐SF	  substrate	  (table	  4.2),	  hFEN-­‐1	  protein	  reor-­‐
ients	   the	   -­‐1	  and	  -­‐2	  nts	  of	   the	  substrate	  as	   in	  3'-­‐SF	  substrate	  except	  with	  the	  mutation	  D181A.	  
However,	  only	   small	   changes	  were	  observed	  with	   the	  5'OH3'-­‐SF+1-­‐1	   ECCD	   signals	   and	  mutated	  
enzymes	  compared	  to	  the	  WThFEN-­‐1.	  Assuming	  that	   the	  position	  adopted	  by	  the	  substrate	   in	  
the	   presence	   of	   hFEN-­‐1:Ca2+	   reflects	   the	   catalytically	   viable	   conformation,	   the	   5'-­‐phosphate	  
monoester	  of	  3'-­‐SF	  substrate	  must	  form	  a	  key	  interaction	  required	  to	  assemble	  this	  state.	  This	  
explains	  earlier	  work	  demonstrated	  that	  neutralization	  of	  the	  charge	  of	  this	  +1	  5'-­‐phosphate	  by	  
conversion	   to	   methyl	   phosphate	   is	   detrimental	   to	   reaction.102	   In	   addition,	   this	   result	   is	   con-­‐
sistent	  with	  earlier	  work	  observed	  reducing	  of	  hFEN-­‐1	  efficiency	  to	  interact	  with	  exo	  substrate	  
lacking	  5'-­‐phosphate	  monoester.5	  	  
	  
S	   2-­‐Aps	  position	   Y40A	   K93A	   R100A	   L130P	   D181A	   K93AR100A	  
3'-­‐SF	   +1,-­‐1	   +	   =	   +	   +	   +	   +	  
	   -­‐1,-­‐2	   -­‐	   =	   -­‐	   +	   =	   +	  
5'OH3'-­‐SF	   +1,-­‐1	   =	   =	   =	   =	   =	   =	  
	   -­‐1,-­‐2	   -­‐	   =	   -­‐	   +	   +	   +	  
Table	  4.2	   Strength	  of	   the	  electronic	   interaction	  between	   the	   two	  adjacent	  2-­‐Aps	  of	  +1,-­‐1	  and	   -­‐1,-­‐2	  positions	  of	   the	  
mutated	  hFEN-­‐1	  complexes	  comparing	  to	  the	  corresponding	  WT	  complex	  with	  DF	  and	  3'-­‐SF	  substrates.	  The	  used	  sym-­‐
bols	  mean	  that	  (+)	  higher	  interaction	  (-­‐)	  less	  interaction	  (=)	  similar	  interaction	  to	  the	  corresponding	  WT	  complex.	  The	  




4.2.	  Measuring	  substrate	  bending	  upon	  enzyme	  binding	  by	  Fluorescence	  Resonance	  
Energy	  Transfer	  (FRET):	  
FRET	  experiments	  were	  used	  to	  investigate	  the	  effects	  of	  substrate	  structure	  and	  mutations	  on	  
substrate	  binding	  and	  bending	  brought	  about	  by	  hFEN-­‐1.	  FRET	  experiments	  that	  were	  used	  to	  
study	  the	  wild	  type	  and	  mutated	  hFEN-­‐1	  proteins	  were	  based	  on	  the	  same	  theoretical	  basis	  de-­‐
scribed	  before	   in	  chapter	  3	   (section	  3.4).	   First,	  WThFEN-­‐1	  was	   studied	  with	   the	  different	   sub-­‐
strates	  DF,	  MMDF+1,	  3'-­‐SF,	  5'-­‐OH3'-­‐SF,	  5'-­‐SF,	  nicked	  DNA	  and	  SA-­‐DF	  substrates	  and	  compared	  to	  
duplex	  DNA	  to	   investigate	  any	   roles	   for	  base	  pairing,	  5'	  and	  3'	   flaps	  and	   the	  presence	  of	  a	  5'-­‐
phosphate	  monoester	  on	  bending	  the	  substrate	  upon	  enzyme	  binding	  (figure	  4.6).	  	  
	  
Figure	  4.6.	  Schematic	  of	  double	  flap	  (DF),	  mismatch	  double	  flap+1	  (MMDF+1),	  3'-­‐single	  flap	  (3'-­‐SF),	  5'OH3'-­‐single	  flap	  
(5'OH3'-­‐SF),	  5'-­‐single	  flap	  (5'-­‐SF),	  nicked	  DNA	  and	  duplex	  DNA	  used	  in	  hFEN-­‐1	  FRET	  studies.	  Each	  DAL	  substrate	  con-­‐
tains	  donor	   (fluorescein)	  and	  acceptor	   (TAMRA).	  Non	   labelled	  (NL),	  donor	  only	   labelled	  (DOL)	  and	  acceptor	  only	   la-­‐
belled	  (AOL)	  substrates	  have	  versions	  of	  these	  constructs	  were	  also	  used.	  	  
Second,	  mutated	  hFEN-­‐1s	  were	  studied	  with	  DF,	  3'-­‐SF	  or	  both	  substrates	  to	  indicate	  their	  effects	  
on	  substrate	  binding	  and	  bending	  (figure	  4.6).	  The	  different	  mutated	  helical	  arch	  residues	  Y40A,	  
K93A,	  R100A,	  R103A,	  R103E,	  R104A,	  R104E,	  R129A,	  R129E,	  L130P,	  K132A,	  and	  K132E,	  the	  active	  
site	  mutated	  residue	  D181A	  and	  the	  mutated	  3'-­‐flap	  pocket	  residue	  L53A	  were	  studied	  as	  a	  sin-­‐
gle,	   double	   or	   quadruple	   hFEN-­‐1	   mutations	   using	   FRET	   (figure	   4.7).	   According	   to	   the	   new	  
D86NhFEN-­‐1	  threaded	  DF	  substrate	  crystal	  structure,	  the	  basic	  residues	  such	  as	  arginine	  (R)	  and	  
lysine	   (K)	   interact	  with	   the	  DNA	   to	   position	   the	   phosphate	   backbone	   by	   specific	   electrostatic	  
interactions	   leading	   to	   rotation	  dsDNA	   into	   the	  active	  site	  with	   fully	  basepairing	   intact.	  Active	  
site	  carboxylate	  residues	  such	  as	  aspartic	  acid	  (D)	  with	  its	  negative	  charge	  affects	  position	  of	  the	  




with	  either	  the	  +1	  or	  -­‐1	  nt,	  which	  it	  is	  stacked	  upon	  in	  substrate	  and	  product	  structures	  respec-­‐
tively.	  Differently,	   the	   leucine	  residue	  (L)	  with	   its	  aliphatic	  side	  chain	  affects	  the	  protein	  struc-­‐
ture.	  While	   the	   L130	   conversion	   to	   proline	   is	   predicted	   to	   dramatically	   affects	   the	   secondary	  
structure	  of	  the	  helical	  cap,	  L53	  alters	  the	  secondary	  structure	  of	  the	  3'-­‐flap	  pocket	  and	  its	  abil-­‐
ity	  to	  accommodate	  the	  3'-­‐flap.	  
	  
Figure	  4.7.	  Cartoon	  represents	  the	  active	  site	  of	  hFEN-­‐1:product	  structure	  to	  show	  the	  -­‐1	  nt	  in	  contact	  with	  metal	  ions	  
active	  site	  and	  the	  studied	  mutated	  residues	  from	  the	  helical	  gateway	  (base	  α2-­‐α4),	  cap	  (top	  of	  α4	  and	  a5),	  active	  site	  
and	  3'-­‐flap	  pocket.	  The	  oxygen	  and	  nitrogen	  atoms	  of	  the	  side	  chains	  were	  shown.	  
4.2.1.	  Watson-­‐Crick	  base	  pair,	  3'-­‐flap	  and	  5'-­‐phosphate	  monoester	  are	  required	  for	  
DNA	  bending	  upon	  WThFEN-­‐1	  binding:	  	  
Several	  different	  DNAs	  with	  the	  potential	  to	   interact	  with	  FEN-­‐1	  were	  studied	  to	  elucidate	  the	  
important	  features	  for	  interaction	  between	  DNA	  and	  protein	  (figure	  4.6).	  All	  of	  the	  Emin	  values	  of	  
the	  protein-­‐free	  substrates	  (DF,	  MM+1DF,	  3'-­‐SF,	  5'OH3'-­‐SF,	  5'-­‐SF,	  nicked	  DNA,	  and	  SA-­‐DF)	  were	  
similar	  ±Ca2+	  and	  greater	  than	  duplex,	  except	  the	  Emin	  value	  of	  the	  nicked	  DNA	  was	  lower	  with	  
˜2-­‐fold	  than	  duplex	   (figure	  4.9	  and	  figure	  4.10.a).	  The	  calculated	  maximum	  distances	  (without	  
protein)	  between	  donor	  and	  acceptor	  pair	  using	  equation	  3.5	  were	   in	   line	  with	  the	  above	  Emin	  
comparisons	  (figure	  4.10.b).	  All	  of	  the	  free	  substrates	  showed	  smaller	  distance	  (less	  than	  67	  Å)	  
than	   the	  DNA	  duplex	   (80	  Å),	   except	   the	  nicked	  DNA	   that	   showed	  bigger	  distance	   (91	  Å).	   This	  




bent	  than	  duplex	  DNA,	  even	  before	  addition	  of	  protein.	  The	  exception	  was	  nicked	  DNA	  that	  has	  
a	  FRET	  value	  that	  was	  less	  than	  DNA	  duplex.	  Indeed,	  the	  nicked	  DNA	  result	  is	  a	  bit	  unexpected	  
and	  since	  it	  implies	  that	  the	  dyes	  become	  further	  apart	  than	  in	  duplex	  DNA.	  One	  possible	  expla-­‐
nation	   is	   that	   the	   duplexes	   of	   the	   nicked	  DNA	   rotate	  with	   respect	   to	   one	   another	   as	  well	   as	  
bending	  and	   this	   rotation	  may	  actually	   increase	   the	  net	  distance	  between	   the	  dyes,	  however,	  
the	  DNA	  duplex	  cannot	  do	  this	   (figure	  4.8).	  The	  exo	  substrates	  3'-­‐SF	  and	  5'-­‐SF	  showed	  slightly	  
lower	  Emin	  ±Ca2+	   than	  DF	  substrate	   (figure	  4.9.a.c.e	  and	  figure	  4.10.a),	  which	  suggests	  that	  the	  
absence	  of	  one	  flap	  may	  reduce	  the	  overall	  bending	  slightly	  (has	  bigger	  net	  bending	  angle).	   In	  
contrast,	  SA-­‐DF	  had	  higher	  Emin	  in	  Ca2+	  than	  DF	  substrate	  (figure	  4.9.a	  and	  figure	  4.10.a),	  which	  
suggests	   that	  more	  bent	  overall	   conformation	   than	  uncomplexed	  DNA,	   likely	  due	   to	   the	  pres-­‐
ence	  of	  a	  bulky	  streptavidin	  (SA)	  homotetramer	  conjugated	  to	  the	  5'-­‐terminus.	  	  
	  
Figure	  4.8.	  Cartoon	  representation	  of	  the	  proposed	  rotation	  of	  the	  nicked	  DNA	  duplexes	  that	  can	  effect	  the	  interaction	  
between	  the	  two	  dyes	  donor	  and	  acceptor.	  a)	  Non-­‐rotated	  nicked	  DNA.	  b)	  Rotated	  nicked	  DNA	  so	  the	  dyes	  become	  
further.	  
Energy	   transfer	   efficiency	   (E)	   of	   the	   donor	   and	   acceptor	   labelled	   (DAL)	   substrates	   ±Ca2+	   in-­‐
creased	   gradually	   upon	   increasing	   WThFEN-­‐1	   concentration	   arriving	   to	   a	   saturated	   situation	  
where	  addition	  of	  more	  enzyme	  produced	  no	  further	  change	  (figure	  4.9).	  For	  unknown	  reasons,	  
the	  3'-­‐SF	  and	  5'OH3'-­‐SF	  substrates	  showed	  slightly	  higher	  Emax	  (around	  10	  %)	  than	  DF	  substrate	  
±Ca2+.	  However,	  MM+1DF	  which	  as	  a	  mismatch	  at	  the	  duplex	  junction	  5'-­‐terminus	  and	  5'-­‐SF	  sub-­‐
strates	  showed	  20	  %	  decrease	  and	  nick	  DNA	  showed	  60	  %	  decrease	  of	  the	  Emax	  values	  compared	  
to	  DF	  substrate	  ±Ca2+.	  The	  small	  differences	  between	  Emax	  values	  of	  the	  different	  substrates	  re-­‐
flected	  the	  effects	  on	  the	  calculated	  rmin	  (minimum	  distance	  at	  saturating	  protein)	  between	  do-­‐
nor	  and	  acceptor	  pair	  using	  equation	  3.5	   (figure	  4.10.b).	  While	  3'-­‐SF	  and	  5'OH3'-­‐SF	   substrates	  
had	   lesser	   rmin	   the	  other	   substrates	  had	   larger	   rmin.	   Each	   substrate	   showed	  slightly	  higher	  Emax	  
values	  that	  were	  reproducibly	  observed	  with	  Ca2+	  ions	  present	  than	  the	  corresponding	  substrate	  




The	  derived	  Kbend	   values	   in	  Ca2+	  were	  generally	   similar	   for	  DF	  and	  3'-­‐SF	   (no	  5'-­‐flap)	   substrates.	  
However,	   compared	   to	   the	   DF	   substrate,	   MM+1DF	   (mismatch),	   SA-­‐DF	   (5'-­‐streptavidin)	   and	  
nicked	  DNA	  increased	  Kbend	  values	  by	  around	  5-­‐fold,	  the	  5'-­‐SF	  (no	  3'-­‐flap)	  by	  around	  10-­‐fold	  and	  
the	  5'OH3'-­‐SF	  by	   around	  20-­‐fold.	   In	   EDTA,	   all	   substrates	   changed	   the	  Kbend	   values	  by	  2-­‐factor.	  
Except	   for	   DF,	   MM+1DF	   and	   3'-­‐SF,	   interestingly	   the	   other	   substrates	   stabilized	   the	   WThFEN-­‐
1:DNA	  complex	  in	  the	  presence	  of	  EDTA	  (figure	  4.10.c)	  (table	  4.3).	  As	  the	  substrate	  cannot	  posi-­‐
tion	  in	  the	  active	  site	  when	  metal	  ions	  are	  absent,	  these	  differences	  ±Ca2+	  suggest	  that	  some	  of	  
the	   alterations	   are	  much	  more	  destabilising	   to	   this	  metal	   ion	  positioned	   state	   than	  when	   the	  
DNA	  is	  not	  positioned	  for	  reaction	  (EDTA)	  state.	  
Hence,	  WThFEN-­‐1	  has	  ability	  to	  bend	  all	  substrates	  with	  and	  without	  metal	  ions	  present.	  In	  this	  
case,	  substrates	  are	  bent	  upon	  WThFEN-­‐1	  binding	  regardless	  either	  of	  whether	  the	  features	  that	  
need	   metal	   ions	   presence	   such	   as	   5'-­‐flap	   threading51	   and	   scissile	   phosphate	   bond	   position37	  
have	  taken	  place.	  In	  addition,	  while	  the	  5'-­‐flap	  presence	  or	  its	  accommodation	  underneath	  the	  
helical	  cap	  are	  not	  required	  for	  global	  substrate	  bending,	  which	  is	  in	  line	  with	  the	  previous	  result	  
of	  DF	  and	  3'-­‐SF	  bending	  upon	  mFEN-­‐1	  binding	  in	  section	  3.1.4,	  a	  Watson-­‐Crick	  base	  pair	  of	  +1	  nt,	  
a	   3'-­‐flap	   and	   a	   5'-­‐phosphate	  monoester	   or	   diester	   at	   the	   terminus	  of	   the	   reacting	  duplex	   are	  
critical	   for	   efficient	   substrate	   bending.	   Furthermore,	   the	   absence	   of	   both	   the	   flaps	   together	  





Figure	  4.9.	  FRET	  curves	  of	  WThFEN-­‐1	  in	  Ca2+	  and	  EDTA	  upon	  binding	  to	  a)	  DF	  and	  SA-­‐DF	  in	  Ca2+,	  b)	  MM+1DF,	  c)	  3'-­‐SF,	  
d)	  5'OH3'-­‐SF,	  e)	  5'-­‐SF,	  and	  f)	  Nick	  DNA.	  The	  data	  points	  were	  fit	  to	  equation	  3.9.	  Each	  DAL	  substrate	  structure	  is	  shown	  









4.10.	  FRET	  data	  of	  WThFEN-­‐1	  binding	  different	  substrates	  and	  free	  DNA	  duplex	  in	  Ca2+	  and	  EDTA.	  a)	  The	  measured	  
Emin	  and	  Emax.	  b)	  The	  calculated	  rmax	  and	  rmin	  using	  equation	  3.5.	  c)	  The	  observed	  Kbend	  values.	  
Substrate	   DF	   MM+1DF	   3'-­‐SF	   5'OH3'-­‐SF	   5'-­‐SF	   Nick	  DNA	   SA-­‐DF	  
Kbend	  (nM)	  (Ca
2+)	   13	  ±	  1	   58	  ±	  7	   12	  ±	  1	   256	  ±	  13	   107	  ±	  10	   78	  ±	  20	   64	  ±	  6	  
Kbend	  (nM)	  (EDTA)	   21	  ±	  1	   63	  ±	  7	   30	  ±	  2	   72	  ±	  4	   27	  ±	  3	   47	  ±	  6	   -­‐	  
Table	  4.3.	  Kbend	  parameters	  for	  WThFEN-­‐1	  bound	  different	  substrates	  that	  were	  determined	  by	  FRET.	  
4.2.2.	  Effects	  of	  helical	  arch	  mutations	  and	  active	  site	  mutation	  on	  DF	  and	  3'-­‐SF	  bend-­‐
ing:	  
To	  investigate	  the	  requirements	  and	  importance	  of	  DF	  and	  3'-­‐SF	  substrates	  bending	  upon	  hFEN-­‐
1	  binding,	  helical	  arch	  and	  active	  site	  mutations	  were	  tested	  using	  FRET.	  Besides	  the	  helical	  arch	  
mutations	   Y40A,	   K93A,	   R100A,	   L130P,	   and	   K93AR100A	   and	   active	   site	   mutation	   D181A	   that	  
were	  studied	  using	  ECCD	  to	  indicate	  their	  effects	  on	  the	  local	  substrate	  conformational	  change	  




R104EK132E	   and	  R103ER104ER129EK132E	   (Quad	   E)	  were	   studied	  using	   FRET	   to	   indicate	   their	  
effects	   on	   DF	   substrate	   bending.	   With	   3'-­‐SF	   substrate	   only	   R104A,	   K132A,	   R103AR129	   and	  
R104AK132A	  mutations	  were	  studied	  to	  indicate	  their	  effects.	  These	  helical	  arch	  residues	  were	  
mutated	  at	  positions	  postulated	  to	  guide	  the	  phosphodiester	  backbone	  and	  stabilize	  the	  invert-­‐
ed	  ssDNA	  orientation	  when	  the	  flap	  is	  threaded	  through	  the	  helical	  arch	  and	  positioned	  to	  react	  
(figure	  4.7).	  	  
DF	  (DAL)	  and	  3'-­‐SF	  (DAL)	  substrates	  adopted	  a	  bent	  conformation	  when	  bound	  to	  the	  mutated	  
proteins	  as	  seen	  by	  an	  increase	  in	  FRET	  signal	  upon	  addition	  of	  hFEN-­‐1	  (figure	  4.11).	  Like	  the	  WT	  
enzyme,	  differences	  between	  Emax	  values	  ±Ca2+	  were	  observed	  with	  all	  proteins	  with	  titrations	  in	  
Ca2+	  buffer	  producing	  a	  higher	  value,	  except	  K93A	  and	  D181A	  where	  the	  end	  points	   remained	  
constant	   ±Ca2+	   (figure	   4.11	   and	   figure	   4.12.a.d).	   In	   addition,	   increasing	   enzyme	   concentration	  
decreased	  the	  distance	  between	  donor	  and	  acceptor	  pair	  of	  both	  substrates,	  which	  was	  calcu-­‐
lated	  using	  equation	  3.5,	  to	  be	  similar	  ±Ca2+	  rmin	  of	  WT,	  except	  R104EK132E	  and	  Quad	  E	  muta-­‐
tions	  (with	  DF	  substrate)	  that	  showed	  slightly	  larger	  rmax	  and	  rmin	  values	  (figure	  4.12.b.e).	  As	  with	  
WThFEN-­‐1,	  only	  subtle	  variations	   in	  Kbend	  were	  observed	  with	  and	  without	  divalent	  metal	   ions	  
(2-­‐fold	  at	  most)	   for	   these	   two	   substrates	   (figure	  4.12.c.f)	   (table	  4.4).	   The	  exception	  was	  Y40A	  
(with	   DF)	   and	   R104A	   (with3'-­‐SF)	   where	   mutation	   stabilized	   the	   hFEN-­‐1:DNA	   complex	   in	   the	  
presence	  of	  EDTA.	  Only	  small	  changes	   in	  Kbend	  were	  observed	  relative	  to	  the	  WT	  protein	  ±Ca2+	  
(less	  than	  3-­‐fold	  at	  most),	  except	  for	  the	  repulsive	  R104EK132E	  and	  Quad	  E	  mutations	  (with	  DF)	  
that	  showed	  5-­‐	  and	  17-­‐fold	  increase,	  respectively.	  This	  suggests	  that	  all	  mutated	  proteins	  do	  not	  
substantially	   affect	   binding	   and	   bending	   of	   the	   DF	   and	   3'-­‐SF	   substrates,	   thus	   only	   the	  
R104EK132E	  and	  Quad	  E	  mutated	  proteins	  are	  critical	  to	  DF	  substrate	  binding	  and	  bending	  and	  
may	  be	  by	  repelling	  the	  ss5'-­‐flap.	  To	  be	  in	  agreement	  with	  the	  WThFEN-­‐1	  FRET	  results	  (section	  
4.2.1)	   and	   the	  previous	   result,	  which	   suggested	   that	  5'-­‐flap	   threading	   is	  not	   required	   for	   sub-­‐
strate	  bending,51	  the	  flap	  may	  be	  directed	  by	  these	  residues	  but	  without	  threading.	  According	  to	  
all	  of	  these	  FRET	  results,	  deficient	  substrate	  positioning,	  not	  poor	  binding,	  is	  the	  major	  contrib-­‐
uting	   factor	   to	  diminished	  protein	  activity	   to	   interact	  with	  DF	  or	  3'-­‐SF	   substrates	  under	   single	  
turnover	  conditions	  (table	  4.1),	  except	  R104EK132E	  and	  Quad	  E	  proteins	  that	  caused	  imperfect	  
DF	   substrate	   bending.	   However,	   comparing	   the	   relative	   increases	   of	   the	   Kbend	   values	   of	   both	  
R104EK132E	  and	  Quad	  E	  proteins	  to	  their	  severe	  impact	  on	  activity	  under	  single	  turnover	  condi-­‐
tions	  with	  4000-­‐	  and	  18,000-­‐fold	  decreased	  reaction	  rates	  respectively	  shows	  that	  the	  enzymes	  
were	  folded	  and	  capable	  of	  substrate	  binding.	  This	  large	  rate	  decrease	  is	  remarkable	  for	  mutat-­‐





Figure	  4.11.	  FRET	  curves	  of	  DF	  and	  3'-­‐SF	  substrates	  in	  Ca2+	  and	  EDTA	  upon	  binding	  to	  mutant	  hFEN-­‐1.	  a)	  Y40A	  with	  
DF.	  b)	  K93A	  with	  DF.	  c)	  R100A	  with	  DF.	  d)	  L130P	  with	  DF.	  e)	  D181A	  with	  DF.	  f)	  K93AR100A	  with	  DF.	  g)	  R103AR129A	  
with	   DF.	   h)	   R103ER129E	   with	   DF.	   i)	   R104AK132A	   with	   DF.	   j)	   R104EK132E	   with	   DF.	   k)	   Quad	   E	  
(R103ER104ER129EK132E)	   with	   DF.	   L)	   R104A	   with	   3'-­‐SF.	   m)	   K132A	   with	   3'-­‐SF.	   n)	   R103AR129A	   with	   3'-­‐SF.	   o)	  





Figure	  4.12.	  FRET	  data	  of	  WT	  and	  mutant	  hFEN-­‐1	  binding	  to	  DF	  and	  3'-­‐SF	  substrates	  compared	  to	  free	  DNA	  duplex	  in	  
Ca2+	  and	  EDTA.	  a)	  The	  measured	  Emin	  and	  Emax	  of	  DF.	  b)	  The	  calculated	  rmax	  and	  rmin	  using	  equation	  3.5	  of	  DF.	  c)	  The	  
observed	  Kbend	  values	  of	  DF.	  d)	  The	  measured	  Emin	  and	  Emax	  of	  3'-­‐SF.	  e)	  The	  calculated	  rmax	  and	  rmin	  using	  equation	  3.5	  of	  






Kbend	  (nM)	  of	  DF	   Kbend	  (nM)	  of	  3'-­‐SF	  
	  Ca2+	   EDTA	   Ca
2+	   	  EDTA	  
WT	   13	  ±	  1	   21	  ±	  1	   12	  ±	  1	   30	  ±	  2	  
Y40A	   24	  ±	  2	   8	  ±	  1	  	   -­‐	   -­‐	  
K93A	   	  8	  ±	  1	  	   17	  ±	  2	   -­‐	   -­‐	  
R100A	   28	  ±	  2	   23	  ±	  2	  	   -­‐	   -­‐	  
R104A	   -­‐	   -­‐	   24	  ±	  2	   8	  ±	  1	  
L130P	   36	  ±	  3	  	   14	  ±	  1	  	   -­‐	   -­‐	  
K132A	   -­‐	   -­‐	   8	  ±	  1	   17	  ±	  2	  
D181A	   13	  ±	  1	   13	  ±	  2	   -­‐	   -­‐	  
K93AR100A	   28	  ±	  2	   59	  ±	  7	   -­‐	   -­‐	  
R103AR129A	   20	  ±	  1	   46	  ±	  4	   28	  ±	  2	   23	  ±	  2	  
R103ER129E	   45	  ±	  2	   123	  ±	  13	   -­‐	   -­‐	  
R104AK132A	   45	  ±	  4	   77	  ±	  6	   36	  ±	  3	   14	  ±	  1	  
R104EK132E	   	  59	  ±	  3	   146	  ±	  15	   -­‐	   -­‐	  
Quad	  E	   	  227	  ±	  16	   638	  ±	  70	   -­‐	   -­‐	  
Table	  4.4.	  Kbend	  parameters	  for	  WT	  and	  mutant	  hFEN-­‐1	  bind	  DF	  and	  3'-­‐SF	  substrates	  that	  were	  determined	  by	  FRET.	  
4.2.3.	  Presence	  and	  positioning	  of	  the	  1nt	  3'-­‐flap	  are	  required	  for	  substrate	  bending:	  
An	  L53A	  3'-­‐flap	  pocket	  mutation	  was	  also	  studied	  with	  DF	  substrate	  to	  investigate	  any	  roles	  for	  
binding	  of	  the	  1nt	  3'-­‐flap	  during	  the	  substrate	  binding	  and	  bending.	  The	  results	  were	  compared	  
to	   the	   previous	   FRET	   results	   of	   the	  WThFEN-­‐1	  with	   DF	   and	   5'-­‐SF	   substrates,	  which	  were	   dis-­‐
cussed	  before	  in	  section	  4.2.1.	  	  
DF	  (DAL)	  substrate	  adopted	  a	  bent	  conformation	  when	  bound	  to	  L53AhFEN-­‐1	  protein	  as	  shown	  
by	  an	   increase	   in	  FRET	  signal	  upon	  addition	  of	  protein	   (figure	  4.11.a).	  Unlike	   the	  WT	  enzyme,	  
where	  differences	  between	  Emax	  values	  ±Ca2+	  were	  observed	  with	  DF	  and	  5'-­‐SF	  substrates	  with	  
titrations	   in	  Ca2+	  buffer	  producing	  a	  higher	  value,	  end	  points	  of	  L53A	  remained	  constant	  ±Ca2+	  
(figure	  4.11.a.b).	   Increasing	  enzyme	  concentration	  decreased	  the	  distance	  between	  donor	  and	  
acceptor	  pair	  of	  both	   substrates,	  which	  was	  calculated	  using	  equation	  3.5,	   to	  be	   similar	  ±Ca2+	  
rmin,	  however,	  the	  rmin	  of	  the	  DF:L53A	  complex	  was	  slightly	  less	  (figure	  4.11.c).	  While,	  WThFEN-­‐1	  
showed	  only	  subtle	  variations	   in	  ±Ca2+	  Kbend	  values	  with	  both	  substrates,	  L53A	   (with	  DF)	  stabi-­‐
lized	   its	   complex	   in	  EDTA	   (figure	  4.11.d)	   (table	  4.5).	  Relative	   to	  WT:DF	  complex,	  WT:5'-­‐SF	  and	  




absence	  of	  the	  1nt	  3'-­‐flap	  or	  its	  imperfect	  contact	  with	  the	  enzyme	  caused	  by	  3'-­‐flap	  pocket	  mu-­‐
tations	  such	  as	  L53A	  mutation	  are	  important	  to	  substrate	  binding	  and	  bending.	  This	  may	  in	  part	  
explain	  decreases	  in	  rate	  of	  the	  L53A	  protein	  catalysing	  reaction	  of	  the	  DF	  substrate,	  although	  it	  
is	  clear	  that	  other	  factors	  are	  at	  play	  to	  produce	  rate	  decreases	  under	  enzyme	  saturating	  condi-­‐
tions	  single	  turnover	  conditions	  (table	  4.1).	  
	  
Figure	  4.11.	  FRET	  data	  of	  WT	  binding	  to	  DF	  and	  5'-­‐SF	  substrates	  and	  L53A	  hFEN-­‐1	  binding	  to	  DF	  substrate	  in	  Ca2+	  and	  
EDTA.	  a)	  FRET	  curve	  of	  DF	  upon	  binding	  to	  L53AhFEN-­‐1.	  b)	  The	  measured	  Emin	  and	  Emax.	  c)	  The	  calculated	  rmax	  and	  rmin	  
using	  equation	  3.5.	  d)	  The	  observed	  Kbend	  values.	  DF	  (DAL)	  structure	  is	  shown	  and	  contain	  donor	  and	  acceptor.	  	  
Substrate	   Kbend	  (nM)	  (Ca
2+)	   Kbend	  (nM)	  (EDTA)	  
WT	  with	  DF	   13	  ±	  1	   21	  ±	  1	  
WT	  with	  5'-­‐SF	   107	  ±	  10	   27	  ±	  3	  
L53A	  with	  DF	   82	  ±	  8	   71	  ±	  




4.2.4.	  Summary	  and	  conclusion	  of	  the	  substrate	  bending	  upon	  WT	  and	  mutant	  hFEN-­‐1:	  
To	  conclude,	   the	   substrates	  are	  bent	  upon	  hFEN-­‐1	  binding	  ±Ca2+,	  which	  means	   that	   substrate	  
bending	  does	  not	  require	  the	  features	  that	  need	  metal	  ions	  present	  such	  as	  5'-­‐flap	  accommoda-­‐
tion51	  and	  scissile	  phosphate	  bond	  position	  on	  active	  site	  metal	  ions37	  to	  take	  place.	  WThFEN-­‐1	  
bends	   DF	   and	   3'-­‐SF	   with	   similar	   efficiency,	   however,	   this	   bending	   efficiency	   reduces	   without	  
DNA	  base	  pairing	  at	  the	  terminus	  of	  the	  reacting	  duplex,	  a	  5'-­‐phosphate	  monoester,	  a	  3'-­‐flap	  or	  
both	   flaps.	   The	   roles	   of	   both	   flaps	   are	   also	   confirmed	   by	  mutated	   enzymes	   results.	   First,	   the	  
non-­‐requirement	  of	   the	  5'-­‐flap	   is	  confirmed	  by	  the	  helical	  arch	  mutations	  results.	  Most	  of	   the	  
mutated	  helical	  arch	  residues	  do	  not	  reduce	  enzyme	  ability	  to	  bend	  DF	  and	  3'-­‐SF	  substrates	  and	  
this	  in	  agreement	  with	  the	  WThFEN-­‐1	  results	  about	  the	  non-­‐requirement	  of	  the	  5'-­‐flap	  thread-­‐
ing	  for	  substrate	  binding.	  However,	  reducing	  of	  DF	  substrate	  bending	  by	  some	  mutated	  cap	  res-­‐
idues	  such	  as	  R104EK132E	  and	  Quad	  E	  may	  suggests	   that	  alteration	  of	   these	  cap	  residues	  are	  
detrimental	  to	  substrate	  binding	  and	  bending	  by	  repelling	  the	  ss5'-­‐flap.	  To	  be	  in	  agreement	  with	  
the	  previous	  result,	  this	  interaction	  does	  not	  mean	  threading	  but	  only	  interaction	  to	  direct	  the	  
substrate.	  Second,	  the	  importance	  of	  the	  3'-­‐flap	  is	  confirmed	  by	  the	  3'-­‐flap	  pocket	  mutation	  re-­‐
sults.	  Lacking	  of	  this	  flap	  or	  its	  imperfect	  contact	  with	  the	  enzyme	  reduces	  the	  enzyme	  ability	  to	  
bend	  the	  substrate	  efficiently.	  
4.3.	  Summary	  and	  conclusion	  of	  hFEN-­‐1	  (ECCD	  and	  FRET):	  
To	   conclude,	   as	   the	   local	   DNA	   conformational	   changes	   and	   substrate	   bending	   are	   important	  
steps	  required	  before	  FEN-­‐1	  catalysis,	  any	  imperfect	  effect	  on	  one	  of	  these	  can	  lead	  to	  deficient	  
enzyme	  efficiency.	  According	  to	  ECCD	  and	  FRET	  results,	  both	  processes	  require	  different	  condi-­‐
tions.	  While	  the	  local	  DNA	  conformational	  change	  requires	  presence	  of	  the	  divalent	  metal	  ions,	  
the	  substrates	  are	  bent	  upon	  hFEN-­‐1	  binding	  ±Ca2+,	  which	  means	  that	  substrate	  bending	  does	  
not	   require	   the	   features	   that	   need	  metal	   ions	   presence	   such	   as	   5'-­‐flap	   accommodation51	   and	  
scissile	  phosphate	  bond	  position37	  to	  take	  place.	  Consistent	  with	  ECCD	  and	  FRET	  WThFEN-­‐1	  re-­‐
sults	   with	   3'-­‐SF	   and	   5'OH3'-­‐SF	   substrates,	   both	   processes	   require	   the	   presence	   of	   the	   5'-­‐
phosphate	  monoester	  to	  be	  achieved	  ideally.	  Further	  requirements	  for	  efficient	  substrate	  bend-­‐
ing	  include	  DNA	  base	  pairing	  and	  3'-­‐flap	  or	  the	  presence	  of	  both	  flaps.	  	  
Most	  of	  the	  studied	  helical	  arch	  mutations	  such	  as	  Y40A,	  R100A,	  D181A	  and	  K93AR100A	  reduce	  
hFEN-­‐1’s	  ability	  to	  produce	  an	  ideal	  local	  DNA	  conformational	  change	  with	  3'-­‐SF	  and	  5'OH3'-­‐SF	  
substrates.	   K93A	  does	   not	   impact	   the	   local	  DNA	   structural	   change,	  while	   L130P	  prevents	   this	  
substrate	  rearrangement	  totally.	   Importantly,	  all	  of	  these	  mutated	  helical	  arch	  residues	  (Y40A,	  




strates	   and	   therefore	   local	   conformational	   change	   deficiencies	   observed	   in	   ECCD	   are	   not	   the	  
consequence	  of	  inability	  to	  bind	  substrate.	  Accordingly,	  deficient	  substrate	  positioning,	  but	  not	  
poor	  bending,	   is	   likely	   to	  be	   the	  main	   cause	  of	   reduced	  hFEN-­‐1	  activity	  under	   single	   turnover	  
conditions	  when	  interacting	  with	  DF	  substrate	  except	  K93A	  where	  the	  cause	  may	  relate	  to	  the	  
chemistry	  (table	  4.1).	  	  
The	  other	  helical	  arch	  mutations	  that	  were	  only	  studied	  by	  FRET	  (R104A,	  K132A,	  R103AR129A,	  
R103ER129E,	  R104AK132A,	  R104EK132E	  and	  Quad	  E)	  also	  do	  not	  affect	   the	  substrate	  bending	  
substantially	  except	  R104EK132E	  and	  Quad	  E	  mutations	  that	  reduces	  enzyme	  ability	  to	  bend	  DF	  
substrate	  but	  not	  3'-­‐SF	  substrate,	  which	  may	  suggest	   that	   these	  cap	  residues	  are	  primarily	   re-­‐
quired	  for	  ss5'-­‐flap	  steering.	  In	  this	  case,	  poor	  bending	  is	  not	  the	  factor	  that	  leads	  to	  reduction	  
of	  the	  enzyme’s	  efficiency	  in	  single	  turnover	  assays	  interacting	  with	  DF	  or	  3'-­‐SF	  substrates.	  Alt-­‐
hough	  R104EK132E	  and	  Quad	  E	  mutations	  reduce	  bending	  ability	  of	  hFEN-­‐1,	  there	  is	  a	  huge	  ef-­‐
fect	  on	  rate	  reaction	  as	  shown	  in	  table	  4.1	   leading	  to	  the	  suggestion	  that	  more	  effects	  such	  as	  




Chapter	  5:	  Conclusion:	  
Overall,	   this	   study	  unravels	   the	   interrelationships	  between	  events	   in	   the	  FEN-­‐1	  catalytic	  cycle.	  
Studies	  of	  the	  mFEN-­‐1	  enzyme	  were	  undertaken	  to	  find	  out	  the	  molecular	  basis	  underlying	  the	  
observation	  that	  mutations	  of	  FEN-­‐1	  result	  in	  cancers	  in	  mice.	  Combined	  studies	  of	  the	  mFEN-­‐1	  
enzyme	  show	  that	   it	  appears	  to	  recognise	  different	  DNA	  structures	  within	  one	  active	  site.	  Alt-­‐
hough	  the	  5'-­‐product	  of	  reaction	  differs	  with	  each	  substrate,	  it	  seems	  likely	  that	  the	  same	  chem-­‐
istry	   is	  used	   to	  hydrolyse	   the	   target	   the	  equivalent	  phosphodiester	  bond	   to	   release	  a	  product	  
that	  corresponds	  to	  hydrolysis	  1nt	  into	  downstream	  duplex	  of	  the	  5'-­‐terminus.	  The	  enzyme	  rec-­‐
ognises	  different	  structures	  of	  DNA	  that	  have	  the	  common	  features	  of	  a	  junction	  between	  two	  
duplexes	  with	  1nt	  3'-­‐flap.	  Although,	  the	  enzyme	  has	  ability	  to	  recognise	  the	  3'-­‐SF	  substrate	  that	  
lacks	  a	  5'-­‐flap,	  its	  catalytic	  efficiency	  is	  slightly	  enhanced	  with	  the	  double	  flap	  substrates	  such	  as	  
DF,	  gap	  and	  DF2'OH.	  Indeed,	  in	  the	  absence	  of	  the	  5'-­‐flap	  the	  enzyme	  ability	  to	  bind	  and	  bend	  
the	   substrate	  and	  position	   the	   substrate	  perfectly	  are	   retained.	  Therefore,	   the	  5'-­‐flap	   is	  not	  a	  
pre-­‐requisite	   for	  efficient	  FEN-­‐1	   reaction.	   In	  contrast,	   it	  was	  demonstrated	   that	   the	  combined	  
absence	  of	  the	  5'-­‐flap	  and	  the	  5'-­‐terminal	  phosphate	  significantly	  reduces	  the	  enzyme’s	  ability	  
to	  bend	  and	  position	  the	  substrate.	  This	  explains	  how	  the	  absence	  of	  the	  5'-­‐phosphate	  further	  
decreases	  the	  rate	  of	  reaction	  of	  an	  exonucleolytic	  FEN-­‐1	  substrate	  and	  suggests	  a	  key	  role	  for	  
interactions	  with	  this	  part	  of	  the	  substrate	  in	  DNA	  binding	  and	  correct	  positioning	  for	  reaction.	  
Furthermore,	   it	  was	   also	   shown	   that	   although	   active	   site	  metal	   ions	   are	   required	   for	   enzyme	  
chemistry	  and	  for	  substrate	  positioning	  for	  reaction,	  they	  are	  not	  required	  for	  initial	  interaction	  
with	  the	  substrate	  including	  bending.	  
Significant	   impacts	  on	   the	  rate	  of	   reactions	  were	  caused	  by	  mutated	  enzymes	  that	  have	  been	  
implicated	   in	   cancer.	   The	   active	   site	  mutations	   A159V	   and	   E160D	   of	  mFEN-­‐1	   reduce	   the	   en-­‐
zyme’s	  ability	  to	  catalyse	  the	  reactions	  of	  all	  of	  the	  substrates	  tested	  (DF,	  gap	  and	  DF2'OH).	  This	  
implies	  that	  it	  is	  unlikely	  that	  genome	  instability	  that	  results	  in	  cancer	  is	  the	  result	  of	  altering	  or	  
abolishing	  the	  ability	  of	  FEN-­‐1	  to	  act	  on	  one	  particular	  substrate.	  However,	  the	  mutations	  them-­‐
selves	  have	  different	  outcomes	  with	  A159V	  producing	  greater	  reductions	  in	  the	  rate	  of	  reaction	  
than	  E160D.	  Using	  a	  DF2'OH	  substrate,	  where	  the	  leaving	  group	  nucleotide	  is	  ribose	  mimicking	  
the	  substrate	  that	  would	  be	  encountered	  during	  RNA	  primer	  removal,	  the	  impact	  of	  both	  muta-­‐
tions	  is	  decreased	  particularly	  with	  A159V.	  Although	  both	  mutations	  produce	  defective	  enzyme	  
chemistry,	  and	  its	  ability	  to	  produce	  ideal	  conformational	  changes	  and	  substrate	  bending,	  they	  




To	   extend	   studies	   of	   the	   important	   requirements	   of	   both	   enzyme	   and	   substrate	   for	   efficient	  
FEN-­‐1	  reaction,	  hFEN-­‐1	  was	  also	  studied.	  Similar	  to	  mFEN-­‐1,	  the	  substrate	  structure	  and	  some	  
mutated	  residues	  of	  hFEN-­‐1	  affect	  the	  enzyme’s	  ability	  to	  bend	  and	  position	  the	  substrate	  per-­‐
fectly	   that	   is	  necessary	   for	  catalysis.	  The	  presence	  of	   the	  5'-­‐phosphate	  monoester	  of	   the	  3'-­‐SF	  
substrate	   is	   important	   for	  hFEN-­‐1	   to	  bend	  and	  position	   the	  substrate	  perfectly	  confirming	   the	  
previous	   results	  with	  mFEN-­‐1.	   Furthermore,	   the	   absence	  of	   the	  3'-­‐flap	   alone	   (5'-­‐SF	   substrate)	  
reduces	  hFEN-­‐1’s	  ability	  to	  bend	  the	  substrate	  perfectly,	  and	  similar	  reduction	  occurs	  when	  ab-­‐
sence	  of	  the	  3'-­‐flap	  combines	  with	  absence	  of	  the	  5'-­‐flap	  in	  the	  product	  of	  the	  reaction	  nicked	  
DNA.	  Additionally	  effects	  of	  substrate	  structure,	  many	  of	  hFEN-­‐1	  mutations	  affect	  the	  enzyme’s	  
ability	  to	  bend	  or	  position	  the	  substrate	  ideally	  beside	  their	  effect	  on	  the	  enzyme	  chemistry	  that	  
was	  proven	  in	  previous	  studies.	  The	  active	  site	  mutation	  D181A	  and	  the	  helical	  arch	  mutations	  
Y40A,	   K93A,	  R100A,	   L130P	  and	  K93AR100A	  hinder	   the	  enzyme’s	   capacity	   to	  produce	   an	   ideal	  
local	  DNA	  conformational	  change	  required	  to	  position	  the	  specific	  target	  phosphate	  bond	  into	  
the	  active	  site.	  The	  exceptions	  to	  this	  were	  K93A,	  which	  did	  not	  impact	  the	  local	  DNA	  structural	  
change,	  and	  L130P,	  which	  prevented	  this	  substrate	  rearrangement	  totally.	  Preventing	  the	  per-­‐
fect	   local	  DNA	  conformational	  changes	  because	  of	  the	  human	  D181A	  active	  site	  mutation	  is	   in	  
agreement	  with	  mFEN-­‐1	  active	  site	  mutations	  A159V	  and	  E160D	  effects.	  On	  the	  other	  hand,	  all	  
of	  these	  mutated	  residues	  had	  little	  effect	  on	  the	  DF	  substrate	  binding	  and	  bending.	  	  
The	   impact	   of	   other	   helical	   arch	   mutations	   R104A,	   K132A,	   R103AR129A,	   R103ER129E,	  
R104AK132A,	  R104EK132E	  and	  Quad	  E	  and	  3'-­‐flap	  pocket	  mutation	  L53A	  on	  substrate	  binding	  
and	  bending	  were	  also	  studied.	  Each	  of	  these	  mutations	  was	  already	  known	  to	  alter	  the	  rate	  of	  
the	  hFEN-­‐1	   reaction	  but	   to	  differing	   extents.	  With	   the	   exception	  of	   R104EK132E,	  Quad	  E	   and	  
L53A	  mutations	   that	   all	   reduced	   the	  enzyme	  ability	   to	  bend	   the	  DF	   substrate	  perfectly,	   other	  
helical	  arch	  mutations	  had	  small	  impacts	  on	  substrate	  dissociation	  constants.	  	  
During	  the	  course	  of	  these	  our	  collaboration	  with	  John	  Tainer’s	  lab	  resulted	  in	  a	  crystal	  structure	  
of	  D86N	  hFEN-­‐1	  bound	  to	  a	  threaded	  substrate.93	  In	  this	  structure	  the	  DNA	  substrate	  appeared	  
to	  be	  positioned	  to	  react,	  with	  the	  scissile	  phosphodiester	  bond	  in	  contact	  with	  active	  site	  metal	  
ions.	  The	  5'-­‐flap	  DNA	  was	  threaded	  through	  the	  helical	  arch,	  with	  the	  +1	  phosphate	  of	  the	  flap	  
surrounded	  by	   basic	   residues,	   notably	  Arg	   104	   and	   Lys	   132	  whereas	  Arg	   100	   is	   positioned	   to	  
stabilise	  both	   the	  positioning	  of	   the	   scissile	  phosphodiester	  bond	  and	   the	  +1	  phosphodiester.	  
The	  functional	  significance	  of	  these	  observations	  is	  demonstrated	  by	  the	  results	  described	  here	  
such	  as	   the	   lack	  of	   ability	  of	  R100A	   to	  bring	  about	  DNA	  conformational	   change.	   Interestingly,	  
although	   removal	  of	  one	  of	   these	  basic	   residues	  alone	  does	  not	  drastically	  alter	   the	  ability	  of	  




creating	  a	  repulsive	  force	  for	  the	  +1	  5'-­‐phosphate	  with	  R104EK132E	  and	  Quad	  E	  was	  detrimental	  
to	  enzyme-­‐substrate	  stability.	  In	  addition,	  it	  is	  shown	  here	  that	  removal	  of	  the	  +1	  5'-­‐phosphate	  
prevents	   proper	   positioning	   of	   the	   DNA	   substrate	   as	  might	   be	   predicted	   on	   the	   basis	   of	   this	  
structure.	  	  	  
As	  the	  DNA	  had	  moved	  towards	  its	  active	  site	  position	  it	  twisted	  towards	  α5	  of	  the	  helical	  cap	  
considerably	   shortening	   the	  distance	  between	  Arg	  129	  and	  other	  basic	   residues	  and	   the	   tem-­‐
plate	  DNA	  of	  the	  substrate.	  Here	  again	  removal	  of	  Arg	  129	  by	  itself	  did	  not	  appear	  to	  impact	  on	  
substrate	  dissociation	   constant	   dramatically,	   but	   it	  would	  be	  of	   interest	   to	   test	   the	   impact	   of	  
mutation	  of	  this	  residue	  on	  the	  ability	  to	  position	  substrate	  for	  reaction	  by	  ECCD	  in	  the	  future.	  
Furthermore,	   the	   results	   obtained	   here	   with	   the	   helical	   cap	   destructive	   mutation	  α5	   L130P,	  
where	  the	  positioning	  of	  all	  basic	  residues	  could	  well	  be	  altered,	  do	  suggest	  a	  role	  for	  α5	  in	  sub-­‐
strate	  positioning	  for	  reaction.	  Finally	  the	  +1	  nucleobase	  at	  end	  of	  the	  DNA	  duplex	  was	  stacked	  
upon	  Tyr	  40,	  which	  had	  flipped	  towards	  the	  active	  site.	  This	  is	  in	  accord	  with	  the	  result	  shown	  
here,	  where	  Y40A	  cannot	  bring	  about	  a	  perfect	  local	  DNA	  conformational	  change.	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Chapter	  7:	  Appendices	  
7.1.	  Alignment	  of	  sequence-­‐1:	  [mFEN-­‐1_mRNA.xdna]	  with	  sequence-­‐2:	  
7.1.1.	  [E160DmFEN1_mRNA.xdna]	  Similarity:	  961/961	  (100%)	  (Parallel):	  
The	  sequence	  reaction	  was	  performed	  by	  the	  University	  of	  Sheffield	  Medical	  School.	  The	  muta-­‐
tion	  position	  is	  highlighted	  (red).	  Nucleotides	  that	  could	  not	  be	  properly	  determined	  are	  denot-­‐
ed	  with	  a	  *.	  
M  G  I  H  G  L  A  K  L  I   
Seq_1  1     ------------------------------atgggaattcacggccttgccaaactaatt  30 
                                           |||||||||||||||||||||||||||||| 
Seq_2  1     tTTTGTTtaACTTtAAGaAggAGATATACCATGGGAATTCaCGGCCttgCCAAACTAATT  60 
             F  C  L  T  L  R  R  R  Y  T  M  G  I  H  G  L  A  K  L  I   
 
             A  D  V  A  P  S  A  I  R  E  N  D  I  K  S  Y  F  G  R  K   
Seq_1  31    gctgatgtggcccccagtgccatccgtgagaatgacatcaagagctactttggtcgcaaa  90 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  61    GCTGATGTGGCCCCCagtGCCATCcgtGAGAATGACATCAAGAGCTACTTTGGTCGCAAA  120 
             A  D  V  A  P  S  A  I  R  E  N  D  I  K  S  Y  F  G  R  K   
 
             V  A  I  D  A  S  M  S  I  Y  Q  F  L  I  A  V  R  Q  G  G   
Seq_1  91    gtggccatcgatgcctccatgagcatctaccagttcctgattgctgttcgtcagggtggg  150 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  121   GTGGCCATCGATGCCTCCATGAGCATCTACCAGTTCCTGATTGCTGTTCGTCAGGGTGGG  180 
             V  A  I  D  A  S  M  S  I  Y  Q  F  L  I  A  V  R  Q  G  G   
 
             D  V  L  Q  N  E  E  G  E  T  T  S  H  L  M  G  M  F  Y  R   
Seq_1  151   gatgtgctgcagaacgaggagggtgagaccaccagccacctgatgggcatgttctaccgt  210 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  181   GATGTGCTGCAGAACGAGGAGGGTGAGACCACCAGCCACCTGATGGGCATGTTCTACCGT  240 
             D  V  L  Q  N  E  E  G  E  T  T  S  H  L  M  G  M  F  Y  R   
 
             T  I  R  M  M  E  N  G  I  K  P  V  Y  V  F  D  G  K  P  P   
Seq_1  211   accatccgcatgatggagaatggcatcaagcctgtgtacgtctttgatggcaaaccacca  270 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  241   ACCATCCGCATGATGGAGAATGGCATCAAGCCTGTGTACGTCTTTGATGGCAAACCACCA  300 
             T  I  R  M  M  E  N  G  I  K  P  V  Y  V  F  D  G  K  P  P   
 
             Q  L  K  S  G  E  L  A  K  R  S  E  R  R  A  E  A  E  K  Q   
Seq_1  271   cagctgaagtcaggcgagctggccaagcgcagtgagaggcgcgccgaggctgagaagcaa  330 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  301   CAGCTGAAGTCAGGCGAGCTGGCCAAGCGCAGTGAGAGGCGCGCCGAGGCTGAGAAGCAA  360 
             Q  L  K  S  G  E  L  A  K  R  S  E  R  R  A  E  A  E  K  Q   
 
             L  Q  Q  A  Q  E  A  G  M  E  E  E  V  E  K  F  T  K  R  L   
Seq_1  331   ctgcagcaggctcaggaggctgggatggaggaggaggtggagaagttcaccaagaggctc  390 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  361   CTGCAGCAGGCTCAGGAGGCTGGGATGGAGGAGGAGGTGGAGAAGTTCACCAAGAGGCTC  420 
             L  Q  Q  A  Q  E  A  G  M  E  E  E  V  E  K  F  T  K  R  L   
 
             V  K  V  T  K  Q  H  N  D  E  C  K  H  L  L  S  L  M  G  I   
Seq_1  391   gtgaaggtcaccaagcaacacaatgatgagtgcaaacacctgctgagcctcatgggcatc  450 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  421   GTGAAGGTCACCAAGCAACACAATGATGAGTGCAAACACCTGCTGAGCCTCATGGGCATC  480 
             V  K  V  T  K  Q  H  N  D  E  C  K  H  L  L  S  L  M  G  I   
 
             P  Y  L  D  A  P  S  E  A  E  A  S  C  A  A  L  A  K  A  G   
Seq_1  451   ccttaccttgatgcacccagcgaggcagaggccagctgtgctgccctggcaaaggctggc  510 
             ||||||||||||||||||||||||||||| |||||||||||||||||||||||||||||| 
Seq_2  481   CCTTACCTTGATGCACCCAGCGAGGCAGATGCCAGCTGTGCTGCCCTGGCAAAGGCTGGC  540 
             P  Y  L  D  A  P  S  E  A  D  A  S  C  A  A  L  A  K  A  G   




Seq_1  511   aaagtctatgctgcggccacggaggacatggactgcctcacttttggcagccccgtgcta  570 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  541   AAAGTCTATGCTGCGGCCACGGAGGACATGGACTGCCTCACTTTTGGCAGCCCCGTGCTA  600 
             K  V  Y  A  A  A  T  E  D  M  D  C  L  T  F  G  S  P  V  L   
 
             M  R  H  L  T  A  S  E  A  K  K  L  P  I  Q  E  F  H  L  S   
Seq_1  571   atgcgacacttaactgccagtgaggccaagaagctgcccatccaagagttccatctgagc  630 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  601   ATGCGACACTTAACTGCCAGTGAGGCCAAGAAGCTGCCCATCCAAGAGTTCCATCTGAGC  660 
             M  R  H  L  T  A  S  E  A  K  K  L  P  I  Q  E  F  H  L  S   
 
             R  V  L  Q  E  L  G  L  N  Q  E  Q  F  V  D  L  C  I  L  L   
Seq_1  631   cgcgtcctgcaggagctgggtctgaaccaggagcagtttgtggatctgtgcatcctgctg  690 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  661   CGCGTCCTGCAGGAGCTGGGTCTGAACCAGGAGCAGTTTGTGGATCTGTGCATCCTGCTG  720 
             R  V  L  Q  E  L  G  L  N  Q  E  Q  F  V  D  L  C  I  L  L   
 
             G  S  D  Y  C  E  S  I  R  G  I  G  P  K  R  A  V  D  L  I   
Seq_1  691   ggtagcgactactgcgagagcatccgtggcattgggcccaagcgggctgtggatctcatc  750 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  721   GGTAGCGACTACTGCGAGAGCATCCGTGGCATTGGGCCCAAGCGGGCTGTGGATCTCATC  780 
             G  S  D  Y  C  E  S  I  R  G  I  G  P  K  R  A  V  D  L  I   
 
             Q  K  H  K  S  I  E  E  I  V  R  R  L  D  P  S  K  Y  P  V   
Seq_1  751   cagaaacataagagcatcgaggagatcgtgaggcggctggaccccagcaagtaccccgtt  810 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  781   CAGAAACATAAGAGCATCGAGGAGATCGTGAGGCGGCTGGACcCCAGCAAGTACCCCGTT  840 
             Q  K  H  K  S  I  E  E  I  V  R  R  L  D  P  S  K  Y  P  V   
 
             P  E  N  W  L  H  K  E  A  Q  Q  L  F  L  E  P  E  V  L  D   
Seq_1  811   ccagagaactggctccacaaggaagcccagcagctcttcctggagccagaagtactggac  870 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  841   CCAGAGAACTGGCTCCACAAGGAAGCCCAGCAGCTctTCCTGGAGCCAGAAGTACTGGAC  900 
             P  E  N  W  L  H  K  E  A  Q  Q  L  F  L  E  P  E  V  L  D   
 
             P  E  S  V  E  L  K  W  S  E  P  N  E  E  E  L  V  K  F  M   
Seq_1  871   ccagagtctgtggagctgaagtggagcgagccaaatgaagaagagttggtcaaatttatg  930 
             ||||||||||||||||||||||||| ||||||||||||||||||||||| ||||||| || 
Seq_2  901   CCAGAGTCTGTGGAGCtgaagtGGa-cGAGCCAAATGAAGAagagTtGg-caaaTTt-tg  957 
             P  E  S  V  E  L  K  W  T   S  Q  M  K  K  S  W   Q  I  L    
 
             C  G  E  K  Q  F  S  E  E  R  I  R  S  G  V  K  R  L  S  K   
Seq_1  931   tgtggtgaaaagcagttttctgaagagcgaattcgcagtggggtcaagcggctgagtaag  990 
             ||||||||||||||||||| ||||||||||||                             
Seq_2  958   TgtggtgaAAAGcagTTTT-TgAAGAGCGaat----------------------------  988 
             C  G  E  K  Q  F  L   K  S  E  X                             
 
             S  R  Q  G  S  T  Q  G  R  L  D  D  F  F  K  V  T  G  S  L   
Seq_1  991   agccgccagggcagcacccagggacgcctcgatgatttcttcaaggtgacaggctcactc  1050 
                                                                          
Seq_2  989   ------------------------------------------------------------  988 
                                                                          
 
             S  S  A  K  R  K  E  P  E  P  K  G  P  A  K  K  K  A  K  T   
Seq_1  1051  tcctcagctaagcgcaaggagccagaacccaaggggcctgctaagaagaaagcaaagact  1110 
                                                                          
Seq_2  989   ------------------------------------------------------------  988 
                                                                          
 
             G  G  A  G  K  F  R  R  G  K  *   
Seq_1  1111  gggggagcggggaagttccgaaggggaaaataa  1143 
                                               
Seq_2  989   ---------------------------------  988 






7.1.2.	  [E160DmFEN1-­‐mRNA.xdna]	  similarity:	  1057/1061	  (99.62%)]	  (anti-­‐parallel):	  
The	  sequence	  reaction	  was	  performed	  by	  the	  University	  of	  Sheffield	  Medical	  School.	  The	  mutation	  position	  is	  high-­‐
lighted	  (red).	  Nucleotides	  that	  could	  not	  be	  properly	  determined	  are	  denoted	  with	  a	  *.	  
M  G  I  H  G  L  A  K  L  I  A  D  V  A  P  S  A  I  R  E   
Seq_1  1     atgggaattcacggccttgccaaactaattgctgatgtggcccccagtgccatccgtgag  60 
                                                                          
Seq_2  1135  ------------------------------------------------------------  1136 
                                                                          
 
             N  D  I  K  S  Y  F  G  R  K  V  A  I  D  A  S  M  S  I  Y   
Seq_1  61    aatgacatcaagagctactttggtcgcaaagtggccatcgatgcctccatgagcatctac  120 
                                || |   |||| ||||||||||||||||||||||||| |   
Seq_2  1135  -------------------tTTGGtccAaa-tggcCAtCgAtgcctccATgAGCAt-t--  1099 
                                 L  V  Q  M   A  I  D  A  S  M  S  I      
 
             Q  F  L  I  A  V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T   
Seq_1  121   cagttcctgattgctgttcgtcagggtggggatgtgctgcagaacgaggagggtgagacc  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  1098  CAGTTCCTGATTGCTGTTCGTCAgGGTGGGGATGtGCtgcaGAACGAGGAGGGTGAGAcc  1039 
             Q  F  L  I  A  V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T   
 
             T  S  H  L  M  G  M  F  Y  R  T  I  R  M  M  E  N  G  I  K   
Seq_1  181   accagccacctgatgggcatgttctaccgtaccatccgcatgatggagaatggcatcaag  240 
               ||||||||||||||||||||||| |||||||||||||||||||||||||||||||||| 
Seq_2  1038  --CAGCCACCTGATGGGCatGTTCt-cCGTACCATCCGCATGATGGAGAATGGCATCAAG  982 
               Q  P  P  D  G  H  V  L   R  T  I  R  M  M  E  N  G  I  K   
 
             P  V  Y  V  F  D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R   
Seq_1  241   cctgtgtacgtctttgatggcaaaccaccacagctgaagtcaggcgagctggccaagcgc  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  981   CCTGTGTACGTCTTTGATGGCAAACCACCACAGCTGAAGTCAGGCGAGCTGgcCAAGCGC  922 
             P  V  Y  V  F  D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R   
 
             S  E  R  R  A  E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E   
Seq_1  301   agtgagaggcgcgccgaggctgagaagcaactgcagcaggctcaggaggctgggatggag  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  921   AGTGAGAGGCGCGCCGAGGCTGAGAAGCAACTGCAGCAGGCTCAGGAGGCTGGGATGGAG  862 
             S  E  R  R  A  E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E   
 
             E  E  V  E  K  F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E   
Seq_1  361   gaggaggtggagaagttcaccaagaggctcgtgaaggtcaccaagcaacacaatgatgag  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  861   GAGGAGGTGGAGAAGTTCACCAAGAGGCTCGTGAAGGTCACCAAGCAACACAATGATGAG  802 
             E  E  V  E  K  F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E   
 
             C  K  H  L  L  S  L  M  G  I  P  Y  L  D  A  P  S  E  A  E   
Seq_1  421   tgcaaacacctgctgagcctcatgggcatcccttaccttgatgcacccagcgaggcagag  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Seq_2  801   TGCAaACACCTGCTGAGCCTCATGGGCATCCCTTACCTTGATGCACCCAGCGAGGCAGAT  742 
             C  K  H  L  L  S  L  M  G  I  P  Y  L  D  A  P  S  E  A  D   
 
             A  S  C  A  A  L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M   
Seq_1  481   gccagctgtgctgccctggcaaaggctggcaaagtctatgctgcggccacggaggacatg  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  741   GCCAGCTGTGCTGCCCTGGCAAAGGCTGGCAAAGTCTATGCTGCGGCCACGGAGGACATG  682 
             A  S  C  A  A  L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M   
 
             D  C  L  T  F  G  S  P  V  L  M  R  H  L  T  A  S  E  A  K   
Seq_1  541   gactgcctcacttttggcagccccgtgctaatgcgacacttaactgccagtgaggccaag  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  681   GACTGCCTCACTTTTGGCAGCCCCGTGCTAATGCGACACTTAACTGCCAGTGAGGCCAAG  622 
             D  C  L  T  F  G  S  P  V  L  M  R  H  L  T  A  S  E  A  K   
 
             K  L  P  I  Q  E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q   




             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  621   AAGCTGCCCATCCAAGAGTTCCATCTGAGCCGCGTCCTGCAGGAGCTGGGTCTGAACCAG  562 
             K  L  P  I  Q  E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q   
 
             E  Q  F  V  D  L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G   
Seq_1  661   gagcagtttgtggatctgtgcatcctgctgggtagcgactactgcgagagcatccgtggc  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  561   GAGCAGTTTGTGGATCTGTGCATCCTGCTGGGTAGCGACTACTGCGAGAGCATCCGTGGC  502 
             E  Q  F  V  D  L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G   
 
             I  G  P  K  R  A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V   
Seq_1  721   attgggcccaagcgggctgtggatctcatccagaaacataagagcatcgaggagatcgtg  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  501   ATTGGGCCCAAGCGGGCTGTGGATCTCATCCAGAAACATAAGAGCATCGAGGAGATCGTG  442 
             I  G  P  K  R  A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V   
 
             R  R  L  D  P  S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q   
Seq_1  781   aggcggctggaccccagcaagtaccccgttccagagaactggctccacaaggaagcccag  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  441   AGGCGGCTGGACCCCAGCAAGTACCCCGTTCCAGAGAACTGGCTCCACAAGGAAGCCCAG  382 
             R  R  L  D  P  S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q   
 
             Q  L  F  L  E  P  E  V  L  D  P  E  S  V  E  L  K  W  S  E   
Seq_1  841   cagctcttcctggagccagaagtactggacccagagtctgtggagctgaagtggagcgag  900 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  381   CAGCTCTTCCTGGAGCCAGAAGTACTGGACCCAGAGTCTGTGGAGCTGAAGTGGAGCGAG  322 
             Q  L  F  L  E  P  E  V  L  D  P  E  S  V  E  L  K  W  S  E   
 
             P  N  E  E  E  L  V  K  F  M  C  G  E  K  Q  F  S  E  E  R   
Seq_1  901   ccaaatgaagaagagttggtcaaatttatgtgtggtgaaaagcagttttctgaagagcga  960 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  321   CCAAATGAAGAAGAGTTGGTCAAATTTATGTGTGGTGAAAAGCAGTTTTCTGAAGAGCGA  262 
             P  N  E  E  E  L  V  K  F  M  C  G  E  K  Q  F  S  E  E  R   
 
             I  R  S  G  V  K  R  L  S  K  S  R  Q  G  S  T  Q  G  R  L   
Seq_1  961   attcgcagtggggtcaagcggctgagtaagagccgccagggcagcacccagggacgcctc  1020 
             ||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| 
Seq_2  261   ATTCGCAGTGGGGTCAAGCGGCTGAGTAAGAGCCGCCAGGGTAGCACCCAGGGACGCCTC  202 
             I  R  S  G  V  K  R  L  S  K  S  R  Q  G  S  T  Q  G  R  L   
 
             D  D  F  F  K  V  T  G  S  L  S  S  A  K  R  K  E  P  E  P   
Seq_1  1021  gatgatttcttcaaggtgacaggctcactctcctcagctaagcgcaaggagccagaaccc  1080 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  201   GATGATTTCTTCAAGGTGACAGGCTCACTCTCCTCAGCTAAGCGCAAGGAGCCAGAACCC  142 
          D  D  F  F  K  V  T  G  S  L  S  S  A  K  R  K  E  P  E  P   
 
             K  G  P  A  K  K  K  A  K  T  G  G  A  G  K  F  R  R  G  K   
Seq_1  1081  aaggggcctgctaagaagaaagcaaagactgggggagcggggaagttccgaaggggaaaa  1140 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  141   AAGGGGCCTGCTAAGAAGAAAGCAAAGACTGGGGGAGCGGGGAAGTTCCGAAGGGGAAAA  82 
             K  G  P  A  K  K  K  A  K  T  G  G  A  G  K  F  R  R  G  K   
 
                               *                                          
Seq_1  1141  ------------------taa---------------------------------------  1143 
                               |||                                        
Seq_2  81    CATCATCATCATCATCACtAaGcTTGCGGCCGCACTCGAGCACCACCACCACCACCActG  22 
             H  H  H  H  H  H  *  A  C  G  R  T  R  A  P  P  P  P  P  L   
 
                              X  X   
Seq_1  1144  ---------------------  1143 
                                   
Seq_2  21    AGATCCgGGCtgtAacaAgcg  1 







7.1.3.	  [WTmFEN1.seq]	  similarity:	  1108/1125	  (98.49	  %)	  (Parallel):	  
The	  sequence	  reaction	  was	  performed	  by	  the	  University	  of	  Sheffield	  Medical	  School.	  Nucleotides	  that	  could	  not	  be	  
properly	  determined	  are	  denoted	  with	  a	  *.	  
                                                          M  G  I  H  G   
Seq_1  1     ---------------------------------------------atgggaattcacggc  15 
                                                          ||||||||||||||| 
Seq_2  1     aGaatTCCTcTagaTaTTTTGTTtaCTTTAaGAaGGAgaTATACCATGGGAATTCACGGC  60 
             R  I  P  L  D  I  L  F  T  L  R  R  R  Y  T  M  G  I  H  G   
 
             L  A  K  L  I  A  D  V  A  P  S  A  I  R  E  N  D  I  K  S   
Seq_1  16    cttgccaaactaattgctgatgtggcccccagtgccatccgtgagaatgacatcaagagc  75 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  61    CttGCCAAACTAATTGCTGATGTGGCCCCCagtGCCATCCGTGAGAATGACATCAAGAGC  120 
             L  A  K  L  I  A  D  V  A  P  S  A  I  R  E  N  D  I  K  S   
 
             Y  F  G  R  K  V  A  I  D  A  S  M  S  I  Y  Q  F  L  I  A   
Seq_1  76    tactttggtcgcaaagtggccatcgatgcctccatgagcatctaccagttcctgattgct  135 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  121   TACTTTGGTCGCAAAGTGGCCATCGATGCCTCCAtgAGCATCTACCAGTTCCTGATTGCT  180 
             Y  F  G  R  K  V  A  I  D  A  S  M  S  I  Y  Q  F  L  I  A   
 
             V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T  T  S  H  L  M   
Seq_1  136   gttcgtcagggtggggatgtgctgcagaacgaggagggtgagaccaccagccacctgatg  195 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  181   GTTCGTCAGGGTGGGGATGTGCTGCAGAACGAGGAGGGTGAGACCACCAGCCACCTGATG  240 
             V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T  T  S  H  L  M   
 
             G  M  F  Y  R  T  I  R  M  M  E  N  G  I  K  P  V  Y  V  F   
Seq_1  196   ggcatgttctaccgtaccatccgcatgatggagaatggcatcaagcctgtgtacgtcttt  255 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  241   GGCATGTTCTACCGTACCATCCGCATGATGGAGAATGGCATCAAGCCTGTGTACGTCTTT  300 
             G  M  F  Y  R  T  I  R  M  M  E  N  G  I  K  P  V  Y  V  F   
 
             D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R  S  E  R  R  A   
Seq_1  256   gatggcaaaccaccacagctgaagtcaggcgagctggccaagcgcagtgagaggcgcgcc  315 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  301   GATGGCAAACCACCACAGCTGAAGTCAGGCGAGCTGGCCAAGCGCAGTGAGAGGCGCGCC  360 
             D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R  S  E  R  R  A   
 
             E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E  E  E  V  E  K   
Seq_1  316   gaggctgagaagcaactgcagcaggctcaggaggctgggatggaggaggaggtggagaag  375 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  361   GAGGCTGAGAAGCAACTGCAGCAGGCTCAGGAGGCTGGGATGGAGGAGGAGGTGGAGAAG  420 
             E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E  E  E  V  E  K   
 
             F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E  C  K  H  L  L   
Seq_1  376   ttcaccaagaggctcgtgaaggtcaccaagcaacacaatgatgagtgcaaacacctgctg  435 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  421   TTCACCAAGAGGCTCGTGAAGGTCACCAAGCAACACAATGATGAGTGCAAACACCTGCTG  480 
             F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E  C  K  H  L  L   
 
             S  L  M  G  I  P  Y  L  D  A  P  S  E  A  E  A  S  C  A  A   
Seq_1  436   agcctcatgggcatcccttaccttgatgcacccagcgaggcagaggccagctgtgctgcc  495 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  481   AGCCTCATGGGCATCCCTTACCTTGATGCACCCAGCGAGGCAGAGGCCAGCTGTGCTGCC  540 
             S  L  M  G  I  P  Y  L  D  A  P  S  E  A  E  A  S  C  A  A   
 
             L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M  D  C  L  T  F   
Seq_1  496   ctggcaaaggctggcaaagtctatgctgcggccacggaggacatggactgcctcactttt  555 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  541   CTGGCAAAGGCTGGCAAAGTCTATGCTGCGGCCACGGAGGACATGGACTGCCTCACTTTT  600 
             L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M  D  C  L  T  F   
 
             G  S  P  V  L  M  R  H  L  T  A  S  E  A  K  K  L  P  I  Q   




             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  601   GGCAGCCCCGTGCTAATGCGACACTTAACTGCCAGTGAGGCCAAGAAGCTGCCCATCCAA  660 
             G  S  P  V  L  M  R  H  L  T  A  S  E  A  K  K  L  P  I  Q   
 
             E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q  E  Q  F  V  D   
Seq_1  616   gagttccatctgagccgcgtcctgcaggagctgggtctgaaccaggagcagtttgtggat  675 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  661   GAGTTCCATCTGAGCCGCGTCCTGCAGGAGCTGGGTCTGAACCAGGAGCAGTTTGTGGAT  720 
             E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q  E  Q  F  V  D   
 
             L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G  I  G  P  K  R   
Seq_1  676   ctgtgcatcctgctgggtagcgactactgcgagagcatccgtggcattgggcccaagcgg  735 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  721   CTGTGCATCCTGCTGGGTAGCGACTACTGCGAGAGCATCCGTGGCATTGGGCCCAAGCGG  780 
             L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G  I  G  P  K  R   
 
             A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V  R  R  L  D  P   
Seq_1  736   gctgtggatctcatccagaaacataagagcatcgaggagatcgtgaggcggctggacccc  795 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  781   GCTGTGGATCTCATCCAGAAACATAAGAGCATCGAGGAGATCGTGAGGCGGCTGGACCCC  840 
             A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V  R  R  L  D  P   
 
             S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q  Q  L  F  L  E   
Seq_1  796   agcaagtaccccgttccagagaactggctccacaaggaagcccagcagctcttcctggag  855 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  841   AGCAAGTACcCCGTTCCAGAGAACTGGCTCCACAAGGAAGCCCAGCAGCTCTTCCTGGAG  900 
             S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q  Q  L  F  L  E   
 
             P  E  V  L  D  P  E  S  V  E  L  K  W  S  E  P  N  E  E  E   
Seq_1  856   ccagaagtactggacccagagtctgtggagctgaagtggagcgagccaaatgaagaagag  915 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Seq_2  901   CCAGAAGTACTGGACCCAGAGTCTGTGGAGCTGAAGTGGAGCGAGCCAAATGAaGAAGa-  959 
             P  E  V  L  D  P  E  S  V  E  L  K  W  S  E  P  N  E  E  D    
 
             L  V  K  F  M  C  G  E  K  Q  F  S  E  E  R  I  R  S  G  V   
Seq_1  916   ttggtcaaatttatgtgtggtgaaaagcagttttctgaagagcgaattcgcagtggggtc  975 
             ||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||| 
Seq_2  960   tTGGTCAAATTTATGTGTGGTGAAA-GCAGTTTTCTGAAGAGCGAATTCgCAGTGGGGTC  1018 
              W  S  N  L  C  V  V  K   A  V  F  *  R  A  N  S  Q  W  G  Q 
 
             K  R  L  S  K  S  R  Q  G  S  T  Q  G  R  L  D  D  F  F  K   
Seq_1  976   aagcggctgagtaagagccgccagggcagcacccagggacgcctcgatgatttcttcaag  1035 
             |||||||||||||||||||||||||| |  |||||||||||||||||||||||||||||| 
Seq_2  1019  AAGCGGCTGagtAagaGCCGCCAGGGTA--ACCcAGGgACGCCTCGATGATTTCTTCAAG  1076 
               A  A  E  *  E  P  P  G  *    P  R  D  A  S  M  I  S  S  R  
 
             V  T  G  S  L  S  S  A  K  R  K  E  P  E  P  K  G  P  A  K   
Seq_1  1036  gtgacaggctcactctcctcagctaagcgcaaggagccagaacccaaggggcctgctaag  1095 
             |||      ||||||||||||||||||||||||||||||  ||||||||||||||||||  
Seq_2  1077  Gtg------tcactctccTCAGCTAAGcgcAAGGAGCCa--accCAAGGGgCCtGCTAa-  1127 
              C        H  S  P  Q  L  S  A  R  S  Q    P  K  G  P  A  K   
 
             K  K  A  K  T  G  G  A  G  K  F  R  R  G  K  *   
Seq_1  1096  aagaaagcaaagactgggggagcggggaagttccgaaggggaaaataa  1143 
                     ||| |    |||     || |  | | |||||||||     
Seq_2  1128  -------aaaaaAaaCTGGGgaaCCGggAaattCcaAGGGgaAa----  1164 












7.1.4.	  [WTmFEN1.seq]	  similarity:	  1039/1049	  (99.05	  %)	  (anti-­‐parallel):	  
	  The	  sequence	  reaction	  was	  performed	  by	  the	  University	  of	  Sheffield	  Medical	  School.	  Nucleotides	  that	  could	  not	  be	  
properly	  determined	  are	  denoted	  with	  a	  *.	  
             M  G  I  H  G  L  A  K  L  I  A  D  V  A  P  S  A  I  R  E   
Seq_1  1     atgggaattcacggccttgccaaactaattgctgatgtggcccccagtgccatccgtgag  60 
                                                                          
Seq_2  1119  ------------------------------------------------------------  1120 
                                                                          
 
             N  D  I  K  S  Y  F  G  R  K  V  A  I  D  A  S  M  S  I  Y   
Seq_1  61    aatgacatcaagagctactttggtcgcaaagtggccatcgatgcctccatgagcatctac  120 
                                              | |        ||||||||||   ||| 
Seq_2  1119  ---------------------------------gGCCATCgatgctCCATgAGct--tAC  1095 
                                               A  I  D  A  P  *  A    Y   
 
             Q  F  L  I  A  V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T   
Seq_1  121   cagttcctgattgctgttcgtcagggtggggatgtgctgcagaacgaggagggtgagacc  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  1094  CAGTTcCTGATTGCTGTTcgtcAGGGTGGGGATgtGCTGCAGAACGAGGaGGGTGAGACc  1035 
             Q  F  L  I  A  V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T   
 
             T  S  H  L  M  G  M  F  Y  R  T  I  R  M  M  E  N  G  I  K   
Seq_1  181   accagccacctgatgggcatgttctaccgtaccatccgcatgatggagaatggcatcaag  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  1034  aCCAGCCaCCTGATGGGCATGTTCTACCGtaCCATCCGCATGATGGAGAATGgcATCAAG  975 
             T  S  H  L  M  G  M  F  Y  R  T  I  R  M  M  E  N  G  I  K   
 
             P  V  Y  V  F  D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R   
Seq_1  241   cctgtgtacgtctttgatggcaaaccaccacagctgaagtcaggcgagctggccaagcgc  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  974   CCTGTGTACGTCTTTGATGGCAAACCACCACAGCTGAAGTCAGGCGAGCTGGCCAAGCGC  915 
             P  V  Y  V  F  D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R   
 
             S  E  R  R  A  E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E   
Seq_1  301   agtgagaggcgcgccgaggctgagaagcaactgcagcaggctcaggaggctgggatggag  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  914   AGTGAGAGGCGCGCCGAGGCTGAGAAGCAACTGCAGCAGGCTCAGGAGGCTGGGATGGAG  855 
             S  E  R  R  A  E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E   
 
             E  E  V  E  K  F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E   
Seq_1  361   gaggaggtggagaagttcaccaagaggctcgtgaaggtcaccaagcaacacaatgatgag  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  854   GAGGAGGTGGAGAAGTTCACCAAGAGGCTCGTGAAGGTCACCAAGCAACACAATGATGAG  795 
             E  E  V  E  K  F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E   
 
             C  K  H  L  L  S  L  M  G  I  P  Y  L  D  A  P  S  E  A  E   
Seq_1  421   tgcaaacacctgctgagcctcatgggcatcccttaccttgatgcacccagcgaggcagag  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  794   TGCAAACACCTGCTGAGCCTCATGGGCATCCCTTACCTTGATGCACCCAGCGAGGCAGAG  735 
             C  K  H  L  L  S  L  M  G  I  P  Y  L  D  A  P  S  E  A  E   
 
             A  S  C  A  A  L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M   
Seq_1  481   gccagctgtgctgccctggcaaaggctggcaaagtctatgctgcggccacggaggacatg  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  734   GCCAGCTGTGCTGCcCTGGCAAAGGCTGGCAAAGTCTATGCTGCGGCCACGGAGGACATG  675 
             A  S  C  A  A  L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M   
 
             D  C  L  T  F  G  S  P  V  L  M  R  H  L  T  A  S  E  A  K   
Seq_1  541   gactgcctcacttttggcagccccgtgctaatgcgacacttaactgccagtgaggccaag  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  674   GACTGCCTCACTTTTGGCAGCCCCGTGCTAATGCGACACTTAACTGCCAGTGAGGCCAAG  615 
             D  C  L  T  F  G  S  P  V  L  M  R  H  L  T  A  S  E  A  K   
 
             K  L  P  I  Q  E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q   
Seq_1  601   aagctgcccatccaagagttccatctgagccgcgtcctgcaggagctgggtctgaaccag  660 




Seq_2  614   AAGCTGCCCATCCAAGAGTTCCATCTGAGCCGCGTCCTGCAGGAGCTGGGTCTGAACCAG  555 
             K  L  P  I  Q  E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q   
 
             E  Q  F  V  D  L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G   
Seq_1  661   gagcagtttgtggatctgtgcatcctgctgggtagcgactactgcgagagcatccgtggc  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  554   GAGCAGTTTGTGGATCTGTGCATCCTGCTGGGTAGCGACTACTGCGAGAGCATCCGTGGC  495 
             E  Q  F  V  D  L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G   
 
             I  G  P  K  R  A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V   
Seq_1  721   attgggcccaagcgggctgtggatctcatccagaaacataagagcatcgaggagatcgtg  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  494   ATTGGGCCCAAGCGGGCTGTGGATCTCATCCAGAAACATAAGAGCATCGAGGAGATCGTG  435 
             I  G  P  K  R  A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V   
 
             R  R  L  D  P  S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q   
Seq_1  781   aggcggctggaccccagcaagtaccccgttccagagaactggctccacaaggaagcccag  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  434   AGGCGGCTGGACCCCAGCAAGTACCCCGTTCCAGAGAACTGGCTCCACAAGGAAGCCCAG  375 
             R  R  L  D  P  S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q   
 
             Q  L  F  L  E  P  E  V  L  D  P  E  S  V  E  L  K  W  S  E   
Seq_1  841   cagctcttcctggagccagaagtactggacccagagtctgtggagctgaagtggagcgag  900 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  374   CAGCTCTTCCTGGAGCCAGAAGTACTGGACCCAGAGTCTGTGGAGCTGAAGTGGAGCGAG  315 
             Q  L  F  L  E  P  E  V  L  D  P  E  S  V  E  L  K  W  S  E   
 
             P  N  E  E  E  L  V  K  F  M  C  G  E  K  Q  F  S  E  E  R   
Seq_1  901   ccaaatgaagaagagttggtcaaatttatgtgtggtgaaaagcagttttctgaagagcga  960 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  314   CCAAATGAAGAAGAGTTGGTCAAATTTATGTGTGGTGAAAAGCAGTTTTCTGAAGAGCGA  255 
             P  N  E  E  E  L  V  K  F  M  C  G  E  K  Q  F  S  E  E  R   
 
             I  R  S  G  V  K  R  L  S  K  S  R  Q  G  S  T  Q  G  R  L   
Seq_1  961   attcgcagtggggtcaagcggctgagtaagagccgccagggcagcacccagggacgcctc  1020 
             ||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| 
Seq_2  254   ATTCGCAGTGGGGTCAAGCGGCTGAGTAAGAGCCGCCAGGGTAGCACCCAGGGACGCCTC  195 
             I  R  S  G  V  K  R  L  S  K  S  R  Q  G  S  T  Q  G  R  L   
 
             D  D  F  F  K  V  T  G  S  L  S  S  A  K  R  K  E  P  E  P   
Seq_1  1021  gatgatttcttcaaggtgacaggctcactctcctcagctaagcgcaaggagccagaaccc  1080 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  194   GATGATTTCTTCAAGGTGACAGGCTCACTCTCCTCAGCTAAGCGCAAGGAGCCAGAACCC  135 
             D  D  F  F  K  V  T  G  S  L  S  S  A  K  R  K  E  P  E  P   
 
             K  G  P  A  K  K  K  A  K  T  G  G  A  G  K  F  R  R  G  K   
Seq_1  1081  aaggggcctgctaagaagaaagcaaagactgggggagcggggaagttccgaaggggaaaa  1140 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  134   AAGGGGCCTGCTAAGAAGAAAGCAAAGACTGGGGGAGCGGGGAAGTTCCGAAGGGGAAAA  75 
             K  G  P  A  K  K  K  A  K  T  G  G  A  G  K  F  R  R  G  K   
 
                               *                                          
Seq_1  1141  ------------------taa---------------------------------------  1143 
                               |||                                        
Seq_2  74    CATCATCATCATCATCACTAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTg  15 
             H  H  H  H  H  H  *  A  C  G  R  T  R  A  P  P  P  P  P  L   
 
                       X  X   
Seq_1  1144  --------------  1143 
                            
Seq_2  14    AgaTCCGGCtgctc  1 








7.1.5.	  [A159VmFEN1.seq]	  similarity:	  1115/1132	  (98.50	  %)	  (Parallel):	  
The	  sequence	  reaction	  was	  performed	  by	  the	  University	  of	  Sheffield	  Medical	  School.	  The	  mutation	  position	  is	  high-­‐
lighted	  (red).	  Nucleotides	  that	  could	  not	  be	  properly	  determined	  are	  denoted	  with	  a	  *.	  
                                                         M  G  I  H  G  L 
Seq_1  1     --------------------------------------------atgggaattcacggcc  16 
                                                         |||||||||||||||| 
Seq_2  1     GgaattCCTTaaATaTTTTGTTtACTTtAaGAAGGAGaTATACCATGGGAATTCACGGCC  60 
               N  S  L  N  I  L  F  T  L  R  R  R  Y  T  M  G  I  H  G  L 
 
               A  K  L  I  A  D  V  A  P  S  A  I  R  E  N  D  I  K  S  Y 
Seq_1  17    ttgccaaactaattgctgatgtggcccccagtgccatccgtgagaatgacatcaagagct  76 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  61    TTGCCAAACTAATTGCTGATGTGGCCCCCAGTGCCATCCgtgAGAATGACATCAAGAGCT  120 
               A  K  L  I  A  D  V  A  P  S  A  I  R  E  N  D  I  K  S  Y 
 
               F  G  R  K  V  A  I  D  A  S  M  S  I  Y  Q  F  L  I  A  V 
Seq_1  77    actttggtcgcaaagtggccatcgatgcctccatgagcatctaccagttcctgattgctg  136 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  121   ACTTTGGTCGCAAAGTGGCCATCGATGCCTCCATGAGCATCTACCAGTTCCTGATTGCTG  180 
               F  G  R  K  V  A  I  D  A  S  M  S  I  Y  Q  F  L  I  A  V 
 
               R  Q  G  G  D  V  L  Q  N  E  E  G  E  T  T  S  H  L  M  G 
Seq_1  137   ttcgtcagggtggggatgtgctgcagaacgaggagggtgagaccaccagccacctgatgg  196 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  181   TTCGTCAGGGTGGGGATGTGCTGCAGAACGAGGAGGGTGAGACCACCAGCCACCTGATGG  240 
               R  Q  G  G  D  V  L  Q  N  E  E  G  E  T  T  S  H  L  M  G 
 
               M  F  Y  R  T  I  R  M  M  E  N  G  I  K  P  V  Y  V  F  D 
Seq_1  197   gcatgttctaccgtaccatccgcatgatggagaatggcatcaagcctgtgtacgtctttg  256 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  241   GCATGTTCTACCGTACCATCCGCATGATGGAGAATGGCATCAAGCCTGTGTACGTCTTTG  300 
               M  F  Y  R  T  I  R  M  M  E  N  G  I  K  P  V  Y  V  F  D 
 
               G  K  P  P  Q  L  K  S  G  E  L  A  K  R  S  E  R  R  A  E 
Seq_1  257   atggcaaaccaccacagctgaagtcaggcgagctggccaagcgcagtgagaggcgcgccg  316 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  301   ATGGCAAACCACCACAGCTGAAGTCAGGCGAGCTGGCCAAGCGCAGTGAGAGGCGCGCCG  360 
               G  K  P  P  Q  L  K  S  G  E  L  A  K  R  S  E  R  R  A  E 
 
               A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E  E  E  V  E  K  F 
Seq_1  317   aggctgagaagcaactgcagcaggctcaggaggctgggatggaggaggaggtggagaagt  376 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  361   AGGCTGAGAAGCAACTGCAGCAGGCTCAGGAGGCTGGGATGGAGGAGGAGGTGGAGAAGT  420 
               A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E  E  E  V  E  K  F 
 
               T  K  R  L  V  K  V  T  K  Q  H  N  D  E  C  K  H  L  L  S 
Seq_1  377   tcaccaagaggctcgtgaaggtcaccaagcaacacaatgatgagtgcaaacacctgctga  436 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  421   TCACCAAGAGGCTCGTGAAGGTCACCAAGCAACACAATGATGAGTGCAAACACCTGCTGA  480 
               T  K  R  L  V  K  V  T  K  Q  H  N  D  E  C  K  H  L  L  S 
 
               L  M  G  I  P  Y  L  D  A  P  S  E  A  E  A  S  C  A  A  L 
Seq_1  437   gcctcatgggcatcccttaccttgatgcacccagcgaggcagaggccagctgtgctgccc  496 
             ||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||| 
Seq_2  481   GCCTCATGGGCATCCCTTACCTTGATGCACCCAGCGAGGTAGAGGCCAGCTGTGCTGCCC  540 
               L  M  G  I  P  Y  L  D  A  P  S  E  V  E  A  S  C  A  A  L 
 
               A  K  A  G  K  V  Y  A  A  A  T  E  D  M  D  C  L  T  F  G 
Seq_1  497   tggcaaaggctggcaaagtctatgctgcggccacggaggacatggactgcctcacttttg  556 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  541   TGGCAAAGGCTGGCAAAGTCTATGCTGCGGCCACGGAGGACATGGACTGCCTCACTTTTG  600 
               A  K  A  G  K  V  Y  A  A  A  T  E  D  M  D  C  L  T  F  G 
 
               S  P  V  L  M  R  H  L  T  A  S  E  A  K  K  L  P  I  Q  E 
Seq_1  557   gcagccccgtgctaatgcgacacttaactgccagtgaggccaagaagctgcccatccaag  616 




Seq_2  601   GCAGCCCCGTGCTAATGCGACACTTAACTGCCAGTGAGGCCAAGAAGCTGCCCATCCAAG  660 
               S  P  V  L  M  R  H  L  T  A  S  E  A  K  K  L  P  I  Q  E 
 
               F  H  L  S  R  V  L  Q  E  L  G  L  N  Q  E  Q  F  V  D  L 
Seq_1  617   agttccatctgagccgcgtcctgcaggagctgggtctgaaccaggagcagtttgtggatc  676 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  661   AGTTCCATCTGAGCCGCGTCCTGCAGGAGCTGGGTCTGAACCAGGAGCAGTTTGTGGATC  720 
               F  H  L  S  R  V  L  Q  E  L  G  L  N  Q  E  Q  F  V  D  L 
 
               C  I  L  L  G  S  D  Y  C  E  S  I  R  G  I  G  P  K  R  A 
Seq_1  677   tgtgcatcctgctgggtagcgactactgcgagagcatccgtggcattgggcccaagcggg  736 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  721   TGTGCATCCTGCTGGGTAGCGACTACTGCGAGAGCATCCGTGGCATTGGGCCCAAGCGGG  780 
               C  I  L  L  G  S  D  Y  C  E  S  I  R  G  I  G  P  K  R  A 
 
               V  D  L  I  Q  K  H  K  S  I  E  E  I  V  R  R  L  D  P  S 
Seq_1  737   ctgtggatctcatccagaaacataagagcatcgaggagatcgtgaggcggctggacccca  796 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  781   CTGTGGATCTCATCCAGAAACATAAGAGCATCGAGGAGATCGTGAGGCGGCTGGACCCCA  840 
               V  D  L  I  Q  K  H  K  S  I  E  E  I  V  R  R  L  D  P  S 
 
               K  Y  P  V  P  E  N  W  L  H  K  E  A  Q  Q  L  F  L  E  P 
Seq_1  797   gcaagtaccccgttccagagaactggctccacaaggaagcccagcagctcttcctggagc  856 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  841   GCAAGTACCCCGTTCCAGAGAACTGGCTCCACAAGGAAGCCCAGCAGCTCTTCCTGGAGC  900 
               K  Y  P  V  P  E  N  W  L  H  K  E  A  Q  Q  L  F  L  E  P 
 
               E  V  L  D  P  E  S  V  E  L  K  W  S  E  P  N  E  E  E  L 
Seq_1  857   cagaagtactggacccagagtctgtggagctgaagtggagcgagccaaatgaagaagagt  916 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  901   CAGAAGTACTGGACCCAGAGTCTGTGGAGCTGAAGTGGAGCGAGCCAAATGAAGAAGAGT  960 
               E  V  L  D  P  E  S  V  E  L  K  W  S  E  P  N  E  E  E  L 
 
               V  K  F  M  C  G  E  K  Q  F  S  E  E  R  I  R  S  G  V  K 
Seq_1  917   tggtcaaatttatgtgtggtgaaaagcagttttctgaagagcgaattcgcagtggggtca  976 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  961   TGGTCAAATTTATGTGTGGTGAAAAGCAGTTTTCTGAAGAGCGAATTcgcAGTGGGGTCA  1020 
               V  K  F  M  C  G  E  K  Q  F  S  E  E  R  I  R  S  G  V  K 
 
               R  L  S  K  S  R  Q  G  S  T  Q  G  R  L  D  D  F  F  K  V 
Seq_1  977   agcggctgagtaagagccgccagggcagcacccagggacgcctcgatgatttcttcaagg  1036 
             |||||||||   | ||||||||||| |||||||||||||||||||||||||||||||||| 
Seq_2  1021  AGCGGCTga-aTAaagccGCCAGGgTAGCACCCAGGgACGCCTCGATGaTTTCTTCAAGg  1079 
               R  L  N   K  A  A  R  V  A  P  R  D  A  S  M  I  S  S  R   
 
               T  G  S  L  S  S  A  K  R  K  E  P  E  P  K  G  P  A  K  K 
Seq_1  1037  tgacaggctcactctcctcagctaagcgcaaggagccagaacccaaggggcctgctaaga  1096 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||   
Seq_2  1080  tgACAGGCTcactctCCTcAGCTAagcgcAAGGAgCCAgAACCcAAGGGGCCtGCTAa--  1137 
             *  Q  A  H  S  P  Q  L  S  A  R  S  Q  N  P  R  G  L  L  K   
 
               K  A  K  T  G  G  A  G  K  F  R  R  G  K  *   
Seq_1  1097  agaaagcaaagactgggggagcggggaagttccgaaggggaaaataa  1143 
                    ||| |  |||||    ||| |  | | |||||||||     
Seq_2  1138  ------aaaacAAaggGGggaacgGGGAAAttccaaGGGGAAA----  1174 










7.1.6.	  [A159VmFEN1.seq]	  similarity:	  1028/1028	  (100	  %)	  (Anti-­‐parallel):	  
The	  sequence	  reaction	  was	  performed	  by	  the	  University	  of	  Sheffield	  Medical	  School.	  The	  mutation	  position	  is	  high-­‐
lighted	  (red).	  Nucleotides	  that	  could	  not	  be	  properly	  determined	  are	  denoted	  with	  a	  *.	  
             M  G  I  H  G  L  A  K  L  I  A  D  V  A  P  S  A  I  R  E   
Seq_1  1     atgggaattcacggccttgccaaactaattgctgatgtggcccccagtgccatccgtgag  60 
                   |||                                                    
Seq_2  1105  ------att---------------------------------------------------  1103 
                    F                                                     
 
             N  D  I  K  S  Y  F  G  R  K  V  A  I  D  A  S  M  S  I  Y   
Seq_1  61    aatgacatcaagagctactttggtcgcaaagtggccatcgatgcctccatgagcatctac  120 
                                                                        | 
Seq_2  1102  -----------------------------------------------------------c  1102 
                                                                          
 
             Q  F  L  I  A  V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T   
Seq_1  121   cagttcctgattgctgttcgtcagggtggggatgtgctgcagaacgaggagggtgagacc  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  1101  CAGtTcCTGATTGCTGTTcgTCAgGGTgGGGATGTGCTGCAGAACGAGGAGGGTGAGACC  1042 
             Q  F  L  I  A  V  R  Q  G  G  D  V  L  Q  N  E  E  G  E  T   
 
             T  S  H  L  M  G  M  F  Y  R  T  I  R  M  M  E  N  G  I  K   
Seq_1  181   accagccacctgatgggcatgttctaccgtaccatccgcatgatggagaatggcatcaag  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  1041  acCAGCcacCTGATGGGCATGTTCTACCGTACCATCCGCATGATGGAGAATGGCATCAAG  982 
             T  S  H  L  M  G  M  F  Y  R  T  I  R  M  M  E  N  G  I  K   
 
             P  V  Y  V  F  D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R   
Seq_1  241   cctgtgtacgtctttgatggcaaaccaccacagctgaagtcaggcgagctggccaagcgc  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  981   CCTGTGTACGTCTTTGATGGCAAACCACCACAGCTGAAGTCAGGCGAGCTGGCCAAGCGC  922 
             P  V  Y  V  F  D  G  K  P  P  Q  L  K  S  G  E  L  A  K  R   
 
             S  E  R  R  A  E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E   
Seq_1  301   agtgagaggcgcgccgaggctgagaagcaactgcagcaggctcaggaggctgggatggag  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  921   AGTGAGAGGCGCGCCGAGGCTGAGAAGCAACTGCAGCAGGCTCAGGAGGCTGGGATGGAG  862 
             S  E  R  R  A  E  A  E  K  Q  L  Q  Q  A  Q  E  A  G  M  E   
 
             E  E  V  E  K  F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E   
Seq_1  361   gaggaggtggagaagttcaccaagaggctcgtgaaggtcaccaagcaacacaatgatgag  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  861   GAGGAGGTGGAGAAGTTCACCAAGAGGCTCGTGAAGGTCACCAAGCAACACAATGATGAG  802 
             E  E  V  E  K  F  T  K  R  L  V  K  V  T  K  Q  H  N  D  E   
 
             C  K  H  L  L  S  L  M  G  I  P  Y  L  D  A  P  S  E  A  E   
Seq_1  421   tgcaaacacctgctgagcctcatgggcatcccttaccttgatgcacccagcgaggcagag  480 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||| |||| 
Seq_2  801   TGCAAACACCTGCTGAGCCTCATGGGCATCCCTTACCTTGATGCACCCAGCGAGGTAGAG  742 
             C  K  H  L  L  S  L  M  G  I  P  Y  L  D  A  P  S  E  V  E   
 
             A  S  C  A  A  L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M   
Seq_1  481   gccagctgtgctgccctggcaaaggctggcaaagtctatgctgcggccacggaggacatg  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  741   GCCAGCTGTGCTGCCCTGGCAAAGGCTGGCAAAGTCTATGCTGCGGCCACGGAGGACATG  682 
             A  S  C  A  A  L  A  K  A  G  K  V  Y  A  A  A  T  E  D  M   
 
             D  C  L  T  F  G  S  P  V  L  M  R  H  L  T  A  S  E  A  K   
Seq_1  541   gactgcctcacttttggcagccccgtgctaatgcgacacttaactgccagtgaggccaag  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  681   GACTGCCTCACTTTTGGCAGCCCCGTGCTAATGCGACACTTAACTGCCAGTGAGGCCAAG  622 
             D  C  L  T  F  G  S  P  V  L  M  R  H  L  T  A  S  E  A  K   
 
             K  L  P  I  Q  E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q   
Seq_1  601   aagctgcccatccaagagttccatctgagccgcgtcctgcaggagctgggtctgaaccag  660 




Seq_2  621   AAGCTGCCCATCCAAGAGTTCCATCTGAGCCGCGTCCTGCAGGAGCTGGGTCTGAACCAG  562 
             K  L  P  I  Q  E  F  H  L  S  R  V  L  Q  E  L  G  L  N  Q   
 
             E  Q  F  V  D  L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G   
Seq_1  661   gagcagtttgtggatctgtgcatcctgctgggtagcgactactgcgagagcatccgtggc  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  561   GAGCAGTTTGTGGATCTGTGCATCCTGCTGGGTAGCGACTACTGCGAGAGCATCCGTGGC  502 
             E  Q  F  V  D  L  C  I  L  L  G  S  D  Y  C  E  S  I  R  G   
 
             I  G  P  K  R  A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V   
Seq_1  721   attgggcccaagcgggctgtggatctcatccagaaacataagagcatcgaggagatcgtg  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  501   ATTGGGCCCAAGCGGGCTGTGGATCTCATCCAGAAACATAAGAGCATCGAGGAGATCGTG  442 
             I  G  P  K  R  A  V  D  L  I  Q  K  H  K  S  I  E  E  I  V   
 
             R  R  L  D  P  S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q   
Seq_1  781   aggcggctggaccccagcaagtaccccgttccagagaactggctccacaaggaagcccag  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  441   AGGCGGCTGGACCCCAGCAAGTACCCCGTTCCAGAGAACTGGCTCCACAAGGAAGCCCAG  382 
             R  R  L  D  P  S  K  Y  P  V  P  E  N  W  L  H  K  E  A  Q   
 
             Q  L  F  L  E  P  E  V  L  D  P  E  S  V  E  L  K  W  S  E   
Seq_1  841   cagctcttcctggagccagaagtactggacccagagtctgtggagctgaagtggagcgag  900 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  381   CAGCTCTTCCTGGAGCCAGAAGTACTGGACCCAGAGTCTGTGGAGCTGAAGTGGAGCGAG  322 
             Q  L  F  L  E  P  E  V  L  D  P  E  S  V  E  L  K  W  S  E   
 
             P  N  E  E  E  L  V  K  F  M  C  G  E  K  Q  F  S  E  E  R   
Seq_1  901   ccaaatgaagaagagttggtcaaatttatgtgtggtgaaaagcagttttctgaagagcga  960 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  321   CCAAATGAAGAAGAGTTGGTCAAATTTATGTGTGGTGAAAAGCAGTTTTCTGAAGAGCGA  262 
             P  N  E  E  E  L  V  K  F  M  C  G  E  K  Q  F  S  E  E  R   
 
             I  R  S  G  V  K  R  L  S  K  S  R  Q  G  S  T  Q  G  R  L   
Seq_1  961   attcgcagtggggtcaagcggctgagtaagagccgccagggcagcacccagggacgcctc  1020 
             ||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| 
Seq_2  261   ATTCGCAGTGGGGTCAAGCGGCTGAGTAAGAGCCGCCAGGGTAGCACCCAGGGACGCCTC  202 
             I  R  S  G  V  K  R  L  S  K  S  R  Q  G  S  T  Q  G  R  L   
 
             D  D  F  F  K  V  T  G  S  L  S  S  A  K  R  K  E  P  E  P   
Seq_1  1021  gatgatttcttcaaggtgacaggctcactctcctcagctaagcgcaaggagccagaaccc  1080 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  201   GATGATTTCTTCAAGGTGACAGGCTCACTCTCCTCAGCTAAGCGCAAGGAGCCAGAACCC  142 
             D  D  F  F  K  V  T  G  S  L  S  S  A  K  R  K  E  P  E  P   
 
             K  G  P  A  K  K  K  A  K  T  G  G  A  G  K  F  R  R  G  K   
Seq_1  1081  aaggggcctgctaagaagaaagcaaagactgggggagcggggaagttccgaaggggaaaa  1140 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  141   AAGGGGCCTGCTAAGAAGAAAGCAAAGACTGGGGGAGCGGGGAAGTTCCGAAGGGGAAAA  82 
             K  G  P  A  K  K  K  A  K  T  G  G  A  G  K  F  R  R  G  K   
 
                               *                                          
Seq_1  1141  ------------------taa---------------------------------------  1143 
                               |||                                        
Seq_2  81    CATCATCATCATCATCACTAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACtG  22 
             H  H  H  H  H  H  *  A  C  G  R  T  R  A  P  P  P  P  P  L   
 
                              X  X   
Seq_1  1144  ---------------------  1143 
                                   
Seq_2  21    AGATCCGGCtgctAaCAaagc  1 




























	  [S]	  in	  tube	  	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   1.5	   4.5	   150	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   1.5	   4.5	   150	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   0.5	   4.5	   50	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   0.3	   4.5	   30	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   0.25	   4.5	   25	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   0.1	   4.5	   10	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   0.06	   18	   6	   100	   18	  
75	   5	   5000	   3	   17	   160	   0.04	   18	   4	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   0.04	   18	   4	   100	   9	  
25	   0.5	   500	   10	   10	   160	   0.02	   18	   2	   50	   9	  
10	   0.5	   500	   4	   16	   160	   0.02	   18	   2	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   0.02	   18	   2	   50	   1.8	  























[S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   8	   4.5	   800	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   6	   4.5	   600	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   2	   4.5	   200	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   1.5	   4.5	   150	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   1.5	   4.5	   150	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   0.5	   4.5	   50	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   0.3	   18	   30	   100	   18	  
75	   5	   5000	   3	   17	   160	   0.3	   18	   30	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   0.3	   18	   30	   100	   9	  
25	   0.5	   500	   10	   10	   160	   0.2	   18	   20	   50	   9	  
10	   0.5	   500	   4	   16	   160	   0.2	   18	   20	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   0.2	   18	   20	   50	   1.8	  


























[S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   3	   4.5	   300	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   2	   4.5	   200	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   1	   4.5	   100	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   0.5	   4.5	   50	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   0.5	   4.5	   50	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   0.3	   4.5	   30	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   0.1	   18	   10	   100	   18	  
75	   5	   5000	   3	   17	   160	   0.1	   18	   10	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   0.1	   18	   10	   100	   9	  
25	   0.5	   500	   10	   10	   160	   0.06	   18	   6	   50	   9	  
10	   0.5	   500	   4	   16	   160	   0.03	   18	   3	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   0.03	   18	   3	   50	   1.8	  























[S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   5	   4.5	   500	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   2	   4.5	   200	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   1	   4.5	   100	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   1	   4.5	   100	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   0.5	   4.5	   50	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   0.25	   4.5	   25	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   0.1	   18	   10	   100	   18	  
75	   5	   5000	   3	   17	   160	   0.1	   18	   10	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   0.06	   18	   6	   100	   9	  
25	   0.5	   500	   10	   10	   160	   0.04	   18	   4	   50	   9	  
10	   0.5	   500	   4	   16	   160	   0.03	   18	   3	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   0.03	   18	   3	   50	   1.8	  




























[S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   400	   4.5	   50000	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   250	   4.5	   50000	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   100	   4.5	   20000	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   75	   4.5	   20000	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   50	   4.5	   20000	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   25	   4.5	   10000	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   20	   18	   2000	   100	   18	  
75	   5	   5000	   3	   17	   160	   15	   18	   2000	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   10	   18	   2000	   100	   9	  
25	   0.5	   500	   10	   10	   160	   8	   18	   800	   50	   9	  
10	   0.5	   500	   4	   16	   160	   6	   18	   800	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   6	   18	   400	   50	   1.8	  























[S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   800	   4.5	   80000	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   500	   4.5	   50000	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   200	   4.5	   20000	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   150	   4.5	   15000	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   100	   4.5	   10000	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   50	   4.5	   5000	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   40	   18	   4000	   100	   18	  
75	   5	   5000	   3	   17	   160	   30	   18	   3000	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   20	   18	   2000	   100	   9	  
25	   0.5	   500	   10	   10	   160	   16	   18	   1600	   50	   9	  
10	   0.5	   500	   4	   16	   160	   12	   18	   1200	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   12	   18	   1200	   50	   1.8	  




























	  [S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   30	   4.5	   3000	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   15	   4.5	   1500	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   10	   4.5	   1000	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   5	   4.5	   500	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   5	   4.5	   500	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   4	   4.5	   400	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   2	   18	   200	   100	   18	  
75	   5	   5000	   3	   17	   160	   1	   18	   100	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   1	   18	   100	   100	   9	  
25	   0.5	   500	   10	   10	   160	   0.5	   18	   50	   50	   9	  
10	   0.5	   500	   4	   16	   160	   0.5	   18	   50	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   0.5	   18	   50	   50	   1.8	  























	  [S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   12	   4.5	   1200	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   8	   4.5	   800	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   4.8	   4.5	   480	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   4.8	   4.5	   480	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   3.2	   4.5	   320	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   1.6	   4.5	   160	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   0.8	   18	   80	   100	   18	  
75	   5	   5000	   3	   17	   160	   0.64	   18	   64	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   0.64	   18	   64	   100	   9	  
25	   0.5	   500	   10	   10	   160	   0.64	   18	   64	   50	   9	  
10	   0.5	   500	   4	   16	   160	   0.64	   18	   64	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   0.64	   18	   64	   50	   1.8	  




























[S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   20	   4.5	   2000	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   16	   4.5	   1600	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   7	   4.5	   700	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   7	   4.5	   700	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   5	   4.5	   500	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   3	   4.5	   300	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   1	   18	   100	   100	   18	  
75	   5	   5000	   3	   17	   160	   1	   18	   100	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   1	   18	   100	   100	   9	  
25	   0.5	   500	   10	   10	   160	   1	   18	   100	   50	   9	  
10	   0.5	   500	   4	   16	   160	   1	   18	   100	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   1	   18	   100	   50	   1.8	  























	  [S]	  in	  tube	  
(nM)	  
5000	   50	   50000	   5	   0	   40	   10	   4.5	   1000	   250	   90	  
2500	   50	   50000	   2.5	   2.5	   40	   6	   4.5	   600	   200	   56.25	  
1000	   50	   50000	   1	   4	   40	   3	   4.5	   300	   200	   22.5	  
750	   50	   50000	   0.75	   4.25	   40	   2	   4.5	   200	   150	   22.5	  
500	   50	   50000	   0.5	   4.5	   40	   2	   4.5	   200	   150	   15	  
250	   5	   5000	   2.5	   2.5	   40	   1	   4.5	   100	   100	   11.25	  
100	   5	   5000	   4	   16	   160	   0.6	   18	   60	   100	   18	  
75	   5	   5000	   3	   17	   160	   0.6	   18	   60	   100	   13.5	  
50	   0.5	   500	   20	   0	   160	   0.4	   18	   40	   100	   9	  
25	   0.5	   500	   10	   10	   160	   0.4	   18	   40	   50	   9	  
10	   0.5	   500	   4	   16	   160	   0.3	   18	   30	   50	   3.6	  
5	   0.5	   500	   2	   18	   160	   0.3	   18	   30	   50	   1.8	  






7.3.	   Reaction	   condition	   for	   single	   turnover	   (ST)	   assay	   of	   WT,	   A159V	   and	   E160D	   of	  
mFEN-­‐1:	  
Loop	   Mode	   Switch	  Position	   Push	  1	   Push	  2	   Delay	   Time	  (ms)	   DF	   3'-­‐SF	   gap	   DF2'OH	  
1	   C	   5	   160	   /	   /	   4.5	   ✓	   ✓	   ✗	   ✗	  
1	   C	   2	   160	   /	   /	   12.1	   ✓	   ✓	   ✗	   ✗	  
2	   C	   6	   180	   /	   /	   9.1	   ✓	   ✓	   ✓	   ✓	  
2	   C	   3	   180	   /	   /	   19.4	   ✓	   ✓	   ✓	   ✓	  
2	   C	   2	   180	   /	   /	   27.6	   ✓	   ✓	   ✓	   ✓	  
2	   C	   1	   180	   /	   /	   41.8	   ✓	   ✓	   ✓	   ✓	  
4	   C	   5	   255	   /	   /	   30.6	   ✓	   ✓	   ✓	   ✓	  
4	   C	   4	   255	   /	   /	   40.8	   ✓	   ✓	   ✓	   ✓	  
4	   C	   3	   255	   /	   /	   57.5	   ✓	   ✓	   ✓	   ✓	  
4	   C	   2	   255	   /	   /	   82.1	   ✓	   ✓	   ✓	   ✓	  
4	   C	   1	   255	   /	   /	   124.2	   ✓	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   100	   140.8	   ✓	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   200	   240.8	   ✓	   ✓	   ✓	   ✓	  
4	   	   	  I	   4	   160	   95	   400	   440.8	   ✓	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   800	   840.8	   ✓	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   1600	   1640.8	   ✓	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   3200	   3240.8	   ✓	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   6400	   6440.8	   ✓	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   9000	   9040.8	   ✗ ✗ ✗ ✓	  
4	   /	   /	   /	   X10	   1280	   12841	   ✓	   ✓	   ✓	   ✓	  
4	   /	   /	   /	   X10	   1500	   15041	   ✗	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   2560	   25641	   ✓	   ✓	   ✓	   ✓	  
4	   /	   /	   /	   X10	   3000	   30041	   ✗	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   5120	   51241	   ✓ ✓ ✓ ✓	  
4	   /	   /	   /	   X10	   6000	   60041	   ✗	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   9000	   90041	   ✗	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   9999	   100030	   ✗	   ✗	   ✗	   ✓	  






Loop	   Mode	   Switch	  Position	   Push	  1	   Push	  2	   Delay	   Time	  (ms)	   DF	   gap	   DF2'OH	  
4	   C	   5	   255	   /	   /	   30.6	   ✗	   ✗	   ✓	  
4	   C	   4	   255	   /	   /	   40.8	   ✗	   ✗	   ✓	  
4	   C	   3	   255	   /	   /	   57.5	   ✗	   ✗	   ✓	  
4	   C	   2	   255	   /	   /	   82.1	   ✗	   ✗	   ✓	  
4	   C	   1	   255	   /	   /	   124.2	   ✗	   ✗	   ✓	  
4	   I	   4	   160	   95	   100	   140.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   200	   240.8	   ✓	   ✓	   ✓	  
4	   	   	  I	   4	   160	   95	   400	   440.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   800	   840.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   1600	   1640.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   3200	   3240.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   6400	   6440.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   9000	   9040.8	   ✗ ✗ ✓	  
4	   /	   /	   /	   X10	   1280	   12841	   ✓	   ✓	   ✓	  
4	   /	   /	   /	   X10	   1500	   15041	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   2560	   25641	   ✓	   ✓	   ✓	  
4	   /	   /	   /	   X10	   3000	   30041	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   5120	   51241	   ✓ ✓ ✓	  
4	   /	   /	   /	   X10	   6000	   60041	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   9000	   90041	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   9999	   100030	   ✗ ✗ ✓ 
/	   /	   /	   /	   /	   /	   120000	   ✓ ✓ ✓ 
/	   /	   /	   /	   /	   /	   240000	   ✓ ✓ ✓ 
/	   /	   /	   /	   /	   /	   360000	   ✓ ✓ ✓ 
/	   /	   /	   /	   /	   /	   480000	   ✓ ✓ ✓ 
/	   /	   /	   /	   /	   /	   600000	   ✓ ✓ ✓ 
/	   /	   /	   /	   /	   /	   720000	   ✓ ✓ ✗ 
/	   /	   /	   /	   /	   /	   840000	   ✓ ✓ ✗ 
/	   /	   /	   /	   /	   /	   960000	   ✓	   ✓	   ✗	  








Loop	   Mode	   Switch	  Position	   Push	  1	   Push	  2	   Delay	   Time	  (ms)	   DF	   gap	   DF2'OH	  
2	   C	   6	   180	   /	   /	   9.1	   ✗ ✗ ✓ 
2	   C	   3	   180	   /	   /	   19.4	   ✗ ✗ ✓ 
2	   C	   2	   180	   /	   /	   27.6	   ✗ ✗ ✓ 
2	   C	   1	   180	   /	   /	   41.8	   ✗ ✗ ✓ 
4	   C	   5	   255	   /	   /	   30.6	   ✓	   ✓	   ✓	  
4	   C	   4	   255	   /	   /	   40.8	   ✓	   ✓	   ✓	  
4	   C	   3	   255	   /	   /	   57.5	   ✓	   ✓	   ✓	  
4	   C	   2	   255	   /	   /	   82.1	   ✓	   ✓	   ✓	  
4	   C	   1	   255	   /	   /	   124.2	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   100	   140.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   200	   240.8	   ✓	   ✓	   ✓	  
4	   	   	  I	   4	   160	   95	   400	   440.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   800	   840.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   1600	   1640.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   3200	   3240.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   6400	   6440.8	   ✓	   ✓	   ✓	  
4	   I	   4	   160	   95	   9000	   9040.8	   ✗ ✗ ✓	  
4	   /	   /	   /	   X10	   1280	   12841	   ✓	   ✓	   ✓	  
4	   /	   /	   /	   X10	   1500	   15041	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   2560	   25641	   ✓	   ✓	   ✓	  
4	   /	   /	   /	   X10	   3000	   30041	   ✗	   ✗	   ✓	  
4	   /	   /	   /	   X10	   5120	   51241	   ✓ ✓ ✓	  









7.4.	  Reaction	  condition	  for	  ECCD	  experiments	  of	  WT	  and	  mutated	  mouse	  and	  human	  
FEN-­‐1:	  
MM	  (uL)	   FB	  (1X)	   SB	   ssDNA	   DNA	   100uM	  E	   500	  mM	  EDTA	   Total	   Description	  
620	   80	   100	   0	   0	   0	   0	   800	   Ca	  Blank	  
	   	   	   	   	   	   40	   840	   EDTA	  Blank	  
620	   0	   100	   80	   0	   0	   0	   800	   10	  uM	  ssDNA,	  10mM	  CaCl2	  
	   	   	   	   	   	   40	   840	   9.52	  uM	  ssDNA,	  9.52	  mM	  CaCl2,	  23.8	  mM	  EDTA	  
620	   0	   100	   0	   80	   0	   0	   800	   10	  uM	  DNA,	  10	  mM	  CaCl2	  
	   	   	   	   	   	   40	   840	   9.52	  uM	  DNA,	  9.52	  mM	  CaCl2,	  23.8	  mM	  EDTA	  
620	   0	   0	   0	   80	   100	   0	   800	   10	  uM	  DNA,	  10	  mM	  CaCl2,	  12.5	  uM	  E	  	  	  
	   	   	   	   	   	   40	   840	  
9.52	  uM	  DNA,	  9.52	  mM	  CaCl2,	  11.9	  	  uM	  E,	  12,1	  mM	  
EDAT	  
Table	  7.14.	  Reaction	  conditions	  for	  ECCD	  reaction	  of	  free	  ssDNA	  and	  dsDNA	  with	  and	  without	  FEN-­‐1	  enzyme	  using	  
JASCO	  CD	  spectrophotometer	  machine.	  	  
	  
MM	  (uL)	   FB	  (1X)	   SB	   ssDNA	   DNA	   100uM	  E	   500	  mM	  EDTA	   Total	   Description	  
387.5	   50	   62.5	   0	   0	   0	   0	   500	   Ca2+	  Blank	  
	   	   	   	   	   	   25	   525	   EDTA	  Blank	  
387.5	   0	   62.5	   50	   0	   0	   0	   500	   5	  uM	  ssDNA,	  5	  mM	  CaCl2	  
	   	   	   	   	   	   25	   525	   4.88	  uM	  ssDNA,	  4.88	  mM	  CaCl2,	  12.1	  mM	  EDTA	  
387.5	   0	   62.5	   0	   50	   0	   0	   500	   5	  uM	  DNA,	  5	  mM	  CaCl2	  
	   	   	   	   	   	   25	   525	   4.88	  uM	  DNA,	  4.88	  mM	  CaCl2,	  12.1	  mM	  EDTA	  
387.5	   0	   0	   0	   50	   62.5	   0	   500	   5uM	  DNA,	  5mM	  CaCl2,	  12.5	  uM	  E	  	  
	   	   	   	   	   	   25	   525	  
4.88	  uM	  DNA,	  4.88	  mM	  CaCl2,	  11.9	  uM	  E,	  12.1	  mM	  
EDTA	  
Table	  7.15.	  Reaction	  conditions	  for	  ECCD	  reaction	  of	  free	  ssDNA	  and	  dsDNA	  with	  and	  without	  FEN-­‐1	  enzyme	  using	  












7.5.	  Kinetic	  MT	  and	  ST	  results	  of	  mFEN-­‐1:	  
	  
	  
Figure	  7.1.	  Multiple	  and	  single	  turnover	  kinetic	  analysis	  of	  WT,	  A159V,	  and	  E160D	  mFEN1	  upon	  different	  substrates.	  
a)	  Cartoon	  of	  DF,	  gab	  and	  DF2'OH	  substrates	  that	  reacted	  with	  mFEN-­‐1	  to	  product	  minor	  product.	  b)	  d)	  and	  f)	  Com-­‐
parison	  of	  weighted	  residual	  plots	  of	  Michaelis-­‐Menten	  plots	  for	  cleavage	  of	  DF,	  gap,	  and	  DF2'OH	  substrates	  respec-­‐
tively	  by	  WT,	  A159V,	  and	  E160D	  mFEN1.	  c)	  e)	  and	  g)	  Comparison	  of	  residual	  plots	  of	  single	  turnover	  rate	  profiles	  for	  









DNAandProtein Requirements for Substrate Conformational
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Human flap endonuclease-1 (hFEN1) catalyzes the essential
removal of single-stranded flaps arising at DNA junctions dur-
ing replication and repair processes. hFEN1 biological function
must be precisely controlled, and consequently, the protein
relies on a combination of protein and substrate conformational
changes as a prerequisite for reaction. These include substrate
bending at the duplex-duplex junction and transfer of unpaired
reacting duplex end into the active site. When present, 5!-flaps
are thought to thread under the helical cap, limiting reaction to
flaps with free 5!-termini in vivo. Here we monitored DNA
bending by FRET and DNA unpairing using 2-aminopurine
exciton pair CD to determine the DNA and protein require-
ments for these substrate conformational changes. Binding of
DNA to hFEN1 in a bent conformation occurred independently
of 5!-flap accommodation and did not require active site metal
ions or the presence of conserved active site residues. More
stringent requirements exist for transfer of the substrate to
the active site. Placement of the scissile phosphate diester in the
active site required the presence of divalent metal ions, a free
5!-flap (if present), a Watson-Crick base pair at the terminus of
the reacting duplex, and the intact secondary structure of the
enzyme helical cap. Optimal positioning of the scissile phos-
phate additionally required active site conserved residues Tyr40,
Asp181, and Arg100 and a reacting duplex 5!-phosphate. These
studies suggest a FEN1 reactionmechanismwhere junctions are
bound and 5!-flaps are threaded (when present), and finally the
substrate is transferred onto active site metals initiating
cleavage.
Flap endonuclease-1 (FEN1)4 is an essential component of
the DNA replicative and repair apparatus and the prototypical
member of the 5!-nuclease superfamily (1–5). FEN1 removes
single-stranded DNA or RNA flaps formed during DNA repli-
cation and repair as a result of strand displacement synthesis.
Flapped DNAs arising in this context (e.g. adjacent Okazaki
fragments) are equilibrating (i.e.migrating) structures that can
have differing lengths of 5!- and 3!-single-strands, because all
flaps are complementary to the continuous DNA template.
However, FEN1 only processes one flapped DNA conformer, a
two-way DNA junction bearing a single nucleotide (nt) 3!-flap
and any length of 5!-flap (see Fig. 1,A and B) (6–8). FEN1 then
catalyzes specific phosphate diester hydrolysis of the flapped
DNA 1 nt into the double-strand, ensuring that the product is
nickedDNA (see Fig. 1A). This exquisite specificity is necessary
for the fidelity and efficiency of DNA replication and repair,
because nickedDNA can be joined immediately by DNA ligase.
Extensive work has led to models for the origins of FEN1
reaction specificity that rely on key DNA conformational
changes for substrate recognition and reaction site selection.
The first selection is for two-way junction DNAs and involves
the substrate bending 100° to contact two separate double-
stranded DNA binding sites (see Fig. 1B) (7–10). One of these
duplex binding sites forms a substrate-induced binding pocket
that can only accommodate a 1-nt 3!-flap, which explains the
preference for substrates with a single 3!-flap nucleotide.
The second requirement of hFEN1 specificity excludes the
reaction of continuous single-stranded DNAs (e.g. template
strand during replication) or flaps with bound protein.
Although controversial (11), the 5!-flap is thought to pass
through a hole in the protein above the active site and bordered by
the helical cap (top of!4 and!5) and gateway (base of!4 and!2)
(see Fig. 1,B andD) (1, 8, 12–14). The final specificity requirement
is for reaction 1 nt into duplex, which is the hallmark of the 5!-nu-
clease superfamily that also includes the DNA repair proteins
EXO1,XPG, andGEN1 (1). This selectivity is believed to involve a
local DNA conformational change at the terminus of the reacting
duplex (5, 8, 15–17),whereby twogating!-helices (basesof!2and
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!4) appear to prevent access of duplexDNAs to the active site (8).
It isproposed that the last two5!nucleotidesof the reactingduplex
unpair to place the scissile phosphate diester bond on the catalytic
metal ions (see Fig. 1,C andD).
Although the overall conformational changes that FEN1 sub-
strates must undergo before reaction have been deduced, the
details of these processes are still not understood and in some
cases remain controversial. Here, we aim to elucidate features
of the FEN1 protein and substrates required for global DNA
bending and local DNA unpairing (i.e. transfer to the active
site). We also investigate the relationship of these processes to
5!-flap accommodation and explore the orientation of the
5!-portion of substrates that is not visible in current x-ray struc-
tures. Our combined results describe substrate and protein
requirements for DNA bending and unpairing, and in turn
Okazaki fragment processing, providing important insights
into the FEN1 catalytic cycle.
Experimental Procedures
DNA Constructs—The oligonucleotide sequences are given
in Table 1. DNA oligonucleotides including those containing
5!-FAM, 5!-biotin, internal TAMRA and fluorescein, and
2-aminopurine (2AP) substitutionswere purchasedwithHPLC
purification fromDNATechnology A/S. The phosphoramidite
synthons used for 5!-FAM, 5!-biotin, internal TAMRA dT, and
internal fluorescein dT modifications were 6-carboxyfluores-
cein-aminohexyl amidite, N-DMT-biotinyl-2-aminoethoxy-
ethanol amidite, 5!-DMT-T(TEG-TAMRA), and fluorescein T
amidite, respectively, and were purchased from Biosearch
Technologies Inc. 2AP was incorporated using 5!-(4,4!-dime-
thoxytrityl)-N2-(dimethylformamidine)-2!-deoxypurine ribo-
side-3!-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite
obtained from Link Technologies Ltd. DNA concentrations
were determined by UV absorbance at 260 nm (20 °C) using
extinction coefficients generated by the Integrated DNATech-
nologies oligo analyzer 3.1 tool.
Substrate constructs are summarized in Table 2. FRET sub-
strates were designed by modeling a range of different fluoro-
phore positions using the accessible volume approach (18) on
both duplex and bent hFEN1 substrate DNAs (obtained by
extending the existing DNA helixes in the crystal structure of
hFEN1-DNA (8)). Labeling sites were chosen to maximize the
FRET change upon bending. FRET substrates (Table 2) were
assembled by heating the appropriate 3!-flap, 5!-flap/exo, and
template strands in 1:1.1:1 ratio in 50 mM HEPES, pH 7.5, and
100 mM KCl to 80 °C for 5 min and then cooling to room tem-
perature. For comparison, a DNA duplex was also created as
above with Tcdonor (see Table 1) and template strands in a 1:1
ratio. 2AP constructs and the kinetic substrate KDF were
formed by heating the appropriate exo/5!-flap strands with the
complementary template in a 1:1.1 ratio at 80 °C for 5min in 50
mMTris-HCl, pH 7.5, and 100mMKClwith subsequent cooling
to room temperature.
Enzymes—hFEN1 andmutantswere overexpressed and puri-
fied as described (8, 13).
Florescence Resonance Energy Transfer—FRET efficiencies
(E) were determined using the (ratio)A method (19) by measur-
ing the enhanced acceptor fluorescence at 37 °C. The steady
state fluorescent spectra of 10 nM nonlabeled (NL) trimolecu-
lar, donor-only labeled (DOL), and doubly labeled (DAL) DNA
substrates (Table 2) were recorded using a Horiba Jobin Yvon
FluoroMax-3! fluorometer. For direct excitation of the donor
(fluorescein, DOL) or acceptor (TAMRA, AOL), the sample
was excited at 490 or 560 nm (2-nm slit width), and the emis-
sion signal was collected from 515–650 or 575–650 nm (5-nm
slit width). Emission spectra were corrected for buffer and
enzyme background signal by subtracting the signal from the
nonlabeled (NL) DNA sample. In addition to 10 nM of the
appropriate DNA construct, samples contained 10 mM CaCl2
or 2 mM EDTA, 110 mM KCl, 55 mMHEPES, pH 7.5, 0.1 mg/ml
bovine serum albumin, and 1 mMDTT. The first measurement
was taken prior to the addition of proteinwith subsequent read-
ings taken on the cumulative addition of the appropriate
enzyme in the same buffer, with corrections made for dilution.
Transfer efficiencies (E) were determined according to Equations
1–3, where FDA and FD represent the fluorescent signal of the
doubly labeled DNA (DAL) and donor-only labeled DNA (DOL)
at the given wavelengths, respectively (e.g. FDA("EXD , "EMA ) denotes
the measured fluorescence of acceptor emission upon excitation
of the donor, for DAL DNA); #D and #A are the molar absorption
coefficients of donor and acceptor at the given wavelengths; and
#D(490)/#A(560) and #A(490)/#A(560) are determined experimen-
tally from the absorbance spectra of doubly labeled molecules
(DAL) and the excitation spectra of singly TAMRA-only labeled
molecules (AOL), respectively. Energy transfer efficiency (E) was
fitted by nonlinear regression in the Kaleidagraph program to
Equation 4,whereEmax andEmin are themaximumandminimum
energy transfer values, [S] is the substrate concentration, [P] is the
protein concentration, and Kbend is the bending equilibrium dis-
sociation constant of the protein substrate [PS] complex. All
experiments were repeated in triplicate.






















% $"$S%& $P%& Kbend#2% 4$S%$P%% (Eq. 4)
Donor (fluorescein) was excited at 490 nm with emission sam-
pled as the average value of the signal between 515 and 525 nm,
and acceptor (TAMRA) was excited at 560 nm with emission
averaged between 580 and 590 nm. For FRET experiments
involving substrate bound to streptavidin, 5 molar equivalents
of streptavidin were preincubated with the biotinylated sub-
strate in buffer containing 10mMCaCl2, 55mMHEPES, pH 7.5,
110 mM KCl, 1 mg/ml BSA, and 1 mM DTT for 10 min at room
temperature before proceeding as above.
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Determination of the Maximal Single Turnover Rate of Reac-
tion (kSTmax)—Maximal single turnover rates of reaction were
determined using the KDF substrate (Table 2) and rapid
quench apparatus (for WT-hFEN1 and Y40A) or manual sam-
pling (for D181A) at 37 °C and pH 7.5, as described (20).
CD Spectroscopy—Samples containing 10 !M of the appro-
priate (2AP)2 DNA construct (Table 2), 50 mM Tris-HCl, pH
7.5, 100 mM KCl, 1 mM DTT and, where appropriate, 12.5 !M
protein and either 10 mM CaCl2 or 10 mM CaCl2 ! 25 mM
EDTA were prepared with subsequent acquisition of CD spec-
tra (300–480 nm) at 20 °C using a JASCO J-810 CD spectro-
photometer as described in detail (17). The CD spectra were
plotted as""permol 2AP residue versuswavelength. Eachmea-
surement was independently repeated typically in triplicate.
Results
Global DNA Conformational Change
Substrate Design for DNA Bending—To study global confor-
mational change of DNA substrates (Fig. 1B), we used FRET to
detect duplex-duplex bending upon binding to human FEN1
(hFEN1) (Fig. 2) (7, 9, 10). Donor- and acceptor-labeled (DAL)
substrates were assembled from three oligonucleotides, a
TAMRA-labeled template strand, a fluorescein-labeled 3#-flap
strand and an unlabeled 5#-flap/exo strand (Tables 1 and 2 and
Fig. 2A). The positions of the fluorophoreswere chosen tomax-
imize the FRET change observed upon substrate bending. In
addition, donor only labeled (DOL), acceptor-only labeled
(AOL), and nonlabeled (NL) versions of the substrates were
also prepared (Table 2) to determine FRET efficiencies using
the (ratio)A method (19). In double flap (DF) FRET substrates,
the 5#-flap strand carried a terminal 5#-biotin to facilitate
experiments with streptavidin; this label did not affect FRET
behavior (data not shown). To reduce any ambiguity in inter-
pretation of our results, all substrates used in our studies were
designed to be static (i.e. the flaps were noncomplementary to
the template strand). Such static flaps permit clearer interpre-
tation of experimental data but are known to behave identically
to their equilibrating counterparts in hFEN1 reactions (6). For
comparison, we also created the equivalent DAL duplex to the
flapped DNAs (Table 2 and Fig. 2A).
To prevent cleavage of the substrate, all experiments were
carried out in the absence of the viable cofactor Mg2!.
Because divalent metal ions are required for accommodation
of the 5#-flap and for DNA conformational changes that lead
to reaction (12, 17), we carried out experiments with or with-
out catalytically nonviable Ca2! ions, allowing us to investi-
gate the relationship between DNA bending and other
events of the hFEN1 catalytic cycle. Calcium ions are com-
petitive inhibitors of Mg2!-supported 5#-nuclease reactions,
implying they occupy similar sites in the protein (15, 22);
they have also been shown to facilitate 5#-flap threading and
local DNA conformational changes (12, 17). Analysis of sam-
ples after both FRET and later CD experiments demon-
strated negligible extent of reaction under all the conditions
used (data not shown).
Catalytically Important Active Site Features Are Not
Required for DNA Junction Bending—The FRET efficiency of
DF(DAL) alone was similar$Ca2! (0.23–0.25) but was signif-
icantly greater than the corresponding duplex (0.1) (Fig. 2D).
This indicates that the DF substrate has an overall conforma-
tion that is more bent than duplex DNA, even before the addi-
tion of protein. This is in line with singlemolecule observations
where a double flap was seen to sample both a linear stacked
and a bent conformation (9). Sequential addition ofWThFEN1
FIGURE1.FEN1DNAbendinganddoublenucleotideunpairing.A, schematic of the FEN1catalyzedhydrolysis of adouble flapDNAyielding single-stranded
DNA and double-stranded nickedDNAproducts. An arrow indicates the site of reaction. Each nucleobase is represented by a different color. B, hFEN1-product
complex (ProteinData Bank code3q8k) showing100° bentDNA.C, schematic of double nucleotide unpairingproposed toposition the scissile phosphodiester
bond between the!1 and%1 nt on active site (pink) metal ions (cyan).D, cartoon representation of the active site in the FEN1-product structure (Protein Data
Bank code 3q8k) showing the phosphatemonoester of the unpaired%1 nt in contact withmetal ions (cyan) and helical gateway (base #2-#4) and cap (top of
#4 and #5) residues mutated in this study.
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to DF(DAL) produced an increase in corrected FRET signal
until a plateau was reached at saturating protein, regardless of
whether divalent ions were present or not (Fig. 2, B and D).
FIGURE 2. FRET data showing DNA bending on complexation with hFEN1 andmutants. A, schematic of double flap (DF, endonucleolytic) and single flap
(SF, exonucleolytic) DNA constructs (Table 2) used in FRET studies, donor! fluorescein (blue) and acceptor! TAMRA (red). Nonlabeled (NL), donor only (DOL),
acceptor-only (AOL), and donor and acceptor (DAL) versions of these constructs were used. B, variation in energy transfer efficiency of DF(DAL) upon addition
of WT hFEN1measured at pH 7.5 and 37 °C in the presence of Ca2" ions (blue) or EDTA (red) fitted to Equation 4. C, derived (Equation 4) values of Kbend for the
DF (double flap) and SF (single flap) substrates (Table 2) with WT and mutated hFEN1s as indicated in Ca2" (purple) and EDTA (pink). MMDF contained a"1
mismatch, 5#-hydroxyl single (3#) flap (HOSF) lacked a 5#-phosphate, and SADF had a 5#-conjugated streptavidin. Standard errors from repeat experiments are
shown.D, derived (Equation 4) minimum (Emin) andmaximum (Emax) energy transfer in Ca
2" (blue) and EDTA (orange) corresponding to the indicated protein
withDF (double flap) or SF (single flap) substrates as inC. DuplexDNAwasmeasured for comparisonwithoutprotein inCa2"-containingbuffer. Standarderrors
from repeat experiments are shown.
TABLE 1
Sequences of oligonucleotides used to construct substrates for FRET,
kinetic, and ECCD experiments
A (in red), 2-aminopurine; Bio, biotin; TAMRA, tetramethylrhodamine; Fluor,
internal fluorescein; FAM, fluorescein; p, phosphate.
TABLE 2
Oligonucleotide combinations used tomake the substrate constructs










DF (NL) Tcflap" Tcca" Tccd
DF (DOL) Tcflap" Tcca" Tcdonor
DF (AOL) Tcflap" Tccd" Tcaccept
DF (DAL) Tcflap" Tcdonor" Tcaccept
SF (NL) EP-Fret" Tcca" Tccd
SF (DOL) EP-Fret" Tcca" Tcdonor
SF (AOL) EP-Fret" Tccd" Tcaccept
SF (DAL) EP-Fret" Tcdonor" Tcaccept
HO-SF (NL) EO-Fret" Tcca" Tccd
HO-SF (DOL) EO-Fret" Tcca" Tcdonor
HO-SF (AOL) EO-Fret" Tccd" Tcaccept
HO-SF (DAL) EO-Fret" Tcdonor" Tcaccept
MM"1-DF (NL) MM"1-Fret" Tcca" Tccd
MM"1-DF (DOL) MM"1-Fret" Tcca" Tcdonor
MM"1-DF (AOL) MM"1-Fret" Tccd" Tcaccept
MM-DF (DAL) MM-Fret" Tcdonor" Tcaccept
Duplex (DOL) TcdonorD" Tcca
Duplex (DAL) TcdonorD" Tcaccept
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When DF (DAL) was fully bound to hFEN1 (FRET efficiency at
end point), a slightly higher energy transfer valuewas reproduc-
ibly observed with Ca2! ions present (Fig. 2, B and D). The
origin of this end point difference is unknown. Nevertheless,
the derived equilibrium dissociation constants Kbend " Ca2!
only varied by a factor of two (13" 1.7 nM with Ca2!, 21" 1.4
nM without), implying that the presence of divalent ions is not
required for DNA to adopt a bent conformationwhen bound to
hFEN1 (Fig. 2, B and C). Because divalent ions are required for
the threading of 5#-flaps (12) and the transfer of the scissile
phosphodiester to the active site (17), these results suggest that
the DF substrate binds with similar affinity regardless of
whether either of these conformational changes have taken
place. This is consistent with the crystal structure that shows
that most of the interaction surface area is with the duplex
portions of the substrate (8).
To investigate the requirements for bending of DF DNA, we
also tested mutated hFEN1s K93A, R100A, K93A/R100A,
L130P, Y40A, andD181A (Fig. 1D). Superfamily conserved res-
idues Lys93 andArg100 are located at the base of!4 forming part
of the hFEN1 helical gateway (8) fromwhere they protrude into
the hFEN1 active site and are not predicted to be involved in
substrate interactions until the DNA is positioned to react.
Leu130 is a component of the helical cap (!5) and is removed
from the active site, although the mutation L130P is presumed
to interferewith formation of the secondary structure of the cap
(13). Tyr40 is an!2 gateway residue seen to interact with the!1
nucleobase (numbered relative to the scissile phosphate diester;
Fig. 1C) of the DNA substrate when base-paired (8), whereas it
stacks on the $1 nucleobase after reaction as seen in hFEN1
product structures (Fig. 1D). Asp181 is an active site carboxylate
in direct contact with the catalytic metal ions in hFEN1 struc-
tures (8). Mutation of Asp181 may alter the number of metal
ions bound and/or their precise positioning. Earlier studies
have shown that undermaximal single turnover conditions, the
mutations K93A, R100A, K93A/R100A, and L130P decrease
the rate of the hFEN1 reaction by factors of at least 2,000 (12,
13). To determine the effects of the Y40A and D181A muta-
tions, we measured the maximal single turnover rate constants
(kSTmax) using KDF substrate (Tables 1 and 2) and compared
them with the WT protein (kSTmax % 740 min$1) (data not
shown). For Y40A, kSTmax% 7.91" 0.01min$1, and forD181A,
kSTmax% 0.075" 0.003min$1, corresponding to rate decreases
of 102 and 104, respectively. Thus, all the mutations studied
have substantive and in most cases, very severe impacts on
hFEN1 catalysis.
DF (DAL) adopted a bent conformation when bound to all
the mutated proteins as seen by an increase in FRET signal
upon addition of hFEN1. As with the wild type protein, only
subtle variations inKbend were observed with and without diva-
lent metal ions (2-fold at most) (Fig. 2C). The exception was
Y40A, where mutation stabilized the hFEN1-DNA complex in
the presence of EDTA. Only small changes in Kbend were
observed relative to theWT protein"Ca2! (less than 3-fold at
most), indicating that none of the mutated residues are critical
to DNA binding and bending. Like theWT protein, differences
between the FRET efficiency at the end point"Ca2! were also
observed with Y40A, R100A, K93A/R100A, and L130P with
titrations in Ca2! buffer producing a higher value (Fig. 2D). In
contrast, the end points with D181A and K93A remained con-
stant"Ca2!. Notably, all the altered FEN1 proteins have Kbend
values in the low nanomolar range"Ca2!, demonstrating that
theywill all fully bind substrate under the conditions of the local
DNA unpairing (2AP)2 CD experiments described later (12.5
"M protein, 10 "M DNA).
A Mismatch at the !1 Position of the Substrate Does Not
Prevent Bending—Previously, we showed that double-flap sub-
strates bearing a mismatch at the!1 position (numbering rel-
ative to scissile phosphodiester bond in the 5#-flap/exo strand;
Fig. 1C) produced reduced reaction rates and reduced reaction-
site specificity (16). This shows that theDNAbase pair integrity
at the!1 position is a requirement for optimal hFEN1 reaction.
To determine whether a mismatch at !1 affects the ability to
bind and bend substrate DNA, we prepared the appropriate
construct MMDF(DAL) (Fig. 2A) and performed the same
FRETmeasurements (Fig. 2C). Like the alteration of conserved
active site residues, the presence of a mismatch at the!1 posi-
tion does not prevent bending, but it does weaken substrate
affinity 4–5-fold (in Ca2! DF Kbend % 13 " 1.7 nM, MMDF
Kbend% 58" 6.8 nM).
A 5#-Flap Is Not Required for DNA Bending—An initial
conundrum in the reactions of 5#-nucleases concerned their
ability to carry out both endonucleolytic reactions on substrates
that possessed 5#-flaps and 5#-exonucleolytic reactions on sub-
strates that lacked such flaps. To test whether the absence of
5#-flap altered the stability of hFEN1-DNA complexes, we car-
ried out a FRET experiment with a single flap substrate
(SF(DAL)) that lacked the 5#-flap (Fig. 2A). Consistent with the
crystal structure and the fact that hFEN1 reaction is susceptible
to dsDNA (nicked) product inhibition (8, 20), the absence of a
5#-flap did not significantly alter the stability of the complex or
the ability to bend (Kbend% 12" 1.1 nMwith Ca2!, 20" 2.1 nM
without) (Fig. 2C). This is also consistent with similarKm values
observed earlier for exonucleolytic substrates bearing a 3#-flap
compared with double flaps (20). However, the dissociation
constant of SF substrate was sensitive to the status of the 5#-ter-
minus. HO-SF (DAL), which lacked a 5#-phosphatemonoester,
was bound an order ofmagnitudemoreweakly by the protein in
the presence of Ca2! ions, and binding was also altered in
EDTA to a lesser extent (Fig. 2C). This suggests that the
5#-phosphate forms an interaction with the protein facilitated
by the local DNA conformational changes that occur in the
presence of Ca2! ions. Nevertheless, even HO-SF(DAL) would
be fully bound to the protein under the conditions used to
probe local DNA conformational changes by CD below. Like
DF(DAL), SF(DAL) and HO-SF(DAL) also had a greater FRET
value in the absence of protein (0.19–0.21) than the corre-
sponding duplex (0.1), suggesting that the SF substrates can
adopt a bent conformation in the absence of protein (Fig. 2D).
Accommodation of the 5#-Flap Is Not Required for DNA
Bending—Although FEN1 substrates correctly positioned to
react have yet to be observed crystallographically, it is suggested
that the 5#-flap departs from the active site passing underneath
the helical cap through the hole created by the cap (top of !4
and !5) and gateway (base of !4 and !2) (Fig. 1, B and D) (1, 8,
12–14). Evidence for this so-called threading hypothesis came
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from experiments where streptavidin is added to 5!-biotin-la-
beled substrates before or after binding to the protein (12, 14).
Prior conjugation—assumed to “block” substrate threading—
severely retards FEN1 action, but conjugation to preformed
DNA-protein complex does not affect the reaction rate. Fur-
thermore, only this latter “trapped” substrate cannot exchange
with competitor DNA.
We wished to ascertain whether, when present, accommo-
dation of the 5!-flap is necessary for global substrate bending. A
5!-strepavidin complex with DF(DAL) (12) was used
(blocked SADF) and showed a higher FRET efficiency in the
absence of protein (Fig. 2D). This suggests a more bent over-
all conformation than uncomplexed DNA, likely because of
the presence of a bulky streptavidin homotetramer conju-
gated to the 5!-terminus. Nevertheless, the blocked SADF
with hFEN1-Ca2" had a similar FRET efficiency at end point
as the unmodified substrate, albeit with a 5-fold increase in
Kbend (Fig. 2C). This result demonstrates that accommoda-
tion of the 5!-flap underneath the helical cap is not required
for global substrate bending.
Local DNA Conformational Change of the Reacting Duplex
A Substrate 5!-Flap Is Not Required for Local DNA Confor-
mational Change—In hFEN1-product structures, the #1 nt is
unpaired and extrahelical (Fig. 1,B andD) such that its 5!-phos-
phate monoester contacts active site metal ions, whereas the
adjacent#2 nt remains base-paired (8) (numbering of 5!-flap/
exo strand, (Fig. 1C)). In contrast, structures of hFEN1-sub-
strate DNA, where the substrate has no 5!-phosphate monoes-
ter, showed a base-paired substrate close to but not in the active
site. Thus, it was deduced that 2 nt of the substrate unpair to
allow the scissile phosphate to contact active site ions. We pre-
viously studied this local DNA conformational change using
substrate or product constructs labeled with tandem 2APs at
the #1 and #2 positions (DF#1#2 and P#1#2, respectively)
(17). An exciton coupling between the adjacent 2APs produces
a signal in the low energy region of the CD spectrum, the mag-
nitude of which varies depending upon the relative orientation
of the electronic transition dipole moments of the nucleobases.
This exciton-coupled CD (ECCD) signal is readily followed
because it is partially visible in a region of the spectrum where
unmodified DNA bases and protein are transparent (24, 25).
When either DF#1#2 or P#1#2 was bound to hFEN1 in EDTA
buffer, a strong ECCD signal was observed (!max $ 326 nm),
consistent with the 2APs remaining stacked in the duplex. In
the presence of hFEN1-Ca2", the signal was dramatically
reduced to nearly zero. This was deduced to reflect the DNAs
adopting a conformation of the kind seen in the product crystal
structure, with transfer of the 5!-nucleotide of product, or the
"1 and#1 nt of substrate, to the active site (Fig. 1D).
By analogy to these earlier experiments, 2APswere located at
the #1 and #2 positions of a SF substrate (SF#1#2) to test
whether exonucleolytic substrates lacking the 5!-flap were also
unpaired by hFEN1-Ca2" (Tables 1 and 2 and Fig. 3). As seen
previously, the ECCDsignal of the isolated (2AP)2 single-strand
(ssSF#1#2) was increased in magnitude, and the maximumwas
red-shifted to 326 nm upon forming the duplex SF#1#2 (Fig.
3A) (17). On addition of hFEN1-Ca2" to this substrate, the sig-
nal was dramatically reduced to near zero (Fig. 3,A andB). This
behavior is similar to that observed earlier with DF#1#2 or
P#1#2 (17). When EDTA was added to the hFEN1-
Ca2"!SF#1#2 sample, a strong ECCD signal at 326 nm was
restored. This demonstrates that the 5!-flap is not required for
a change in respective orientation of the #1 and #2 nt, while
confirming the presence of active site divalent metal ion(s) is
essential. Moreover, both exonucleolytic (SF) and endonucleo-
lytic (DF) substrates undergo analogous local DNA conforma-
tional changes.
FEN1 Conserved Residues Are Not Required for#1#2 Local
DNA Conformational Change—Similar experiments were con-
ducted with SF#1#2 andmutant hFEN1 proteins. Fig. 3B shows
the magnitude of the ECCD signal at 326 nm for each mutated
protein %Ca2". K93A, R100A, Y40A, and K93A/R100A were
all capable of effecting local conformational change of SF#1#2
in the presence of Ca2", with K93A most closely matching the
spectra obtained withWT protein in Ca2". As seen previously
with DF#1#2 (13, 17), spectra of SF#1#2 produced by R100A,
Y40A, and K93A/R100A with Ca2" contained an additional
minimum at 310 nm (data not shown). This suggests an
altered orientation of the #1 and #2 nt to that produced by
WT and K93A hFEN1s. We found that D181A-Ca2" was
able to bring about an analogous conformational change to
WT protein (Fig. 3B), which was surprising given that no
active site metal ions were visible in an x-ray structure of
D181A bound to SF DNA substrate in the presence of Ca2"
and the DNA remained base-paired (8). In contrast, the
ECCD signal at 326 nm with L130P was similar%Ca2", indi-
cating that this protein does not facilitate the local DNA
conformational change. Together, these results demonstrate
that conserved residues are not required to bring about a
change in the orientation of the#1 and#2 nt in exonucleo-
lytic DNA substrates, although the intact secondary struc-
ture of the helical cap is. The results obtained with mutated
hFEN1s strongly resemble those previously obtained with
DFs (13, 17), underscoring that there are no overall
differences between the behaviors of exonucleolytic (with-
out 5!-flap) and endonucleolytic (with 5!-flap) hFEN1
substrates.
A 5!-Phosphate Is Not Required for Local DNA Conforma-
tional Change Monitored at the #1 and #2 nt—In the exonu-
cleolytic FEN1 substrate SF#1#2, the "1 nt has a terminal
5!-phosphate, whereas the double flap substrate DF#1#2 has a
5!-phosphate diester (followed by the flap) in the correspond-
ing position. Both substrates underwent a similar local DNA
conformational changewhenboundby hFEN1-Ca2". A SF sub-
strate lacking a 5!-phosphate (i.e. 5!-OH) crystallized with
hFEN1 in base-paired form, despite the presence of active site
metal ions (8). Furthermore, we previously reported that SF
substrates lacking the 5!-phosphate monoester showed a
20-fold decrease in reaction efficiency, and we hypothesized
that this was due to the inability to affect the local conforma-
tional change. To test whether the 5!-phosphate monoester is
required for reorientation of the #1 and #2 nt, we created a
substrate lacking the 5!-phosphate, HO-SF#1#2. Surprisingly,
we observed that this substrate underwent a change in orienta-
tion of the 2APs upon addition of hFEN1-Ca2" with the signal
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reducing close to zero at 326 nm (Fig. 3C). However, unlike the
5!-phosphorylated SF"1"2, the spectra also contained a mini-
mum at 315 nm. Thus, the presence of a 5!-phosphate is not
required for the WT protein to bring about local DNA confor-
mational change involving the "1 and "2 nt in substrate
DNAs, but the orientation of the 2APs may differ from that
adopted by the 5!-phosphorylated form (Fig. 3,A andC). Addi-
tionally, all the mutated proteins had the same response to
HO-SF"1"2 asSF"1"2 with the exception of D181A, where
hFEN1-Ca2# reduced the ECCD signal to a lesser extent (Fig.
3D).
StreptavidinBlocking of 5!-Flaps Prevents LocalDNAConfor-
mational Change—To test whether the severely reduced reac-
tion rates observed with 5!-streptavidin blocked substrates
resulted from inability to transfer substrate to the active site, we
created a 5!-biotinylated double flap with 2AP at "1 and "2,
BDF"1"2. The addition of biotin did not alter behavior of the
substrate in ECCD experiments (Fig. 4A), but its behavior when
the 5!-flap was blocked with streptavidin was markedly differ-
ent. In this case, addition of hFEN1-Ca2# did not alter the
ECCD signal, indicating that local substrate conformational
change is prevented by the addition of the streptavidin block.
In contrast, when streptavidin was added to trap a preformed
complex of hFEN1-Ca2#!BDF"1"2, the ability to change the
conformation of the substrate was retained. These results dem-
onstrate that proper accommodation of the 5!-flap of the DNA
substrate is required for the local conformational change nec-
essary for reaction.
AWatson-Crick Base Pair Is Required at the Terminus of the
Hydrolyzed Duplex—To test whether the decreased rate and
specificity with mismatched substrates could be attributed
to inhibition of the local DNA conformational change, we
created a double flap substrate with a #1 C-C mismatch
retaining 2APs at positions "1 and "2, denoted
MM#1DF"1"2 (Fig. 4B). The ECCD signal produced by WT
hFEN1-Ca2# and MM#1DF"1"2 was decreased slightly
compared with that for the mismatch substrate alone or the
same sample in EDTA but did not approach the nearly zero
signal produced with fully base-paired substrate under these
conditions. This implies that although the local DNA struc-
ture of the mismatched substrate may be subtly altered by
FIGURE 3. hFEN1 and mutant mediated conformational change of 2AP-containing single flap SF!1!2 monitored by ECCD. All measurements were
carriedout at 20 °CandpH7.5.A, divalentmetal ion-dependent reduction in2APexcitoncoupling signal occurredwhensubstrateSF"1"2wasbound tohFEN1,
indicative of local substrate conformational change. Unbound SF"1"2 (black), the corresponding single strand (ssSF"1"2, dashed line) and SF"1"2 bound to
hFEN1 (blue) all in Ca2#-containing buffer. SF"1"2 bound to hFEN1 in buffer containing 25mM EDTA (red). B, comparison ofmolar ellipticity per 2AP residue at
326 nm of SF"1"2 bound toWT- andmutant hFEN1s in Ca
2# (purple) and EDTA (pink) buffers. Standard errors from repeat experiments are shown. C, divalent
metal ion-dependent reduction in 2AP exciton coupling signal occurred when substrate HO-SF"1"2, which lacks a 5!-phosphate, was bound to hFEN1,
indicative of local substrate conformational change. UnboundHO-SF"1"2 (black), the corresponding single strand (ssHO-SF"1"2, dashed line) and HO-SF"1"2
bound to hFEN1 (blue) all in Ca2#-containing buffer. HO-SF"1"2 bound to hFEN1 in buffer containing 25mM EDTA (red).D, comparison of molar ellipticity per
2AP residue at 326 nmof single flapHO-SF"1"2 free or bound toWT andmutant hFEN1s in Ca
2# (purple) and EDTA (pink) buffers. The unbound corresponding
single strand is also shown.
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hFEN1-Ca2!, it does not adopt the same conformation as the
Watson-Crick base-paired substrate, or there is a significant
change in the partition between the base-paired and active
site positioned forms.
Local DNA Conformational Change at the !1"1 Position
Requires Conserved Residues and a!1 Phosphate—Placing the
scissile phosphodiester bond on hFEN1 active site metal ions is
presumed to require that both the !1 and "1 nt of the sub-
strate unpair from duplex (Fig. 1C). Because there are currently
no x-ray structures of hFEN1 in complex with substrate posi-
tioned to react, the relative juxtaposition of the "1 and !1
nucleobases in this catalytically competent state are unknown.
To use ECCD to inform on this state, we created single flap
SF!1"1 and double flap DF!1"1 substrates containing tandem
2APs at the"1 and!1 positions (Fig. 4, C and D, and 5, A and
B). In both cases, addition of Ca2! to hFEN1 complexes with
the respective substrates substantially decreased the ECCD sig-
nal at 326 nm. This implies that in the presence of hFEN1-Ca2!
stacking interactions between the !1 and "1 nt are signifi-
cantly altered.
When the same mutated FEN1s detailed above were
employed, K93A most closely resembled the behavior of the
WT protein with SF!1"1 (Fig. 5B). Both R100A-Ca2! and
K93A/R100A-Ca2! also reduced the ECCD signal of SF!1"1,
although not to the same extent (Fig. 5B). However, Y40A,
L130P, and D181A did not significantly alter the signal with
SF!1"1 at 326 nm #Ca2!. With double flap substrates and
identically positioned 2APs (DF!1"1), R100A-Ca2! and Y40A-
Ca2! both reduced the ECCD signal but not to the same extent
as the WT protein in Ca2! buffer (Fig. 4D).
When the 5$-phosphate was removed from the SF substrate
(HO-SF!1"1) ECCD signals were significantly altered. A
smaller decrease in ECCD signal at 326 nm was observed in
the presence of divalent ions and WT protein relative to the
same sample in EDTA (Fig. 5C). Moreover, the maximum of
the signal with hFEN1-Ca2! was blue-shifted relative to free
HO-SF!1"1. When mutated hFEN1s interacted with
HO-SF!1"1, only K93A was able to mimic the small change
of WT hFEN1-Ca2! with other proteins producing negligi-
ble effects within error.
Combined results imply that changes in the relative orienta-
tion of the!1 and"1 nt occur consistent with reduced stack-
ing of these nucleobases once unpaired and extrahelical. These
changes evidently require the presence of the!1 5$-phosphate,
FIGURE 4. ECCDmonitored conformational change of!1"1 2AP and 5!-modified"1"2 double flap substrates. All measurements were carried out at
20 °C and pH 7.5. ss, single strand. Standard errors from repeat experiments are shown. A, comparison of molar ellipticity per 2AP residue at 326 nm of
5$-streptavidin blocked (BL) and free and bound to hFEN1 and streptavidin-trapped (TR) complexes in Ca2! (purple) and EDTA (pink) buffers. Blocked complex
was formed by adding streptavidin to the substrate before the addition of hFEN1, whereas trapped was formed by adding streptavidin to the preformed
hFEN1-Ca2!-BDF complex.B, comparisonofmolar ellipticity per 2AP residue at 326nmof adoubled flap substratewith a!1mismatch (MMDF"1"2)when free
and bound to WT-hFEN1 in Ca2! (purple) and EDTA (pink) buffers. The corresponding single strand is also shown. C, divalent metal ion-dependent reduction
in 2AP exciton coupling signal occurred when substrate DF!1"1 was bound to hFEN1, indicative of local substrate conformational change. Unbound DF!1"1
(black), the corresponding single strand (ssDF!1"1, dashed line) and DF!1"1 bound to hFEN1 (blue) all in Ca
2!-containing buffer. DF!1"1 bound to hFEN1 in
buffer containing 25mMEDTA (red).D, comparison ofmolar ellipticity per 2AP residue of double flapDF!1"1 at 326 nmwhen free andbound toWT andR100A
hFEN1s in Ca2! (purple) and EDTA (pink) buffers. The corresponding single strand is also shown. Standard errors from repeat experiments are shown.
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Tyr40, Arg100, and Asp181 (Fig. 6A). We presume this reflects a
conformation of the unpaired substrate that allows optimal ori-
entation of the scissile phosphate relative to active site metal
ions, basic residues, and attacking hydroxide. However,
changes involving the!1 and!2 nt do not require these sub-
strate and protein features, suggesting that in addition to
requirements to effect unpairing of the substrate, additional
residues are important to optimally position the unpairedDNA
for reaction. (Fig. 6B). In contrast, perturbation of the second-
ary structure of the helical cap (L130P), prevention of substrate
FIGURE 5. ECCD monitored conformational change of single flap!1"1 2AP containing substrates upon binding hFEN1 and mutants. All measure-
ments were carried out at 20 °C and pH 7.5. ss, single strand. A, divalent metal ion-dependent reduction in 2AP exciton coupling signal occurred when single
flap SF"1!1 was bound to hFEN1, indicative of local substrate conformational change. Unbound SF"1!1 (black), the corresponding single strand (ssSF"1!1,
dashed line) and SF"1!1 bound to hFEN1 (blue) all in Ca
2"-containing buffer. SF"1!1 bound to hFEN1 in buffer containing 25mM EDTA (red). B, comparison of
molar ellipticity per 2AP residue of SF"1!1 at 326 nm when free and bound to WT and mutant hFEN1s in Ca
2" (purple) and EDTA (pink) buffers. The corre-
sponding single strand is also shown. Standard errors from repeat experiments are shown. C, a small divalent metal ion-dependent reduction in 2AP exciton
coupling signal occurredwhen single flap HO-SF"1!1 that lacks a 5#-phosphatewas bound to hFEN1, indicative of deficiency in bringing about local substrate
conformational change. UnboundHO-SF"1!1 (black), the corresponding single strand (ssHO-SF"1!1, dashed line) and HO-SF"1!1 bound to hFEN1 (blue) all in
Ca2"-containing buffer. HO-SF"1!1 bound to hFEN1 in buffer containing 25 mM EDTA (red). D, comparison of molar ellipticity per 2AP residue of single flap
HO-SF"1!1 at 326 nmwhen free and bound toWT andmutant hFEN1s in Ca
2" (purple) and EDTA (pink) buffers. The corresponding single strand is also shown.
Standard errors from repeat experiments are shown.
FIGURE 6. Schematicmodel summarizing the responses of hFEN1-substrate complexes to addition of divalentmetal ions based on ECCD results. Part
(a), in the presence of divalent ions, unmodified substrates interacting withWT and K93A hFEN1s adopt an orientation of the!1 and!2 nt that is unstacked
consistentwith unpairedDNA. Also, stacking between the!1 and"1 nt is substantially reduced, suggesting control of their relative positions after unpairing.
This observed conformational ordering of nucleobases is presumed to effect optimal contact between the scissile bond and active sitemetal ions and catalytic
residues. Part (b), a divalent metal ion-induced substrate state where there is a gross change in the orientation of the!1 and!2 nt suggestive of local DNA
unpairing is adopted by R100A, D181A, and Y40A with unmodified substrates and by all proteins (except L130P) with substrates lacking a 5#-phosphate. In
these cases, however, there is evidence that stacking reminiscent of ssDNA remains between the!1 and"1 nt, suggesting an unpaired DNA state that is not
optimally positioned for reaction. Part (c), the L130Pmutation,modifications of the substrate that prevent accommodation of the 5#-flap under the helical cap
(i.e. streptavidin conjugation to terminus of 5#-flap), or a mismatch at the"1 position prevent a DNA conformational change on addition of divalent ions. In
these cases, the substrate is assumed to remain base-paired.
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threading with a 5!-streptavidin block, or the inclusion of a"1
mismatch abolishes the ability of the protein-substrate com-
plex to undergo the usual local DNA conformational changes
when divalent metal ions are added (Fig. 6C).
Discussion
Selection of both the correct DNA substrate and the correct
phosphate diester bond for hydrolysis are key to hFEN1 biolog-
ical function during replication and repair. Incorrect hydrolysis
by hFEN1 would endanger genome integrity and necessitate
the action of DNA repairmechanisms. The data presented here
begin to reveal the details, interrelationships, and complexity of
this process. The DNA junction itself is first recognized by its
ability to bend 100°. This bent substrate conformation allows
recognition of a single-nt 3!-flap and places the 5!-end of the
reacting duplex close to the hFEN1 active site. However, the
FRET results presented here demonstrate that junction bend-
ing does not require the 5!-portion of substrates to be accom-
modated by the protein either by threading 5!-flaps under the
helical cap or by transfer to the active site metal ions (Fig. 2).
Substrates that cannot transfer to the active site because metal
ions are not present are still bent when bound to hFEN1 pro-
tein. Similarly, substrates that lack a 5!-flap or where the 5!-flap
is prevented from threading underneath the helical cap are also
bent, albeit with modestly reduced stability in the case of the
streptavidin-blocked substrate. Thus, although global DNA
bending must precede the local DNA conformational change
necessary for reaction, it is not required to occur concomitantly
with this process.
The key process in enforcing hFEN1 reaction site specificity
is the transfer of the scissile phosphate diester located one nt
into the reacting duplex onto active site metal ions. ECCD of
(2AP)2 containing DNAs demonstrates that FEN1 substrates
do not require a 5!-flap to enable this change (Fig. 3), under-
scoring the fact that exonucleolytic and endonucleolytic reac-
tions of FEN1 substrates proceed by a common mechanism.
However, DNAs with a mismatch at the end of the reacting
duplex of the substrate are deficient in local DNA conforma-
tional changes (Figs. 4B and 6C). Similarly, the status of the
5!-termini of 5!-flaps is a determinant of the ability to bring
about local DNA conformational change. Notably, the DNA
substrate cannot position for reaction when the protein cannot
properly accommodate 5!-flaps, as demonstrated by 5!-strepta-
vidin blocking (Figs. 4A and 6C). Thus, when 5!-flaps with
bound protein (e.g.RPA) or lacking free 5!-termini (continuous
DNA of template strand) are encountered, reaction is pre-
vented because the scissile phosphodiester bond cannot access
the active site.
Alongside a requirement for threading of 5!-flaps demon-
strated here, earlier work examining changes in orientation of
the #1 and #2 nt in a (2AP)2 DF substrate concluded that
individual conserved residues of the hFEN1protein played little
part in this DNA conformational change. However, the pres-
ence of active site divalentmetal ions and the intact structure of
the helical cap were essential for this reorientation (12, 17).
Here, we show that this is also the case with exonucleolytic
substrates lacking a 5!-flap and that a 5!-phosphate is not
required for this #1 and #2 substrate distortion in these SF
substrates (Fig. 3). The orientation of the"1 and#1 nt is also
dependent on an intact helical cap and the presence of active
site divalent metal ions (Figs. 4, C and D, and 5). However, the
local conformational changes that occur with"1 and#1 nt are
markedly altered by changes in both the substrate and protein.
Despite clear evidence of hFEN1-Ca2" reorientation of the
#1 and#2 nt when SF substrates lack a 5!-phosphate (Fig. 3C),
only a small change is observed in the"1 and#1 ECCD signal
(Fig. 5C). Assuming that the position adopted by the substrate
in the presence of hFEN1-Ca2" reflects the catalytically viable
conformation, the 5!-phosphate monoester of SF substrates
must form a key interaction required to assemble this state.
Contacts to the 5!-phosphate monoester are also implied from
the FRET studies (Fig. 2C), and although the substrate could
still adopt the bent state, removal of the 5!-phosphate monoes-
ter of the SF substrate (HO-SF) increased the magnitude of
Kbend substantially in Ca2" buffer.With DF substrates, interac-
tions with the equivalent 5!-phosphate diester ("1 position, i.e.
the next phosphate 5! in the chain to the scissile phosphate)
presumably also play a key role in productive substrate posi-
tioning. This would explain earlier work demonstrating that
neutralization of the charge of this"1 5!-phosphate by conver-
sion to methyl phosphonate is detrimental to reaction (21).
Thus, both ECCD and FRET behaviors reported here are con-
sistent with earlier work in suggesting key interactions involv-
ing the substrate 5!-phosphatemonoester/diesterwhenDNA is
positioned to react within the active site.
The mutation of conserved residues did not produce any
substantive variation in the value of Kbend in the presence of
Ca2" (Fig. 2C). However, several of these residues were impli-
cated in active site substrate positioning by studies of the "1
and#1 ECCD signal (Figs. 5B and 6).When the hFEN1 protein
was altered to Y40A, there was no change in"1 and#1 ECCD
signal in the presence of divalent metal ions compared with
their absence with SF substrate and a substantially reduced
effect with DF substrate compared with that seen with WT
protein (Fig. 4D). Because Tyr40 forms stacking interactions
with either the"1 or#1 nucleobases in substrate and product
structures, respectively, these interactions are likely in the cat-
alytically competent state. Previous fluorescence studies have
revealed evidence for unusually fast quenching of substrate
2APs at both the "1 or #1 positions when bound to hFEN1-
Ca2", consistent with an interaction with Tyr40 (17). This was
interpreted as an equilibrium between paired and unpaired
forms of the substrate with Tyr40 interacting with the 2AP at
"1 in paired and#1 in unpaired conformations. The data pre-
sented here support the idea that the Tyr40 residue plays an
important role in optimal substrate positioning, and its muta-
tion to alanine was found to reduce the rate of cleavage of DF
substrate by a factor of 100.
There was also no change in "1 and #1 ECCD signal with
D181A-Ca2", and the lack of reorientation of the nucleobases
in this instance may be related to metal ion positioning in the
mutated protein (because Asp181 is directly coordinated to one
of the active site M2" ions). In addition, Arg100 appears to play
a role in reorientation of the "1 and #1 nt because with this
mutant the ECCD signal was reduced in the presence of Ca2",
but to a lesser extent than with WT hFEN1. Because the Arg100
DNA Conformational Changes for FEN1 Catalysis
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residue contacts the cleaved phosphate monoester in product
structures, it may well position the scissile phosphate diester in
active site positioned substrate complexes. In contrast, Lys93 does
not play a role in substrate positioning, and the impact of itsmuta-
tion to alanine seems to be entirely related to catalysis (23).
Overall, these studies unravel the interrelationships between
events in the hFEN1 catalytic cycle. Global DNA bending
involving interactions with the duplex regions of substrates is
essential to position the reacting duplex close to the active site.
This facilitates accommodation of the 5!-flap (when present)
and the local DNA conformational change required for reac-
tion, but neither of these events is a prerequisite for the initial
DNA interaction, suggesting that they occur after binding the
substrate duplex regions. Once substrate is bound in a bent
conformation, 5!-flaps, if present, are threaded underneath the
cap. Threading is a prerequisite for transfer of the scissile phos-
phodiester to the active site in double flap substrates. Finally,
the substrate adopts a single-stranded catalytically competent
conformation traveling through the helical gateway (base of !4
and!2) contacting active sitemetal ions. ECCD results with"1
and"2 (2AP)2 substrates show that metal ions are sufficient to
draw the substrate toward the active site providing the cap can
adopt a helical state and that 5!-flaps can be threaded (Fig. 6B).
However, ECCD data with #1 and "1 (2AP)2 DNAs demon-
strate that the precise positioning of substrate is dependent on
interaction with Tyr40 and Arg100 residues of the helical gate-
way and requires the presence of active site Asp181 and contacts
to#1 phosphate of substrate (Fig. 6A).
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Phosphate steering by Flap Endonuclease 1
promotes 50-flap specificity and incision to prevent
genome instability
Susan E. Tsutakawa1,*, Mark J. Thompson2,*, Andrew S. Arvai3,*, Alexander J. Neil4,*, Steven J. Shaw2,
Sana I. Algasaier2, Jane C. Kim4, L. David Finger2, Emma Jardine2, Victoria J.B. Gotham2, Altaf H. Sarker5,
Mai Z. Her1, Fahad Rashid6, Samir M. Hamdan6, Sergei M. Mirkin4, Jane A. Grasby2 & John A. Tainer1,7
DNA replication and repair enzyme Flap Endonuclease 1 (FEN1) is vital for genome integrity,
and FEN1 mutations arise in multiple cancers. FEN1 precisely cleaves single-stranded (ss)
50-flaps one nucleotide into duplex (ds) DNA. Yet, how FEN1 selects for but does not incise
the ss 50-flap was enigmatic. Here we combine crystallographic, biochemical and genetic
analyses to show that two dsDNA binding sites set the 50polarity and to reveal unexpected
control of the DNA phosphodiester backbone by electrostatic interactions. Via ‘phosphate
steering’, basic residues energetically steer an inverted ss 50-flap through a gateway over
FEN1’s active site and shift dsDNA for catalysis. Mutations of these residues cause
an 18,000-fold reduction in catalytic rate in vitro and large-scale trinucleotide (GAA)n
repeat expansions in vivo, implying failed phosphate-steering promotes an unanticipated
lagging-strand template-switch mechanism during replication. Thus, phosphate steering is an
unappreciated FEN1 function that enforces 50-flap specificity and catalysis, preventing
genomic instability.
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The structure-specific nuclease, flap endonuclease-1 (FEN1)plays a vital role in maintaining genome integrity byprecisely processing intermediates of Okazaki fragment
maturation, long-patch excision repair, telomere maintenance,
and stalled replication forks. During DNA replication and repair,
strand displacement synthesis produces single-stranded (ss)
50-flaps, at junctions in double-stranded (ds) DNA. During
replication in humans, FEN1 removes B50 million Okazaki
fragment 50-flaps with remarkable efficiency and selectivity to
maintain genome integrity1–3. Consequently, FEN1 deletion is
embryonically lethal in mammals4, and functional mutations can
lead to cancer5. FEN1 also safeguards against DNA instability
responsible for trinucleotide repeat expansion diseases6. As FEN1
is overexpressed in many cancer types7,8, it is an oncological
therapy target9,10.
Precise FEN1 incision site selection is central to DNA
replication fidelity and repair. FEN1 preferentially binds to
double flap substrates with a one nt 30-flap and any length of
50-flap, including zero. It catalyses a single hydrolytic incision one
nucleotide (nt) into dsDNA (Fig. 1a) to yield nicked DNA ready
for direct ligation11,12. Thus, FEN1 acts on dsDNA as both an
endonuclease (with 50-flap) and an exonuclease (without 50-flap).
Recent single molecule experiments show that FEN1 binds both
ideal and non-ideal substrates but decisively incises only its true
substrate13. In contrast to homologs in bacteriophage14–16 and
some eubacteria17, eukaryotic FEN1s do not hydrolyse within
50-flap ssDNA.
However, key features of FEN1 substrate selection remain
unclear. FEN1 must efficiently remove 50-flaps at discontinuous
ss-dsDNA junctions yet avoid genome-threatening action on
continuous ss–ds junctions, such as ss gaps or Holliday junctions.
Paradoxically, other FEN1 50-nuclease superfamily members3 are
specific for continuous DNA junctions: namely, ERCC5/XPG
(nucleotide excision repair), which acts on continuous ss-ds
bubble-like structures; and GEN1 (Holliday junction resolution),
which processes four-way junctions. Structures determined with
DNA of eukaryotic superfamily members lack ss-ds junction
substrate with 50-ssDNA or the attacking water molecule leaving
cardinal questions unanswered18–22. For example, structures of
FEN1 and Exo1 go from substrate duplex DNA with the scissile
phosphodiester far from the catalytic metals to an unpaired
terminal nt in the product; is the unpairing occurring before or
after incision?
Models of FEN1 specificity must address how ss–ds junctions
are recognized and how 50-flaps, as opposed to continuous
ssDNA are recognized. There are threading and kinking models.
To exclude continuous DNAs, 50-flaps may thread through a
‘tunnel’21,23–25 formed by two superfamily-conserved helices
flanking the active site, known as the ‘helical gateway,’ topped
by a ‘helical cap’ (Fig. 1b). Due to cap and gateway disorder in
DNA-free FEN1, they are thought disordered during threading
and to undergo a disorder-to-order transition on 30-flap
binding21,24,26. In this threading model, however, ssDNA passes
through a tunnel without an energy source and directly over the
active site, risking non-specific incision. These issues prompted
an alternative clamping model where the ss flap kinks away from
the active site11,20 (Fig. 1b). Whereas these models explain
selection against continuous DNA junctions, FEN1 exonuclease
activity does not require a 50-flap. Furthermore, how FEN1
prevents off target incisions and moves the dsDNA junction onto
the metal ions are not explained by these models.
Here crystallographic analyses uncover an unprecedented
electrostatic steering of an inverted 50-flap through the human
FEN1 (hFEN1) helical gateway. Gateway and cap positively-
charged side chains are positioned to ‘steer’ the phosphodiester
backbone across the active site, energetically promoting threading
and preventing nonspecific hydrolysis within the 50-flap.
Mutational analysis of these positively charged ‘steering’ residues
revealed an added role of phosphate steering in moving
dsDNA towards the catalytic metal ions for reaction.
Moreover, phosphate steering mutations efficiently blocked
Rad27 (S. cerevisae homolog of hFEN1) function, causing
a compromised response to DNA damaging agents and
dramatically increased expandable repeat instability.
Results
FEN1 selects for 50-flaps by steering flap through a gateway. To
obtain structures of hFEN1 with a ss 50-flap substrate for insight
into ss 50-flap selection, we crystallized three hFEN1 active site
mutants D86N, R100A and D233N with a double-flap (DF)
substrate and with Sm3þ (Fig. 1 and Supplementary Figs 1
and 2A)27. Mg2þ is the physiological cofactor. D86N, R100A and
D233N mutations slow the hFEN1 catalysed reaction rate by
factors of 530, 7,900 and 16 respectively (Supplementary Fig. 2B).
The DF substrates in the crystal structures had a ss 50-flap
(4–5 nt) and a 1 nt 30-flap, termed S4,1 or S5,1 (Supplementary
Fig. 1). The DNA-enzyme complex structures for hFEN1-D86N,
hFEN1-R100A, and hFEN1-D233N were determined to 2.8, 2.65,
and 2.1 Å resolution, respectively (Figs 1c,d and 2, Supplementary
Fig. 2 and Table 1). In all cases, the overall protein resembled
wild-type (wt) hFEN1 (with product DNA, PDB code 3Q8K)21,
with root mean square deviation (RMSD) values of 0.26
for hFEN1-R100A, 0.22 for hFEN1-D233N, and 0.42 for
hFEN1-D86N.
These structures show that FEN1 interacts primarily (88% by
PISA interface analysis28) with two regions of B100! bent
dsDNA supporting prior observations21, rather than to the ss
50-flap in these structures (Figs 1c,d and 2, Supplementary
Movie 2). FEN1 binding to dsDNA is mediated by four regions:
(1) a hydrophobic wedge (composed of helix 2 and helix
2–3 loop) and b pin (formed between b strands 8 and 9)
sandwich upstream and downstream dsDNA portions at the
bending point of the two-way junction with Tyr40 packing at
the ss/dsDNA junction; (2) a C-terminal helix-hairpin-helix
motif binds upstream dsDNA and the one nt 30-flap and is
absent from superfamily-related members hEXO1 (ref. 20) and
bacteriophage 50-nuclease structures29; (3) the helix-2turn-helix
(H2TH) motif with bound Kþ ion and positive side chains bind
downstream dsDNA; and (4) the two-metal ion active site near
the 50-flap strand. Much of the interaction (43% by PISA analysis)
is to the strand complementary to the flap strands, reinforcing
dsDNA specificity.
The dsDNA binding sites on either side of the active site,
the Kþ and the hydrophobic wedge, are spaced one helical turn
apart (Supplementary Movie 2). Their spacing enforces the
specificity for helical dsDNA and places the 50-flap in the active
site, selecting against unstructured ssDNA or 30-flaps that would
require a narrower spacing. Additionally, the minor-groove
phosphate backbone is recognized by superfamily-conserved
Arg70 and Arg192 pair spaced 14Å apart (Fig. 2, Supplementary
Movie 1). Unique to FEN1, cap positive side chains (Lys125,
Lys128, Arg129) interact with the template strand at the
ss/dsDNA junction (Supplementary Fig. 3, Supplementary
Movie 1). Lys128 and Arg47 pack against each other, linking
the 30-flap pocket to the gateway helices. The active site consists
of seven superfamily-conserved metal-coordinating carboxylate
residues plus invariant Lys93 and Arg100 from gateway helix 4
and Gly2 at the processed N-terminus (Figs 2 and 3c,
Supplementary Movie 4). An ordered gateway and cap formed
by helices 2, 4 and 5 are observed above the active site in these
three structures. Helix 2 Tyr40 forms part of the hydrophobic
wedge and packs against the duplex DNA at the bend.
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In the hFEN1-D86N and hFEN1-R100A structures, the ssDNA
(50-flap) region of the substrate threaded through the tunnel
formed by the gateway/cap (Figs 1d and 2a, and Supplementary
Fig. 2A and Supplementary Movie 1). This observation explains
how FEN1 excludes continuous DNA like Holliday junctions and
DNA bubbles. The third independent hFEN1-D233N crystal
structure captures two cleaved nts from the 50-flap bound on the
other side of the tunnel from the dsDNA, consistent with
threading (Fig. 3a and Supplementary Fig. 2A). Together, these
three distinct structures support the threading model to validate
substrates have a ss 50-flap.
Phosphate steering inverts the ss phosphodiester backbone. In
both threaded substrate structures, the ss 50-flap phosphodiester
backbone is ‘inverted’ between the þ 1 and þ 2 positions,
with the þ 2 and þ 3 phosphates facing away from the active
site metals and the DNA bases facing the metals (Fig. 1b,d
and Supplementary Movie 1). (We denote the plus and minus
positions relative to the scissile phosphate). This inversion would
place the flap phosphodiesters away from the catalytic metals and
thereby logically reduce inadvertent incision within the ssDNA.
In both structures, the inverted þ 1 phosphodiester is directly
between the gateway helices with the bases on either side of the
5’ flap substrate
hFEN1-D86N/substrate (front and side views)











































































Figure 1 | Specificity and inverted threading of ss50-flap in hFEN1 D86N substrate structure. (a) Schematic FEN1 incision on an optimal double-flap
substrate, incising 1 nt into dsDNA to ensure a ligatable product. (b) Proposed models for ssDNA selection. (c) Top view of hFEN1-D86N crystal structure
showing extensive interaction to dsDNA arms of 5’ flap substrate. The 5’-flap substrate is composed of three strands; the 50-flap strand (orange), the
template strand (brown), and the 30-flap strand (pink). Functionally critical regions in FEN1 include the gateway (blue) and the cap (violet) for selecting
substrates with ss-50-flaps, the hydrophobic wedge between the 30-flap binding site and the gateway/cap (dark green), the Kþ ion and H2TH (purple) that
interacts with the downstream DNA, the beta pin (grey) that locks in the DNA at the bend. Relative DNA orientation shown in schematic on lower right. (d)
Front and side views of hFEN1-D86N crystal structure showing helical gateway and cap architecture position positively-charged residues to steer ss 50-flaps
through a protecting gateway in an inverted orientation across the active site. Relative DNA orientation is shown in schematic. The inverted 50-flap ssDNA
is threaded between gateway helices (blue) and under the helical cap (violet). The inverted threading reveals charged interactions to basic sidechains in the
cap and van der Waals interactions to ssDNA. See also Supplementary Figs 1–3; Table 1, and Supplementary Movies 1 and 2.
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gateway. In the hFEN1-D86N structure, two basic residues of the
gateway/cap, Arg104 and Lys132, were within 4–7Å of the þ 1,
þ 2 and þ 3 phosphodiester. These residues are positioned to
energetically promote threading and an inverted orientation.
They are conserved in FEN1 and semi-conserved across the
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Figure 2 | FEN1 superfamily sequence and secondary structure alignment. Map of FEN1 secondary structure (PDB code 3q8k), structural elements,
and mutants to a sequence alignment of FEN superfamily human members. XPG residues 117–766 were removed (dash) to facilitate alignment.
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(Fig. 2 and Supplementary Fig. 3)3,21,30. The þ 2 and þ 3 nt of
the 50-flap were sandwiched between the main chain (residues
86–89 and residues 132–135) on one side of the channel and
Leu97 on the other (Supplementary Fig. 2C) by non-sequence
specific van der Waals contacts. The overall inverted flap orientation
resembles the hFEN1-R100A structure with the þ 1 phosphate
remaining within 7Å of Arg104, but shifted towards Arg103,
presumably due to Arg100 removal. Together, these substrate
structures suggest that basic residues enable a phosphate
steering mechanism, which we here define as electrostatic
interactions that can dynamically position the phosphodiester
backbone.
Shifting of the scissile phosphate and the catalytic mechanism.
In the hFEN1-D86N structure, we were surprised that the
scissile phosphate was within catalytic distance of the active site
while surrounding bases remained basepaired to the template
strand (Fig. 3). This contradicts the prevailing hypothesis
that surrounding bases must unpair for the scissile phosphate to
move into the active site for incision3. Similarities and
functionally-significant differences appeared on closer
examination of hFEN1-D86N, hFEN1-R100A, and an earlier
structure of FEN1-substrate with no 50-flap or þ 1 phosphate
(PDB code 3Q8L). In all three substrate structures, the dsDNA
major groove is widened as it approaches the active site, and
DNA bases flanking the scissile phosphate are stacked with one
another, with the þ 1 base packed against Tyr40. However, the
basepairing, the scissile phosphodiester bond location and the
Tyr40 rotamer are distinctly different in the respective complexes,
despite containing the same dsDNA sequence. In the 3Q8L
structure, the DNA remained fully basepaired, and the scissile
phosphodiester was positionedB6Å away from catalytic metals.
In the hFEN1-R100A structure, the scissile phosphodiester bond
wasB4–5Å away from the metal ions, although " 1 and þ 1 nts
have moved towards the active site and away from the template
strand. The " 1 and " 2 nts display less base overlap (stacking),
and the þ 1 and " 1 nts are no longer hydrogen bonded to the
template strand (4–6Å apart).
In striking contrast, the scissile phosphodiester bond was
directly coordinated to the one active site metal ion in the
hFEN1-D86N structure (Fig. 3c). Furthermore, the þ 1 and
" 1 nts remained unexpectedly basepaired to the template strand,
which is shifted relative to the other substrate structures via
a dsDNA distortion surrounding the scissile phosphodiester
(Fig. 3b and Supplementary Fig. 2D,E). There is no base stacking
between " 1 and " 2 nts in the 50-flap strand; instead, an unusual
interstrand base stacking interaction occurs between the " 2 nt of
the 50-flap strand and the template strand opposite of the " 1 nt.
We had hypothesized that unpairing of the þ 1 and " 1 was
required to move the scissile phosphate to within catalytic
distance of the active site metals3,21,31,32. This new hFEN1-D86N
substrate structure shows instead that basic residues can rotate
dsDNA into the active site with basepairing intact (Fig. 3,
Supplementary Movie 3). Moreover, since the DNA in 3Q8L,
which was the furthest from the active site, lacked a 50-flap or þ 1
phosphate, the DNA movements observed in the hFEN1-R100A
and hFEN1-D86N structures are likely partly a consequence of
either the 50-flap and/or the þ 1 phosphate.
In concert with the DNA rotation in hFEN1-D86N, Tyr40 is in
a different rotamer conformation from all other substrate or
product bound or DNA-free hFEN1 structures (Fig. 3a,b and
Supplementary Movie 3)21,26. This Tyr40 rotamer shift tracks
duplex DNA rotation into the active site. The Tyr ring is fully
stacked on the þ 1 base, and its side chain hydroxyl forms a
hydrogen bond to the þ 1 phosphate. Notably, as duplex DNA is
not shifted close to the catalytic metal in the R100A structure, this
structure may represent a pre-reactive substrate form. Its Tyr40
stacks at a 50! angle with the þ 1 nt and resembles the other
hFEN1 structures, suggesting that the Tyr40 rotamer is linked
Table 1 | X-ray data collection and refinement statistics (molecular replacement).
hFEN1-D86N hFEN1-R100A hFEN1-D233N
Data collection
Space group P 31 2 1 P 31 2 1 P 31 2 1
Cell dimensions
a, b, c (Å) 105.8 105.8 100.7 105.2 105.25 104.1 105.2 105.2 104.5
a, b, g (!) 90 90 120 90 90 120 90 90 120
Resolution (Å) 18.2–2.8 (2.9–2.8) 37.0–2.6 (2.7–2.6) 34.5–2.1 (2.2–2.1)
Rmeas 0.08 (1.0) 0.07 (0.70) 0.09 (0.65)
I/sI 22.7 (1.95) 12.7 (2.9) 73.9 (5.00)
Completeness (%) 1.00 0.98 0.99
Redundancy 8.6 (8.5) 5.2 (5.4) 13.8 (10.4)
Refinement
Resolution (Å) 18.2–2.8 37.0–2.6 34.5–2.1
No. reflections 30,758 (3,031) 34,943 (4,282) 39,092 (3,705)
Rwork/Rfree 0.21/0.26 0.22/0.25 0.18/0.22
No. heavy atoms 3,534 3,703 4,183
Protein/DNA 3,492 3,519 3,545
Sm3þ , Kþ 7 6 9
Water 36 173 625
B-factors 91 64
Protein/DNA 113.97 92 63
Sm3þ , Kþ 144 91.5 93.3
Water 110 77.3 69
R.m.s. deviations
Bond lengths (Å) 0.004 0.005 0.003
Bond angles (!) 0.56 0.60 0.54
Related to Figs 1 and 3.
One crystal was used for each mutant. Values in parentheses are for highest-resolution shell.
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to shifting duplex DNA into a catalytic position. In the
hFEN1-D86N-substrate structure, cap and gateway helices 4
and 5 are shifted 1–3Å towards the dsDNA relative to all other
hFEN1 crystal structures with DNA (Fig. 3b and Supplementary





































































Figure 3 | Three FEN1 crystal structures show threading through the capped gateway. (a) DNA from hFEN1-D86N, hFEN1-R100A, and hFEN1-D233N
structures showed threading not clamping. Tyr40 (stick model) changes its rotamer to track DNA movement through the gateway in the hFEN1-D86N
structure. (b) A protein chain overlay between hFEN1-R100A (outline) and hFEN1-D86N (coloured) highlights how the helical gateway and cap and the
DNA rotate closer together in the hFEN1-D86N complex. See Supplementary Movie 3. (c) The hFEN1-D86N active site revealed a water molecule
positioned for linear attack on the scissile phosphate. Orthogonal views are shown. The 2nd metal position (outlined in black and denoted by Me*) is not
observed in the hFEN1-D86N and is shown by overlaying the protein from the wt-product structure (PDB code 3Q8K). See also Supplementary Figs 1–4,
and Supplementary Movie 4. (d) Protein chain overlay of hFEN1-D86N-substrate (coloured) and wt-product (outline, PDB code 3Q8K) structures shows
that the scissile phosphate is shifted in the active site B2Å (demarked by arrow).
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Close examination of the hFEN1-D86N structure revealed a
water molecule 3.3 Å from the scissile phosphate (Fig. 3c,
Supplementary Fig. 4, and Supplementary Movie 4). This water
is positioned for a linear attack on the scissile phosphate and for
its evident activation by the catalytic metal and the Gly2 at the
FEN1 N terminus, which was proposed to replace the ‘third’
metal in bacteriophage FEN33. Asp233 is 3 Å from the attacking
water and contributes modestly to catalysis; the D233N mutant
has 16-fold reduced but still substantial catalytic activity
compared to mutants of other invariant carboxylates, such as
D181A21 and D86N (Supplementary Fig. 2B). When a second
metal ion is modeled by overlay with the hFEN1-product
structure (PDB code 3Q8K), the structure is reminiscent
of the classical two-metal-ion catalysis34. Moreover, superfamily
conserved and catalytically required21 Lys93 and Arg100
sidechains point towards the scissile phosphodiester bond,
poised to assist metal ion mediated hydrolysis. On the basis of
the hFEN1-R100A structure, Arg100 is also likely essential for
shifting of the scissile phosphate into direct contact with
the catalytic metals. Notably, the scissile phosphate has moved
B1–2Å between hFEN1-D86N-substrate and wt hFEN1-product
(Fig. 3d). An analogous metal movement into more optimal
coordination geometry in an RNaseH-product structure was
proposed to favour product formation35. We cannot exclude a
possible third metal ion as time-resolved experiments on other
enzymes show metals ions can appear and disappear during
reaction36–40.
Together these structures reinforce and extend biochemical
data that suggest that FEN1 checks for the ss 50-flap by threading
it through a tunnel formed between the active site and capped
gateway helices (Fig. 1d)24,41. The substrate structures imply the
50-flap is (1) electrostatically steered through the capped gateway
by conserved basic residues in the gateway and cap and (2)
positioned in an inverted orientation.
Biochemically testing phosphate steering. If the gateway/cap
region basic residues steer the phosphodiester backbone as
implied by the structures, then their mutation should affect
50-flap substrate incision rates. On the basis of the hFEN1-R100A
structure, we mutated three basic residues (Arg103, Arg104 and
Lys132) positioned to guide the phosphodiester backbone and
stabilize the inverted ssDNA orientation (Fig. 1d). We also
mutated Arg129, which is adjacent the other residues and could
act in steering. When the helical cap is structured, Arg129 makes
a long-range electrostatic interaction with a phosphate of
the template strand21, a distance shortened in hFEN1-D86N by
template strand relocation. Strikingly, these four basic residues
are conserved across all FEN1s including yeast and archaeal,
except for the less-specific phage 50 nucleases (Supplementary
Fig. 3). As the helical gateway and cap regions are flexible before
productive DNA binding22,24,26, specific interactions would seem
unlikely during the flap threading process but electrostatic
guidance is possible. Notably, as these side chains range from
10 to 19Å from the target phosphate, they are unlikely to impact
FEN1 activity by aspects other than electrostatic guidance and
substrate-positioning. To test this idea, we mutated them to
alanine or glutamate to either remove the attractive positive
charge or provide a repulsive charge, respectively.
These charge mutations all reduced specific incision activity on
a 50-flap substrate, S5,1 (Fig. 4a), indicating an important
functional role. Under multiple turnover conditions, single
mutations R103A and K132A moderately decreased the reaction
rate relative to wt hFEN1 by 3- and 5-fold, respectively, whereas a
20-fold decrease was observed with either R104A or R129A
(Fig. 4b and Supplementary Fig. 5A,B). These rate decreases
are consistent with a single residue electrostatic guidance
interaction42. Double mutant R104AK132A showed an additive
effect with 200-fold reduced activity and, significantly,
the corresponding repulsive mutant R104EK132E was far
more severely compromised with a rate reduction of 11,000
compared to the wt enzyme. Importantly, the substrate
dissociation constant (Kd) for each of these double mutants was
only modestly raised (Supplementary Fig. 6). This suggests
deficient substrate positioning, not poor binding, as the
major contributing factor to diminished activity. Similarly,
double mutants R103AR129A or R103ER129E showed
























































































Figure 4 | Phosphate steering residue mutants show reduced activity. (a) Schematic of substrates used with fluorescent positions. (b) Comparison of
multiple turnover rates for cleavage of each substrate at 50 nM. Reaction rates for glutamate mutants with S0,1-5OH were too slow to measure accurately,
so threshold values are indicated. See also Supplementary Figs 1, 5 and 6. Error bars are shown as a function of s.e.m., with replicate number given in
Supplementary Fig. 5E.
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without any substantial effect on Kd. Analogous trends in rate
effects were observed under single turnover kinetic conditions
(Supplementary Fig. 5C,D).
Mutating all four gateway/cap residues to glutamate
(‘QUAD-E’ mutant) severely impaired activity (18,000-fold
slower than wt FEN1). Strikingly, the Kd increased only 17-fold
showing the enzyme was folded and capable of substrate
binding. This large rate decrease is remarkable for mutation of
residues not acting in catalysis and distant from the active
site: it resembles the penalty for streptavidin added to
50-biotinylated substrates, which would prevent 5’-flap gate-
way/cap threading24.
If the FEN1 basic cap residues are primarily required for ss
50-flap steering, then their mutation should not be deleterious to
incision activity on an exonucleolytic substrate lacking a 50-flap
but with a 50-phosphate (S0,1-5P; Fig. 4a). This substrate was
hydrolysed sevenfold more slowly than the DF S5,1 by wt hFEN1
(Fig. 4b and Supplementary Fig. 5A,B) showing that threading
the 50-flap facilitates access to the catalytically competent
conformation, as well as being a key mechanism in substrate
selection. For reaction rates expressed relative to wt hFEN1 to
normalize for this sevenfold difference, the gateway mutants all
proved similarly defective on both the exonucleolytic (S0,1-5P)
and endonucleolytic (S5,1) substrates (relative rates given in
Supplementary Fig. 4B). These results unmask a key universal
role for þ 1 phosphate steering in the FEN1 incisions of
both exonucleolytic and endonucleolytic substrates (since this
phosphate is present in both substrates).
Given the results with the exonucleolytic substrate and the
observation that DNA movement towards the active site required
a þ 1 phosphate43, we reasoned that some basic residues were
electrostatically interacting with the þ 1 phosphodiester of
dsDNA to facilitate this movement44. To test this hypothesis,
we measured reaction rates with an analogous exonucleolytic
substrate lacking the 50-phosphate at the þ 1 position (S0,1-5OH;
Fig. 4a). This substrate was bound 20-fold more weakly and
incised 300-fold more slowly than S0,1-5P by wt hFEN1 (Fig. 4b,
Supplementary Figs 4 and 5). These data indicate that
50-phosphate (þ 1 phosphate) interactions stabilize the enzyme-
substrate complex and contribute to catalysis. Combined and
individual mutations of R103A and R129A all decreased incision
rates of S0,1-5OH analogously to the other substrates. However,
R104A, K132A and R104AK132A all processed S0,1-5OH at a
similar rate to wt hFEN1. These results imply that the þ 1
phosphate group functionally interacts with Arg104 and Lys132,
consistent with the phosphate steering hypothesis, but that
Arg103 and Arg129 (along with Arg100 and Lys93) have long-
range interactions to other parts of the DNA substrate, including
the scissile phosphate itself.
A role for phosphate steering in genome stability. To test
the biological importance of the basic cap and gateway residues,
we made equivalent mutations in the helical gateway/cap region
of Rad27, the S. cerevisiae homolog of hFEN1, to analyse their
role in genome integrity in vivo. Alanine or glutamate mutations
were introduced at Rad27 Arg104, Arg105, Arg127 and Lys130;
equivalent to hFEN1 Arg103, Arg104, Arg129 and Lys132,
respectively (Fig. 5a). Growth characteristics of double- or
quadruple-mutant yeast strains were compared to wild type
RAD27 (wt) strain and rad27-D179A (corresponding to human
D181A whose incision rate is given in Supplementary Fig. 2B), a
severely catalytically impaired mutant, which displays an
equivalent phenotype to the rad27 null strain (that is, sensitivity
to hydroxyurea, a replication inhibitor and DNA-damaging UV
light1,45).
Even without exogenous treatment, quadruple glutamate
mutant (Fig. 5a) showed growth inhibition resembling that for
the active site mutant rad27-D179A. Replication stress induced by
hydroxyurea greatly accentuated this effect. Moderate UV
irradiation (100 Jm" 2) was strongly deleterious to both strains,
and higher-dose irradiation (200 Jm" 2) further revealed UV
sensitivity for the double glutamate (2E-1; R105EK130E)
and quadruple alanine (4A) mutants (Fig. 5a). Thus, electrostatic
interactions of gateway/cap basic residues with DNA are critical
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Figure 5 | Phenotypic and DNA repeat expansion defects of Rad27 basic
cap residue mutations in yeast S. cerevisiae. (a) Table of the tested basic
residues in yeast (and their human counterpart) and spot-test (serial
fivefold dilutions) for yeast growth with and without exposure to
hydroxyurea (replication inhibitor) or UV light (DNA-damaging).
(b) Experimental system to measure the rates of large-scale repeat
expansions in yeast. The (GAA)100/(TTC)100 repeat is incorporated into
the intron of an artificially split URA3 gene. Addition of Z10 extra repeats
inhibits reporter’s splicing, which allows cells with repeat expansions to
grow on 5-FOA-containing media. (c) Effect of active site control and
phosphate steering mutations in the RAD27 gene on repeat expansion rates
(error bars represent 95% confidence intervals of calculated expansion
rates). (d) Rad27 protein expression was not substantially altered in the
mutated strains. See also Supplementary Fig. 7 and Supplementary Table 1.
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deleterious effects on cells under replication stress and/or with
damaged DNA.
Rad27 inactivation in yeast stimulates expansion of trinucleo-
tide repeats relevant to human disease46–48. We therefore tested
the effect of phosphate steering mutations on expansion rates of
(GAA)n repeats using our system (Fig. 5b), which contains a
(GAA)100 tract situated in the intron of a Ura3 reporter gene49,50.
Addition of 10 or more repeats to the (GAA)100 tract effectively
blocks splicing, resulting in gene inactivation and rendering the
yeast resistant to 5-fluoroorotic acid (5-FOA). The repeat
expansion rates in the rad27 knockout and in the severely
catalytically impaired D179A active site metal ligand mutant was
increased byB100-fold compared to wt (Fig. 5c,d). Strikingly for
a non-active site mutant, phosphate steering 4E mutant exhibited
a quantitatively similar phenotype. The double glutamate (2E-1,
2E-2) and 4A mutants showed intermediate (B10-fold) increases
in repeat expansion rates. These results match growth
characteristics of these mutants and emphasize the role of
electrostatic interactions of the gateway basic residues with DNA
in repeat-mediated genome instability.
Ligation of unprocessed 50-flaps to the 30-end of the
approaching Okazaki fragment is proposed to cause the elevated
repeat expansions in Rad27 mutants48,51,52. In this scenario, one
expects added repeat lengths to be relatively short: less than the
size of an Okazaki fragment. In fact, the major mutations caused
by disruption of the RAD27 gene in yeast were repeat-related
expansions of 5–108 bases53. Recently, the median size of the
unprocessed 50-flap in S. pombe FEN1 knockout was measured as
89 nts54. Given these numbers, the median expansion size of GAA
repeats in our experimental system should be B30 repeats in
Rad27 mutants.
To define the size distribution of expansion products, we
measured the scale of repeat expansions in wt and Rad27 mutants
described above via PCR (Fig. 6a). In the wt strain, median
expansion size corresponded to 47 triplets49. The rad27 knockout
was different: median expansion size was 32 repeats, and
Kolmogorov-Smirnov (KS) comparison confirms a significant
difference from the wt strain (Po0.001), which agrees with
known flap size in FEN1 knockouts54. The expansion scale in
near-catalytic-dead (D179A) and 4E Rad27 mutants lies between
the wt and knockout mutant: the median is 40 repeats and KS
shows significant difference from wt (Po0.05). Finally, the scale
of expansions in 2E and 4A mutants is greater than wt with
medians from 50 to 66 added repeats. Thus, the 100-fold increase
in expansions (Fig. 5c) in phosphate steering mutants cannot
be explained by an increase in small-scale expansions alone
(caused by simple 50-flap ligation), but is a consequence of larger
expansions. Thus, most expansions in the Rad27 phosphate
steering mutants originate via mechanisms distinct from simple
50-flap ligation (see Discussion). Overall, these Rad27 results
suggest that functional phosphate steering of 50-flaps and dsDNA
is vital for genome integrity: in promoting normal growth,
in response to DNA damage, and in preventing trinucleotide
repeat expansions.
Discussion
We sought to understand the mechanism whereby FEN1s binds
and precisely incises ss-dsDNA junctions yet excludes hydrolysis
of continuous DNA substrates, reasoning that this specificity
was key to FEN1 functions during replication and repair.
These investigations resolve controversies and improve our
understanding of how FEN1-DNA interactions provide specificity
and genome stability.
First, elucidation of a 50-flap DNA threaded through the helical
gateway/cap answers a longstanding question in eukaryotic FEN1
function and explains the selection of 50-flap substrates with
free 50-termini. Although threading occurs in other enzymes,
phosphate steering and inverted threading are extraordinary. For
example, bacteriophage T5 50-nuclease threads substrates29, but
positions the 50 flap primarily through hydrophobic interactions
to the 50 flap nucleobases. The phosphodiester is closer to the
metals than the nucleobases, consistent with its lower incision site
specificity and tendency to cleave within the ssDNA 50-flap. In
other enzymes, threading selects for free ss 50-termini that will
undergo incision and there is no inversion. However, FEN1
preserves, rather than degrades, the threaded nucleic acid.
Second, our results uncover an essential function in FEN1
specificity and catalysis for phosphate steering, which we
define as electrostatic interactions that dynamically control
the phosphodiester backbone. The parallel effects of steering

























































































































Figure 6 | FEN1 phosphate steering is essential for lagging strand
precision at DNA repeats. (a) Graphed distributions of repeat expansion
lengths shows that the majority of expansions in the wt, phosphate steering
and D179A Rad27 mutants are 430 repeats. The numbers of added
repeats in each strain are shown as scatter plots alongside box-and-whisker
plots with 5 and 95% whiskers. The number of colonies tested are given in
the parentheses. (b) Two models for repeat expansions driven by the
presence of an unprocessed 50-flap. In model 1 (left panel) the repeat on the
50-flap ligates to the 30-end of the oncoming Okazaki fragment followed by
its equilibration into a loop. After the next round of replication, up toB30
repeats can be added (see text for details). In model 2 (right panel), the 50-
flap folds back forming a triplex, which blocks Pol(d) DNA synthesis along
the lagging strand template and promotes its switch to the nascent leading
strand. This template switch mechanism explains the accumulation of
large-scale repeat expansions 430 repeats.
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(that is, on substrates with or without a 50-flap) indicated
involvement of basic gateway/cap residues in a rate-limiting step
in the FEN1 catalytic pathway, that is, in moving the target
phosphodiester bond from the ss-ds junction onto catalytic metal
ions. Thus, phosphate steering may act in orienting the ss 50-flap
during threading (negative design to avoid off-target reactions)
and moving the scissile phosphate into catalytic distance of the
metals (positive design to enhance target reactions) (Fig. 7a).
Notably, steering residue Arg104, is semiconserved throughout
the superfamily suggesting that phosphate positioning occurs in
other members.
Third, the proposed requirement for double base unpairing
for the dsDNA to reach the active site metal ions3 needs
re-evaluation. Our observation of basepaired DNA contacting an
active site metal ion with a water molecule positioned for in-line
attack, would generate the arrangement for ‘two-metal-ion’
catalysis. This basepaired catalytically competent conformation
appears at odds with spectroscopic characterization of FEN1 and
GEN1 substrate complexes19,32,44, and the inability of FEN1 to
process duplexes cross-linked at the terminal basepair31,55,
consistent with an unpairing mechanism. Yet, the DNA
distortion seen in structures here (Supplementary Fig. 2E)
provides an alternative explanation implying dsDNA can
remain basepaired and roll onto the active site metal ions aided
by Tyr40 rotation and by positive side chains on the helical
gateway and cap.
Whereas replication fidelity is canonically based on sequence, it
furthermore depends on sequence-independent specificity in
FEN1. Importantly, structural elements critically involved in
FEN1 function, including phosphate steering and inverted
threading, require key residues distant from the active site metal
ions. Indeed, clinically relevant FEN1 mutations compiled by
The Cancer Genome Atlas (TCGA) and others5,56,57 map to these
structural elements (Fig. 7b). So, although tumour mutation data
has been called ‘a bewildering hodgepodge of genetic oddities’58,
for FEN1, there is a clear link of structurally-mapped mutations
to compromised function, genomic instability and cancer.





















































Figure 7 | Multiple motifs for FEN1 substrate recognition and hydrolysis ensure accurate incision activity and prevent genomic instability.
(a) Schematic model of the FEN1 mechanism emphasizing the functional role of phosphate steering in the dynamic processes of 50-flap inverted threading
and shifting of the duplex DNA towards the catalytic metals. (b) Tumour-associated mutations from breast, lung, skin, kidney, colorectal, ovarian and
testicular cancers map to functionally-important structural motifs: dsDNA binding (P269L, L263H, R245G/W, R70L and R73G), 30-flap binding (Leu53ins,
A45V, S317F, E318V and R320Q), helical gateway/cap (I39T, Q112R and A119V) or active site (A159V).
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tiny off target activity risks toxicity and genomic instability, and
replication mutations account for two-thirds of the mutations in
human cancers59.
We uncovered a role for phosphate steering in triplet (GAA)n
repeat expansions, that also implicates template switching from
the lagging strand due to FEN1 defects. Most expansions in
Rad27 phosphate steering mutants were large-scale (430 repeats;
Fig. 6a) which is difficult to explain by the canonical flap-ligation
model for repeat instability46,48,51,60. In this model, an
unprocessed 50-flap is ligated to the 30-end of the approaching
Okazaki fragment (Fig. 6b, left), limiting the length of expansions
to the size of those flaps. Recently, the median size of the 50-flap
in a FEN1 knockout was found to be 89 nts54, that is,B30 triplet
repeats. Since median expansion size in phosphate steering
mutants is 430 repeats, we propose that besides a flap-ligation
model, a template switch between nascent repetitive strands
occurs as a replication fork stumbles through the repeat
sequence50 (Fig. 6b, right). Unprocessed (TTC)n 50-flaps of the
Okazaki fragments may form a stable triplex61 with the
downstream repetitive run. This could block displacement
synthesis by the lagging strand polymerase62 and prompt it to
search for a new template. Large-scale repeat expansions would
then occur when the polymerase switches template—continuing
DNA synthesis along the nascent leading strand. As a starting
repeat gets longer, larger expansions become feasible, consistent
with the progressive increase in expansion amplitudes with the
length of original repeat tract, as observed in human pedigrees63.
The profound stimulation of large-scale expansions in the
phosphate steering mutants unexpectedly sheds light on the
molecular mechanism of template switching. A priori, either a
nascent leading strand can switch onto the nascent lagging strand
to use it as a template49,50, or the nascent lagging strand can
switch onto the nascent leading strand serving as a template47.
Since it is the lagging strand synthesis and specifically Okazaki
fragment maturation that are unraveled in Rad27 mutants, the
sheer magnitude of their effects on large-scale repeat expansions
implies that the lagging strand likely switches onto the nascent
leading strand accounting for the repeat instability, and this
merits further biochemical investigation. Another question
emerges from biochemical studies of FEN1 functions during
long-patch base excision repair where expansions occur on
dysregulation of DNA handoffs from polymerase b to FEN1 (ref.
64), which suggests studies to investigate whether phosphate
steering may prevent expansions during long-patch repair.
In summary, we find FEN1 phosphate steering energetically
promotes dsDNA rotation into the active site and inverted
threading of the 50-flap to enforce efficiency and fidelity in
replication and repair. Interestingly, elevated FEN1 expression
safeguards against repeat instability in somatic tissues6.
Phosphate steering mutations could thus be the trans-modifiers
of repeat expansions during either somatic, or intergenerational
transmissions in human disease65. Moreover, as the basic residues
implicated in phosphate steering are largely conserved in the
50-nuclease superfamily, control over the þ 1 and " 1
phosphates may be a superfamily-conserved mechanism.
Methods
Site-directed mutagenesis. Plasmids for expression of mutant proteins were
prepared from either the pET29b-hFEN1D336(wt) or pET28b-hFEN1-(His)6
constructs, as indicated above, following the protocol outlined in the QuikChange
site-directed mutagenesis kit (Agilent Technologies, Inc.). Mutagenic primers were
purchased from Fisher Scientific, with desalting, then reconstituted in ultrapure
water and used as supplied. Mutagenic primer sequences were as follows: D86N,
50-ggcggcttgccattaaagacatacacgggctt-30 and 50-aagcccgtgtatgtctttaatggcaagccgcc-30 ;
R103A, 50-caaacgcagtgaggcgcgggctgaggca-30 and 50-tgcctcagcccgcgcctcactgcgtttg-30 ;
R103E, 50-ccaaacgcagtgaggagcgggctgaggcag-30 and 50-ctgcctcagcccgctcctcactgcgtt
tgg-30; R104A, 50-ctctgcctcagccgcccgctcactgcgt-30 and 50-acgcagtgagcgggcggctgaggc
agag-30; R104E, 50-acgcagtgagcgggaggctgaggcagag-30 and 50-ctctgcctcagcctcccgctcac
tgcgt-30 ; R129A, 50-ttagtgaccttcaccagcgccttagtgaatttttccacctc-30 and 50-gaggtggaaaaa
ttcactaaggcgctggtgaaggtcactaa-30; R129E, 50-ttagtgaccttcaccagctccttagtgaatttttccac
ctc-30 and 50-gaggtggaaaaattcactaaggagctggtgaaggtcactaa-30 ; K132A, 50-cactaagcgg
ctggtggcggtcactaagcagcac-30 and 50-gtgctgcttagtgaccgccaccagccgcttagtg-30 ; K132E,
50-gctgcttagtgacctccaccagccgcttagt-30 and 50-actaagcggctggtggaggtcactaagcagc-30;
R103ER104E, 50-gcttctctgcctcagcctcctcctcactgcgtttggcca-30 and 50-tggccaaacgcagtga
ggaggaggctgaggcagagaagc-30 ; R129EK132E, 50-gtgctgcttagtgacctccaccagctccttagtgaa
tttttccacc-30 and 50-ggtggaaaaattcactaaggagctggtggaggtcactaagcagcac-30 .
Protein expression. Plasmids encoding R100AD336 and D233ND336 human
FEN1 for crystallography were generated by site-directed mutagenesis from the
pET29b-hFEN1D336(wt) construct bearing a PreScission protease site and
(His)6-tag after residue 336 of the wt sequence21. Full length wt hFEN1 was
encoded using the pET28b-hFEN1-(His)6 vector reported previously12, and all
reported mutants were generated from this by site-directed mutagenesis. Proteins
were expressed in Rosetta (DE3)pLysS competent cells grown in 2#YT media or
Terrific Broth to an OD600 of 0.6–0.8 at 37 !C then induced by addition of 1mM
IPTG, followed by incubation at 18 !C for 18–24 h. Cells were collected by
centrifugation at 6,000 g/4 !C, washed with PBS, then resuspended in buffer IMAC-
A1 (20mM Tris pH 7.0, 1.0M NaCl, 5mM imidazole, 0.02% NaN3, 5mM
b-mercaptoethanol supplemented with SIGMAFAST protease inhibitor tablets and
1mgml" 1 chicken egg white lysozyme). Each suspension was kept on ice for 2 h
then stored frozen at " 20 !C until further processing, as detailed below.
Purification of hFEN1 D86ND336 and R100AD336 and D233ND336. All steps
were carried out at 4 !C. Chromatography was on an A¨KTA system with flow rate
of 5.0mlmin" 1 unless stated otherwise. Columns were from GE Healthcare,
unless stated otherwise. Frozen lysates were thawed on ice and homogenized by
sonication. Next, 0.1 volume of a 10% v/v TWEEN 20 solution was added. The
mixture was clarified by centrifugation at 30,000 g for 30min. Supernatant was
loaded onto a Ni-IDA affinity column, which was then washed with 5 column
volumes (CV) of buffer IMAC-A1, 5 CV of buffer IMAC-A2 (20mM Tris pH 7.0,
0.5M NaCl, 40mM imidazole, 0.02% NaN3, 0.1% v/v TWEEN 20, 5mM
b-mercaptoethanol). FEN1 was eluted with 5 CV of buffer IMAC-B1 (250mM
imidazole pH 7.2, 0.5M NaCl, 0.02% NaN3, 5mM b-mercaptoethanol). Pooled
fractions were diluted 1:5 with water and then loaded onto a HiPrep Heparin FF
16/10 column. The column was washed with 5 CV buffer HEP-A1 (25mM Tris
pH 7.5, 1mM CaCl2, 0.02% NaN3, 20mM b-mercaptoethanol). FEN1 was eluted
with a linear gradient of 100% HEP-A1 to 100% HEP-A2 (25mM Tris pH 7.5,
1mM CaCl2, 1.0M NaCl, 0.02% NaN3, 20mM b-mercaptoethanol) in 20 CV.
Pooled FEN1 fractions were diluted by slow addition of two volumes of 3.0M
(NH4)2SO4 at 4 !C. The solution was loaded onto a HiPrep Phenyl FF (high sub)
16/10 phenylsepharose column. The column was washed with 7 CV buffer P/S-B1
(25mM Tris pH 7.5, 2.0M (NH4)2SO4, 2mM CaCl2, 0.02% NaN3, 20mM
b-mercaptoethanol). FEN1 was eluted with a gradient of 100% P/S-B1 to 100%
P/S-A1 (25mM Tris pH 7.5, 10% v/v glycerol, 1mM CaCl2, 0.02% NaN3, 20mM
b-mercaptoethanol) in 20 CV. Pooled fractions were concentrated toB7ml using
an Amicon stirred cell (Merck Millipore), then passed through 5# 5ml HiTrap
Desalting columns arranged in tandem, injected in 1.5ml portions. The desalting
columns were equilibrated in 1#TBS supplemented with 1mM EDTA and 1mM
DTT, and eluted with the same buffer. Combined protein-containing eluent
(35–40ml) was treated with PreScission protease (20 ml of activity 10U ml" 1) and
incubated at 4 !C overnight. Complete cleavage of the (His)6 tag was verified by
SDS-PAGE, then the protein solution concentrated to 5ml using a Vivaspin
20 Centrifugal Concentrator (10,000 MWCO). A final purification step at a
0.5mlmin" 1 flow rate with a Sephacryl S-100 HR column, equilibrated with 2 CV
of 2# SB (100mM HEPES pH 7.5, 200mM KCl, 2mM CaCl2, 10mM DTT, 0.04%
NaN3). FEN1 fractions were pooled and the protein concentration determined by
A280, using the calculated OD280. The solution was concentrated to4200 mM using
a Vivaspin 20 Centrifugal Concentrator (10,000 MWCO). Finally, the solution was
mixed 1:1 v/v with cold glycerol, placed on a roller mixer until homogenous,
then divided into 1ml aliquots and stored as a 100 mM stock solution at " 20 !C.
Crystallography of mutant FEN1-DNA complexes. hFEN1 mutants were
crystallized with DF substrates (S5,1) or (S4,1) of slightly different sequence
(desalted purity from IDT, Supplementary Fig. 1). hFEN1-D86ND336
(19mgml" 1) was mixed in volumetric ratio 1:2:1 with 4.25mM SmSO4,
and 1.3mM substrate S5,1-D86N. This mixture was in turn combined 1:1 with 12%
mPEG 2,000, 20% saturated KCl, 5% ethylene glycol, 100mM HEPES pH 7.5.
Crystals were collected after 5 days at 15 !C. hFEN1-R100AD336 (19mgml" 1)
was mixed in volumetric ratio 1:2:1 with 3.75mM SmSO4, and 1.3mM substrate
S4,1-R100A. This mixture was in turn combined 1:1 with 22% mPEG 2000, 20%
saturated KCl, 5% ethylene glycol, 100mM HEPES pH 7.5. Crystals were collected
afterB3 weeks at 15 !C. hFEN1-D233ND336 (8.2mgml" 1) with 1.6mM SmSO4,
0.25mM substrate S4,1-D233N was mixed 1:1 with 24% mPEG 2000, 20% satu-
rated KCl, 5% ethylene glycol, 100mM HEPES pH 7.5. hFEN1-D86N data was
collected at 0.98 Å (SSRL beamline 12-2) and processed with HKL2000. hFEN1-
R100A data was collected at 0.98 Å (SSRL beamline 9-2) and processed with XDS.
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hFEN1-D233N data was collected at 1.12Å (ALS beamline 12.3.1) and processed
with HKL2000. hFEN1-D86N, hFEN1-R100 and hFEN1-D233N crystals diffracted
to 2.8, 2.65 and 2.1 Å, respectively. Structures were solved by molecular replace-
ment using PHASER66 with human FEN1 protein as the search model and refined
in PHENIX67 with rounds of manual rebuilding in COOT68. For hFEN1-R100A,
we refined the model using higher diffraction data to 2.1 Å, based on the theory
that cutting off resolution at an arbitrary point leads to series termination errors.
Flexible regions became more visible and we could follow the path of the 50-flap
more easily. The R and Rfree measures dropped substantially. We used a higher
resolution structure (PDB code: 3Q8K) for reference in refinement. For the three
structures, anomalous differences from the Sm3þ atoms were used in refinement
and modelling. In the active sites of the hFEN1-D86N, hFEN1-R100A and hFEN1-
D233N structures there were, respectively, one, three and four Sm3þ atoms, with
partial occupancy. For all structures, there were no Ramachandran outliers. For
hFEN1-D86n, 95% were favoured and 5% were allowed. For hFEN1-R100A, 96%
were favoured and 4% were allowed. For hFEN1-D233N, 98% were favoured and
2% were allowed. Structure figures were created in PyMol (Schro¨dinger, LLC).
Movies were created in Chimera69.
Protein purification of full-length FEN1 proteins. All steps were carried out
using an A¨KTA FPLC system at 4 !C, at a flow rate of 5.0mlmin" 1 unless stated
otherwise. Frozen/thawed lysates were loaded onto a Ni-IDA column, followed by
washing with 4 CV buffer IMAC-A1, 4 CV buffer IMAC-A2, a gradient of 100%
IMAC-A2 to 100% IMAC-B1 in 2 CV, then 4 CV IMAC-B1. Pooled fractions were
diluted 1:1 with 20mM b-mercaptoethanol and loaded onto a 5ml HiTrap Q FF
column to remove nucleic acid contamination, with a 20 CV elution gradient from
0 to 1.0M NaCl in 20mM Tris pH 8.0, 1mM EDTA, 0.02% NaN3, 20mM
b-mercaptoethanol. The flow-through containing FEN1 was diluted 1:4 with
20mM b-mercaptoethanol and passed through the HiPrep Heparin FF 16/10
column as above. The purified FEN1 was exchanged into 2# SB using a HiPrep
26/10 Desalting column, concentrated and prepared for storage as detailed above.
Proteins requiring further purification (wt hFEN1 and D233N) were passed
through the HiPrep Phenyl FF (high sub) 16/10 phenylsepharose column, as above.
Protein-containing fractions were pooled and concentrated to 5ml using an
Amicon stirred cell, subjected to gel filtration and prepared for storage as
outlined above.
Oligonucleotide synthesis. The DNA oligonucleotides used for crystallization
(Supplementary Fig. 1) were purchased from IDT as desalted oligonucleotides.
They were resuspended in 10mM HEPES 7.5, 50mM KCl, 0.5mM EDTA and
annealed at B1–2mM. The DNA oligonucleotides used to construct the kinetic
substrates (Supplementary Fig. 1) were purchased from DNA Technology A/S
(Denmark) with HPLC purification. Except for E1 and E2 (Supplementary
Fig. 1A), the oligonucleotides as supplied were reconstituted in ultrapure water
and concentrations of stock solutions determined using calculated extinction
coefficients (OD260). Oligonucleotides E1 and E2 required additional HPLC
purification, which was carried out using an OligoSep GC cartridge (Transgenomic;
#NUC-99–3860) using buffers A (100mM triethylammonium acetate pH 7.0,
0.025% v/v acetonitrile) and B (100mM triethylammonium acetate pH 7.0, 25%
acetonitrile) and a gradient of 5–50% B over 18min, at 50 !C and a flow rate of
1.5mlmin" 1. Purified oligonucleotide in solution was loaded onto a 5ml HiTrap
DEAE FF column equilibrated with 3 CV of buffer C (10mM Tris pH 7.5, 100mM
NaCl, 1mM EDTA, 0.02% NaN3). The column was washed with a further 3 CV of
buffer C, then eluted using a step gradient of 100% buffer C-100% buffer D (10mM
Tris pH 7.5, 1.0M NaCl, 1mM EDTA, 0.02% NaN3) in 3 CV. Fractions containing
DNA were desalted into ultrapure water using NAP-25 columns. Desalted samples
were dried then reconstituted as above. DNA constructs were annealed in 1# FB
(50mM HEPES pH 7.5, 100mM KCl) for at least 5min at 95 !C, then left at
ambient temperature for 30min.
FRET binding assay. Values for Kd were obtained using sequential titration of the
appropriate enzyme into a 10 nM solution of the appropriate DNA construct,
according to the reported protocol44. FRET efficiencies (E) were determined using
the (ratio)A method by measuring the enhanced acceptor fluorescence at 37 !C.
The steady state fluorescent spectra of 10 nM non-labelled (NL) trimolecular,
donor-only labelled (DOL) and doubly labelled (DAL) DNA substrates
(Supplementary Fig. 1A,B) were recorded using a Horiba Jobin Yvon FluoroMax-3
fluorometer. For direct excitation of the donor (fluorescein, DOL) or acceptor
(TAMRA, AOL), the sample was excited at 490 nm or 560 nm (2 nm slit width) and
the emission signal collected from 515–650 nm or 575–650 nm (5 nm slit width).
Emission spectra were corrected for buffer and enzyme background signal by
subtracting the signal from the NL DNA sample. In addition to 10 nM of the
appropriate DNA construct, samples contained 10mM CaCl2 or 2mM EDTA,
110mM KCl, 55mM HEPES pH 7.5, 0.1mgml" 1 bovine serum albumin and
1mM DTT. The first measurement was taken before the addition of protein with
subsequent readings taken on the cumulative addition of the appropriate enzyme in
the same buffer, with corrections made for dilution. Transfer efficiencies (E) were
determined according to equation (1), where FDA and FD represent the fluorescent
signal of the DAL and DOL DNA at the given wavelengths, respectively (for
example, FDA(lDEX, lAEM), denotes the measured fluorescence of acceptor
emission on excitation of the donor, for DAL DNA); eD and eA are the molar
absorption coefficients of donor and acceptor at the given wavelengths; and
eD(490)/eA(560) and eA(490)/eA(560) are determined experimentally from the
absorbance spectra of DAL and the excitation spectra of singly TAMRA-AOL,
respectively. Energy transfer efficiency (E) was fitted by non-linear regression in the
Kaleidagraph program to equation (2), where Emax and Emin are the maximum and
minimum energy transfer values, [S] is the substrate concentration, [P] is the
protein concentration and Kbend is the bending equilibrium dissociation constant of
the protein substrate [PS] complex.
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Donor (fluorescein) was excited at 490 nm with emission sampled as the
average value of the signal between 515 and 525 nm, and acceptor (TAMRA) was
excited at 560 nm with emission averaged between 580 and 590 nm.
Multiple turnover rates. Reaction mixtures (final volume 180ml) were prepared
in 1.5ml microcentrifuge tubes with 50 nM final substrate concentration (S5,1;
S0,1-5P; S0,1-5OH; or S0,1-5FAM) and incubated at 37 !C before addition of
enzyme to initiate the reaction. The final composition of each reaction mixture was
1#RB (55mM HEPES pH 7.5, 110mM KCl, 8mM MgCl2, 0.1mgml" 1 BSA)
supplemented with 1mM DTT. Enzyme concentrations were chosen to giveB15%
cleavage after 20min, and any data points showing greater cleavage were discarded
due to effects of substrate depletion. For substrates S5,1 and S0,1-5FAM, aliquots
(20 ml) of each reaction mixture were quenched into 250mM EDTA (50 ml) at
seven different time points—typically 2, 4, 6, 8, 10, 12 and 20min—and reaction
progress monitored by dHPLC analysis using a WAVE system equipped with an
OligoSep cartridge (4.6# 50mm; ADS Biotec). The 6-FAM label was detected by
fluorescence (excitation 494 nm, emission 525 nm) and product(s) separated from
unreacted substrate using the following gradient: 5–30% B over 1min; 30–55% B
over 4.5min; 55–100% B over 1.5min; 100% B for 1.4min; ramp back to 5% B over
0.1min; hold at 5% B for 2.4min, where A is 0.1% v/v MeCN, 1mM EDTA,
2.5mM tetrabutylammonium bromide and B is 70% v/v MeCN, 1mM EDTA,
2.5mM tetrabutylammonium bromide12. Initial rates (v, nMmin" 1) were
determined by linear regression of plots of product concentration versus time and
adjusted for enzyme concentration to give normalized rates (v/[E], min" 1). For
analysis of exonucleolytic activity, reactions with substrates S0,1-5P and S0,1-5OH
were run as above but quenched in 98% deionised formamide containing 10mM
EDTA. Time points and enzyme concentrations were selected to give 10–15%
cleavage at the reaction end point (Z20min). The quenched samples were
analysed by capillary electrophoresis as detailed below, then rates determined and
normalized as above.
Analysis of reaction aliquots by capillary electrophoresis. Capillary electro-
phoresis was performed with the P/ACE MDQ Plus system (Beckman Coultier)
using the ssDNA 100-R Kit (AB SciEx UK Limited; #477480) according to the
manufacturer’s instructions. Briefly, the supplied capillary (ID 100 mm, 30 cm long;
20 cm to detection window) was loaded with the commercially supplied gel using
70 psi of pressure for 5min. The capillary was then equilibrated between two buffer
vials containing Tris-Borate-Urea buffer (AB SciEx UK Limited; #338481) at 3,
5 and 9.3 kV for 2, 2 and 10min, respectively, with a ramp time of 0.17min.
Samples were then run using a 5 s electrokinetic injection preceded by a 1 s plug
injection of deionised water, before separation over 20min with a voltage of 9.3 kV
applied between two buffer vials; runs were carried out at 50 !C with constant
pressure of 40 psi maintained on both sides of the capillary. The gel was replaced
every five sample runs and running buffer was replaced every 20 sample runs. Peak
detection was by laser induced fluorescence (LIF) using an excitation wavelength of
488 nm and a 520 nm filter to measure the emission. The electrophoretograms were
integrated to determine the concentration of product formed at each time point.
Initial rates of reaction (v, nMmin" 1) were then obtained using linear regression,
and converted to the reported normalized rates (v/[E], min" 1) as above.
Single turnover rapid quench experiments. Rapid quench experiments for
determination of single turnover rate were carried out for wt hFEN1 and the
mutants R104A, K132A, R103AR129A and D233N. Reactions were carried out at
37 !C using an RQF-63 device (HiTech Limited, Salisbury, UK)12,70. Premix stock
solutions of enzyme and substrate were prepared at 2# final concentration in
reaction buffer (55mM HEPES pH 7.5, 110mM KCl, 8mM MgCl2, 2.5mM DTT
and 0.1mgml" 1 BSA) and kept on ice until use. For individual reactions, the two
80 ml sample injection loops of the instrument (lines A and B) were filled with
aliquots of enzyme and substrate stock, respectively. The syringe feeding the
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quench line contained 1.5M NaOH, 20mM EDTA. Individual reactions were
carried out using a controlled time delay of between 0.0091 and 51.241 s before
quenching, with final concentrations of 5 nM substrate S5,1 and either 400 nM
or 1,000 nM enzyme, as indicated (Supplementary Fig. 4C,D). Quenched reaction
mixtures were analysed by dHPLC as described above for multiple turnover
reactions, and rates were derived from curves consisting of at least 14 individual
time points. The single turnover rate of the reaction was obtained as the first-order
rate constant (kST) derived using nonlinear least squares regression for a one- or
two-phase exponential in GraphPad Prism 6.05 (GraphPad Software, Inc.). Model
selection was by statistical analysis using Aikake’s Information Criteria (AIC).
Benchtop single turnover experiments. For the remaining proteins—hFEN1
mutants R104AK132A, R103ER129E, R104EK132E, QUAD-E (R103E/R104E/
R129E/K132E) and D181A—reactions to determine single turnover rates were
carried out using manual sampling, as described for the multiple turnover reactions
above, except using 5 nM substrate S5,1 and an enzyme concentration of either
400 nM or 1,000 nM as indicated in each case (Supplementary Fig. 4C,D). A final
reaction volume of 360ml was used, permitting sampling of 14 time points per tube,
which were typically chosen to span a reaction duration of at least 20 half-times.
Quenched samples were analysed by dHPLC as detailed above, then single turnover
rates were derived as described for the rapid quench experiments.
Yeast strain construction. To construct the individual yeast mutants, the
hphMX4 hygromycin resistance marker was first integrated downstream of Rad27,
replacing genomic region ChrXI:224,681–224,712, in a strain containing the
Ura3-(GAA)100 cassette49 derived from parent strain CH1585 (MATa leu2-D1,
trp1-D63, ura3–52, and his3–200). The rate of (GAA)100 expansion in this strain
(designated Rad27-Hyg) was indistinguishable from the wild type strain not
carrying the downstream hphMX4 cassette. Genomic DNA from Rad27-Hyg was
used as a template for PCR with aB100 bp forward primer containing the specific
mutations and a reverse primer downstream of the hphMX4 cassette. These
PCR products were used to transform the wt (GAA)100 strain with selection on
200mgml! 1 hygromycin. Transformants were screened by PCR and/or restriction
digest, and the full-length sequences of the mutated Rad27 alleles were verified by
Sanger sequencing. The length of the starting (GAA)100 tract in the mutant strains
was confirmed by PCR using primers A2 (50-CTCGATGTGCAGAACCTGAAGC
TTGATCT-30) and B2 (50-GCTCGAGTGCAGACCTCAAATTCGATGA-30).
Yeast spot assay. Fivefold serial dilutions were made on an equivalent starting
number of cells for each strain. A 2.5 ml aliquot of each dilution was spotted onto
YPD, YPD with 10mgml! 1 camptothecin, or YPD with 100mM hydroxyurea. For
UV treatment, cells spotted onto YPD were immediately irradiated using a UV
Stratalinker 1,800 (Stratagene).
Fluctuation assay and expansion rates. At least two independent isolates of each
yeast mutant were diluted from frozen stocks and grown for 40 h on solid rich
growth media (YPD) supplemented with uracil. 16 individual colonies (8 per
isolate) were dissolved in 200ml of water and serially diluted. Appropriate dilutions
were plated on synthetic complete media containing 0.09% 5-fluoro-orotic acid
(5FOA) to select for large-scale expansion events or YPD to assess total cell
number. Colonies on each plate were counted after three days of growth. For each
mutant, at least 96 representative 5FOA colonies (8–12 per plate) were analysed for
large-scale GAA expansion via PCR using primers A2 and B2 followed by agarose
gel electrophoresis (1.5% agarose in 0.5X TBE). To determine a true expansion rate
(as opposed to a gene inactivation rate), the number of 5FOA-r colonies counted
per plate was adjusted by the overall percentage of GAA expansion events observed
for that mutant. Expansion rates were calculated using the Ma-Sandri-Sarkar
maximum likelihood estimator method with a correction for plating efficiency
determined as z-1/zln(z), where z is the fraction of the culture analysed (Rosche
and Foster, 2000). PCR product lengths for the calculation of GAA expansion size
were determined using cubic spline interpolation on Total Lab Quant software.
Kolmogorov-Smirnov comparison of expansion lengths between strains was
conducted using SPSS software—non-parametric testing of independent samples.
Genotype information for each strain used is shown in Supplementary Table 1.
Extraction of Rad27 proteins and western blotting. Wt and mutant strains in
mid-log phase (OD600 0.6–0.8, 10mls) were pelleted, washed with water and
frozen. Pellets were resuspended in 150 ml of distilled water, mixed with an equal
volume of 0.6M NaOH with a 10min incubation at room temperature. After low
speed centrifugation (153 g) for 5min, the supernatant was removed and each
pellet resuspended in SDS sample loading buffer (60mM Tris-HCl pH 6.8, 4%
b-mercaptoethanol, 4% SDS, 0.01% bromophenol blue, 5% glycerol). The samples
were boiled for 3min, then 10 ml of each separated by 4–12% SDS–PAGE gel
(Invitrogen) followed by Western blotting using anti-RAD27 goat polyclonal
antibody (1:125 dilution; Santa Cruz Biotechnology, #sc-26719), donkey anti-goat
IgG-HRP secondary antibody (1:2,500; Santa Cruz Biotechnology; #sc-2020) and
visualized using an ECL detection kit (GE Healthcare). A nonspecific band present
in all lanes was used as a loading control (Fig. 5d).
Data availability. Coordinates and structure factors are deposited with the Protein
Data Bank (PDB) under the accession codes: 5UM9 (D86N), 5KSE (R100A), and
5K97 (D233N). The data that support the findings of this study are available from
the corresponding authors on request.
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